ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
GO:0007409,axonogenesis,18/137,455/18888,0.03956043956043956,5.454142937354616,8.220559809231062,5.379074444534641e-9,1.6416935204719723e-5,1.1567841147562389e-5,NTN1/APOE/NGFR/NEFH/LGI1/LMO4/MAP2/SPP1/CXCL12/DRAXIN/B4GALT6/DSCAML1/NDN/GAP43/UNC5D/SEMA5B/RELN/CRABP2,18
GO:0048638,regulation of developmental growth,15/137,330/18888,0.045454545454545456,6.266755142667552,8.250192264353897,1.7840539812097136e-8,2.722466375326023e-5,1.918327517690234e-5,SYT4/NTN1/APOE/AKAP6/BASP1/MAP2/SPP1/CXCL12/CXCR4/IGF2/DRAXIN/NKX2-5/SEMA5B/DIO3/CRABP2,15
GO:0050767,regulation of neurogenesis,16/137,393/18888,0.04071246819338423,5.612971527274754,7.8991332177848275,2.7221260665326704e-8,2.7693095850192367e-5,1.951334580324999e-5,SYT4/LEF1/NTN1/BHLHE41/ASCL1/MAP2/SPP1/CXCL12/IL33/CXCR4/TNF/DRAXIN/SEMA5B/RELN/VEGFC/CRABP2,16
GO:0051960,regulation of nervous system development,17/137,468/18888,0.03632478632478633,5.0080479131574025,7.504825091765852,5.132413301019239e-8,3.8978348327894366e-5,2.7465256823442157e-5,SYT4/LEF1/NTN1/BHLHE41/ASCL1/MAP2/SPP1/CXCL12/IL33/CXCR4/TNF/DRAXIN/TPPP/SEMA5B/RELN/VEGFC/CRABP2,17
GO:0001558,regulation of cell growth,16/137,418/18888,0.03827751196172249,5.277267488562148,7.558761819034012,6.385705820428304e-8,3.8978348327894366e-5,2.7465256823442157e-5,SYT4/NTN1/APOE/GJA1/AKAP6/LGI1/MAP2/SPP1/CXCL12/IGFBP3/CXCR4/NPR1/DRAXIN/SEMA5B/CDKN2A/CRABP2,16
GO:0016049,cell growth,17/137,496/18888,0.034274193548387094,4.725335530963033,7.186564214828066,1.1814193380691824e-7,6.009486366311908e-5,4.234455627500596e-5,SYT4/NTN1/APOE/GJA1/AKAP6/LGI1/MAP2/SPP1/CXCL12/IGFBP3/CXCR4/NPR1/DRAXIN/NDN/SEMA5B/CDKN2A/CRABP2,17
GO:0048588,developmental cell growth,12/137,238/18888,0.05042016806722689,6.95135864564804,7.897592843636545,1.6837407795539055e-7,7.341109798855028e-5,5.172755507712225e-5,SYT4/NTN1/APOE/AKAP6/MAP2/SPP1/CXCL12/CXCR4/DRAXIN/NDN/SEMA5B/CRABP2,12
GO:0060560,developmental growth involved in morphogenesis,12/137,243/18888,0.04938271604938271,6.808326574749931,7.789373459644057,2.1078847733525083e-7,8.041580410339819e-5,5.666327094683124e-5,SYT4/NTN1/APOE/MAP2/SPP1/CXCL12/CXCR4/DRAXIN/NDN/SEMA5B/FGF1/CRABP2,12
GO:0002275,myeloid cell activation involved in immune response,8/137,97/18888,0.08247422680412371,11.370607269169989,8.752752853175233,5.239400157252216e-7,1.7357239682105422e-4,1.2230406522225763e-4,CHGA/PTGDS/SYK/IL33/TNF/S100A13/CD177/NR4A3,8
GO:0048660,regulation of smooth muscle cell proliferation,10/137,174/18888,0.05747126436781609,7.923483513717593,7.842337541292912,5.687168965303219e-7,1.7357239682105422e-4,1.2230406522225763e-4,APOE/GJA1/VIPR2/IGFBP3/MAP3K5/TNF/NPR1/VIP/PDE1A/NR4A3,10
GO:0048659,smooth muscle cell proliferation,10/137,178/18888,0.056179775280898875,7.745427704420568,7.728801550675361,7.007749274509297e-7,1.9443318896183973e-4,1.370031748116985e-4,APOE/GJA1/VIPR2/IGFBP3/MAP3K5/TNF/NPR1/VIP/PDE1A/NR4A3,10
GO:0007411,axon guidance,11/137,234/18888,0.04700854700854701,6.481003181733109,7.211266630025019,1.122491553743641e-6,2.6352647861735325e-4,1.8568827889054725e-4,NTN1/NGFR/LGI1/LMO4/CXCL12/DRAXIN/DSCAML1/GAP43/UNC5D/SEMA5B/RELN,11
GO:0097485,neuron projection guidance,11/137,234/18888,0.04700854700854701,6.481003181733109,7.211266630025019,1.122491553743641e-6,2.6352647861735325e-4,1.8568827889054725e-4,NTN1/NGFR/LGI1/LMO4/CXCL12/DRAXIN/DSCAML1/GAP43/UNC5D/SEMA5B/RELN,11
GO:0061387,regulation of extent of cell growth,8/137,109/18888,0.07339449541284404,10.11879729458247,8.161014256678403,1.2805117793559884e-6,2.791515678996055e-4,1.9669816279881838e-4,NTN1/APOE/MAP2/SPP1/CXCL12/DRAXIN/SEMA5B/CRABP2,8
GO:0033002,muscle cell proliferation,11/137,251/18888,0.043824701195219126,6.042050775002181,6.873621753634009,2.2234215370617274e-6,4.5239216874082614e-4,3.18768435102955e-4,APOE/GJA1/VIPR2/IGFBP3/MAP3K5/TNF/NPR1/NKX2-5/VIP/PDE1A/NR4A3,11
GO:0023061,signal release,15/137,487/18888,0.030800821355236138,4.2464665237788335,6.2041780622797855,2.5957015241699614e-6,4.951300657354201e-4,3.4888277722889676e-4,SYT4/VGF/PTPRN/GJA1/CHGA/GRIK5/SYK/FOXO1/SPP1/CXCL12/TNF/VIP/RIMS3/SLC18A3/MAOB,15
GO:0001649,osteoblast differentiation,11/137,257/18888,0.042801556420233464,5.900991223834815,6.761794384203146,2.793615370498951e-6,5.015361241625175e-4,3.5339666885011496e-4,LEF1/GJA1/ACHE/FAM20C/SPP1/IGFBP3/TNF/IGF2/CEBPD/WWTR1/VEGFC,11
GO:0050966,detection of mechanical stimulus involved in sensory perception of pain,4/137,15/18888,0.26666666666666666,36.76496350364964,11.844384645012067,3.398270150929705e-6,5.761955833687478e-4,4.060038548742332e-4,TRPA1/CXCL12/CXCR4/TNF,4
GO:0048639,positive regulation of developmental growth,9/137,169/18888,0.05325443786982249,7.342115492592753,7.078899284802144,3.994706225434202e-6,6.416759684223781e-4,4.521432032444362e-4,SYT4/NTN1/AKAP6/BASP1/CXCL12/CXCR4/IGF2/DIO3/CRABP2,9
GO:0050679,positive regulation of epithelial cell proliferation,10/137,219/18888,0.045662100456621,6.295370462953704,6.737324028516738,4.549848512753882e-6,6.943068830462424e-4,4.892284479766411e-4,PTPRN/CXCL12/TNF/IGF2/NKX2-5/VIP/ODAM/VEGFC/FGF1/NR4A3,10
GO:1990138,neuron projection extension,9/137,177/18888,0.05084745762711865,7.010268464678957,6.866913266022267,5.826278384507743e-6,8.467524585484586e-4,5.966459518571087e-4,SYT4/NTN1/APOE/MAP2/CXCL12/CXCR4/DRAXIN/NDN/SEMA5B,9
GO:0021700,developmental maturation,12/137,341/18888,0.03519061583577713,4.851681400774879,6.135080516743,7.294047710424141e-6,0.001011883346009749,7.130018886314124e-4,PTPRN/GJA1/ASCL1/SHANK1/SPINK5/C3/FAM20C/IL15/CDKN1C/SIX3/B4GALT6/RELN,12
GO:0042063,gliogenesis,12/137,346/18888,0.03468208092485549,4.781570397873507,6.068222654754404,8.447523833607427e-6,0.0010824101319518646,7.626970751112848e-4,LEF1/NTN1/ASCL1/IL33/CXCR4/TNF/B4GALT6/NDN/TPPP/GAP43/RELN/VEGFC,12
GO:0050678,regulation of epithelial cell proliferation,13/137,407/18888,0.03194103194103194,4.403665775928549,5.933499850286948,8.511744156895397e-6,0.0010824101319518646,7.626970751112848e-4,APOE/PTPRN/NGFR/CXCL12/TNF/IGF2/CDKN1C/NKX2-5/VIP/ODAM/VEGFC/FGF1/NR4A3,13
GO:0002274,myeloid leukocyte activation,10/137,241/18888,0.04149377593360996,5.720689341854197,6.3043311018446255,1.0558667902214922e-5,0.0012890021775023976,9.082677273357932e-4,CHGA/PTGDS/SYK/IL15/IL33/TNF/PTPRC/S100A13/CD177/NR4A3,10
GO:0050673,epithelial cell proliferation,14/137,482/18888,0.029045643153526972,4.004482539297938,5.711406237926297,1.1096933945008246e-5,0.0013026093230832758,9.178557105122204e-4,APOE/PTPRN/NGFR/CXCL12/IGFBP3/TNF/IGF2/CDKN1C/NKX2-5/VIP/ODAM/VEGFC/FGF1/NR4A3,14
GO:0002366,leukocyte activation involved in immune response,11/137,301/18888,0.036544850498338874,5.0383878555666035,6.036930587241233,1.252584695065691e-5,0.0014158846256816626,9.976727220347785e-4,LEF1/CHGA/RORC/PTGDS/SYK/IL33/TNF/PTPRC/S100A13/CD177/NR4A3,11
GO:0002263,cell activation involved in immune response,11/137,305/18888,0.036065573770491806,4.97231063778868,5.9781218982380375,1.4167094364048984e-5,0.0014865303848757626,0.0010474517404639521,LEF1/CHGA/RORC/PTGDS/SYK/IL33/TNF/PTPRC/S100A13/CD177/NR4A3,11
GO:0050804,modulation of chemical synaptic transmission,14/137,493/18888,0.028397565922920892,3.9151330303075174,5.606108498714599,1.4285484439570128e-5,0.0014865303848757626,0.0010474517404639521,SYT4/VGF/APOE/NGFR/ACHE/NEFH/GRIK5/SHANK1/GRIN1/LGI1/TNF/RIMS3/SLC18A3/RELN,14
GO:0099177,regulation of trans-synaptic signaling,14/137,494/18888,0.02834008097165992,3.9072076598008216,5.596686680236139,1.4612028684886264e-5,0.0014865303848757626,0.0010474517404639521,SYT4/VGF/APOE/NGFR/ACHE/NEFH/GRIK5/SHANK1/GRIN1/LGI1/TNF/RIMS3/SLC18A3/RELN,14
GO:0002444,myeloid leukocyte mediated immunity,7/137,112/18888,0.0625,8.616788321167883,6.910491165735987,1.741124745449078e-5,0.001714165394551802,0.0012078498658582228,CHGA/PTGDS/C3/SYK/S100A13/CD177/NR4A3,7
GO:0031960,response to corticosteroid,8/137,156/18888,0.05128205128205128,7.0701852891633905,6.507313489241642,1.837120923456144e-5,0.0017521540807462974,0.0012346177784937178,TRIM63/PTGDS/AKR1C3/TNF/ASS1/PTPRC/MAOB/CPS1,8
GO:0045927,positive regulation of growth,10/137,258/18888,0.03875968992248062,5.343744695297912,6.004782396806513,1.90516561837012e-5,0.0017619895355350324,0.0012415481206794754,SYT4/NTN1/AKAP6/LGI1/BASP1/CXCL12/CXCR4/IGF2/DIO3/CRABP2,10
GO:0043299,leukocyte degranulation,6/137,79/18888,0.0759493670886076,10.4710339092673,7.210371488755425,2.348589040351046e-5,0.0020931845596470254,0.0014749175882454552,CHGA/PTGDS/SYK/S100A13/CD177/NR4A3,6
GO:0048732,gland development,13/137,449/18888,0.028953229398663696,3.991741583079999,5.4841348231449265,2.4004410087695246e-5,0.0020931845596470254,0.0014749175882454552,LEF1/NTN1/GJA1/ASCL1/LMO4/TNF/ASS1/IGF2/CDKN1C/SIX3/NKX2-5/CPS1/FGF1,13
GO:0048675,axon extension,7/137,119/18888,0.058823529411764705,8.109918419922714,6.650389594514101,2.5813745760043903e-5,0.0021884320016570553,0.001542031654613149,NTN1/APOE/MAP2/CXCL12/DRAXIN/NDN/SEMA5B,7
GO:0010720,positive regulation of cell development,13/137,454/18888,0.028634361233480177,3.9477796713720696,5.434288754348885,2.6934554092345906e-5,0.00222173673215783,0.001565499118368782,LEF1/NTN1/ASCL1/SYK/CXCL12/IL15/IL33/CXCR4/TNF/PTPRC/RELN/VEGFC/CRABP2,13
GO:0071695,anatomical structure maturation,10/137,271/18888,0.03690036900369004,5.087402698844507,5.793043374801184,2.9013965006849625e-5,0.002330279505286975,0.0016419814545427641,PTPRN/GJA1/ASCL1/SPINK5/C3/FAM20C/IL15/CDKN1C/SIX3/B4GALT6,10
GO:0010975,regulation of neuron projection development,13/137,460/18888,0.02826086956521739,3.8962868930498256,5.375402015064789,3.086063748621988e-5,0.0024150427078959763,0.001701708026568076,PRRX1/NTN1/APOE/MAP2/SPP1/CXCL12/VLDLR/DRAXIN/RIT2/SEMA5B/RELN/TNIK/CRABP2,13
GO:0043303,mast cell degranulation,5/137,52/18888,0.09615384615384616,13.256597417181359,7.564963016019578,3.687577340346492e-5,0.002757765735392729,0.001943200454372403,CHGA/PTGDS/SYK/S100A13/NR4A3,5
GO:0009266,response to temperature stimulus,8/137,172/18888,0.046511627906976744,6.412493634357494,6.095153686236519,3.7047311648460645e-5,0.002757765735392729,0.001943200454372403,VGF/NGFR/TRPA1/FOXO1/CXCL12/CXCR4/GMPR/FGF1,8
GO:0043269,regulation of monoatomic ion transport,13/137,470/18888,0.027659574468085105,3.813387171921106,5.279426577181642,3.8522722370135044e-5,0.0027971335457653364,0.0019709401372692906,AKAP6/DMD/GRIN1/KCNIP3/UTRN/CXCL12/CXCR4/NKX2-5/VIP/DPP6/MAOB/TF/RELN,13
GO:0045055,regulated exocytosis,9/137,225/18888,0.04,5.514744525547445,5.823220937789779,3.940915546130716e-5,0.0027971335457653364,0.0019709401372692906,SYT4/CHGA/GRIK5/PTGDS/SYK/S100A13/RIMS3/CD177/NR4A3,9
GO:0015844,monoamine transport,6/137,87/18888,0.06896551724137931,9.508180216461112,6.798848890898804,4.069190313299159e-5,0.0028225383718611437,0.0019888411028876033,SYT4/CHGA/SYK/CXCL12/SLC18A3/MAOB,6
GO:0062149,detection of stimulus involved in sensory perception of pain,4/137,28/18888,0.14285714285714285,19.695516162669445,8.462042229844295,4.73755571243842e-5,0.003149833751502621,0.0022194627696488422,TRPA1/CXCL12/CXCR4/TNF,4
GO:0002279,mast cell activation involved in immune response,5/137,55/18888,0.09090909090909091,12.533510285335105,7.321712231761066,4.850661412864455e-5,0.003149833751502621,0.0022194627696488422,CHGA/PTGDS/SYK/S100A13/NR4A3,5
GO:0002448,mast cell mediated immunity,5/137,55/18888,0.09090909090909091,12.533510285335105,7.321712231761066,4.850661412864455e-5,0.003149833751502621,0.0022194627696488422,CHGA/PTGDS/SYK/S100A13/NR4A3,5
GO:0019722,calcium-mediated signaling,9/137,232/18888,0.03879310344827586,5.348351371759376,5.696248314110811,5.000107889441002e-5,0.0031792352663695704,0.0022401799162561327,AKAP6/DMD/GRIN1/TRPA1/SYK/CXCR4/TNF/PTPRC/RIT2,9
GO:0030100,regulation of endocytosis,10/137,291/18888,0.03436426116838488,4.73775302882083,5.492438564948455,5.294031330541044e-5,0.003232304687943079,0.002277574145501728,SYT4/SERPINE1/APOE/C3/SYK/IL15/PTPRC/RIT2/TF/CD177,10
GO:0002455,humoral immune response mediated by circulating immunoglobulin,5/137,56/18888,0.08928571428571429,12.309697601668406,7.244798993665634,5.295387758753406e-5,0.003232304687943079,0.002277574145501728,C3/TNF/PTPRC/CFI/C1S,5
GO:0030516,regulation of axon extension,6/137,92/18888,0.06521739130434782,8.991431291653443,6.567730477676161,5.578329158333685e-5,0.0032616649367665177,0.0022982622148768695,NTN1/APOE/MAP2/CXCL12/DRAXIN/SEMA5B,6
GO:0001659,temperature homeostasis,8/137,183/18888,0.04371584699453552,6.027043197319612,5.841022276526841,5.748973869176261e-5,0.0032616649367665177,0.0022982622148768695,GJA1/ACHE/SYK/FOXO1/IL15/CXCR4/TNF/PDGFC,8
GO:0001764,neuron migration,8/137,183/18888,0.04371584699453552,6.027043197319612,5.841022276526841,5.748973869176261e-5,0.0032616649367665177,0.0022982622148768695,NTN1/GJA1/ASCL1/CXCL12/CXCR4/NDN/UNC5D/RELN,8
GO:0070542,response to fatty acid,5/137,57/18888,0.08771929824561403,12.09373799462159,7.1698190918551425,5.7709667950652674e-5,0.0032616649367665177,0.0022982622148768695,AKR1C3/FOXO1/ASS1/AKR1C1/CPS1,5
GO:0046643,regulation of gamma-delta T cell activation,3/137,11/18888,0.2727272727272727,37.60053085600531,10.378791702860447,5.902961768957141e-5,0.003275607148883126,0.0023080862954984573,LEF1/SYK/PTPRC,3
GO:0008361,regulation of cell size,8/137,188/18888,0.0425531914893617,5.866749495263239,5.73227042844428,6.948960248793789e-5,0.003723146052606159,0.0026234349815390714,NTN1/APOE/MAP2/SPP1/CXCL12/DRAXIN/SEMA5B/CRABP2,8
GO:0003002,regionalization,12/137,429/18888,0.027972027972027972,3.8564647031800314,5.115439821452235,6.953451015679917e-5,0.003723146052606159,0.0026234349815390714,LEF1/BHLHE41/GJA1/ASCL1/BASP1/C3/SIX3/DSCAML1/GREM2/NKX2-5/RELN/FGF1,12
GO:0030308,negative regulation of cell growth,8/137,190/18888,0.042105263157894736,5.804994237418363,5.689860918506045,7.483930450627093e-5,0.003927943517282229,0.0027677411208552093,NTN1/GJA1/MAP2/SPP1/NPR1/DRAXIN/SEMA5B/CDKN2A,8
GO:0019336,phenol-containing compound catabolic process,3/137,12/18888,0.25,34.46715328467153,9.91251753006816,7.828836689191077e-5,0.003927943517282229,0.0027677411208552093,MAOA/MAOB/DIO3,3
GO:0097475,motor neuron migration,3/137,12/18888,0.25,34.46715328467153,9.91251753006816,7.828836689191077e-5,0.003927943517282229,0.0027677411208552093,NTN1/ASCL1/RELN,3
GO:0050769,positive regulation of neurogenesis,9/137,246/18888,0.036585365853658534,5.043973651415346,5.457065616561573,7.850739008984796e-5,0.003927943517282229,0.0027677411208552093,NTN1/ASCL1/CXCL12/IL33/CXCR4/TNF/RELN/VEGFC/CRABP2,9
GO:0055123,digestive system development,7/137,145/18888,0.04827586206896552,6.655726151522779,5.8436255362572105,9.100528283261571e-5,0.004479808438792632,0.003156600896893615,ASCL1/TNF/ASS1/IGF2/CDKN1C/PDGFC/CPS1,7
GO:0051047,positive regulation of secretion,10/137,312/18888,0.03205128205128205,4.418865805727119,5.204905000742486,9.446236395961415e-5,0.004531123444129456,0.0031927589143810713,SYT4/ACHE/SYK/SPP1/CXCL12/NPR1/VIP/SLC18A3/CD177/VEGFC,10
GO:0010977,negative regulation of neuron projection development,7/137,146/18888,0.04794520547945205,6.61013898610139,5.8166326745902035,9.50170053814827e-5,0.004531123444129456,0.0031927589143810713,NTN1/APOE/MAP2/SPP1/DRAXIN/RIT2/SEMA5B,7
GO:1904019,epithelial cell apoptotic process,7/137,147/18888,0.047619047619047616,6.565172054223148,5.789891689111554,9.917163985089794e-5,0.0046564899203837,0.0032810957119900324,SERPINE1/LEF1/AKR1C3/MAP3K5/TNF/SIX3/NKX2-5,7
GO:0042492,gamma-delta T cell differentiation,3/137,13/18888,0.23076923076923078,31.815833801235264,9.500176545003102,1.0123480538842967e-4,0.00468134281887102,0.003298607773661273,LEF1/SYK/PTPRC,3
GO:0050768,negative regulation of neurogenesis,7/137,149/18888,0.04697986577181208,6.477048939401363,5.7371487071089415,1.0792505230032555e-4,0.004843930288538141,0.0034131715456589026,SYT4/NTN1/MAP2/SPP1/TNF/DRAXIN/SEMA5B,7
GO:2000377,regulation of reactive oxygen species metabolic process,7/137,149/18888,0.04697986577181208,6.477048939401363,5.7371487071089415,1.0792505230032555e-4,0.004843930288538141,0.0034131715456589026,GRIN1/AKR1C3/SYK/FOXO1/TNF/AKR1C1/CD177,7
GO:0010469,regulation of signaling receptor activity,6/137,104/18888,0.057692307692307696,7.953958450308816,6.07833004741862,1.1056797834244982e-4,0.0048906299985674905,0.003446077494334477,SERPINE1/CNIH3/SHANK1/TNF/GREM2/RELN,6
GO:0050974,detection of mechanical stimulus involved in sensory perception,4/137,35/18888,0.11428571428571428,15.756412930135557,7.46885700733881,1.1647804423263125e-4,0.004955688804978684,0.0034919197863597473,TRPA1/CXCL12/CXCR4/TNF,4
GO:0071398,cellular response to fatty acid,4/137,35/18888,0.11428571428571428,15.756412930135557,7.46885700733881,1.1647804423263125e-4,0.004955688804978684,0.0034919197863597473,AKR1C3/ASS1/AKR1C1/CPS1,4
GO:0050771,negative regulation of axonogenesis,5/137,66/18888,0.07575757575757576,10.44459190444592,6.569795284345342,1.1691008976358626e-4,0.004955688804978684,0.0034919197863597473,NTN1/MAP2/SPP1/DRAXIN/SEMA5B,5
GO:0010001,glial cell differentiation,9/137,260/18888,0.03461538461538462,4.77237507018529,5.2353772604195505,1.1960547278874071e-4,0.0050004918212498166,0.003523489270474366,LEF1/ASCL1/IL33/CXCR4/TNF/B4GALT6/TPPP/GAP43/RELN,9
GO:0007623,circadian rhythm,8/137,205/18888,0.03902439024390244,5.380238561509703,5.38990294060382,1.2692193649688923e-4,0.005164876669180079,0.0036393195265002763,BHLHE41/NGFR/RORC/PTGDS/TNF/ASS1/BMAL2/NRIP1,8
GO:0048469,cell maturation,8/137,205/18888,0.03902439024390244,5.380238561509703,5.38990294060382,1.2692193649688923e-4,0.005164876669180079,0.0036393195265002763,GJA1/ASCL1/C3/FAM20C/IL15/CDKN1C/SIX3/B4GALT6,8
GO:0045576,mast cell activation,5/137,68/18888,0.07352941176470588,10.137398024903392,6.45203547842523,1.3479360854544266e-4,0.005400779317814076,0.0038055432662944593,CHGA/PTGDS/SYK/S100A13/NR4A3,5
GO:0045807,positive regulation of endocytosis,7/137,155/18888,0.04516129032258064,6.226324464327761,5.584549024094376,1.3802778073050389e-4,0.005400779317814076,0.0038055432662944593,SERPINE1/APOE/C3/SYK/IL15/PTPRC/TF,7
GO:0051961,negative regulation of nervous system development,7/137,155/18888,0.04516129032258064,6.226324464327761,5.584549024094376,1.3802778073050389e-4,0.005400779317814076,0.0038055432662944593,SYT4/NTN1/MAP2/SPP1/TNF/DRAXIN/SEMA5B,7
GO:0010959,regulation of metal ion transport,11/137,394/18888,0.027918781725888325,3.8491237170699177,4.885101020404297,1.430428371779559e-4,0.005480218139687449,0.0038615181276751946,AKAP6/DMD/GRIN1/KCNIP3/UTRN/CXCL12/CXCR4/NKX2-5/VIP/DPP6/TF,11
GO:0050770,regulation of axonogenesis,7/137,156/18888,0.04487179487179487,6.186412128017968,5.559897761550739,1.4364923039809828e-4,0.005480218139687449,0.0038615181276751946,NTN1/MAP2/SPP1/CXCL12/DRAXIN/SEMA5B/CRABP2,7
GO:0062012,regulation of small molecule metabolic process,10/137,331/18888,0.030211480362537766,4.165214898449733,4.965841700015174,1.5319074890940673e-4,0.005688486878676451,0.004008270225955711,APOE/CBFA2T3/RORC/AKR1C3/FOXO1/IGFBP3/TNF/IGF2/FGF1/NR4A3,10
GO:0032922,circadian regulation of gene expression,5/137,70/18888,0.07142857142857142,9.847758081334723,6.339063237110092,1.5470000358130582e-4,0.005688486878676451,0.004008270225955711,BHLHE41/NGFR/RORC/BMAL2/NRIP1,5
GO:2000379,positive regulation of reactive oxygen species metabolic process,5/137,70/18888,0.07142857142857142,9.847758081334723,6.339063237110092,1.5470000358130582e-4,0.005688486878676451,0.004008270225955711,GRIN1/AKR1C3/SYK/AKR1C1/CD177,5
GO:0061043,regulation of vascular wound healing,3/137,15/18888,0.2,27.57372262773723,8.800495272997047,1.5935143257662717e-4,0.005789768716950788,0.004079636300176056,SERPINE1/CXCR4/TNF,3
GO:0048662,negative regulation of smooth muscle cell proliferation,5/137,71/18888,0.07042253521126761,9.709057263287756,6.284267813047729,1.6545842013864932e-4,0.0059409305678018555,0.004186149255024898,APOE/VIPR2/IGFBP3/NPR1/VIP,5
GO:0007389,pattern specification process,12/137,474/18888,0.02531645569620253,3.4903446364224338,4.693578773251955,1.772043765033816e-4,0.006288694849864194,0.004431193894692884,LEF1/BHLHE41/GJA1/ASCL1/BASP1/C3/SIX3/DSCAML1/GREM2/NKX2-5/RELN/FGF1,12
GO:0043410,positive regulation of MAPK cascade,12/137,475/18888,0.02526315789473684,3.482996542451018,4.6847907750878,1.8068417959140844e-4,0.006293536079270313,0.004434605163119698,APOE/GDF6/SYK/IGFBP3/MAP3K5/TNF/IGF2/PTPRC/PDGFC/RIT2/TNIK/FGF1,12
GO:0048545,response to steroid hormone,10/137,338/18888,0.029585798816568046,4.0789530514404175,4.882238787860966,1.814649983537967e-4,0.006293536079270313,0.004434605163119698,TRIM63/PTGDS/AKR1C3/SPP1/TNF/ASS1/PTPRC/MAOB/CPS1/NR4A3,10
GO:0030307,positive regulation of cell growth,7/137,163/18888,0.04294478527607362,5.920737987550938,5.393152325754278,1.8841686355907587e-4,0.006461216489688759,0.004552757566542779,SYT4/NTN1/AKAP6/LGI1/CXCL12/CXCR4/CRABP2,7
GO:0071895,odontoblast differentiation,3/137,16/18888,0.1875,25.85036496350365,8.499890982095158,1.9508509740544377e-4,0.006615552414237938,0.004661507064319551,SERPINE1/LEF1/FAM20C,3
GO:0014015,positive regulation of gliogenesis,5/137,74/18888,0.06756756756756757,9.31544683369501,6.12618966084092,2.0118595431956377e-4,0.00674746739102537,0.004754458122323526,NTN1/IL33/CXCR4/TNF/VEGFC,5
GO:0032488,Cdc42 protein signal transduction,3/137,17/18888,0.17647058823529413,24.32975525976814,8.22558402478323,2.3563359928652965e-4,0.007611015925589208,0.005362939068765521,NTN1/APOE/RIT2,3
GO:0034762,regulation of transmembrane transport,12/137,489/18888,0.024539877300613498,3.3832788500291078,4.5641691967618065,2.3589786101032762e-4,0.007611015925589208,0.005362939068765521,AKAP6/DMD/CNIH3/SHANK1/GRIN1/KCNIP3/UTRN/C3/TNF/DPP6/RELN/NR4A3,12
GO:0009409,response to cold,4/137,42/18888,0.09523809523809523,13.130344108446296,6.726942718192916,2.3940286004474573e-4,0.007611015925589208,0.005362939068765521,VGF/TRPA1/FOXO1/GMPR,4
GO:0042119,neutrophil activation,4/137,42/18888,0.09523809523809523,13.130344108446296,6.726942718192916,2.3940286004474573e-4,0.007611015925589208,0.005362939068765521,SYK/IL15/TNF/CD177,4
GO:0060563,neuroepithelial cell differentiation,4/137,42/18888,0.09523809523809523,13.130344108446296,6.726942718192916,2.3940286004474573e-4,0.007611015925589208,0.005362939068765521,SERPINE1/LEF1/ASCL1/FAM20C,4
GO:0007159,leukocyte cell-cell adhesion,11/137,419/18888,0.026252983293556086,3.619462397435674,4.634757822998874,2.4350640564942792e-4,0.007661665464351072,0.005398628179509292,LEF1/SYK/CXCL12/IL15/TNF/ASS1/IGF2/PTPRC/CARD11/CD177/NR4A3,11
GO:0030856,regulation of epithelial cell differentiation,7/137,171/18888,0.04093567251461988,5.643744397490075,5.2140813050306525,2.5273858030353354e-4,0.00780844088480199,0.005502050330292635,SERPINE1/LEF1/ASCL1/TNF/CDKN1C/WWTR1/PROM1,7
GO:0072009,nephron epithelium development,6/137,121/18888,0.049586776859504134,6.836460155637329,5.505215703427467,2.5328822005091646e-4,0.00780844088480199,0.005502050330292635,BASP1/ADAMTS16/POU3F3/WWTR1/PROM1/FGF1,6
GO:0051048,negative regulation of secretion,7/137,173/18888,0.04046242774566474,5.578498797519091,5.171074528618339,2.7130454370429154e-4,0.008280214673854978,0.005834475608293343,SYT4/APOE/GJA1/CHGA/FOXO1/TNF/MAOB,7
GO:0001819,positive regulation of cytokine production,12/137,500/18888,0.024,3.308846715328467,4.472418265290881,2.8882611236919484e-4,0.00872769598961171,0.00614978371620912,SERPINE1/LUM/C3/SYK/IL15/IL33/TNF/PTPRC/S100A13/CARD11/LTB/NR4A3,12
GO:0007517,muscle organ development,10/137,359/18888,0.027855153203342618,3.840351340910477,4.644327687482564,2.939782601202924e-4,0.008796290685167966,0.006198117496653843,LEF1/GJA1/DMD/UTRN/BASP1/ASS1/IGF2/COL6A3/NKX2-5/ITGA7,10
GO:0051962,positive regulation of nervous system development,9/137,294/18888,0.030612244897959183,4.220467749143452,4.757028606467888,2.9883023814422383e-4,0.008854659095302633,0.006239245544493095,NTN1/ASCL1/CXCL12/IL33/CXCR4/TNF/RELN/VEGFC/CRABP2,9
GO:0019233,sensory perception of pain,5/137,81/18888,0.06172839506172839,8.510408218437416,5.789963782711588,3.072895888513706e-4,0.00887404687675613,0.006252906728706895,TRPA1/CXCL12/CXCR4/TNF/NDN,5
GO:0050806,positive regulation of synaptic transmission,7/137,177/18888,0.03954802259887006,5.452431028083633,5.08703693894476,3.117289875123288e-4,0.00887404687675613,0.006252906728706895,APOE/GRIN1/LGI1/TNF/RIMS3/SLC18A3/RELN,7
GO:0008038,neuron recognition,4/137,45/18888,0.08888888888888889,12.254987834549878,6.461090430857509,3.133646102660416e-4,0.00887404687675613,0.006252906728706895,CXCR4/DSCAML1/NDN/GAP43,4
GO:0021517,ventral spinal cord development,4/137,45/18888,0.08888888888888889,12.254987834549878,6.461090430857509,3.133646102660416e-4,0.00887404687675613,0.006252906728706895,ASCL1/LMO4/VLDLR/RELN,4
GO:0002696,positive regulation of leukocyte activation,10/137,362/18888,0.027624309392265192,3.8085252248255834,4.611809303539541,3.140226286663375e-4,0.00887404687675613,0.006252906728706895,LEF1/SYK/TNFRSF4/IL15/IL33/TNF/IGF2/PTPRC/CARD11/NR4A3,10
GO:0048511,rhythmic process,9/137,297/18888,0.030303030303030304,4.177836761778368,4.7183265083338775,3.219117228580494e-4,0.009013528240025383,0.006351189278599661,PTPRN/BHLHE41/NGFR/RORC/PTGDS/TNF/ASS1/BMAL2/NRIP1,9
GO:0002281,macrophage activation involved in immune response,3/137,19/18888,0.15789473684210525,21.768728390318863,7.741797756603067,3.322299587044701e-4,0.009134827333027413,0.0064366600818703875,SYK/IL33/TNF,3
GO:0045780,positive regulation of bone resorption,3/137,19/18888,0.15789473684210525,21.768728390318863,7.741797756603067,3.322299587044701e-4,0.009134827333027413,0.0064366600818703875,SYK/SPP1/TF,3
GO:0002920,regulation of humoral immune response,4/137,46/18888,0.08695652173913043,11.988575055537924,6.378026977031775,3.4129084723575167e-4,0.00913701461196065,0.006438201301040081,SPINK5/C3/TNF/PTPRC,4
GO:0030517,negative regulation of axon extension,4/137,46/18888,0.08695652173913043,11.988575055537924,6.378026977031775,3.4129084723575167e-4,0.00913701461196065,0.006438201301040081,NTN1/MAP2/DRAXIN/SEMA5B,4
GO:0046633,alpha-beta T cell proliferation,4/137,46/18888,0.08695652173913043,11.988575055537924,6.378026977031775,3.4129084723575167e-4,0.00913701461196065,0.006438201301040081,SYK/IL15/PTPRC/CARD11,4
GO:0072593,reactive oxygen species metabolic process,8/137,238/18888,0.03361344537815126,4.6342390970986935,4.822720725510143,3.499137740921601e-4,0.009286407291558893,0.006543467647325246,GRIN1/AKR1C3/SYK/FOXO1/TNF/MAOB/AKR1C1/CD177,8
GO:0001936,regulation of endothelial cell proliferation,7/137,181/18888,0.03867403314917127,5.331935314755817,5.005514619870294,3.568557418608467e-4,0.009388997622062965,0.0066157557225200525,APOE/NGFR/CXCL12/TNF/IGF2/VIP/VEGFC,7
GO:0032418,lysosome localization,5/137,84/18888,0.05952380952380952,8.206465067778936,5.658044572685094,3.6389141552523084e-4,0.009411835594771226,0.006631848009973655,CHGA/PTGDS/SYK/S100A13/NR4A3,5
GO:1990849,vacuolar localization,5/137,84/18888,0.05952380952380952,8.206465067778936,5.658044572685094,3.6389141552523084e-4,0.009411835594771226,0.006631848009973655,CHGA/PTGDS/SYK/S100A13/NR4A3,5
GO:0009306,protein secretion,10/137,370/18888,0.02702702702702703,3.7261787334780037,4.526762448737083,3.731392023005339e-4,0.009569923070766635,0.0067432409579831105,SYT4/VGF/APOE/PTPRN/ACHE/CHGA/FOXO1/TNF/VIP/VEGFC,10
GO:0035592,establishment of protein localization to extracellular region,10/137,371/18888,0.026954177897574125,3.7161351250319714,4.5162977905583634,3.8114192353972954e-4,0.009693709588693788,0.006830464471856732,SYT4/VGF/APOE/PTPRN/ACHE/CHGA/FOXO1/TNF/VIP/VEGFC,10
GO:0021516,dorsal spinal cord development,3/137,20/18888,0.15,20.68029197080292,7.526848212488725,3.887893348180943e-4,0.009726106966105114,0.0068532925887262,ASCL1/LMO4/DRAXIN,3
GO:0071514,genomic imprinting,3/137,20/18888,0.15,20.68029197080292,7.526848212488725,3.887893348180943e-4,0.009726106966105114,0.0068532925887262,IGF2/CDKN1C/NDN,3
GO:0001503,ossification,11/137,446/18888,0.02466367713004484,3.400346960819613,4.384973763118287,4.1354560339187967e-4,0.010261310419122087,0.007230412218481901,LEF1/GJA1/ACHE/FAM20C/SPP1/IGFBP3/TNF/IGF2/CEBPD/WWTR1/VEGFC,11
GO:0034103,regulation of tissue remodeling,5/137,87/18888,0.05747126436781609,7.923483513717593,5.5325248185650215,4.28043555774013e-4,0.010415427018341495,0.007339007173370929,GJA1/SYK/SPP1/IL15/TF,5
GO:0002700,regulation of production of molecular mediator of immune response,7/137,187/18888,0.0374331550802139,5.160857176314454,4.887657368277115,4.342225964096236e-4,0.010415427018341495,0.007339007173370929,SPINK5/SYK/TNFRSF4/IL33/TNF/PTPRC/NR4A3,7
GO:0036230,granulocyte activation,4/137,49/18888,0.08163265306122448,11.254580664382539,6.143510140453253,4.3574024525587415e-4,0.010415427018341495,0.007339007173370929,SYK/IL15/TNF/CD177,4
GO:0051384,response to glucocorticoid,6/137,134/18888,0.04477611940298507,6.173221483821767,5.136840401363423,4.3812558614701454e-4,0.010415427018341495,0.007339007173370929,TRIM63/PTGDS/TNF/ASS1/MAOB/CPS1,6
GO:0045936,negative regulation of phosphate metabolic process,10/137,378/18888,0.026455026455026454,3.647317807901749,4.444043777280372,4.412695101930441e-4,0.010415427018341495,0.007339007173370929,APOE/CBFA2T3/PPP4R4/DMD/IGFBP3/TNF/CDKN1C/PTPRC/CDKN2A/WWTR1,10
GO:0045926,negative regulation of growth,8/137,247/18888,0.032388663967611336,4.46538018262951,4.685914042399803,4.479567711902649e-4,0.010415427018341495,0.007339007173370929,NTN1/GJA1/MAP2/SPP1/NPR1/DRAXIN/SEMA5B/CDKN2A,8
GO:0015850,organic hydroxy compound transport,9/137,311/18888,0.028938906752411574,3.9897669397047433,4.544219448053552,4.5003968218865404e-4,0.010415427018341495,0.007339007173370929,SYT4/APOE/CHGA/SYK/SPP1/CXCL12/SLC18A3/MAOB/AKR1C1,9
GO:0010563,negative regulation of phosphorus metabolic process,10/137,379/18888,0.026385224274406333,3.637694278065597,4.433861687275661,4.504706311995666e-4,0.010415427018341495,0.007339007173370929,APOE/CBFA2T3/PPP4R4/DMD/IGFBP3/TNF/CDKN1C/PTPRC/CDKN2A/WWTR1,10
GO:0071692,protein localization to extracellular region,10/137,379/18888,0.026385224274406333,3.637694278065597,4.433861687275661,4.504706311995666e-4,0.010415427018341495,0.007339007173370929,SYT4/VGF/APOE/PTPRN/ACHE/CHGA/FOXO1/TNF/VIP/VEGFC,10
GO:0050867,positive regulation of cell activation,10/137,380/18888,0.02631578947368421,3.628121398386477,4.423713904748442,4.598308938334617e-4,0.010479397820530579,0.007384082826565488,LEF1/SYK/TNFRSF4/IL15/IL33/TNF/IGF2/PTPRC/CARD11/NR4A3,10
GO:0045444,fat cell differentiation,8/137,248/18888,0.03225806451612903,4.447374617376972,4.671118908498326,4.60104622526572e-4,0.010479397820530579,0.007384082826565488,GDF6/RORC/FOXO1/TNF/LAMB3/CEBPD/WWTR1/NR4A3,8
GO:1903037,regulation of leukocyte cell-cell adhesion,10/137,382/18888,0.02617801047120419,3.609125998394925,4.403520390372428,4.790374210155473e-4,0.010829794140292226,0.007630982075124858,LEF1/SYK/CXCL12/IL15/TNF/ASS1/IGF2/PTPRC/CARD11/NR4A3,10
GO:0048568,embryonic organ development,11/137,455/18888,0.024175824175824177,3.3330873506055987,4.305942664068306,4.887735785923915e-4,0.010968654131352786,0.007728826788423033,PRRX1/LEF1/NTN1/GJA1/TNF/PHLDA2/IGF2/CDKN1C/SIX3/DSCAML1/NKX2-5,11
GO:0046850,regulation of bone remodeling,4/137,51/18888,0.0784313725490196,10.813224559896952,5.99819406922648,5.08216833752152e-4,0.011321735595704875,0.007977618066505158,GJA1/SYK/SPP1/TF,4
GO:0060004,reflex,3/137,22/18888,0.13636363636363635,18.800265428002653,7.14048087878725,5.196625418459098e-4,0.01147596399224518,0.008086291796977617,GJA1/ASCL1/SHANK1,3
GO:0003012,muscle system process,11/137,459/18888,0.023965141612200435,3.3040408377462906,4.2714486227269735,5.257152986625165e-4,0.01147596399224518,0.008086291796977617,GJA1/AKAP6/CHGA/DMD/TRIM63/UTRN/FOXO1/CXCR4/TNF/NKX2-5/NR4A3,11
GO:0010660,regulation of muscle cell apoptotic process,5/137,91/18888,0.054945054945054944,7.575198524103633,5.3742127165449585,5.264203666167514e-4,0.01147596399224518,0.008086291796977617,FOXO1/MAP3K5/NKX2-5/PDE1A/CDKN2A,5
GO:0001822,kidney development,9/137,319/18888,0.02821316614420063,3.8897100885522735,4.4492305891386295,5.403933552399101e-4,0.011697024965902168,0.008242057668944654,GDF6/BASP1/ADAMTS16/ASS1/CDKN1C/POU3F3/WWTR1/PROM1/FGF1,9
GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,4/137,52/18888,0.07692307692307693,10.605277933745088,5.928527294656051,5.474952554478767e-4,0.01176729239173887,0.008291570102891119,GJA1/MAP3K5/TNF/NR4A3,4
GO:0009581,detection of external stimulus,6/137,140/18888,0.04285714285714286,5.908654848800834,4.982858999616714,5.527380059334473e-4,0.011796897860901268,0.00831243096151662,NGFR/TRPA1/CXCL12/CXCR4/TNF/SEMA5B,6
GO:0042475,odontogenesis of dentin-containing tooth,5/137,93/18888,0.053763440860215055,7.41229102896162,5.298623864172769,5.815474547081719e-4,0.012093533772860276,0.008521449092209954,SERPINE1/LEF1/NGFR/FAM20C/ODAM,5
GO:0002699,positive regulation of immune effector process,8/137,257/18888,0.0311284046692607,4.291629980970774,4.541392568091051,5.819517522984531e-4,0.012093533772860276,0.008521449092209954,C3/SYK/TNFRSF4/IL33/TNF/PTPRC/CD177/NR4A3,8
GO:0048260,positive regulation of receptor-mediated endocytosis,4/137,53/18888,0.07547169811320754,10.405178350089518,5.86073000885597,5.888841554382415e-4,0.012093533772860276,0.008521449092209954,SERPINE1/C3/SYK/TF,4
GO:0050982,detection of mechanical stimulus,4/137,53/18888,0.07547169811320754,10.405178350089518,5.86073000885597,5.888841554382415e-4,0.012093533772860276,0.008521449092209954,TRPA1/CXCL12/CXCR4/TNF,4
GO:0006837,serotonin transport,3/137,23/18888,0.13043478260869565,17.982862583306886,6.965879629899327,5.944508882220001e-4,0.012093533772860276,0.008521449092209954,SYK/SLC18A3/MAOB,3
GO:2000311,regulation of AMPA receptor activity,3/137,23/18888,0.13043478260869565,17.982862583306886,6.965879629899327,5.944508882220001e-4,0.012093533772860276,0.008521449092209954,CNIH3/SHANK1/RELN,3
GO:0062013,positive regulation of small molecule metabolic process,6/137,142/18888,0.04225352112676056,5.825434357972654,4.933507977754133,5.957119561735548e-4,0.012093533772860276,0.008521449092209954,APOE/FOXO1/TNF/IGF2/FGF1/NR4A3,6
GO:0051952,regulation of amine transport,5/137,94/18888,0.05319148936170213,7.3334368690790495,5.261666506411083,6.106823459039023e-4,0.012093533772860276,0.008521449092209954,SYT4/CHGA/CXCL12/TNF/SLC18A3,5
GO:0001894,tissue homeostasis,8/137,259/18888,0.03088803088803089,4.258489981117719,4.51337124364246,6.122881569583854e-4,0.012093533772860276,0.008521449092209954,GJA1/DMD/LDB2/SYK/SPP1/TF/WWTR1/PROM1,8
GO:0006898,receptor-mediated endocytosis,8/137,259/18888,0.03088803088803089,4.258489981117719,4.51337124364246,6.122881569583854e-4,0.012093533772860276,0.008521449092209954,SERPINE1/APOE/ACHE/C3/SYK/VLDLR/LRP1B/TF,8
GO:0060249,anatomical structure homeostasis,8/137,259/18888,0.03088803088803089,4.258489981117719,4.51337124364246,6.122881569583854e-4,0.012093533772860276,0.008521449092209954,GJA1/DMD/LDB2/SYK/SPP1/TF/WWTR1/PROM1,8
GO:0009582,detection of abiotic stimulus,6/137,143/18888,0.04195804195804196,5.784697054770048,4.90918387022989,6.181491705655973e-4,0.012093533772860276,0.008521449092209954,NGFR/TRPA1/CXCL12/CXCR4/TNF/SEMA5B,6
GO:0050671,positive regulation of lymphocyte proliferation,6/137,143/18888,0.04195804195804196,5.784697054770048,4.90918387022989,6.181491705655973e-4,0.012093533772860276,0.008521449092209954,SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,6
GO:0002443,leukocyte mediated immunity,11/137,469/18888,0.023454157782515993,3.233592205811402,4.1868445797489215,6.284240686194165e-4,0.012216243677875535,0.008607913993895192,CHGA/PTGDS/C3/SYK/TNF/PTPRC/S100A13/CFI/C1S/CD177/NR4A3,11
GO:0050900,leukocyte migration,10/137,396/18888,0.025252525252525252,3.4815306348153063,4.265842810955556,6.330433677705985e-4,0.01222815416731561,0.008616306464725734,SERPINE1/CHGA/SYK/CXCL12/IL33/CXCR4/TNF/ITGA7/CD177/VEGFC,10
GO:0045859,regulation of protein kinase activity,11/137,470/18888,0.023404255319148935,3.2267122223947817,4.178509024272992,6.39557588884036e-4,0.012276287806755206,0.008650222800993614,APOE/MAP3K5/TNF/CDKN1C/PTPRC/PDGFC/DLG3/RELN/CDKN2A/WWTR1/FGF1,11
GO:0031099,regeneration,7/137,200/18888,0.035,4.825401459854015,4.648792493978758,6.479585874833103e-4,0.012350185037601344,0.00870229289915829,PRRX1/GJA1/SPP1/CXCL12/TNF/GAP43/NR4A3,7
GO:0031345,negative regulation of cell projection organization,7/137,201/18888,0.03482587064676617,4.80139448741693,4.631276745089029,6.673421805858007e-4,0.012350185037601344,0.00870229289915829,NTN1/APOE/MAP2/SPP1/DRAXIN/RIT2/SEMA5B,7
GO:0008202,steroid metabolic process,9/137,329/18888,0.02735562310030395,3.771481818383511,4.334732019087748,6.737691436120786e-4,0.012350185037601344,0.00870229289915829,APOE/RORC/AKR1C3/SPP1/VLDLR/TNF/APOL1/AKR1C1/FGF1,9
GO:0072001,renal system development,9/137,329/18888,0.02735562310030395,3.771481818383511,4.334732019087748,6.737691436120786e-4,0.012350185037601344,0.00870229289915829,GDF6/BASP1/ADAMTS16/ASS1/CDKN1C/POU3F3/WWTR1/PROM1/FGF1,9
GO:0002922,positive regulation of humoral immune response,3/137,24/18888,0.125,17.233576642335766,6.8019353462760686,6.757801118215676e-4,0.012350185037601344,0.00870229289915829,C3/TNF/PTPRC,3
GO:0046641,positive regulation of alpha-beta T cell proliferation,3/137,24/18888,0.125,17.233576642335766,6.8019353462760686,6.757801118215676e-4,0.012350185037601344,0.00870229289915829,SYK/PTPRC/CARD11,3
GO:0060252,positive regulation of glial cell proliferation,3/137,24/18888,0.125,17.233576642335766,6.8019353462760686,6.757801118215676e-4,0.012350185037601344,0.00870229289915829,NTN1/TNF/VEGFC,3
GO:0061042,vascular wound healing,3/137,24/18888,0.125,17.233576642335766,6.8019353462760686,6.757801118215676e-4,0.012350185037601344,0.00870229289915829,SERPINE1/CXCR4/TNF,3
GO:0001935,endothelial cell proliferation,7/137,202/18888,0.034653465346534656,4.777625207776252,4.613876197277611,6.87183196835351e-4,0.012450266810273775,0.008772813372901056,APOE/NGFR/CXCL12/TNF/IGF2/VIP/VEGFC,7
GO:0032946,positive regulation of mononuclear cell proliferation,6/137,146/18888,0.0410958904109589,5.665833416658334,4.837569830759133,6.894151674103106e-4,0.012450266810273775,0.008772813372901056,SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,6
GO:0045058,T cell selection,4/137,56/18888,0.07142857142857142,9.847758081334723,5.667722613060382,7.263451867473028e-4,0.01294975977871823,0.009124770375912722,SYK/IL15/PTPRC/CARD11,4
GO:2000648,positive regulation of stem cell proliferation,4/137,56/18888,0.07142857142857142,9.847758081334723,5.667722613060382,7.263451867473028e-4,0.01294975977871823,0.009124770375912722,PRRX1/GJA1/PTPRC/VEGFC,4
GO:0010657,muscle cell apoptotic process,5/137,98/18888,0.05102040816326531,7.034112915239088,5.119088495427446,7.382890568469765e-4,0.01294975977871823,0.009124770375912722,FOXO1/MAP3K5/NKX2-5/PDE1A/CDKN2A,5
GO:0021510,spinal cord development,5/137,98/18888,0.05102040816326531,7.034112915239088,5.119088495427446,7.382890568469765e-4,0.01294975977871823,0.009124770375912722,ASCL1/LMO4/VLDLR/DRAXIN/RELN,5
GO:0048534,hematopoietic or lymphoid organ development,5/137,98/18888,0.05102040816326531,7.034112915239088,5.119088495427446,7.382890568469765e-4,0.01294975977871823,0.009124770375912722,LMO4/IL15/PTPRC/NKX2-5/LTB,5
GO:0060562,epithelial tube morphogenesis,9/137,335/18888,0.026865671641791045,3.70393289029306,4.2681610336571305,7.659584234041666e-4,0.013358314904168667,0.009412649979035865,LEF1/NTN1/GJA1/LMO4/ADAMTS16/CXCR4/TNF/NKX2-5/FGF1,9
GO:1901616,organic hydroxy compound catabolic process,4/137,57/18888,0.07017543859649122,9.674990395697272,5.6065964232150485,7.768082447696923e-4,0.01347056115361989,0.009491741890337807,MAOA/AKR1C3/MAOB/DIO3,4
GO:0072080,nephron tubule development,5/137,100/18888,0.05,6.893430656934307,5.050768450458451,8.090938858516577e-4,0.013872778312467748,0.00977515558128289,ADAMTS16/POU3F3/WWTR1/PROM1/FGF1,5
GO:1903035,negative regulation of response to wounding,5/137,100/18888,0.05,6.893430656934307,5.050768450458451,8.090938858516577e-4,0.013872778312467748,0.00977515558128289,SERPINE1/APOE/SPP1/IL33/TNF,5
GO:0120161,regulation of cold-induced thermogenesis,6/137,151/18888,0.039735099337748346,5.47822303862329,4.722519087913911,8.221592314296195e-4,0.013944153217378602,0.009825448376596704,GJA1/ACHE/SYK/IL15/CXCR4/PDGFC,6
GO:0048168,regulation of neuronal synaptic plasticity,4/137,58/18888,0.06896551724137931,9.508180216461112,5.546960508806011,8.296985937779775e-4,0.013944153217378602,0.009825448376596704,SYT4/VGF/APOE/GRIN1,4
GO:0061005,cell differentiation involved in kidney development,4/137,58/18888,0.06896551724137931,9.508180216461112,5.546960508806011,8.296985937779775e-4,0.013944153217378602,0.009825448376596704,BASP1/POU3F3/WWTR1/PROM1,4
GO:0120162,positive regulation of cold-induced thermogenesis,5/137,101/18888,0.04950495049504951,6.825178868251789,5.0173083385830255,8.463382901380706e-4,0.013944153217378602,0.009825448376596704,GJA1/ACHE/SYK/CXCR4/PDGFC,5
GO:0072073,kidney epithelium development,6/137,152/18888,0.039473684210526314,5.442182097579716,4.700123498963048,8.509236496747209e-4,0.013944153217378602,0.009825448376596704,BASP1/ADAMTS16/POU3F3/WWTR1/PROM1/FGF1,6
GO:0106106,cold-induced thermogenesis,6/137,152/18888,0.039473684210526314,5.442182097579716,4.700123498963048,8.509236496747209e-4,0.013944153217378602,0.009825448376596704,GJA1/ACHE/SYK/IL15/CXCR4/PDGFC,6
GO:1903531,negative regulation of secretion by cell,6/137,152/18888,0.039473684210526314,5.442182097579716,4.700123498963048,8.509236496747209e-4,0.013944153217378602,0.009825448376596704,SYT4/APOE/GJA1/CHGA/FOXO1/MAOB,6
GO:0006929,substrate-dependent cell migration,3/137,26/18888,0.11538461538461539,15.907916900617632,6.501885599218843,8.589452178463883e-4,0.013944153217378602,0.009825448376596704,NTN1/PTPRC/VEGFC,3
GO:0016048,detection of temperature stimulus,3/137,26/18888,0.11538461538461539,15.907916900617632,6.501885599218843,8.589452178463883e-4,0.013944153217378602,0.009825448376596704,NGFR/CXCL12/CXCR4,3
GO:0046629,gamma-delta T cell activation,3/137,26/18888,0.11538461538461539,15.907916900617632,6.501885599218843,8.589452178463883e-4,0.013944153217378602,0.009825448376596704,LEF1/SYK/PTPRC,3
GO:0021537,telencephalon development,8/137,275/18888,0.02909090909090909,4.010723291307233,4.298912023097985,9.039194341802473e-4,0.014596624937132882,0.010285198574381762,LEF1/ASCL1/CXCL12/CXCR4/SIX3/DRAXIN/POU3F3/RELN,8
GO:0042098,T cell proliferation,7/137,213/18888,0.03286384976525822,4.530893389534286,4.429693302592039,9.378732005677816e-4,0.014886344688406262,0.010489343380842241,GJA1/SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,7
GO:0014009,glial cell proliferation,4/137,60/18888,0.06666666666666667,9.19124087591241,5.43191273665308,9.430159546288516e-4,0.014886344688406262,0.010489343380842241,NTN1/IL33/TNF/VEGFC,4
GO:0022029,telencephalon cell migration,4/137,60/18888,0.06666666666666667,9.19124087591241,5.43191273665308,9.430159546288516e-4,0.014886344688406262,0.010489343380842241,CXCL12/CXCR4/POU3F3/RELN,4
GO:1903039,positive regulation of leukocyte cell-cell adhesion,8/137,277/18888,0.02888086642599278,3.9817650003952676,4.273247030835642,9.471091076300221e-4,0.014886344688406262,0.010489343380842241,LEF1/SYK/IL15/TNF/IGF2/PTPRC/CARD11/NR4A3,8
GO:0045940,positive regulation of steroid metabolic process,3/137,27/18888,0.1111111111111111,15.318734793187346,6.364052104230637,9.612087857495286e-4,0.014886344688406262,0.010489343380842241,APOE/TNF/FGF1,3
GO:0060669,embryonic placenta morphogenesis,3/137,27/18888,0.1111111111111111,15.318734793187346,6.364052104230637,9.612087857495286e-4,0.014886344688406262,0.010489343380842241,LEF1/IGF2/CDKN1C,3
GO:0019218,regulation of steroid metabolic process,5/137,104/18888,0.04807692307692308,6.6282987085906795,4.919594702892551,9.657589280158716e-4,0.014886344688406262,0.010489343380842241,APOE/RORC/AKR1C3/TNF/FGF1,5
GO:0042102,positive regulation of T cell proliferation,5/137,104/18888,0.04807692307692308,6.6282987085906795,4.919594702892551,9.657589280158716e-4,0.014886344688406262,0.010489343380842241,SYK/IL15/IGF2/PTPRC/CARD11,5
GO:0061326,renal tubule development,5/137,104/18888,0.04807692307692308,6.6282987085906795,4.919594702892551,9.657589280158716e-4,0.014886344688406262,0.010489343380842241,ADAMTS16/POU3F3/WWTR1/PROM1/FGF1,5
GO:0006887,exocytosis,9/137,348/18888,0.02586206896551724,3.565567581172917,4.12902747810871,0.0010012496142430191,0.015355848355124092,0.010820169065847596,SYT4/CHGA/GRIK5/PTGDS/SYK/S100A13/RIMS3/CD177/NR4A3,9
GO:0015837,amine transport,5/137,105/18888,0.047619047619047616,6.565172054223148,4.887877608751499,0.0010082179931599005,0.015385406575620082,0.010840996631714088,SYT4/CHGA/CXCL12/TNF/SLC18A3,5
GO:0048167,regulation of synaptic plasticity,7/137,216/18888,0.032407407407407406,4.467964314679643,4.381629309405861,0.0010174184213831406,0.015448562298812661,0.010885497956982225,SYT4/VGF/APOE/GRIN1/RIMS3/SLC18A3/RELN,7
GO:0072006,nephron development,6/137,158/18888,0.0379746835443038,5.23551695463365,4.569783614981737,0.0010401786488914394,0.01571596651691422,0.01107391860179891,BASP1/ADAMTS16/POU3F3/WWTR1/PROM1/FGF1,6
GO:0048709,oligodendrocyte differentiation,5/137,106/18888,0.04716981132075472,6.50323646880595,4.8565710397732795,0.0010520484014868608,0.015817003553388668,0.011145112181683466,ASCL1/IL33/CXCR4/B4GALT6/TPPP,5
GO:0097120,receptor localization to synapse,4/137,62/18888,0.06451612903225806,8.894749234753943,5.322120633463014,0.0010668071883324273,0.01586549269786034,0.011179279016944429,KIF17/LGI1/DLG3/RELN,4
GO:0044342,type B pancreatic cell proliferation,3/137,28/18888,0.10714285714285714,14.771637122002085,6.233375633306577,0.0010708687731845446,0.01586549269786034,0.011179279016944429,PTPRN/IGFBP3/NR4A3,3
GO:0051953,negative regulation of amine transport,3/137,28/18888,0.10714285714285714,14.771637122002085,6.233375633306577,0.0010708687731845446,0.01586549269786034,0.011179279016944429,SYT4/CHGA/TNF,3
GO:0070661,leukocyte proliferation,9/137,352/18888,0.02556818181818182,3.5250497677504975,4.087547575343277,0.0010844232275926458,0.01598869415754954,0.01126609028208378,LEF1/GJA1/SYK/TNFRSF4/IL15/IL33/IGF2/PTPRC/CARD11,9
GO:0031400,negative regulation of protein modification process,10/137,426/18888,0.023474178403755867,3.2363524210959183,3.9905726988054684,0.0011032525910833844,0.01618811013455043,0.01140660447157568,APOE/PPP4R4/DMD/IGFBP3/TNF/CDKN1C/PTPRC/TPPP/CDKN2A/WWTR1,10
GO:0021885,forebrain cell migration,4/137,63/18888,0.06349206349206349,8.753562738964199,5.269066072235461,0.0011327898810246397,0.016541984291326316,0.011655954303366097,CXCL12/CXCR4/POU3F3/RELN,4
GO:0050951,sensory perception of temperature stimulus,3/137,29/18888,0.10344827586206896,14.262270324691668,6.109238801314402,0.0011881250785353626,0.01726741780804727,0.012167115465903489,TRPA1/CXCL12/CXCR4,3
GO:1903532,positive regulation of secretion by cell,8/137,288/18888,0.027777777777777776,3.8296836982968365,4.136254202817623,0.0012151966918408658,0.01757715783648494,0.012385367131109448,SYT4/ACHE/SYK/SPP1/CXCL12/SLC18A3/CD177/VEGFC,8
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,6/137,164/18888,0.036585365853658534,5.043973651415346,4.445908106256952,0.0012602344538508582,0.018057443911515585,0.012723790408783313,SYK/IL15/TNF/PTPRC/DLG3/RELN,6
GO:0070665,positive regulation of leukocyte proliferation,6/137,164/18888,0.036585365853658534,5.043973651415346,4.445908106256952,0.0012602344538508582,0.018057443911515585,0.012723790408783313,SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,6
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,7/137,225/18888,0.03111111111111111,4.289245742092457,4.24254452638516,0.001288318680802813,0.018373591653318623,0.012946557131727236,SYK/IL15/TNF/PTPRC/PDGFC/DLG3/RELN,7
GO:0007271,"synaptic transmission, cholinergic",3/137,30/18888,0.1,13.786861313868615,5.991096615985338,0.0013131721730812963,0.018609918852317525,0.01311308002182683,APOE/ACHE/SLC18A3,3
GO:1901342,regulation of vasculature development,9/137,362/18888,0.024861878453038673,3.4276727023430253,3.9864208644627146,0.0013170846894169678,0.018609918852317525,0.01311308002182683,SERPINE1/SPINK5/C3/CXCL12/CXCR4/TNF/NPR1/VEGFC/FGF1,9
GO:0051402,neuron apoptotic process,8/137,292/18888,0.0273972602739726,3.7772222777722226,4.088103233384209,0.001326489262116526,0.01865642962202598,0.01314585283775922,NGFR/ASCL1/FAIM2/MAP3K5/TNF/COL6A3/DRAXIN/DIO3,8
GO:0014013,regulation of gliogenesis,5/137,112/18888,0.044642857142857144,6.154848800834203,4.676844832338401,0.0013453718403114814,0.01883520576436074,0.013271823610605296,NTN1/IL33/CXCR4/TNF/VEGFC,5
GO:0061351,neural precursor cell proliferation,6/137,167/18888,0.03592814371257485,4.9533633463001,4.386215872395202,0.001382802596963587,0.0192708380179583,0.013578782531106025,LEF1/ASCL1/FOXO1/SIX3/POU3F3/VEGFC,6
GO:0002431,Fc receptor mediated stimulatory signaling pathway,3/137,31/18888,0.0967741935483871,13.342123852130916,5.878465901989804,0.0014461991831193704,0.020062726849455995,0.014136770005324753,SYK/PTPRC/NR4A3,3
GO:0048640,negative regulation of developmental growth,5/137,114/18888,0.043859649122807015,6.046868997310795,4.619825881197048,0.0014553738775494288,0.020098647394936005,0.014162080646980154,NTN1/MAP2/SPP1/DRAXIN/SEMA5B,5
GO:1990845,adaptive thermogenesis,6/137,169/18888,0.03550295857988166,4.894743661728502,4.3472084596533165,0.0014694353864451789,0.02020142702446255,0.014234502107669512,GJA1/ACHE/SYK/IL15/CXCR4/PDGFC,6
GO:0009410,response to xenobiotic stimulus,10/137,444/18888,0.02252252252252252,3.1051489445650025,3.8368631885995703,0.001502009479197249,0.020429669825208323,0.014395328500000209,GRIN1/TRPA1/RORC/CXCR4/TNF/ASS1/MAOB/AKR1C1/CPS1/VEGFC,10
GO:0010611,regulation of cardiac muscle hypertrophy,4/137,68/18888,0.058823529411764705,8.109918419922714,5.020405783903171,0.0015061191712555284,0.020429669825208323,0.014395328500000209,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0072577,endothelial cell apoptotic process,4/137,68/18888,0.058823529411764705,8.109918419922714,5.020405783903171,0.0015061191712555284,0.020429669825208323,0.014395328500000209,SERPINE1/AKR1C3/MAP3K5/TNF,4
GO:0019318,hexose metabolic process,7/137,232/18888,0.03017241379310345,4.159828844701736,4.139308945088395,0.0015356679167978268,0.020738311867552952,0.014612806492864278,CHST1/RORC/FOXO1/IGFBP3/TNF/IGF2/CHST15,7
GO:2000463,positive regulation of excitatory postsynaptic potential,3/137,32/18888,0.09375,12.925182481751825,5.770916555293252,0.001587389971095715,0.021342353267771463,0.0150384313051173,SHANK1/GRIN1/RELN,3
GO:0043086,negative regulation of catalytic activity,10/137,449/18888,0.022271714922048998,3.070570448523076,3.795544229067384,0.001631473252929001,0.021838843719032067,0.01538827264881786,SERPINE1/APOE/PPP4R4/SPINK5/TNF/CDKN1C/PTPRC/IFIT1/CDKN2A/WWTR1,10
GO:0033674,positive regulation of kinase activity,8/137,303/18888,0.026402640264026403,3.640095396400954,3.9599454938876115,0.0016748789195700452,0.02232196708527414,0.015728695162866475,LMO4/MAP3K5/TNF/PTPRC/PDGFC/DLG3/RELN/FGF1,8
GO:0051347,positive regulation of transferase activity,9/137,376/18888,0.023936170212765957,3.300046591085572,3.850644646024765,0.0017089338222191837,0.022676808806143256,0.015978726767934978,APOE/LMO4/MAP3K5/TNF/PTPRC/PDGFC/DLG3/RELN/FGF1,9
GO:0060055,angiogenesis involved in wound healing,3/137,33/18888,0.09090909090909091,12.533510285335105,5.668064264730356,0.0017369232157566172,0.022948440062723792,0.016170125904719838,SERPINE1/CXCR4/TNF,3
GO:0031644,regulation of nervous system process,5/137,119/18888,0.04201680672268908,5.792798871373368,4.4830303050266,0.00175927159586319,0.023143521166269203,0.016307585618641093,SHANK1/GRIN1/TNF/TPPP/RELN,5
GO:0014743,regulation of muscle hypertrophy,4/137,71/18888,0.056338028169014086,7.767245810630206,4.883098565673117,0.0017671296073848604,0.023147122582569075,0.01631012327936422,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0048608,reproductive structure development,8/137,307/18888,0.026058631921824105,3.5926674433533847,3.9148129574254513,0.0018181775263038666,0.02361868890035274,0.016642402367186535,VGF/PTPRN/GJA1/AKR1C3/BASP1/C3/CDKN1C/NRIP1,8
GO:0002573,myeloid leukocyte differentiation,7/137,239/18888,0.029288702928870293,4.0379928534343215,4.040056890522349,0.0018186080902958365,0.02361868890035274,0.016642402367186535,LEF1/CBFA2T3/FAM20C/IL15/IL33/TNF/TF,7
GO:0046651,lymphocyte proliferation,8/137,308/18888,0.025974025974025976,3.5810029386671722,3.903647188710363,0.0018554744034376786,0.02399537236988049,0.016907824291807216,LEF1/GJA1/SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,8
GO:0021953,central nervous system neuron differentiation,6/137,178/18888,0.033707865168539325,4.647256622652341,4.178967424466351,0.0019115763945279482,0.024616587156537122,0.017345549962338877,ASCL1/FAIM2/LMO4/MAP2/DRAXIN/B4GALT6,6
GO:1903034,regulation of response to wounding,6/137,179/18888,0.0335195530726257,4.621294295151491,4.160970198261334,0.001966301104827689,0.025064635442900305,0.017661257573927475,SERPINE1/APOE/SPP1/IL33/CXCR4/TNF,6
GO:0046879,hormone secretion,8/137,311/18888,0.02572347266881029,3.546459501959772,3.8704256973385105,0.0019710067189698797,0.025064635442900305,0.017661257573927475,VGF/PTPRN/GJA1/CHGA/FOXO1/SPP1/TNF/VIP,8
GO:0061458,reproductive system development,8/137,311/18888,0.02572347266881029,3.546459501959772,3.8704256973385105,0.0019710067189698797,0.025064635442900305,0.017661257573927475,VGF/PTPRN/GJA1/AKR1C3/BASP1/C3/CDKN1C/NRIP1,8
GO:0002697,regulation of immune effector process,9/137,385/18888,0.023376623376623377,3.222902644800455,3.766684888606014,0.0020067848288344826,0.025358768194803316,0.017868511906595566,SPINK5/C3/SYK/TNFRSF4/IL33/TNF/PTPRC/CD177/NR4A3,9
GO:0042886,amide transport,8/137,312/18888,0.02564102564102564,3.5350926445816953,3.8594426142802307,0.002010754227766187,0.025358768194803316,0.017868511906595566,VGF/PTPRN/GJA1/CHGA/FOXO1/TNF/POU3F3/VIP,8
GO:0050709,negative regulation of protein secretion,4/137,74/18888,0.05405405405405406,7.452357466956007,4.753606918866076,0.0020579739686850044,0.02557856815940488,0.018023389235588112,SYT4/APOE/CHGA/FOXO1,4
GO:0050795,regulation of behavior,4/137,74/18888,0.05405405405405406,7.452357466956007,4.753606918866076,0.0020579739686850044,0.02557856815940488,0.018023389235588112,APOE/PTGDS/RELN/NR4A3,4
GO:0032633,interleukin-4 production,3/137,35/18888,0.08571428571428572,11.817309697601669,5.475106973354675,0.0020617063457449543,0.02557856815940488,0.018023389235588112,LEF1/SYK/IL33,3
GO:0032673,regulation of interleukin-4 production,3/137,35/18888,0.08571428571428572,11.817309697601669,5.475106973354675,0.0020617063457449543,0.02557856815940488,0.018023389235588112,LEF1/SYK/IL33,3
GO:0046631,alpha-beta T cell activation,6/137,181/18888,0.03314917127071823,4.5702302697907005,4.125370882355421,0.002079301832587204,0.02569242588281841,0.01810361663744154,LEF1/RORC/SYK/IL15/PTPRC/CARD11,6
GO:0090257,regulation of muscle system process,7/137,245/18888,0.02857142857142857,3.9391032325338893,3.957943038161654,0.0020919993853101867,0.025745089209543104,0.01814072472066516,AKAP6/CHGA/DMD/TRIM63/FOXO1/NKX2-5/NR4A3,7
GO:0043200,response to amino acid,5/137,124/18888,0.04032258064516129,5.559218271721215,4.353795957023571,0.0021073159602426833,0.025829430966508714,0.01820015433006046,GRIN1/TNF/ASS1/PDGFC/CPS1,5
GO:0032943,mononuclear cell proliferation,8/137,315/18888,0.025396825396825397,3.5014250955856796,3.826760715431391,0.0021338038957478315,0.025931437310345445,0.01827203091158024,LEF1/GJA1/SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,8
GO:0006109,regulation of carbohydrate metabolic process,6/137,182/18888,0.03296703296703297,4.54511911446218,4.10776525996067,0.0021376103873236374,0.025931437310345445,0.01827203091158024,CBFA2T3/RORC/FOXO1/IGFBP3/PHLDA2/IGF2,6
GO:0006935,chemotaxis,10/137,466/18888,0.02145922746781116,2.958553930014724,3.6592296039314816,0.002141127851312927,0.025931437310345445,0.01827203091158024,SERPINE1/LEF1/NTN1/CHGA/SYK/CXCL12/CXCR4/SEMA5B/VEGFC/FGF1,10
GO:0002637,regulation of immunoglobulin production,4/137,75/18888,0.05333333333333334,7.352992700729927,4.712045952852586,0.0021618422504600717,0.02595745787664164,0.018290365745319333,TNFRSF4/IL33/TNF/PTPRC,4
GO:0002065,columnar/cuboidal epithelial cell differentiation,5/137,125/18888,0.04,5.514744525547445,4.328790861684743,0.0021825410083398875,0.02595745787664164,0.018290365745319333,SERPINE1/LEF1/GJA1/ASCL1/FAM20C,5
GO:0045580,regulation of T cell differentiation,6/137,183/18888,0.03278688524590164,4.5202823979897095,4.090286695226086,0.0021971462006521274,0.02595745787664164,0.018290365745319333,LEF1/SPINK5/SYK/IL15/PTPRC/CARD11,6
GO:0042330,taxis,10/137,468/18888,0.021367521367521368,2.945910537151413,3.643598714876935,0.0022087063609333756,0.02595745787664164,0.018290365745319333,SERPINE1/LEF1/NTN1/CHGA/SYK/CXCL12/CXCR4/SEMA5B/VEGFC/FGF1,10
GO:0007613,memory,5/137,126/18888,0.03968253968253968,5.470976711852624,4.304053601952092,0.0022597061226814837,0.02595745787664164,0.018290365745319333,SYT4/APOE/SHANK1/VLDLR/RELN,5
GO:0019614,catechol-containing compound catabolic process,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,MAOA/MAOB,2
GO:0030638,polyketide metabolic process,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,AKR1C3/AKR1C1,2
GO:0030647,aminoglycoside antibiotic metabolic process,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,AKR1C3/AKR1C1,2
GO:0042420,dopamine catabolic process,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,MAOA/MAOB,2
GO:0042424,catecholamine catabolic process,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,MAOA/MAOB,2
GO:0044598,doxorubicin metabolic process,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,AKR1C3/AKR1C1,2
GO:1901329,regulation of odontoblast differentiation,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,SERPINE1/LEF1,2
GO:1902513,regulation of organelle transport along microtubule,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,NEFH/MAP2,2
GO:2000347,positive regulation of hepatocyte proliferation,2/137,10/18888,0.2,27.57372262773723,7.184622657404894,0.0022623472461293175,0.02595745787664164,0.018290365745319333,TNF/FGF1,2
GO:0051656,establishment of organelle localization,10/137,472/18888,0.0211864406779661,2.9209451936162316,3.612583360222371,0.002349026765544633,0.026851047522255506,0.01892001451609574,SYT4/NTN1/GJA1/NEFH/CHGA/PTGDS/MAP2/SYK/S100A13/NR4A3,10
GO:0046683,response to organophosphorus,5/137,128/18888,0.0390625,5.385492700729927,4.2553620595642645,0.0024199735601169755,0.02749095443697907,0.019370911193608415,VGF/AKAP6/ASS1/AKR1C1/CPS1,5
GO:0009914,hormone transport,8/137,322/18888,0.024844720496894408,3.4253071587251207,3.75201933979212,0.0024440322101349494,0.02749095443697907,0.019370911193608415,VGF/PTPRN/GJA1/CHGA/FOXO1/SPP1/TNF/VIP,8
GO:0050890,cognition,8/137,322/18888,0.024844720496894408,3.4253071587251207,3.75201933979212,0.0024440322101349494,0.02749095443697907,0.019370911193608415,SYT4/APOE/SHANK1/GRIN1/VLDLR/TNF/VIP/RELN,8
GO:0060326,cell chemotaxis,8/137,322/18888,0.024844720496894408,3.4253071587251207,3.75201933979212,0.0024440322101349494,0.02749095443697907,0.019370911193608415,SERPINE1/LEF1/CHGA/SYK/CXCL12/CXCR4/VEGFC/FGF1,8
GO:0005996,monosaccharide metabolic process,7/137,252/18888,0.027777777777777776,3.8296836982968365,3.8653726479376496,0.0024500457427451858,0.02749095443697907,0.019370911193608415,CHST1/RORC/FOXO1/IGFBP3/TNF/IGF2/CHST15,7
GO:0022409,positive regulation of cell-cell adhesion,8/137,325/18888,0.024615384615384615,3.393688938798428,3.7206161589400057,0.002587358106786236,0.028819111398666213,0.020306768499508545,LEF1/SYK/IL15/TNF/IGF2/PTPRC/CARD11/NR4A3,8
GO:0097009,energy homeostasis,4/137,79/18888,0.05063291139240506,6.9806892728448675,4.553145076783083,0.002613556167578353,0.028819111398666213,0.020306768499508545,VGF/APOE/FOXO1/NR4A3,4
GO:0010661,positive regulation of muscle cell apoptotic process,3/137,38/18888,0.07894736842105263,10.884364195159431,5.213320401525737,0.0026156270830375297,0.028819111398666213,0.020306768499508545,FOXO1/MAP3K5/CDKN2A,3
GO:0031952,regulation of protein autophosphorylation,3/137,38/18888,0.07894736842105263,10.884364195159431,5.213320401525737,0.0026156270830375297,0.028819111398666213,0.020306768499508545,PTPRC/PDGFC/VEGFC,3
GO:0034391,regulation of smooth muscle cell apoptotic process,3/137,38/18888,0.07894736842105263,10.884364195159431,5.213320401525737,0.0026156270830375297,0.028819111398666213,0.020306768499508545,FOXO1/PDE1A/CDKN2A,3
GO:1904018,positive regulation of vasculature development,6/137,190/18888,0.031578947368421054,4.353745678063772,3.9713567844935054,0.0026496472244062377,0.029088932837726032,0.020496892387209177,SERPINE1/C3/CXCL12/CXCR4/VEGFC/FGF1,6
GO:0006941,striated muscle contraction,6/137,191/18888,0.031413612565445025,4.330951198073909,3.9548366148064233,0.002719597243591702,0.029470255345292903,0.02076558311044816,GJA1/CHGA/DMD/CXCR4/TNF/NKX2-5,6
GO:0045860,positive regulation of protein kinase activity,7/137,257/18888,0.027237354085603113,3.7551762333494274,3.8012586293870188,0.0027334441549217593,0.029470255345292903,0.02076558311044816,MAP3K5/TNF/PTPRC/PDGFC/DLG3/RELN/FGF1,7
GO:0000050,urea cycle,2/137,11/18888,0.18181818181818182,25.06702057067021,6.824671324964113,0.0027519733857825942,0.029470255345292903,0.02076558311044816,ASS1/CPS1,2
GO:0001820,serotonin secretion,2/137,11/18888,0.18181818181818182,25.06702057067021,6.824671324964113,0.0027519733857825942,0.029470255345292903,0.02076558311044816,SYK/MAOB,2
GO:0042447,hormone catabolic process,2/137,11/18888,0.18181818181818182,25.06702057067021,6.824671324964113,0.0027519733857825942,0.029470255345292903,0.02076558311044816,SPP1/DIO3,2
GO:0099519,dense core granule cytoskeletal transport,2/137,11/18888,0.18181818181818182,25.06702057067021,6.824671324964113,0.0027519733857825942,0.029470255345292903,0.02076558311044816,SYT4/MAP2,2
GO:1901950,dense core granule transport,2/137,11/18888,0.18181818181818182,25.06702057067021,6.824671324964113,0.0027519733857825942,0.029470255345292903,0.02076558311044816,SYT4/MAP2,2
GO:0006959,humoral immune response,7/137,258/18888,0.027131782945736434,3.7406212867085387,3.788628387058546,0.0027930272655764593,0.029562310623637112,0.02083044788718032,SPINK5/C3/TNF/PTPRC/CFI/C1S/TF,7
GO:0007616,long-term memory,3/137,39/18888,0.07692307692307693,10.605277933745088,5.132484412046843,0.0028186868910479684,0.029562310623637112,0.02083044788718032,APOE/SHANK1/RELN,3
GO:0034390,smooth muscle cell apoptotic process,3/137,39/18888,0.07692307692307693,10.605277933745088,5.132484412046843,0.0028186868910479684,0.029562310623637112,0.02083044788718032,FOXO1/PDE1A/CDKN2A,3
GO:0051954,positive regulation of amine transport,3/137,39/18888,0.07692307692307693,10.605277933745088,5.132484412046843,0.0028186868910479684,0.029562310623637112,0.02083044788718032,SYT4/CXCL12/SLC18A3,3
GO:0060999,positive regulation of dendritic spine development,3/137,39/18888,0.07692307692307693,10.605277933745088,5.132484412046843,0.0028186868910479684,0.029562310623637112,0.02083044788718032,APOE/SHANK1/RELN,3
GO:0097242,amyloid-beta clearance,3/137,39/18888,0.07692307692307693,10.605277933745088,5.132484412046843,0.0028186868910479684,0.029562310623637112,0.02083044788718032,APOE/C3/TNF,3
GO:0045785,positive regulation of cell adhesion,10/137,485/18888,0.020618556701030927,2.8426518172924973,3.5139808700127655,0.0028554045938327353,0.029609654083963904,0.020863807440690576,LEF1/UTRN/SYK/CXCL12/IL15/TNF/IGF2/PTPRC/CARD11/NR4A3,10
GO:0042476,odontogenesis,5/137,133/18888,0.03759398496240601,5.183030569123538,4.137975180402287,0.0028566444690985406,0.029609654083963904,0.020863807440690576,SERPINE1/LEF1/NGFR/FAM20C/ODAM,5
GO:0048565,digestive tract development,5/137,133/18888,0.03759398496240601,5.183030569123538,4.137975180402287,0.0028566444690985406,0.029609654083963904,0.020863807440690576,ASCL1/TNF/ASS1/PDGFC/CPS1,5
GO:0050810,regulation of steroid biosynthetic process,4/137,81/18888,0.04938271604938271,6.808326574749931,4.477785964204257,0.0028620078488759346,0.029609654083963904,0.020863807440690576,APOE/AKR1C3/TNF/FGF1,4
GO:0003015,heart process,7/137,260/18888,0.026923076923076925,3.7118472768107806,3.763555665224056,0.0029151832781082,0.030057903259412926,0.021179656604463203,GJA1/CHGA/DMD/CXCR4/TNF/NKX2-5/WWTR1,7
GO:0002702,positive regulation of production of molecular mediator of immune response,5/137,134/18888,0.03731343283582089,5.144351236518139,4.115205764099525,0.002950385511073409,0.030216699932201493,0.021291549272776312,SYK/TNFRSF4/IL33/PTPRC/NR4A3,5
GO:0043405,regulation of MAP kinase activity,5/137,134/18888,0.03731343283582089,5.144351236518139,4.115205764099525,0.002950385511073409,0.030216699932201493,0.021291549272776312,APOE/MAP3K5/TNF/PDGFC/FGF1,5
GO:0007405,neuroblast proliferation,4/137,82/18888,0.04878048780487805,6.725298201887129,4.441057323734066,0.0029920925521648056,0.030439554897356624,0.021448579242360342,LEF1/ASCL1/SIX3/VEGFC,4
GO:0043406,positive regulation of MAP kinase activity,4/137,82/18888,0.04878048780487805,6.725298201887129,4.441057323734066,0.0029920925521648056,0.030439554897356624,0.021448579242360342,MAP3K5/TNF/PDGFC/FGF1,4
GO:0009615,response to virus,9/137,409/18888,0.022004889975550123,3.0337836631984723,3.554321695987078,0.003007593971665378,0.03049560399176988,0.02148807303414012,IFI44/IFI44L/CXCL12/IL15/IL33/CXCR4/TNF/PTPRC/IFIT1,9
GO:0150077,regulation of neuroinflammatory response,3/137,40/18888,0.075,10.34014598540146,5.054527691526623,0.0030312012949516858,0.030532100172252625,0.021513789284649275,IL33/TNF/PTPRC,3
GO:1902742,apoptotic process involved in development,3/137,40/18888,0.075,10.34014598540146,5.054527691526623,0.0030312012949516858,0.030532100172252625,0.021513789284649275,LEF1/SIX3/NKX2-5,3
GO:0009154,purine ribonucleotide catabolic process,5/137,135/18888,0.037037037037037035,5.10624493106245,4.0926623386524685,0.0030463307952014644,0.030583557851825226,0.021550047834475734,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0031667,response to nutrient levels,10/137,490/18888,0.02040816326530612,2.8136451660956348,3.4769193123781013,0.003072016020307889,0.030740304570425172,0.021660496046553984,VGF/APOE/ASCL1/AKR1C3/FOXO1/SPP1/MAP3K5/TNF/ASS1/CPS1,10
GO:0045664,regulation of neuron differentiation,6/137,196/18888,0.030612244897959183,4.220467749143452,3.8739022739387523,0.0030903425145590454,0.030822631877235968,0.02171850621687007,GDF6/ASCL1/CXCL12/SIX3/NKX2-5/RELN,6
GO:0050871,positive regulation of B cell activation,4/137,83/18888,0.04819277108433735,6.644270512707766,4.404937534286469,0.0031261622582309245,0.031078329681175187,0.021898678188121995,SYK/TNFRSF4/PTPRC/CARD11,4
GO:0002520,immune system development,6/137,197/18888,0.030456852791878174,4.1990440549853645,3.858039076215417,0.0031688095116750577,0.031400021524780115,0.02212535144344547,LEF1/LMO4/IL15/PTPRC/NKX2-5/LTB,6
GO:0050808,synapse organization,10/137,493/18888,0.02028397565922921,2.7965235930767975,3.454904485860353,0.003208163092082656,0.03154415128597283,0.022226909387198204,NTN1/APOE/ACHE/NEFH/SHANK1/C3/TNF/SLC18A3/GAP43/RELN,10
GO:0051235,maintenance of location,8/137,337/18888,0.02373887240356083,3.2728454157551607,3.59857653191053,0.0032277469391705565,0.03154415128597283,0.022226909387198204,APOE/AKAP6/DMD/C3/TNF/PTPRC/RIT2/NRIP1,8
GO:0042417,dopamine metabolic process,3/137,41/18888,0.07317073170731707,10.087947302830692,4.9792756585573805,0.0032533102750838235,0.03154415128597283,0.022226909387198204,MAOA/NPR1/MAOB,3
GO:0002551,mast cell chemotaxis,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,CHGA/VEGFC,2
GO:0007494,midgut development,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,ASS1/CPS1,2
GO:0021527,spinal cord association neuron differentiation,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,ASCL1/LMO4,2
GO:0030656,regulation of vitamin metabolic process,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,AKR1C3/TNF,2
GO:0043312,neutrophil degranulation,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,SYK/CD177,2
GO:0071377,cellular response to glucagon stimulus,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,ASS1/CPS1,2
GO:0072182,regulation of nephron tubule epithelial cell differentiation,2/137,12/18888,0.16666666666666666,22.978102189781023,6.509616201316298,0.0032867103895607335,0.03154415128597283,0.022226909387198204,WWTR1/PROM1,2
GO:0022407,regulation of cell-cell adhesion,10/137,496/18888,0.020161290322580645,2.7796091358606074,3.433053271540026,0.003349087547087648,0.03204205389878214,0.022577745780234502,LEF1/SYK/CXCL12/IL15/TNF/ASS1/IGF2/PTPRC/CARD11/NR4A3,10
GO:0070663,regulation of leukocyte proliferation,7/137,267/18888,0.026217228464419477,3.614532928729599,3.6777127329651096,0.003375270652446242,0.032091358352853365,0.022612487105911374,SYK/TNFRSF4/IL15/IL33/IGF2/PTPRC/CARD11,7
GO:0071900,regulation of protein serine/threonine kinase activity,7/137,267/18888,0.026217228464419477,3.614532928729599,3.6777127329651096,0.003375270652446242,0.032091358352853365,0.022612487105911374,APOE/MAP3K5/TNF/CDKN1C/PDGFC/CDKN2A/FGF1,7
GO:0051591,response to cAMP,4/137,85/18888,0.047058823529411764,6.487934735938171,4.33445386365986,0.0034064916064315484,0.0322876160957425,0.022750775913500013,VGF/AKAP6/ASS1/CPS1,4
GO:0001101,response to acid chemical,5/137,139/18888,0.03597122302158273,4.95930263088799,4.004668769271012,0.00345274258687047,0.03242888928351898,0.022850321034086112,GRIN1/TNF/ASS1/PDGFC/CPS1,5
GO:0001709,cell fate determination,3/137,42/18888,0.07142857142857142,9.847758081334723,4.906568293979789,0.003485149307009904,0.03242888928351898,0.022850321034086112,PRRX1/ASCL1/DSCAML1,3
GO:0002714,positive regulation of B cell mediated immunity,3/137,42/18888,0.07142857142857142,9.847758081334723,4.906568293979789,0.003485149307009904,0.03242888928351898,0.022850321034086112,C3/TNF/PTPRC,3
GO:0002891,positive regulation of immunoglobulin mediated immune response,3/137,42/18888,0.07142857142857142,9.847758081334723,4.906568293979789,0.003485149307009904,0.03242888928351898,0.022850321034086112,C3/TNF/PTPRC,3
GO:0006958,"complement activation, classical pathway",3/137,42/18888,0.07142857142857142,9.847758081334723,4.906568293979789,0.003485149307009904,0.03242888928351898,0.022850321034086112,C3/CFI/C1S,3
GO:0060251,regulation of glial cell proliferation,3/137,42/18888,0.07142857142857142,9.847758081334723,4.906568293979789,0.003485149307009904,0.03242888928351898,0.022850321034086112,NTN1/TNF/VEGFC,3
GO:0018108,peptidyl-tyrosine phosphorylation,7/137,269/18888,0.026022304832713755,3.5876590779583752,3.6537142472176636,0.0035163861987973083,0.032521244480998135,0.022915397142401598,SYK/IL15/TNF/PTPRC/PDGFC/DLG3/RELN,7
GO:0050708,regulation of protein secretion,7/137,269/18888,0.026022304832713755,3.5876590779583752,3.6537142472176636,0.0035163861987973083,0.032521244480998135,0.022915397142401598,SYT4/APOE/ACHE/CHGA/FOXO1/TNF/VEGFC,7
GO:0021954,central nervous system neuron development,4/137,86/18888,0.046511627906976744,6.412493634357494,4.300056449449564,0.003552867686426168,0.032727645482986865,0.023060833179879336,ASCL1/MAP2/DRAXIN/B4GALT6,4
GO:0048813,dendrite morphogenesis,5/137,140/18888,0.03571428571428571,4.923879040667361,3.9831963324887827,0.003560150163942214,0.032727645482986865,0.023060833179879336,SHANK1/MAP2/VLDLR/RELN/TNIK,5
GO:0015833,peptide transport,7/137,271/18888,0.025830258302583026,3.561181889191155,3.6299427455567255,0.003661959562243275,0.03343478130863906,0.02355910126700338,VGF/PTPRN/GJA1/CHGA/FOXO1/TNF/VIP,7
GO:0018212,peptidyl-tyrosine modification,7/137,271/18888,0.025830258302583026,3.561181889191155,3.6299427455567255,0.003661959562243275,0.03343478130863906,0.02355910126700338,SYK/IL15/TNF/PTPRC/PDGFC/DLG3/RELN,7
GO:0009261,ribonucleotide catabolic process,5/137,141/18888,0.03546099290780142,4.888957912719366,3.9619269758699676,0.0036699383153322696,0.03343478130863906,0.02355910126700338,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0045124,regulation of bone resorption,3/137,43/18888,0.06976744186046512,9.618740451536242,4.836258612200954,0.003726849432430209,0.033651906709399396,0.023712094021971084,SYK/SPP1/TF,3
GO:0046640,regulation of alpha-beta T cell proliferation,3/137,43/18888,0.06976744186046512,9.618740451536242,4.836258612200954,0.003726849432430209,0.033651906709399396,0.023712094021971084,SYK/PTPRC/CARD11,3
GO:1903307,positive regulation of regulated secretory pathway,3/137,43/18888,0.06976744186046512,9.618740451536242,4.836258612200954,0.003726849432430209,0.033651906709399396,0.023712094021971084,SYT4/SYK/CD177,3
GO:0045732,positive regulation of protein catabolic process,6/137,205/18888,0.02926829268292683,4.035178921132277,3.7348010987399625,0.003851238153770324,0.03419909991149423,0.024097661971160485,APOE/CBFA2T3/FOXO1/IL33/TNF/VIP,6
GO:0001892,embryonic placenta development,4/137,88/18888,0.045454545454545456,6.266755142667552,4.232871614476228,0.0038583305469370695,0.03419909991149423,0.024097661971160485,LEF1/PHLDA2/IGF2/CDKN1C,4
GO:0002863,positive regulation of inflammatory response to antigenic stimulus,2/137,13/18888,0.15384615384615385,21.210555867490175,6.2306880953553305,0.00386588776850115,0.03419909991149423,0.024097661971160485,C3/TNF,2
GO:0019627,urea metabolic process,2/137,13/18888,0.15384615384615385,21.210555867490175,6.2306880953553305,0.00386588776850115,0.03419909991149423,0.024097661971160485,ASS1/CPS1,2
GO:0021514,ventral spinal cord interneuron differentiation,2/137,13/18888,0.15384615384615385,21.210555867490175,6.2306880953553305,0.00386588776850115,0.03419909991149423,0.024097661971160485,ASCL1/LMO4,2
GO:0033604,negative regulation of catecholamine secretion,2/137,13/18888,0.15384615384615385,21.210555867490175,6.2306880953553305,0.00386588776850115,0.03419909991149423,0.024097661971160485,SYT4/CHGA,2
GO:0071941,nitrogen cycle metabolic process,2/137,13/18888,0.15384615384615385,21.210555867490175,6.2306880953553305,0.00386588776850115,0.03419909991149423,0.024097661971160485,ASS1/CPS1,2
GO:0030890,positive regulation of B cell proliferation,3/137,44/18888,0.06818181818181818,9.400132714001327,4.7682113243672015,0.003978537329213055,0.035093918869243484,0.02472817695035677,TNFRSF4/PTPRC/CARD11,3
GO:0006195,purine nucleotide catabolic process,5/137,144/18888,0.034722222222222224,4.7871046228710465,3.89930285951518,0.004013879212383155,0.03530362926856885,0.024875944883660808,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0060048,cardiac muscle contraction,5/137,145/18888,0.034482758620689655,4.754090108230556,3.878811709431883,0.004133482475479591,0.036147245029122387,0.025470380628577306,GJA1/CHGA/DMD/CXCR4/NKX2-5,5
GO:0090090,negative regulation of canonical Wnt signaling pathway,5/137,145/18888,0.034482758620689655,4.754090108230556,3.878811709431883,0.004133482475479591,0.036147245029122387,0.025470380628577306,APOE/FOXO1/DRAXIN/NKX2-5/WWTR1,5
GO:0009953,dorsal/ventral pattern formation,4/137,90/18888,0.044444444444444446,6.127493917274939,4.167735437929132,0.004181119655802525,0.03635549056840258,0.025617116379680786,ASCL1/SIX3/DSCAML1/GREM2,4
GO:0046849,bone remodeling,4/137,90/18888,0.044444444444444446,6.127493917274939,4.167735437929132,0.004181119655802525,0.03635549056840258,0.025617116379680786,GJA1/SYK/SPP1/TF,4
GO:0007611,learning or memory,7/137,278/18888,0.025179856115107913,3.4715118416215933,3.548472663078383,0.0042078757073596845,0.03648419505358454,0.025707805233659793,SYT4/APOE/SHANK1/GRIN1/VLDLR/VIP/RELN,7
GO:0040013,negative regulation of locomotion,9/137,431/18888,0.02088167053364269,2.8789269564922857,3.3728539269469526,0.004238795163990293,0.0365579197217195,0.02575975373921257,SERPINE1/APOE/GJA1/NGFR/CXCL12/IGFBP3/IL33/TNF/SEMA5B,9
GO:0099084,postsynaptic specialization organization,3/137,45/18888,0.06666666666666667,9.19124087591241,4.702301665555123,0.004240335380566416,0.0365579197217195,0.02575975373921257,SHANK1/GAP43/RELN,3
GO:0045765,regulation of angiogenesis,8/137,353/18888,0.0226628895184136,3.124501147618949,3.4441145251381076,0.00426625627330851,0.03667778632714809,0.025844215170850365,SERPINE1/SPINK5/C3/CXCR4/TNF/NPR1/VEGFC/FGF1,8
GO:0006936,muscle contraction,8/137,355/18888,0.022535211267605635,3.1068983242520822,3.4254248829454945,0.004412323564541205,0.03782699864881954,0.026653982975628862,GJA1/CHGA/DMD/TRIM63/UTRN/CXCR4/TNF/NKX2-5,8
GO:0043270,positive regulation of monoatomic ion transport,6/137,211/18888,0.02843601895734597,3.9204344968346763,3.6464032495835994,0.004430495844243049,0.037834417694300335,0.02665921064684265,AKAP6/DMD/GRIN1/CXCL12/NKX2-5/RELN,6
GO:0007512,adult heart development,2/137,14/18888,0.14285714285714285,19.695516162669445,5.981347842787435,0.004488842263236096,0.037834417694300335,0.02665921064684265,GJA1/NKX2-5,2
GO:0050930,induction of positive chemotaxis,2/137,14/18888,0.14285714285714285,19.695516162669445,5.981347842787435,0.004488842263236096,0.037834417694300335,0.02665921064684265,CXCL12/VEGFC,2
GO:0060019,radial glial cell differentiation,2/137,14/18888,0.14285714285714285,19.695516162669445,5.981347842787435,0.004488842263236096,0.037834417694300335,0.02665921064684265,LEF1/GAP43,2
GO:0061469,regulation of type B pancreatic cell proliferation,2/137,14/18888,0.14285714285714285,19.695516162669445,5.981347842787435,0.004488842263236096,0.037834417694300335,0.02665921064684265,PTPRN/NR4A3,2
GO:0072160,nephron tubule epithelial cell differentiation,2/137,14/18888,0.14285714285714285,19.695516162669445,5.981347842787435,0.004488842263236096,0.037834417694300335,0.02665921064684265,WWTR1/PROM1,2
GO:0002701,negative regulation of production of molecular mediator of immune response,3/137,46/18888,0.06521739130434782,8.991431291653443,4.638414362704322,0.004512361743356921,0.037834417694300335,0.02665921064684265,SPINK5/IL33/TNF,3
GO:0099601,regulation of neurotransmitter receptor activity,3/137,46/18888,0.06521739130434782,8.991431291653443,4.638414362704322,0.004512361743356921,0.037834417694300335,0.02665921064684265,CNIH3/SHANK1/RELN,3
GO:0034764,positive regulation of transmembrane transport,6/137,213/18888,0.028169014084507043,3.883622905315103,3.617658099997208,0.0046371678713016135,0.03867079255639969,0.027248544248025305,AKAP6/DMD/GRIN1/C3/RELN/NR4A3,6
GO:0072523,purine-containing compound catabolic process,5/137,149/18888,0.03355704697986577,4.626463528143829,3.7986807808480423,0.004637454153224865,0.03867079255639969,0.027248544248025305,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0001656,metanephros development,4/137,93/18888,0.043010752688172046,5.9298328231692965,4.0736344818486865,0.004698767605262816,0.038969126987125305,0.027458759203523836,GDF6/BASP1/POU3F3/WWTR1,4
GO:1904705,regulation of vascular associated smooth muscle cell proliferation,4/137,93/18888,0.043010752688172046,5.9298328231692965,4.0736344818486865,0.004698767605262816,0.038969126987125305,0.027458759203523836,GJA1/MAP3K5/TNF/NR4A3,4
GO:0001890,placenta development,5/137,150/18888,0.03333333333333333,4.595620437956205,3.7790915186274256,0.004769981832279513,0.039197802066077286,0.027619890191417498,LEF1/SPP1/PHLDA2/IGF2/CDKN1C,5
GO:0014003,oligodendrocyte development,3/137,47/18888,0.06382978723404255,8.800124242894858,4.576442723746606,0.004794730415585677,0.039197802066077286,0.027619890191417498,ASCL1/B4GALT6/TPPP,3
GO:0043666,regulation of phosphoprotein phosphatase activity,3/137,47/18888,0.06382978723404255,8.800124242894858,4.576442723746606,0.004794730415585677,0.039197802066077286,0.027619890191417498,PPP4R4/TNF/PTPRC,3
GO:1900271,regulation of long-term synaptic potentiation,3/137,47/18888,0.06382978723404255,8.800124242894858,4.576442723746606,0.004794730415585677,0.039197802066077286,0.027619890191417498,APOE/SLC18A3/RELN,3
GO:1901861,regulation of muscle tissue development,3/137,47/18888,0.06382978723404255,8.800124242894858,4.576442723746606,0.004794730415585677,0.039197802066077286,0.027619890191417498,LEF1/GJA1/IGF2,3
GO:0045619,regulation of lymphocyte differentiation,6/137,215/18888,0.027906976744186046,3.8474961806144963,3.5892597468448546,0.00485086548580244,0.039197802066077286,0.027619890191417498,LEF1/SPINK5/SYK/IL15/PTPRC/CARD11,6
GO:0001942,hair follicle development,4/137,94/18888,0.0425531914893617,5.866749495263239,4.0431780317158506,0.004880460283456543,0.039197802066077286,0.027619890191417498,NGFR/LDB2/SPINK5/TNF,4
GO:0019915,lipid storage,4/137,94/18888,0.0425531914893617,5.866749495263239,4.0431780317158506,0.004880460283456543,0.039197802066077286,0.027619890191417498,APOE/C3/TNF/NRIP1,4
GO:0043502,regulation of muscle adaptation,4/137,94/18888,0.0425531914893617,5.866749495263239,4.0431780317158506,0.004880460283456543,0.039197802066077286,0.027619890191417498,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0045666,positive regulation of neuron differentiation,4/137,94/18888,0.0425531914893617,5.866749495263239,4.0431780317158506,0.004880460283456543,0.039197802066077286,0.027619890191417498,GDF6/ASCL1/CXCL12/NKX2-5,4
GO:0050848,regulation of calcium-mediated signaling,4/137,94/18888,0.0425531914893617,5.866749495263239,4.0431780317158506,0.004880460283456543,0.039197802066077286,0.027619890191417498,AKAP6/SYK/TNF/RIT2,4
GO:0051781,positive regulation of cell division,4/137,94/18888,0.0425531914893617,5.866749495263239,4.0431780317158506,0.004880460283456543,0.039197802066077286,0.027619890191417498,IGF2/PDGFC/VEGFC/FGF1,4
GO:0009612,response to mechanical stimulus,6/137,216/18888,0.027777777777777776,3.8296836982968365,3.5751881806634818,0.004960392544785836,0.039735217970305436,0.02799856877744844,DMD/TRPA1/CXCL12/IL33/CXCR4/TNF,6
GO:1990874,vascular associated smooth muscle cell proliferation,4/137,95/18888,0.042105263157894736,5.804994237418363,4.013157217279609,0.005066814652088744,0.04005478536849334,0.02822374508789125,GJA1/MAP3K5/TNF/NR4A3,4
GO:1901654,response to ketone,6/137,217/18888,0.027649769585253458,3.812035386323119,3.5612004187525854,0.005071728396864343,0.04005478536849334,0.02822374508789125,AKR1C3/SPP1/ASS1/PTPRC/MAOB/CPS1,6
GO:0001774,microglial cell activation,3/137,48/18888,0.0625,8.616788321167883,4.516287831453818,0.005087551303029742,0.04005478536849334,0.02822374508789125,IL33/TNF/PTPRC,3
GO:0002861,regulation of inflammatory response to antigenic stimulus,3/137,48/18888,0.0625,8.616788321167883,4.516287831453818,0.005087551303029742,0.04005478536849334,0.02822374508789125,C3/SYK/TNF,3
GO:0035850,epithelial cell differentiation involved in kidney development,3/137,48/18888,0.0625,8.616788321167883,4.516287831453818,0.005087551303029742,0.04005478536849334,0.02822374508789125,BASP1/WWTR1/PROM1,3
GO:0042311,vasodilation,3/137,48/18888,0.0625,8.616788321167883,4.516287831453818,0.005087551303029742,0.04005478536849334,0.02822374508789125,APOE/TNF/CPS1,3
GO:0010721,negative regulation of cell development,7/137,288/18888,0.024305555555555556,3.3509732360097324,3.436505265238632,0.005092154889572548,0.04005478536849334,0.02822374508789125,SYT4/NTN1/MAP2/SPP1/TNF/DRAXIN/SEMA5B,7
GO:0048934,peripheral nervous system neuron differentiation,2/137,15/18888,0.13333333333333333,18.38248175182482,5.756605900982027,0.005154917775645244,0.04013471696752369,0.02828006717412254,NEFH/ASCL1,2
GO:0048935,peripheral nervous system neuron development,2/137,15/18888,0.13333333333333333,18.38248175182482,5.756605900982027,0.005154917775645244,0.04013471696752369,0.02828006717412254,NEFH/ASCL1,2
GO:0090205,positive regulation of cholesterol metabolic process,2/137,15/18888,0.13333333333333333,18.38248175182482,5.756605900982027,0.005154917775645244,0.04013471696752369,0.02828006717412254,APOE/FGF1,2
GO:0097531,mast cell migration,2/137,15/18888,0.13333333333333333,18.38248175182482,5.756605900982027,0.005154917775645244,0.04013471696752369,0.02828006717412254,CHGA/VEGFC,2
GO:0050729,positive regulation of inflammatory response,5/137,153/18888,0.032679738562091505,4.505510233290396,3.721342670371461,0.0051837102983598405,0.04025619295316599,0.028365662620996795,SERPINE1/C3/IL15/IL33/TNF,5
GO:0072091,regulation of stem cell proliferation,4/137,96/18888,0.041666666666666664,5.744525547445256,3.983560899795024,0.005257883938568143,0.04072858319926389,0.028698522272227394,PRRX1/GJA1/PTPRC/VEGFC,4
GO:0042391,regulation of membrane potential,9/137,446/18888,0.020179372197309416,2.7821020588524106,3.2555588416262142,0.005282829705291016,0.040818218381134634,0.028761681779905516,GJA1/AKAP6/DMD/GRIK5/SHANK1/GRIN1/TNF/RIMS3/RELN,9
GO:0042551,neuron maturation,3/137,49/18888,0.061224489795918366,8.440935498286905,4.4578578280593915,0.0053909302850584755,0.04144362526447977,0.02920236132142242,C3/CDKN1C/B4GALT6,3
GO:0098815,modulation of excitatory postsynaptic potential,3/137,49/18888,0.061224489795918366,8.440935498286905,4.4578578280593915,0.0053909302850584755,0.04144362526447977,0.02920236132142242,SHANK1/GRIN1/RELN,3
GO:0060541,respiratory system development,6/137,220/18888,0.02727272727272727,3.7600530856005308,3.5197307007190823,0.005416763419977669,0.04153759285872323,0.029268573570522025,LEF1/ASCL1/BASP1/TNF/ASS1/FGF1,6
GO:0022404,molting cycle process,4/137,97/18888,0.041237113402061855,5.6853036345849945,3.9543783397834025,0.005453720839180301,0.0416118900029457,0.029320925459066723,NGFR/LDB2/SPINK5/TNF,4
GO:0022405,hair cycle process,4/137,97/18888,0.041237113402061855,5.6853036345849945,3.9543783397834025,0.005453720839180301,0.0416118900029457,0.029320925459066723,NGFR/LDB2/SPINK5/TNF,4
GO:0032412,regulation of monoatomic ion transmembrane transporter activity,6/137,221/18888,0.027149321266968326,3.7430392707335605,3.5060689704051073,0.005535509144018462,0.04213060824824026,0.029686429140910138,AKAP6/DMD/CNIH3/SHANK1/UTRN/RELN,6
GO:0045667,regulation of osteoblast differentiation,5/137,156/18888,0.03205128205128205,4.418865805727119,3.665066306168935,0.005622258978783431,0.04267002538560504,0.030066517852932014,FAM20C/TNF/CEBPD/WWTR1/VEGFC,5
GO:0032535,regulation of cellular component size,8/137,370/18888,0.021621621621621623,2.980942986782403,3.289314165478583,0.00563434476749634,0.04267002538560504,0.030066517852932014,NTN1/APOE/MAP2/SPP1/CXCL12/DRAXIN/SEMA5B/CRABP2,8
GO:0060993,kidney morphogenesis,4/137,98/18888,0.04081632653061224,5.6272903321912695,3.925599178745964,0.005654377510768959,0.04271574297739322,0.03009873177306145,BASP1/ADAMTS16/WWTR1/FGF1,4
GO:0006693,prostaglandin metabolic process,3/137,50/18888,0.06,8.272116788321167,4.4010672788091565,0.005704969279633477,0.042780261035482485,0.03014419303838405,PTGDS/AKR1C3/AKR1C1,3
GO:0021515,cell differentiation in spinal cord,3/137,50/18888,0.06,8.272116788321167,4.4010672788091565,0.005704969279633477,0.042780261035482485,0.03014419303838405,ASCL1/LMO4/DRAXIN,3
GO:0071320,cellular response to cAMP,3/137,50/18888,0.06,8.272116788321167,4.4010672788091565,0.005704969279633477,0.042780261035482485,0.03014419303838405,AKAP6/ASS1/CPS1,3
GO:2001236,regulation of extrinsic apoptotic signaling pathway,5/137,157/18888,0.03184713375796178,4.390720163652424,3.646622858771437,0.005774090480083349,0.04319246114023133,0.030434640997962545,SERPINE1/FAIM2/TNF/PTPRC/LTB,5
GO:0010832,negative regulation of myotube differentiation,2/137,16/18888,0.125,17.233576642335766,5.552579686937769,0.005863465301108067,0.043225352896091356,0.030457817467998426,BHLHE41/NKX2-5,2
GO:0035641,locomotory exploration behavior,2/137,16/18888,0.125,17.233576642335766,5.552579686937769,0.005863465301108067,0.043225352896091356,0.030457817467998426,APOE/GAD1,2
GO:0042448,progesterone metabolic process,2/137,16/18888,0.125,17.233576642335766,5.552579686937769,0.005863465301108067,0.043225352896091356,0.030457817467998426,AKR1C3/AKR1C1,2
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,2/137,16/18888,0.125,17.233576642335766,5.552579686937769,0.005863465301108067,0.043225352896091356,0.030457817467998426,APOE/TNF,2
GO:2000345,regulation of hepatocyte proliferation,2/137,16/18888,0.125,17.233576642335766,5.552579686937769,0.005863465301108067,0.043225352896091356,0.030457817467998426,TNF/FGF1,2
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,2/137,16/18888,0.125,17.233576642335766,5.552579686937769,0.005863465301108067,0.043225352896091356,0.030457817467998426,WWTR1/PROM1,2
GO:0001933,negative regulation of protein phosphorylation,7/137,296/18888,0.02364864864864865,3.260406391793253,3.3504171549142097,0.005894952540065214,0.04333717397076803,0.030536609789018107,APOE/DMD/IGFBP3/CDKN1C/PTPRC/CDKN2A/WWTR1,7
GO:0006066,alcohol metabolic process,8/137,373/18888,0.021447721179624665,2.956967574020078,3.2629148782252493,0.0059070328872344365,0.04333717397076803,0.030536609789018107,APOE/NUDT11/AKR1C3/VLDLR/APOL1/NUDT10/AKR1C1/FGF1,8
GO:0002269,leukocyte activation involved in inflammatory response,3/137,51/18888,0.058823529411764705,8.109918419922714,4.345836604345714,0.0060297663075010504,0.04378561749444126,0.030852595896096947,IL33/TNF/PTPRC,3
GO:0006692,prostanoid metabolic process,3/137,51/18888,0.058823529411764705,8.109918419922714,4.345836604345714,0.0060297663075010504,0.04378561749444126,0.030852595896096947,PTGDS/AKR1C3/AKR1C1,3
GO:0061097,regulation of protein tyrosine kinase activity,3/137,51/18888,0.058823529411764705,8.109918419922714,4.345836604345714,0.0060297663075010504,0.04378561749444126,0.030852595896096947,PTPRC/DLG3/RELN,3
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,3/137,51/18888,0.058823529411764705,8.109918419922714,4.345836604345714,0.0060297663075010504,0.04378561749444126,0.030852595896096947,TNF/PTPRC/LTB,3
GO:0019935,cyclic-nucleotide-mediated signaling,4/137,100/18888,0.04,5.514744525547445,3.8692114218201152,0.006070356049258562,0.04378561749444126,0.030852595896096947,APOE/AKAP6/NPR1/PDE1A,4
GO:0048661,positive regulation of smooth muscle cell proliferation,4/137,100/18888,0.04,5.514744525547445,3.8692114218201152,0.006070356049258562,0.04378561749444126,0.030852595896096947,GJA1/MAP3K5/TNF/NR4A3,4
GO:0050764,regulation of phagocytosis,4/137,100/18888,0.04,5.514744525547445,3.8692114218201152,0.006070356049258562,0.04378561749444126,0.030852595896096947,C3/SYK/IL15/PTPRC,4
GO:0032102,negative regulation of response to external stimulus,9/137,456/18888,0.019736842105263157,2.721091048789858,3.180018109321235,0.006082929822294592,0.04378561749444126,0.030852595896096947,SERPINE1/APOE/SPINK5/SYK/SPP1/IL33/TNF/PTPRC/SEMA5B,9
GO:0003300,cardiac muscle hypertrophy,4/137,101/18888,0.039603960396039604,5.46014309460143,3.8415838630776946,0.006285779462005791,0.04503333079352506,0.031731770301155995,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0010906,regulation of glucose metabolic process,4/137,101/18888,0.039603960396039604,5.46014309460143,3.8415838630776946,0.006285779462005791,0.04503333079352506,0.031731770301155995,RORC/FOXO1/IGFBP3/IGF2,4
GO:0032677,regulation of interleukin-8 production,4/137,102/18888,0.0392156862745098,5.406612279948476,3.814321747564933,0.006506225722870116,0.04587601912009795,0.0323255525496172,SERPINE1/SYK/TNF/PTPRC,4
GO:0043266,regulation of potassium ion transport,4/137,102/18888,0.0392156862745098,5.406612279948476,3.814321747564933,0.006506225722870116,0.04587601912009795,0.0323255525496172,AKAP6/KCNIP3/VIP/DPP6,4
GO:0046620,regulation of organ growth,4/137,102/18888,0.0392156862745098,5.406612279948476,3.814321747564933,0.006506225722870116,0.04587601912009795,0.0323255525496172,AKAP6/BASP1/IGF2/NKX2-5,4
GO:2000177,regulation of neural precursor cell proliferation,4/137,102/18888,0.0392156862745098,5.406612279948476,3.814321747564933,0.006506225722870116,0.04587601912009795,0.0323255525496172,ASCL1/FOXO1/SIX3/VEGFC,4
GO:0022898,regulation of transmembrane transporter activity,6/137,229/18888,0.026200873362445413,3.612278073502693,3.39955851420132,0.006555200144281629,0.04587601912009795,0.0323255525496172,AKAP6/DMD/CNIH3/SHANK1/UTRN/RELN,6
GO:0050920,regulation of chemotaxis,6/137,229/18888,0.026200873362445413,3.612278073502693,3.39955851420132,0.006555200144281629,0.04587601912009795,0.0323255525496172,SERPINE1/CXCL12/CXCR4/SEMA5B/VEGFC/FGF1,6
GO:0003159,morphogenesis of an endothelium,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,CXCR4/FGF1,2
GO:0036005,response to macrophage colony-stimulating factor,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,SPP1/TNF,2
GO:0046068,cGMP metabolic process,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,NPR1/PDE1A,2
GO:0061154,endothelial tube morphogenesis,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,CXCR4/FGF1,2
GO:0072578,neurotransmitter-gated ion channel clustering,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,APOE/RELN,2
GO:0090399,replicative senescence,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,SERPINE1/CDKN2A,2
GO:0170043,non-proteinogenic amino acid biosynthetic process,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,GAD1/CPS1,2
GO:1902170,cellular response to reactive nitrogen species,2/137,17/18888,0.11764705882352941,16.219836839845428,5.366196317778432,0.00661384286135095,0.04587601912009795,0.0323255525496172,FOXO1/MAP3K5,2
GO:0030336,negative regulation of cell migration,8/137,381/18888,0.02099737532808399,2.894879016035404,3.1937838362908746,0.006683495238342732,0.04593059799471602,0.032364010382563584,SERPINE1/APOE/GJA1/NGFR/CXCL12/IGFBP3/IL33/TNF,8
GO:0097191,extrinsic apoptotic signaling pathway,6/137,230/18888,0.02608695652173913,3.596572516661377,3.386580368245673,0.006691638308750462,0.04593059799471602,0.032364010382563584,SERPINE1/FAIM2/IL33/TNF/PTPRC/LTB,6
GO:0002639,positive regulation of immunoglobulin production,3/137,53/18888,0.05660377358490566,7.803883762567139,4.239762847630163,0.006712007439594806,0.04593059799471602,0.032364010382563584,TNFRSF4/IL33/PTPRC,3
GO:0046622,positive regulation of organ growth,3/137,53/18888,0.05660377358490566,7.803883762567139,4.239762847630163,0.006712007439594806,0.04593059799471602,0.032364010382563584,AKAP6/BASP1/IGF2,3
GO:0050433,regulation of catecholamine secretion,3/137,53/18888,0.05660377358490566,7.803883762567139,4.239762847630163,0.006712007439594806,0.04593059799471602,0.032364010382563584,SYT4/CHGA/CXCL12,3
GO:0050850,positive regulation of calcium-mediated signaling,3/137,53/18888,0.05660377358490566,7.803883762567139,4.239762847630163,0.006712007439594806,0.04593059799471602,0.032364010382563584,AKAP6/SYK/TNF,3
GO:0032637,interleukin-8 production,4/137,103/18888,0.038834951456310676,5.354120898589752,3.7874163807080095,0.0067317441771876,0.04596260230151355,0.03238656153065882,SERPINE1/SYK/TNF/PTPRC,4
GO:0014897,striated muscle hypertrophy,4/137,104/18888,0.038461538461538464,5.302638966872544,3.760859358366482,0.006962383587154472,0.04732560068595868,0.033346969097542103,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0042100,B cell proliferation,4/137,104/18888,0.038461538461538464,5.302638966872544,3.760859358366482,0.006962383587154472,0.04732560068595868,0.033346969097542103,LEF1/TNFRSF4/PTPRC/CARD11,4
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8/137,385/18888,0.02077922077922078,2.8648023509337377,3.1598877494383557,0.007099632778243016,0.04813726971545088,0.03391889426387051,LEF1/RORC/C3/IL33/TNF/PTPRC/CFI/C1S,8
GO:0008406,gonad development,6/137,233/18888,0.02575107296137339,3.5502647160176686,3.348074806607731,0.007113338349170494,0.04813726971545088,0.03391889426387051,VGF/PTPRN/GJA1/AKR1C3/BASP1/NRIP1,6
GO:0016358,dendrite development,6/137,235/18888,0.02553191489361702,3.5200496971579436,3.3227544500321864,0.007404965763713349,0.04924036583098448,0.03469616727347082,APOE/SHANK1/MAP2/VLDLR/RELN/TNIK,6
GO:0002923,regulation of humoral immune response mediated by circulating immunoglobulin,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,TNF/PTPRC,2
GO:0021511,spinal cord patterning,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,ASCL1/RELN,2
GO:0032930,positive regulation of superoxide anion generation,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,SYK/CD177,2
GO:0042574,retinal metabolic process,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,AKR1C3/AKR1C1,2
GO:0042753,positive regulation of circadian rhythm,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,RORC/BMAL2,2
GO:0048535,lymph node development,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,IL15/LTB,2
GO:0150078,positive regulation of neuroinflammatory response,2/137,18/18888,0.1111111111111111,15.318734793187346,5.194987472380985,0.00740541543788397,0.04924036583098448,0.03469616727347082,IL33/TNF,2
GO:0014896,muscle hypertrophy,4/137,106/18888,0.03773584905660377,5.202589175044759,3.708758109028795,0.0074392173696106265,0.04935467818159751,0.03477671501862582,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0009166,nucleotide catabolic process,5/137,167/18888,0.029940119760479042,4.127802788583417,3.4702649453777608,0.007454949751545364,0.04935467818159751,0.03477671501862582,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0002440,production of molecular mediator of immune response,7/137,310/18888,0.02258064516129032,3.1131622321638805,3.2065924417489744,0.007523081889791543,0.0495905959560341,0.034942949416492265,SPINK5/SYK/TNFRSF4/IL33/TNF/PTPRC/NR4A3,7
GO:0030217,T cell differentiation,7/137,310/18888,0.02258064516129032,3.1131622321638805,3.2065924417489744,0.007523081889791543,0.0495905959560341,0.034942949416492265,LEF1/RORC/SPINK5/SYK/IL15/PTPRC/CARD11,7
GO:0060079,excitatory postsynaptic potential,4/137,107/18888,0.037383177570093455,5.153966846306023,3.6831984174214063,0.007685506295459991,0.05046376657265319,0.03555821035660152,GRIK5/SHANK1/GRIN1/RELN,4
GO:0030595,leukocyte chemotaxis,6/137,237/18888,0.02531645569620253,3.4903446364224338,3.297707421573422,0.007705149155588592,0.05046376657265319,0.03555821035660152,SERPINE1/CHGA/SYK/CXCL12/CXCR4/VEGFC,6
GO:0050670,regulation of lymphocyte proliferation,6/137,237/18888,0.02531645569620253,3.4903446364224338,3.297707421573422,0.007705149155588592,0.05046376657265319,0.03555821035660152,SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,6
GO:0006584,catecholamine metabolic process,3/137,56/18888,0.05357142857142857,7.3858185610010425,4.09064623245513,0.007818287788819132,0.0508772160585842,0.03584953866582311,MAOA/NPR1/MAOB,3
GO:0009712,catechol-containing compound metabolic process,3/137,56/18888,0.05357142857142857,7.3858185610010425,4.09064623245513,0.007818287788819132,0.0508772160585842,0.03584953866582311,MAOA/NPR1/MAOB,3
GO:1902895,positive regulation of miRNA transcription,3/137,56/18888,0.05357142857142857,7.3858185610010425,4.09064623245513,0.007818287788819132,0.0508772160585842,0.03584953866582311,NGFR/TNF/MYCN,3
GO:0045137,development of primary sexual characteristics,6/137,238/18888,0.025210084033613446,3.47567932282402,3.285284666446942,0.007858492244251024,0.05103003899883857,0.035957222071679375,VGF/PTPRN/GJA1/AKR1C3/BASP1/NRIP1,6
GO:0097529,myeloid leukocyte migration,6/137,239/18888,0.02510460251046025,3.461136731515133,3.2729281767187426,0.008014025741777784,0.05192952561338811,0.036591026015089984,SERPINE1/CHGA/SYK/CXCL12/CD177/VEGFC,6
GO:0042445,hormone metabolic process,6/137,240/18888,0.025,3.4467153284671537,3.2606372841200506,0.008171766713755576,0.05226822780287194,0.036829685245660264,AKR1C3/SPP1/PCSK2/AKR1C1/DIO3/CRABP2,6
GO:0002886,regulation of myeloid leukocyte mediated immunity,3/137,57/18888,0.05263157894736842,7.256242796772954,4.043373754574955,0.00820948109682188,0.05226822780287194,0.036829685245660264,C3/SYK/CD177,3
GO:0061900,glial cell activation,3/137,57/18888,0.05263157894736842,7.256242796772954,4.043373754574955,0.00820948109682188,0.05226822780287194,0.036829685245660264,IL33/TNF/PTPRC,3
GO:0006469,negative regulation of protein kinase activity,5/137,171/18888,0.029239766081871343,4.031245998207197,3.4035385536602205,0.008213902432536176,0.05226822780287194,0.036829685245660264,APOE/CDKN1C/PTPRC/CDKN2A/WWTR1,5
GO:0002283,neutrophil activation involved in immune response,2/137,19/18888,0.10526315789473684,14.512485593545907,5.036944423762041,0.00823755490602274,0.05226822780287194,0.036829685245660264,SYK/CD177,2
GO:0016202,regulation of striated muscle tissue development,2/137,19/18888,0.10526315789473684,14.512485593545907,5.036944423762041,0.00823755490602274,0.05226822780287194,0.036829685245660264,LEF1/GJA1,2
GO:0030206,chondroitin sulfate biosynthetic process,2/137,19/18888,0.10526315789473684,14.512485593545907,5.036944423762041,0.00823755490602274,0.05226822780287194,0.036829685245660264,CHST13/CHST15,2
GO:0042402,cellular biogenic amine catabolic process,2/137,19/18888,0.10526315789473684,14.512485593545907,5.036944423762041,0.00823755490602274,0.05226822780287194,0.036829685245660264,MAOA/MAOB,2
GO:0050965,detection of temperature stimulus involved in sensory perception of pain,2/137,19/18888,0.10526315789473684,14.512485593545907,5.036944423762041,0.00823755490602274,0.05226822780287194,0.036829685245660264,CXCL12/CXCR4,2
GO:0051797,regulation of hair follicle development,2/137,19/18888,0.10526315789473684,14.512485593545907,5.036944423762041,0.00823755490602274,0.05226822780287194,0.036829685245660264,NGFR/TNF,2
GO:0042326,negative regulation of phosphorylation,7/137,316/18888,0.022151898734177215,3.0540515568696294,3.1474229038796158,0.008314421251800234,0.052623947736698505,0.03708033566464616,APOE/DMD/IGFBP3/CDKN1C/PTPRC/CDKN2A/WWTR1,7
GO:0032944,regulation of mononuclear cell proliferation,6/137,241/18888,0.024896265560165973,3.432413605112518,3.2484113299515838,0.008331732188062792,0.052623947736698505,0.03708033566464616,SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,6
GO:2000146,negative regulation of cell motility,8/137,396/18888,0.020202020202020204,2.7852245078522455,3.068866862217871,0.008345344267549829,0.052623947736698505,0.03708033566464616,SERPINE1/APOE/GJA1/NGFR/CXCL12/IGFBP3/IL33/TNF,8
GO:0042116,macrophage activation,4/137,110/18888,0.03636363636363636,5.01340411413404,3.608395425500433,0.008456415791956553,0.0532143938083534,0.03749638082033042,SYK/IL33/TNF/PTPRC,4
GO:0030072,peptide hormone secretion,6/137,242/18888,0.024793388429752067,3.4182300778186643,3.236249664906929,0.00849393915325547,0.05334053970315986,0.03758526681849886,VGF/PTPRN/CHGA/FOXO1/TNF/VIP,6
GO:0060998,regulation of dendritic spine development,3/137,58/18888,0.05172413793103448,7.131135162345834,3.9972313414195666,0.008612014687897,0.05397098321860706,0.03802949531475969,APOE/SHANK1/RELN,3
GO:0001938,positive regulation of endothelial cell proliferation,4/137,111/18888,0.036036036036036036,4.968238311304004,3.5840634436899537,0.008724216993495359,0.05445053223752113,0.03836739924165541,CXCL12/IGF2/VIP/VEGFC,4
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/137,111/18888,0.036036036036036036,4.968238311304004,3.5840634436899537,0.008724216993495359,0.05445053223752113,0.03836739924165541,NGFR/SYK/MAP3K5/TNF,4
GO:0010921,regulation of phosphatase activity,3/137,59/18888,0.05084745762711865,7.010268464678957,3.9521717206572777,0.009025957621937428,0.0557166757252169,0.03925956008367873,PPP4R4/TNF/PTPRC,3
GO:0050432,catecholamine secretion,3/137,59/18888,0.05084745762711865,7.010268464678957,3.9521717206572777,0.009025957621937428,0.0557166757252169,0.03925956008367873,SYT4/CHGA/CXCL12,3
GO:0050881,musculoskeletal movement,3/137,59/18888,0.05084745762711865,7.010268464678957,3.9521717206572777,0.009025957621937428,0.0557166757252169,0.03925956008367873,ASCL1/DMD/TNF,3
GO:0032253,dense core granule localization,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,SYT4/MAP2,2
GO:0032515,negative regulation of phosphoprotein phosphatase activity,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,PPP4R4/TNF,2
GO:0032634,interleukin-5 production,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,LEF1/IL33,2
GO:0032674,regulation of interleukin-5 production,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,LEF1/IL33,2
GO:0034393,positive regulation of smooth muscle cell apoptotic process,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,FOXO1/CDKN2A,2
GO:0090026,positive regulation of monocyte chemotaxis,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,SERPINE1/CXCL12,2
GO:1900221,regulation of amyloid-beta clearance,2/137,20/18888,0.1,13.786861313868615,4.890413433216285,0.009109639969489918,0.0557166757252169,0.03925956008367873,APOE/TNF,2
GO:1901292,nucleoside phosphate catabolic process,5/137,176/18888,0.028409090909090908,3.9167219641672197,3.322927136668305,0.009236024438480822,0.05637669317248694,0.03972462721645541,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0018958,phenol-containing compound metabolic process,4/137,113/18888,0.035398230088495575,4.880304889864996,3.5362638123491204,0.009276330737401101,0.05639713428396048,0.03973903060706741,MAOA/NPR1/MAOB/DIO3,4
GO:0035249,"synaptic transmission, glutamatergic",4/137,113/18888,0.035398230088495575,4.880304889864996,3.5362638123491204,0.009276330737401101,0.05639713428396048,0.03973903060706741,GRIK5/GRIN1/TNF/RELN,4
GO:0002790,peptide secretion,6/137,247/18888,0.024291497975708502,3.3490351369721325,3.1763835868871184,0.009339187987934408,0.056666405048063244,0.03992876647347493,VGF/PTPRN/CHGA/FOXO1/TNF/VIP,6
GO:0030178,negative regulation of Wnt signaling pathway,5/137,177/18888,0.02824858757062147,3.8945935914883085,3.3071606118672525,0.009450501489842219,0.05700711135318633,0.04016883786112977,APOE/FOXO1/DRAXIN/NKX2-5/WWTR1,5
GO:0043113,receptor clustering,3/137,60/18888,0.05,6.893430656934307,3.908150368538315,0.009451375604427353,0.05700711135318633,0.04016883786112977,APOE/DLG3/RELN,3
GO:0046456,icosanoid biosynthetic process,3/137,60/18888,0.05,6.893430656934307,3.908150368538315,0.009451375604427353,0.05700711135318633,0.04016883786112977,PTGDS/AKR1C3/SYK,3
GO:0060047,heart contraction,6/137,249/18888,0.024096385542168676,3.322135256353883,3.1528654578243387,0.009693567698155936,0.05792474091618755,0.040815425843888795,GJA1/CHGA/DMD/CXCR4/TNF/NKX2-5,6
GO:0019216,regulation of lipid metabolic process,7/137,326/18888,0.02147239263803681,2.960368993775469,3.051854311509293,0.0097674932849484,0.05792474091618755,0.040815425843888795,APOE/RORC/AKR1C3/C3/TNF/FGF1/NR4A3,7
GO:0055074,calcium ion homeostasis,7/137,326/18888,0.02147239263803681,2.960368993775469,3.051854311509293,0.0097674932849484,0.05792474091618755,0.040815425843888795,APOE/AKAP6/DMD/GRIN1/TRPA1/CXCL12/PTPRC,7
GO:0048259,regulation of receptor-mediated endocytosis,4/137,115/18888,0.034782608695652174,4.79543002221517,3.489575712210967,0.00985074483722626,0.05792474091618755,0.040815425843888795,SERPINE1/C3/SYK/TF,4
GO:0099565,"chemical synaptic transmission, postsynaptic",4/137,115/18888,0.034782608695652174,4.79543002221517,3.489575712210967,0.00985074483722626,0.05792474091618755,0.040815425843888795,GRIK5/SHANK1/GRIN1/RELN,4
GO:1904035,regulation of epithelial cell apoptotic process,4/137,115/18888,0.034782608695652174,4.79543002221517,3.489575712210967,0.00985074483722626,0.05792474091618755,0.040815425843888795,SERPINE1/AKR1C3/TNF/NKX2-5,4
GO:0030900,forebrain development,8/137,408/18888,0.0196078431372549,2.703306139974238,2.9730442068330696,0.00988447482718175,0.05792474091618755,0.040815425843888795,LEF1/ASCL1/CXCL12/CXCR4/SIX3/DRAXIN/POU3F3/RELN,8
GO:0008347,glial cell migration,3/137,61/18888,0.04918032786885246,6.780423596984564,3.865125307134345,0.009888331043025781,0.05792474091618755,0.040815425843888795,NTN1/NDN/RELN,3
GO:0031102,neuron projection regeneration,3/137,61/18888,0.04918032786885246,6.780423596984564,3.865125307134345,0.009888331043025781,0.05792474091618755,0.040815425843888795,PRRX1/SPP1/GAP43,3
GO:0045599,negative regulation of fat cell differentiation,3/137,61/18888,0.04918032786885246,6.780423596984564,3.865125307134345,0.009888331043025781,0.05792474091618755,0.040815425843888795,FOXO1/TNF/WWTR1,3
GO:0050879,multicellular organismal movement,3/137,61/18888,0.04918032786885246,6.780423596984564,3.865125307134345,0.009888331043025781,0.05792474091618755,0.040815425843888795,ASCL1/DMD/TNF,3
GO:0015718,monocarboxylic acid transport,5/137,179/18888,0.027932960893854747,3.8510785792929085,3.2759704222942148,0.009889713877502307,0.05792474091618755,0.040815425843888795,APOE/SYK/TNF/AKR1C1/CRABP2,5
GO:0002888,positive regulation of myeloid leukocyte mediated immunity,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,C3/CD177,2
GO:0009310,amine catabolic process,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,MAOA/MAOB,2
GO:0016137,glycoside metabolic process,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,AKR1C3/AKR1C1,2
GO:0032616,interleukin-13 production,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,LEF1/IL33,2
GO:0032656,regulation of interleukin-13 production,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,LEF1/IL33,2
GO:0032928,regulation of superoxide anion generation,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,SYK/CD177,2
GO:0048670,regulation of collateral sprouting,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,SPP1/CRABP2,2
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,SYT4/RIMS3,2
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,AKAP6/TNF,2
GO:0106058,positive regulation of calcineurin-mediated signaling,2/137,21/18888,0.09523809523809523,13.130344108446296,4.754018860859044,0.01002105609559208,0.05792474091618755,0.040815425843888795,AKAP6/TNF,2
GO:0051251,positive regulation of lymphocyte activation,7/137,328/18888,0.021341463414634148,2.942317963325619,3.0331774560648332,0.010079076341691704,0.05804026602800581,0.040896828135205864,LEF1/SYK/TNFRSF4/IL15/IGF2/PTPRC/CARD11,7
GO:1902105,regulation of leukocyte differentiation,7/137,328/18888,0.021341463414634148,2.942317963325619,3.0331774560648332,0.010079076341691704,0.05804026602800581,0.040896828135205864,LEF1/SPINK5/SYK/IL15/TNF/PTPRC/CARD11,7
GO:0044344,cellular response to fibroblast growth factor stimulus,4/137,116/18888,0.034482758620689655,4.754090108230556,3.4666338335305324,0.010146419089724386,0.058318024598566526,0.04109254475231821,NGFR/FAM20C/CPS1/FGF1,4
GO:0002712,regulation of B cell mediated immunity,3/137,62/18888,0.04838709677419355,6.671061926065458,3.823056919590703,0.010336883103433904,0.05889205558551873,0.041497023370771456,C3/TNF/PTPRC,3
GO:0002889,regulation of immunoglobulin mediated immune response,3/137,62/18888,0.04838709677419355,6.671061926065458,3.823056919590703,0.010336883103433904,0.05889205558551873,0.041497023370771456,C3/TNF/PTPRC,3
GO:0034113,heterotypic cell-cell adhesion,3/137,62/18888,0.04838709677419355,6.671061926065458,3.823056919590703,0.010336883103433904,0.05889205558551873,0.041497023370771456,TNF/PTPRC/ITGA7,3
GO:2000351,regulation of endothelial cell apoptotic process,3/137,62/18888,0.04838709677419355,6.671061926065458,3.823056919590703,0.010336883103433904,0.05889205558551873,0.041497023370771456,SERPINE1/AKR1C3/TNF,3
GO:0042129,regulation of T cell proliferation,5/137,181/18888,0.027624309392265192,3.8085252248255834,3.245227144840548,0.010342772540576028,0.05889205558551873,0.041497023370771456,SYK/IL15/IGF2/PTPRC/CARD11,5
GO:0042742,defense response to bacterium,7/137,330/18888,0.021212121212121213,2.9244857332448575,3.0146412504824456,0.010397866157077485,0.05909550747001952,0.041640381375888075,SERPINE1/VGF/CHGA/SPINK5/SYK/TNF/TF,7
GO:0050870,positive regulation of T cell activation,6/137,253/18888,0.023715415019762844,3.26961137878307,3.106537632542116,0.010430968761054557,0.05917345103854741,0.04169530263908131,LEF1/SYK/IL15/IGF2/PTPRC/CARD11,6
GO:0033673,negative regulation of kinase activity,5/137,182/18888,0.027472527472527472,3.7875992620518164,3.2300193696271955,0.010574556782193325,0.05987671113034142,0.04219083977350056,APOE/CDKN1C/PTPRC/CDKN2A/WWTR1,5
GO:0030198,extracellular matrix organization,7/137,332/18888,0.02108433734939759,2.906868349309647,2.9962436527584866,0.010723955270201547,0.06033818307802993,0.042516006080021776,ADAMTS17/ADAMTS10/LUM/SPINK5/MMP19/ADAMTS16/TNF,7
GO:0070371,ERK1 and ERK2 cascade,7/137,332/18888,0.02108433734939759,2.906868349309647,2.9962436527584866,0.010723955270201547,0.06033818307802993,0.042516006080021776,APOE/SYK/TNF/PTPRC/PDGFC/TF/FGF1,7
GO:0042303,molting cycle,4/137,118/18888,0.03389830508474576,4.673512309785971,3.4215266234151036,0.010754905502768114,0.06033818307802993,0.042516006080021776,NGFR/LDB2/SPINK5/TNF,4
GO:0042633,hair cycle,4/137,118/18888,0.03389830508474576,4.673512309785971,3.4215266234151036,0.010754905502768114,0.06033818307802993,0.042516006080021776,NGFR/LDB2/SPINK5/TNF,4
GO:0051224,negative regulation of protein transport,4/137,118/18888,0.03389830508474576,4.673512309785971,3.4215266234151036,0.010754905502768114,0.06033818307802993,0.042516006080021776,SYT4/APOE/CHGA/FOXO1,4
GO:0032757,positive regulation of interleukin-8 production,3/137,63/18888,0.047619047619047616,6.565172054223148,3.7819077815287563,0.010797087764554352,0.06046369148150437,0.04260444288360124,SERPINE1/SYK/TNF,3
GO:0043062,extracellular structure organization,7/137,333/18888,0.021021021021021023,2.8981390149273363,2.9870962052639416,0.010889765894454317,0.0605498888179934,0.04266517998729409,ADAMTS17/ADAMTS10/LUM/SPINK5/MMP19/ADAMTS16/TNF,7
GO:0010923,negative regulation of phosphatase activity,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,PPP4R4/TNF,2
GO:0035235,ionotropic glutamate receptor signaling pathway,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,GRIK5/GRIN1,2
GO:0061318,renal filtration cell differentiation,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,BASP1/PROM1,2
GO:0072112,podocyte differentiation,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,BASP1/PROM1,2
GO:0072234,metanephric nephron tubule development,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,POU3F3/WWTR1,2
GO:1900273,positive regulation of long-term synaptic potentiation,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,SLC18A3/RELN,2
GO:1902644,tertiary alcohol metabolic process,2/137,22/18888,0.09090909090909091,12.533510285335105,4.626605709383083,0.010971195450966694,0.0605498888179934,0.04266517998729409,AKR1C3/AKR1C1,2
GO:0045229,external encapsulating structure organization,7/137,334/18888,0.020958083832335328,2.889461952008392,2.9779826630043296,0.01105743589781956,0.06086291315467366,0.04288574586983455,ADAMTS17/ADAMTS10/LUM/SPINK5/MMP19/ADAMTS16/TNF,7
GO:0043500,muscle adaptation,4/137,119/18888,0.03361344537815126,4.6342390970986935,3.3993506602828494,0.011067797116921324,0.06086291315467366,0.04288574586983455,AKAP6/TRIM63/FOXO1/NR4A3,4
GO:0030888,regulation of B cell proliferation,3/137,64/18888,0.046875,6.462591240875913,3.741642506954708,0.011268997872949785,0.06185788041050853,0.043586828198478623,TNFRSF4/PTPRC/CARD11,3
GO:0045862,positive regulation of proteolysis,7/137,336/18888,0.020833333333333332,2.872262773722628,2.9598563223277656,0.011398399908371663,0.06245586448895927,0.04400818484891488,APOE/CBFA2T3/NGFR/SYK/MAP3K5/IL33/TNF,7
GO:1905952,regulation of lipid localization,5/137,186/18888,0.026881720430107527,3.70614551448081,3.1702473509042135,0.011537300897153418,0.06310366010414378,0.04446464012994611,APOE/C3/SYK/SPP1/TNF,5
GO:0002698,negative regulation of immune effector process,4/137,121/18888,0.03305785123966942,4.55764010375822,3.3557285827498924,0.01171107089127068,0.06336851088412292,0.044651261549376806,SPINK5/IL33/TNF/PTPRC,4
GO:1905330,regulation of morphogenesis of an epithelium,3/137,65/18888,0.046153846153846156,6.3631667602470525,3.7022276072212814,0.011752663196608549,0.06336851088412292,0.044651261549376806,GJA1/TNF/FGF1,3
GO:0008217,regulation of blood pressure,5/137,187/18888,0.026737967914438502,3.686326554510324,3.1555622366689433,0.011787009948075685,0.06336851088412292,0.044651261549376806,CHGA/ADAMTS16/TNF/NPR1/VEGFC,5
GO:0045766,positive regulation of angiogenesis,5/137,187/18888,0.026737967914438502,3.686326554510324,3.1555622366689433,0.011787009948075685,0.06336851088412292,0.044651261549376806,SERPINE1/C3/CXCR4/VEGFC/FGF1,5
GO:0046890,regulation of lipid biosynthetic process,5/137,187/18888,0.026737967914438502,3.686326554510324,3.1555622366689433,0.011787009948075685,0.06336851088412292,0.044651261549376806,APOE/AKR1C3/C3/TNF/FGF1,5
GO:0032409,regulation of transporter activity,6/137,260/18888,0.023076923076923078,3.1815833801235263,3.0276448676263095,0.01181604952112511,0.06336851088412292,0.044651261549376806,AKAP6/DMD/CNIH3/SHANK1/UTRN/RELN,6
GO:0010560,positive regulation of glycoprotein biosynthetic process,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,IL15/IL33,2
GO:0010893,positive regulation of steroid biosynthetic process,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,TNF/FGF1,2
GO:0031338,regulation of vesicle fusion,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,SYT4/GRIK5,2
GO:0032252,secretory granule localization,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,SYT4/MAP2,2
GO:0033762,response to glucagon,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,ASS1/CPS1,2
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,CDKN1C/CDKN2A,2
GO:0050961,detection of temperature stimulus involved in sensory perception,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,CXCL12/CXCR4,2
GO:0072202,cell differentiation involved in metanephros development,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,POU3F3/WWTR1,2
GO:0072311,glomerular epithelial cell differentiation,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,BASP1/PROM1,2
GO:0072574,hepatocyte proliferation,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,TNF/FGF1,2
GO:0072575,epithelial cell proliferation involved in liver morphogenesis,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,TNF/FGF1,2
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,2/137,23/18888,0.08695652173913043,11.988575055537924,4.507196049282682,0.011959456837894757,0.06336851088412292,0.044651261549376806,CDKN1C/CDKN2A,2
GO:0048771,tissue remodeling,5/137,188/18888,0.026595744680851064,3.6667184345395247,3.1409776151774813,0.01204037603660481,0.0634727896388587,0.044724739336479385,GJA1/SYK/SPP1/IL15/TF,5
GO:0030326,embryonic limb morphogenesis,4/137,122/18888,0.03278688524590164,4.5202823979897095,3.334272728399463,0.012041528571723194,0.0634727896388587,0.044724739336479385,PRRX1/LEF1/GJA1/CRABP2,4
GO:0035113,embryonic appendage morphogenesis,4/137,122/18888,0.03278688524590164,4.5202823979897095,3.334272728399463,0.012041528571723194,0.0634727896388587,0.044724739336479385,PRRX1/LEF1/GJA1/CRABP2,4
GO:0015800,acidic amino acid transport,3/137,66/18888,0.045454545454545456,6.266755142667552,3.6636313617543017,0.012248130478025334,0.06422902786758303,0.045257606378379014,SYT4/GJA1/TNF,3
GO:0031100,animal organ regeneration,3/137,66/18888,0.045454545454545456,6.266755142667552,3.6636313617543017,0.012248130478025334,0.06422902786758303,0.045257606378379014,CXCL12/TNF/NR4A3,3
GO:0045453,bone resorption,3/137,66/18888,0.045454545454545456,6.266755142667552,3.6636313617543017,0.012248130478025334,0.06422902786758303,0.045257606378379014,SYK/SPP1/TF,3
GO:0045834,positive regulation of lipid metabolic process,4/137,123/18888,0.032520325203252036,4.48353213459142,3.3130473992202942,0.012377916026911831,0.06479828424379916,0.04565872066982192,APOE/TNF/FGF1/NR4A3,4
GO:0050727,regulation of inflammatory response,8/137,425/18888,0.018823529411764704,2.595173894375268,2.843026584117019,0.01241498373880725,0.06488104515554748,0.04571703637055373,SERPINE1/APOE/C3/SYK/IL15/IL33/TNF/PTPRC,8
GO:1902107,positive regulation of leukocyte differentiation,5/137,190/18888,0.02631578947368421,3.628121398386477,3.112104717487236,0.012558173426905735,0.06540536740429403,0.04608648879318918,LEF1/SYK/IL15/TNF/PTPRC,5
GO:1903708,positive regulation of hemopoiesis,5/137,190/18888,0.02631578947368421,3.628121398386477,3.112104717487236,0.012558173426905735,0.06540536740429403,0.04608648879318918,LEF1/SYK/IL15/TNF/PTPRC,5
GO:0071774,response to fibroblast growth factor,4/137,124/18888,0.03225806451612903,4.447374617376972,3.292048061084652,0.012720269362467469,0.0658707504587391,0.04641441097716906,NGFR/FAM20C/CPS1/FGF1,4
GO:0006956,complement activation,3/137,67/18888,0.04477611940298507,6.173221483821767,3.625823699400731,0.0127554434866038,0.0658707504587391,0.04641441097716906,C3/CFI/C1S,3
GO:0046888,negative regulation of hormone secretion,3/137,67/18888,0.04477611940298507,6.173221483821767,3.625823699400731,0.0127554434866038,0.0658707504587391,0.04641441097716906,GJA1/CHGA/FOXO1,3
GO:0048857,neural nucleus development,3/137,67/18888,0.04477611940298507,6.173221483821767,3.625823699400731,0.0127554434866038,0.0658707504587391,0.04641441097716906,ASCL1/BASP1/MAOB,3
GO:2000630,positive regulation of miRNA metabolic process,3/137,67/18888,0.04477611940298507,6.173221483821767,3.625823699400731,0.0127554434866038,0.0658707504587391,0.04641441097716906,NGFR/TNF/MYCN,3
GO:0006816,calcium ion transport,8/137,428/18888,0.018691588785046728,2.5769834231530115,2.8207378175588906,0.012906884930961187,0.06616188592043992,0.046619553333606525,AKAP6/DMD/GRIN1/TRPA1/CXCL12/CXCR4/PTPRC/TRPM3,8
GO:0001779,natural killer cell differentiation,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,IL15/PTPRC,2
GO:0043302,positive regulation of leukocyte degranulation,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,SYK/CD177,2
GO:0045061,thymic T cell selection,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,PTPRC/CARD11,2
GO:0048634,regulation of muscle organ development,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,LEF1/GJA1,2
GO:0050650,chondroitin sulfate proteoglycan biosynthetic process,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,CHST13/CHST15,2
GO:0097150,neuronal stem cell population maintenance,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,PRRX1/FOXO1,2
GO:1903861,positive regulation of dendrite extension,2/137,24/18888,0.08333333333333333,11.489051094890511,4.394955527247622,0.012985245631174152,0.06616188592043992,0.046619553333606525,SYT4/CXCR4,2
GO:0006690,icosanoid metabolic process,4/137,125/18888,0.032,4.411795620437957,3.2712703055765955,0.013068624018802254,0.06625765098442454,0.04668703213119244,PTGDS/AKR1C3/SYK/AKR1C1,4
GO:1903305,regulation of regulated secretory pathway,4/137,125/18888,0.032,4.411795620437957,3.2712703055765955,0.013068624018802254,0.06625765098442454,0.04668703213119244,SYT4/SYK/RIMS3/CD177,4
GO:0006006,glucose metabolic process,5/137,192/18888,0.026041666666666668,3.5903284671532845,3.0836186230690092,0.013090879273790303,0.06625765098442454,0.04668703213119244,RORC/FOXO1/IGFBP3/TNF/IGF2,5
GO:0046777,protein autophosphorylation,5/137,192/18888,0.026041666666666668,3.5903284671532845,3.0836186230690092,0.013090879273790303,0.06625765098442454,0.04668703213119244,FAM20C/PTPRC/PDGFC/TNIK/VEGFC,5
GO:0072089,stem cell proliferation,4/137,126/18888,0.031746031746031744,4.376781369482099,3.2507098455231733,0.013423014769494755,0.06782622694784436,0.04779229552819412,PRRX1/GJA1/PTPRC/VEGFC,4
GO:0071902,positive regulation of protein serine/threonine kinase activity,4/137,127/18888,0.031496062992125984,4.342318524053106,3.230362510718696,0.013783475719852783,0.06926399964435495,0.048805391209704466,MAP3K5/TNF/PDGFC/FGF1,4
GO:2001056,positive regulation of cysteine-type endopeptidase activity,4/137,127/18888,0.031496062992125984,4.342318524053106,3.230362510718696,0.013783475719852783,0.06926399964435495,0.048805391209704466,NGFR/SYK/MAP3K5/TNF,4
GO:0034765,regulation of monoatomic ion transmembrane transport,7/137,349/18888,0.02005730659025788,2.7652730428962835,2.845188255494737,0.01380335213164537,0.06926399964435495,0.048805391209704466,AKAP6/DMD/GRIN1/KCNIP3/UTRN/DPP6/RELN,7
GO:0002070,epithelial cell maturation,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,GJA1/SIX3,2
GO:0031954,positive regulation of protein autophosphorylation,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,PDGFC/VEGFC,2
GO:0038095,Fc-epsilon receptor signaling pathway,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,SYK/NR4A3,2
GO:0045540,regulation of cholesterol biosynthetic process,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,APOE/FGF1,2
GO:0050927,positive regulation of positive chemotaxis,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,CXCL12/VEGFC,2
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,AKAP6/DMD,2
GO:0060561,apoptotic process involved in morphogenesis,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,LEF1/NKX2-5,2
GO:0072170,metanephric tubule development,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,POU3F3/WWTR1,2
GO:0072243,metanephric nephron epithelium development,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,POU3F3/WWTR1,2
GO:0072576,liver morphogenesis,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,TNF/FGF1,2
GO:0106118,regulation of sterol biosynthetic process,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,APOE/FGF1,2
GO:1901863,positive regulation of muscle tissue development,2/137,25/18888,0.08,11.02948905109489,4.28916731048623,0.014047973715549054,0.06926399964435495,0.048805391209704466,GJA1/IGF2,2
GO:0099173,postsynapse organization,5/137,196/18888,0.025510204081632654,3.517056457619544,3.0277684778548077,0.014201744863745562,0.06990923439379267,0.04926004203163358,APOE/NEFH/SHANK1/GAP43/RELN,5
GO:0098773,skin epidermis development,4/137,129/18888,0.031007751937984496,4.274995756238329,3.190291096489662,0.014522741292037147,0.07137424544814391,0.050292330637565705,NGFR/LDB2/SPINK5/TNF,4
GO:0070482,response to oxygen levels,7/137,354/18888,0.01977401129943503,2.7262155140418165,2.80247420533386,0.014818781195016588,0.07254670686898719,0.05111848042123916,CBFA2T3/FOXO1/CXCL12/CXCR4/TNF/DIO3/VEGFC,7
GO:0030099,myeloid cell differentiation,8/137,439/18888,0.018223234624145785,2.512412084531866,2.740599286594515,0.014833619125792558,0.07254670686898719,0.05111848042123916,LEF1/CBFA2T3/FAM20C/IL15/IL33/TNF/CDKN1C/TF,8
GO:0043393,regulation of protein binding,4/137,130/18888,0.03076923076923077,4.242111173498035,3.1705592255198667,0.014901610772609873,0.07254670686898719,0.05111848042123916,APOE/MAP2/GREM2/IFIT1,4
GO:0050864,regulation of B cell activation,4/137,130/18888,0.03076923076923077,4.242111173498035,3.1705592255198667,0.014901610772609873,0.07254670686898719,0.05111848042123916,SYK/TNFRSF4/PTPRC/CARD11,4
GO:0032835,glomerulus development,3/137,71/18888,0.04225352112676056,5.825434357972654,3.481929318298505,0.014903927000935442,0.07254670686898719,0.05111848042123916,BASP1/WWTR1/PROM1,3
GO:0071677,positive regulation of mononuclear cell migration,3/137,71/18888,0.04225352112676056,5.825434357972654,3.481929318298505,0.014903927000935442,0.07254670686898719,0.05111848042123916,SERPINE1/CXCL12/TNF,3
GO:0030204,chondroitin sulfate metabolic process,2/137,26/18888,0.07692307692307693,10.605277933745088,4.18921159074373,0.015147059423690941,0.07326279771965888,0.051623058474602704,CHST13/CHST15,2
GO:0050926,regulation of positive chemotaxis,2/137,26/18888,0.07692307692307693,10.605277933745088,4.18921159074373,0.015147059423690941,0.07326279771965888,0.051623058474602704,CXCL12/VEGFC,2
GO:0072010,glomerular epithelium development,2/137,26/18888,0.07692307692307693,10.605277933745088,4.18921159074373,0.015147059423690941,0.07326279771965888,0.051623058474602704,BASP1/PROM1,2
GO:1903020,positive regulation of glycoprotein metabolic process,2/137,26/18888,0.07692307692307693,10.605277933745088,4.18921159074373,0.015147059423690941,0.07326279771965888,0.051623058474602704,IL15/IL33,2
GO:0001704,formation of primary germ layer,4/137,131/18888,0.030534351145038167,4.209728645456065,3.151024889359748,0.015286680168654102,0.0738211200549562,0.05201646832871474,LEF1/GJA1/LAMB3/ITGA7,4
GO:0007369,gastrulation,5/137,200/18888,0.025,3.4467153284671537,2.973353770381773,0.015374396267401282,0.0738929067647523,0.052067051293505195,LEF1/GJA1/LAMB3/ITGA7/NR4A3,5
GO:0030073,insulin secretion,5/137,200/18888,0.025,3.4467153284671537,2.973353770381773,0.015374396267401282,0.0738929067647523,0.052067051293505195,VGF/PTPRN/CHGA/FOXO1/TNF,5
GO:0006024,glycosaminoglycan biosynthetic process,3/137,72/18888,0.041666666666666664,5.744525547445256,3.4476640657478392,0.015471024712541522,0.0738929067647523,0.052067051293505195,CHST1/CHST13/CHST15,3
GO:0032722,positive regulation of chemokine production,3/137,72/18888,0.041666666666666664,5.744525547445256,3.4476640657478392,0.015471024712541522,0.0738929067647523,0.052067051293505195,SYK/IL33/TNF,3
GO:0043954,cellular component maintenance,3/137,72/18888,0.041666666666666664,5.744525547445256,3.4476640657478392,0.015471024712541522,0.0738929067647523,0.052067051293505195,APOE/SHANK1/CD177,3
GO:0050766,positive regulation of phagocytosis,3/137,72/18888,0.041666666666666664,5.744525547445256,3.4476640657478392,0.015471024712541522,0.0738929067647523,0.052067051293505195,C3/IL15/PTPRC,3
GO:0051148,negative regulation of muscle cell differentiation,3/137,72/18888,0.041666666666666664,5.744525547445256,3.4476640657478392,0.015471024712541522,0.0738929067647523,0.052067051293505195,BHLHE41/IGF2/NKX2-5,3
GO:0046942,carboxylic acid transport,7/137,358/18888,0.019553072625698324,2.695755005505036,2.768831124152412,0.01566875639513973,0.07472038205932258,0.05265011400537906,SYT4/APOE/GJA1/SYK/TNF/AKR1C1/CRABP2,7
GO:0015849,organic acid transport,7/137,359/18888,0.019498607242339833,2.6882459386373343,2.760492071230876,0.015886566822493637,0.0755971513332346,0.053267910662136396,SYT4/APOE/GJA1/SYK/TNF/AKR1C1/CRABP2,7
GO:0030858,positive regulation of epithelial cell differentiation,3/137,73/18888,0.0410958904109589,5.665833416658334,3.414036066460297,0.016050171183836597,0.0755971513332346,0.053267910662136396,SERPINE1/LEF1/PROM1,3
GO:0045661,regulation of myoblast differentiation,3/137,73/18888,0.0410958904109589,5.665833416658334,3.414036066460297,0.016050171183836597,0.0755971513332346,0.053267910662136396,IGFBP3/MAP3K5/TNF,3
GO:0046635,positive regulation of alpha-beta T cell activation,3/137,73/18888,0.0410958904109589,5.665833416658334,3.414036066460297,0.016050171183836597,0.0755971513332346,0.053267910662136396,SYK/PTPRC/CARD11,3
GO:0060420,regulation of heart growth,3/137,73/18888,0.0410958904109589,5.665833416658334,3.414036066460297,0.016050171183836597,0.0755971513332346,0.053267910662136396,AKAP6/BASP1/NKX2-5,3
GO:0170041,non-proteinogenic amino acid metabolic process,3/137,73/18888,0.0410958904109589,5.665833416658334,3.414036066460297,0.016050171183836597,0.0755971513332346,0.053267910662136396,GAD1/ASS1/CPS1,3
GO:0021782,glial cell development,4/137,133/18888,0.03007518796992481,4.14642445529883,3.1125343427182663,0.016075541027283504,0.0755971513332346,0.053267910662136396,ASCL1/TNF/B4GALT6/TPPP,4
GO:0045621,positive regulation of lymphocyte differentiation,4/137,133/18888,0.03007518796992481,4.14642445529883,3.1125343427182663,0.016075541027283504,0.0755971513332346,0.053267910662136396,LEF1/SYK/IL15/PTPRC,4
GO:1904950,negative regulation of establishment of protein localization,4/137,133/18888,0.03007518796992481,4.14642445529883,3.1125343427182663,0.016075541027283504,0.0755971513332346,0.053267910662136396,SYT4/APOE/CHGA/FOXO1,4
GO:0031346,positive regulation of cell projection organization,7/137,360/18888,0.019444444444444445,2.6807785888077857,2.752181322459229,0.016106525271363515,0.07562633096646376,0.053288471464608356,NTN1/APOE/CXCL12/VLDLR/RIT2/RELN/CRABP2,7
GO:0021846,cell proliferation in forebrain,2/137,27/18888,0.07407407407407407,10.2124898621249,4.09454929776017,0.016281927474726267,0.07586632466086193,0.05345757787202212,SIX3/POU3F3,2
GO:0032753,positive regulation of interleukin-4 production,2/137,27/18888,0.07407407407407407,10.2124898621249,4.09454929776017,0.016281927474726267,0.07586632466086193,0.05345757787202212,SYK/IL33,2
GO:0051043,regulation of membrane protein ectodomain proteolysis,2/137,27/18888,0.07407407407407407,10.2124898621249,4.09454929776017,0.016281927474726267,0.07586632466086193,0.05345757787202212,APOE/TNF,2
GO:0061098,positive regulation of protein tyrosine kinase activity,2/137,27/18888,0.07407407407407407,10.2124898621249,4.09454929776017,0.016281927474726267,0.07586632466086193,0.05345757787202212,DLG3/RELN,2
GO:1903859,regulation of dendrite extension,2/137,27/18888,0.07407407407407407,10.2124898621249,4.09454929776017,0.016281927474726267,0.07586632466086193,0.05345757787202212,SYT4/CXCR4,2
GO:0009064,glutamine family amino acid metabolic process,3/137,74/18888,0.04054054054054054,5.589268100217006,3.381024176891232,0.016641390784476812,0.07718772746842437,0.0543886760081365,GAD1/ASS1/CPS1,3
GO:0048663,neuron fate commitment,3/137,74/18888,0.04054054054054054,5.589268100217006,3.381024176891232,0.016641390784476812,0.07718772746842437,0.0543886760081365,PRRX1/ASCL1/LMO4,3
GO:0051937,catecholamine transport,3/137,74/18888,0.04054054054054054,5.589268100217006,3.381024176891232,0.016641390784476812,0.07718772746842437,0.0543886760081365,SYT4/CHGA/CXCL12,3
GO:0045123,cellular extravasation,3/137,75/18888,0.04,5.514744525547445,3.348608234246038,0.01724470530672752,0.07914343418040277,0.055766722780769426,CXCL12/TNF/CD177,3
GO:1902893,regulation of miRNA transcription,3/137,75/18888,0.04,5.514744525547445,3.348608234246038,0.01724470530672752,0.07914343418040277,0.055766722780769426,NGFR/TNF/MYCN,3
GO:0006836,neurotransmitter transport,5/137,206/18888,0.024271844660194174,3.3463255616185954,2.8942747455191795,0.017252199141078194,0.07914343418040277,0.055766722780769426,SYT4/CHAT/GRIK5/RIMS3/SLC18A3,5
GO:0002675,positive regulation of acute inflammatory response,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,C3/TNF,2
GO:0014047,glutamate secretion,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,SYT4/GJA1,2
GO:0030325,adrenal gland development,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,ASCL1/CDKN1C,2
GO:0032770,positive regulation of monooxygenase activity,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,APOE/TNF,2
GO:0035308,negative regulation of protein dephosphorylation,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,PPP4R4/TNF,2
GO:0042634,regulation of hair cycle,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,NGFR/TNF,2
GO:0043507,positive regulation of JUN kinase activity,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,MAP3K5/TNF,2
GO:0048668,collateral sprouting,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,SPP1/CRABP2,2
GO:0048714,positive regulation of oligodendrocyte differentiation,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,IL33/CXCR4,2
GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,PTPRC/CARD11,2
GO:0090025,regulation of monocyte chemotaxis,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,SERPINE1/CXCL12,2
GO:0090594,inflammatory response to wounding,2/137,28/18888,0.07142857142857142,9.847758081334723,4.004709036768857,0.01745200891330638,0.07914343418040277,0.055766722780769426,IL33/TNF,2
GO:0035270,endocrine system development,4/137,137/18888,0.029197080291970802,4.02536096755288,3.0377695389928676,0.017728969531364176,0.0802801409639814,0.056567678826451674,ASCL1/CDKN1C/SIX3/NKX2-5,4
GO:0006023,aminoglycan biosynthetic process,3/137,76/18888,0.039473684210526314,5.442182097579716,3.316768998522226,0.017860134012092303,0.08050480255620747,0.05672598179703797,CHST1/CHST13/CHST15,3
GO:0061614,miRNA transcription,3/137,76/18888,0.039473684210526314,5.442182097579716,3.316768998522226,0.017860134012092303,0.08050480255620747,0.05672598179703797,NGFR/TNF/MYCN,3
GO:0008016,regulation of heart contraction,5/137,208/18888,0.02403846153846154,3.3141493542953397,2.868561551413636,0.01791047212833056,0.08050480255620747,0.05672598179703797,GJA1/CHGA/DMD/TNF/NKX2-5,5
GO:0016064,immunoglobulin mediated immune response,5/137,208/18888,0.02403846153846154,3.3141493542953397,2.868561551413636,0.01791047212833056,0.08050480255620747,0.05672598179703797,C3/TNF/PTPRC/CFI/C1S,5
GO:0043123,positive regulation of canonical NF-kappaB signal transduction,5/137,208/18888,0.02403846153846154,3.3141493542953397,2.868561551413636,0.01791047212833056,0.08050480255620747,0.05672598179703797,GJA1/TNF/S100A13/CARD11/LTB,5
GO:0061041,regulation of wound healing,4/137,138/18888,0.028985507246376812,3.9961916851793085,3.0195210284626626,0.018158261569936465,0.08149855045800895,0.05742620493402507,SERPINE1/APOE/CXCR4/TNF,4
GO:0001937,negative regulation of endothelial cell proliferation,3/137,77/18888,0.03896103896103896,5.371504408000758,3.2854880986910238,0.01848769367733553,0.08225137187059481,0.0579566643897445,APOE/NGFR/TNF,3
GO:0032890,regulation of organic acid transport,3/137,77/18888,0.03896103896103896,5.371504408000758,3.2854880986910238,0.01848769367733553,0.08225137187059481,0.0579566643897445,SYT4/SYK/TNF,3
GO:0045669,positive regulation of osteoblast differentiation,3/137,77/18888,0.03896103896103896,5.371504408000758,3.2854880986910238,0.01848769367733553,0.08225137187059481,0.0579566643897445,FAM20C/CEBPD/WWTR1,3
GO:0045921,positive regulation of exocytosis,3/137,77/18888,0.03896103896103896,5.371504408000758,3.2854880986910238,0.01848769367733553,0.08225137187059481,0.0579566643897445,SYT4/SYK/CD177,3
GO:0055117,regulation of cardiac muscle contraction,3/137,77/18888,0.03896103896103896,5.371504408000758,3.2854880986910238,0.01848769367733553,0.08225137187059481,0.0579566643897445,CHGA/DMD/NKX2-5,3
GO:0061045,negative regulation of wound healing,3/137,77/18888,0.03896103896103896,5.371504408000758,3.2854880986910238,0.01848769367733553,0.08225137187059481,0.0579566643897445,SERPINE1/APOE/TNF,3
GO:0072207,metanephric epithelium development,2/137,29/18888,0.06896551724137931,9.508180216461112,3.9192765216228715,0.018656741049215372,0.08265991596501583,0.058244536220089446,POU3F3/WWTR1,2
GO:0090311,regulation of protein deacetylation,2/137,29/18888,0.06896551724137931,9.508180216461112,3.9192765216228715,0.018656741049215372,0.08265991596501583,0.058244536220089446,NDN/TPPP,2
GO:0007548,sex differentiation,6/137,288/18888,0.020833333333333332,2.872262773722628,2.73675632765964,0.018660773951473104,0.08265991596501583,0.058244536220089446,VGF/PTPRN/GJA1/AKR1C3/BASP1/NRIP1,6
GO:0045165,cell fate commitment,6/137,289/18888,0.020761245674740483,2.862324148208016,2.72702397217195,0.018946421763457837,0.08380359307546857,0.05905040375704707,PRRX1/ASCL1/LMO4/DSCAML1/NKX2-5/GAP43,6
GO:0043467,regulation of generation of precursor metabolites and energy,4/137,140/18888,0.02857142857142857,3.9391032325338893,2.9835336653608513,0.019036152135827204,0.08407863432495605,0.05924420567216845,CBFA2T3/TNF/PHLDA2/IGF2,4
GO:0010827,regulation of glucose transmembrane transport,3/137,78/18888,0.038461538461538464,5.302638966872544,3.254747982673238,0.01912739863990467,0.08411645626655484,0.05927085609180227,C3/TNF/NR4A3,3
GO:0035418,protein localization to synapse,3/137,78/18888,0.038461538461538464,5.302638966872544,3.254747982673238,0.01912739863990467,0.08411645626655484,0.05927085609180227,SHANK1/LGI1/RELN,3
GO:0050772,positive regulation of axonogenesis,3/137,78/18888,0.038461538461538464,5.302638966872544,3.254747982673238,0.01912739863990467,0.08411645626655484,0.05927085609180227,NTN1/CXCL12/CRABP2,3
GO:0019724,B cell mediated immunity,5/137,212/18888,0.02358490566037736,3.251618234402975,2.818060494419716,0.01927645945774811,0.0846500061367586,0.0596468105599082,C3/TNF/PTPRC/CFI/C1S,5
GO:0008203,cholesterol metabolic process,4/137,141/18888,0.028368794326241134,3.9111663301754933,2.9657889526249965,0.019484800714527833,0.08544197094933756,0.06020485157256559,APOE/VLDLR/APOL1/FGF1,4
GO:0051051,negative regulation of transport,8/137,462/18888,0.017316017316017316,2.3873352924447815,2.580574762428627,0.019527049086143305,0.08550438136428891,0.060248827732372986,SYT4/APOE/GJA1/CHGA/FOXO1/TNF/VIP/MAOB,8
GO:0051348,negative regulation of transferase activity,5/137,213/18888,0.023474178403755867,3.2363524210959183,2.805622897402377,0.019628365505499235,0.08582488756845796,0.06047466555230725,APOE/CDKN1C/PTPRC/CDKN2A/WWTR1,5
GO:0035304,regulation of protein dephosphorylation,3/137,79/18888,0.0379746835443038,5.23551695463365,3.2245318707969117,0.019779260842759654,0.08636095006023242,0.06085239048529173,PPP4R4/TNF/PTPRC,3
GO:1901653,cellular response to peptide,7/137,376/18888,0.018617021276595744,2.5667029041776672,2.6229104111477266,0.019926512393625258,0.08681416353667518,0.06117173763724473,GJA1/FOXO1/TNF/ASS1/IGF2/CPS1/NR4A3,7
GO:0050921,positive regulation of chemotaxis,4/137,142/18888,0.028169014084507043,3.883622905315103,2.9482064313446896,0.01993995040603188,0.08681416353667518,0.06117173763724473,SERPINE1/CXCL12/CXCR4/VEGFC,4
GO:0070374,positive regulation of ERK1 and ERK2 cascade,5/137,215/18888,0.023255813953488372,3.206246817178747,2.7809669935344252,0.020344795579720517,0.0883202243339834,0.0622329510637815,APOE/TNF/PTPRC/PDGFC/FGF1,5
GO:0001889,liver development,4/137,143/18888,0.027972027972027972,3.8564647031800314,2.9307833466180364,0.020401624559455538,0.0883202243339834,0.0622329510637815,TNF/ASS1/CPS1/FGF1,4
GO:0014074,response to purine-containing compound,4/137,143/18888,0.027972027972027972,3.8564647031800314,2.9307833466180364,0.020401624559455538,0.0883202243339834,0.0622329510637815,VGF/AKAP6/ASS1/CPS1,4
GO:2001235,positive regulation of apoptotic signaling pathway,4/137,143/18888,0.027972027972027972,3.8564647031800314,2.9307833466180364,0.020401624559455538,0.0883202243339834,0.0622329510637815,NGFR/TNF/PTPRC/LTB,4
GO:0051966,"regulation of synaptic transmission, glutamatergic",3/137,80/18888,0.0375,5.17007299270073,3.1948237124536774,0.02044328987861566,0.0883752417982082,0.06227171793948381,GRIN1/TNF/RELN,3
GO:0007269,neurotransmitter secretion,4/137,144/18888,0.027777777777777776,3.8296836982968365,2.9135170097116316,0.02086984585508615,0.0896040854560006,0.06313759625667699,SYT4/GRIK5/RIMS3/SLC18A3,4
GO:0099643,signal release from synapse,4/137,144/18888,0.027777777777777776,3.8296836982968365,2.9135170097116316,0.02086984585508615,0.0896040854560006,0.06313759625667699,SYT4/GRIK5/RIMS3/SLC18A3,4
GO:0097061,dendritic spine organization,3/137,81/18888,0.037037037037037035,5.10624493106245,3.1656081456969263,0.021119493033605666,0.0896040854560006,0.06313759625667699,APOE/SHANK1/RELN,3
GO:0001516,prostaglandin biosynthetic process,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,PTGDS/AKR1C3,2
GO:0001945,lymph vessel development,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,SYK/VEGFC,2
GO:0010765,positive regulation of sodium ion transport,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,DMD/NKX2-5,2
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,AKAP6/DMD,2
GO:0040018,positive regulation of multicellular organism growth,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,IGF2/DIO3,2
GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,CHGA/C3,2
GO:0046457,prostanoid biosynthetic process,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,PTGDS/AKR1C3,2
GO:0050654,chondroitin sulfate proteoglycan metabolic process,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,CHST13/CHST15,2
GO:0090322,regulation of superoxide metabolic process,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,SYK/CD177,2
GO:1900745,positive regulation of p38MAPK cascade,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,GDF6/MAP3K5,2
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,SERPINE1/FAIM2,2
GO:1990806,ligand-gated ion channel signaling pathway,2/137,31/18888,0.06451612903225806,8.894749234753943,3.760212969605589,0.021167937619192802,0.0896040854560006,0.06313759625667699,GRIK5/GRIN1,2
GO:0048562,embryonic organ morphogenesis,6/137,297/18888,0.020202020202020204,2.7852245078522455,2.650630837945481,0.021340048455127034,0.09010211618894053,0.06348852292681434,PRRX1/NTN1/GJA1/SIX3/DSCAML1/NKX2-5,6
GO:0007266,Rho protein signal transduction,4/137,145/18888,0.027586206896551724,3.803272086584445,2.896404796019219,0.02134463630557143,0.09010211618894053,0.06348852292681434,NTN1/APOE/NGFR/RIT2,4
GO:0050863,regulation of T cell activation,7/137,382/18888,0.01832460732984293,2.526388198876447,2.5761429541966097,0.021510050253976357,0.09067496322532574,0.0638921672999036,LEF1/SPINK5/SYK/IL15/IGF2/PTPRC/CARD11,7
GO:0003407,neural retina development,3/137,82/18888,0.036585365853658534,5.043973651415346,3.1368704595484718,0.021807875330369226,0.09150138003990535,0.06447448417656296,SIX3/PROM1/DIO3,3
GO:0046928,regulation of neurotransmitter secretion,3/137,82/18888,0.036585365853658534,5.043973651415346,3.1368704595484718,0.021807875330369226,0.09150138003990535,0.06447448417656296,SYT4/RIMS3/SLC18A3,3
GO:0045598,regulation of fat cell differentiation,4/137,146/18888,0.0273972602739726,3.7772222777722226,2.8794441430969915,0.02182601725722513,0.09150138003990535,0.06447448417656296,RORC/FOXO1/TNF/WWTR1,4
GO:0061008,hepaticobiliary system development,4/137,146/18888,0.0273972602739726,3.7772222777722226,2.8794441430969915,0.02182601725722513,0.09150138003990535,0.06447448417656296,TNF/ASS1/CPS1/FGF1,4
GO:0035264,multicellular organism growth,4/137,147/18888,0.027210884353741496,3.751526888127514,2.862632548772171,0.02231400939144719,0.09341887059354846,0.06582560275319703,IGF2/CDKN1C/WWTR1/DIO3,4
GO:0060219,camera-type eye photoreceptor cell differentiation,2/137,32/18888,0.0625,8.616788321167883,3.685968737841474,0.022473307462399263,0.0937186324275486,0.06603682349778636,PROM1/DIO3,2
GO:0032414,positive regulation of ion transmembrane transporter activity,3/137,83/18888,0.03614457831325301,4.983202884530824,3.1085965588014686,0.02250843957057442,0.0937186324275486,0.06603682349778636,AKAP6/DMD/RELN,3
GO:0150076,neuroinflammatory response,3/137,83/18888,0.03614457831325301,4.983202884530824,3.1085965588014686,0.02250843957057442,0.0937186324275486,0.06603682349778636,IL33/TNF/PTPRC,3
GO:1901657,glycosyl compound metabolic process,3/137,83/18888,0.03614457831325301,4.983202884530824,3.1085965588014686,0.02250843957057442,0.0937186324275486,0.06603682349778636,NT5C1A/AKR1C3/AKR1C1,3
GO:0060078,regulation of postsynaptic membrane potential,4/137,148/18888,0.02702702702702703,3.7261787334780037,2.84596756932164,0.022808632726255197,0.09483916495985131,0.06682638270434442,GRIK5/SHANK1/GRIN1/RELN,4
GO:0008544,epidermis development,7/137,387/18888,0.01808785529715762,2.493747524472359,2.5378423264179744,0.022895022913630794,0.09506885705088597,0.06698823030798096,NGFR/LDB2/SPINK5/AKR1C3/TNF/LAMB3/CRABP2,7
GO:0006874,intracellular calcium ion homeostasis,6/137,302/18888,0.019867549668874173,2.739111519311645,2.6041589793638007,0.0229359107006194,0.0951092383944163,0.06701668415527091,APOE/AKAP6/DMD/TRPA1/CXCL12/PTPRC,6
GO:0001523,retinoid metabolic process,3/137,84/18888,0.03571428571428571,4.923879040667361,3.080772931126322,0.023221186376878405,0.09564245724997691,0.06739240538101084,AKR1C3/AKR1C1/CRABP2,3
GO:0002028,regulation of sodium ion transport,3/137,84/18888,0.03571428571428571,4.923879040667361,3.080772931126322,0.023221186376878405,0.09564245724997691,0.06739240538101084,DMD/UTRN/NKX2-5,3
GO:0002437,inflammatory response to antigenic stimulus,3/137,84/18888,0.03571428571428571,4.923879040667361,3.080772931126322,0.023221186376878405,0.09564245724997691,0.06739240538101084,C3/SYK/TNF,3
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,3/137,84/18888,0.03571428571428571,4.923879040667361,3.080772931126322,0.023221186376878405,0.09564245724997691,0.06739240538101084,SERPINE1/FAIM2/TNF,3
GO:0046209,nitric oxide metabolic process,3/137,84/18888,0.03571428571428571,4.923879040667361,3.080772931126322,0.023221186376878405,0.09564245724997691,0.06739240538101084,TNF/ASS1/CPS1,3
GO:0001508,action potential,4/137,149/18888,0.026845637583892617,3.701170822515064,2.829446817717592,0.023309906617925,0.0957494414507498,0.06746778950261496,GJA1/AKAP6/DMD/TNF,4
GO:0002687,positive regulation of leukocyte migration,4/137,149/18888,0.026845637583892617,3.701170822515064,2.829446817717592,0.023309906617925,0.0957494414507498,0.06746778950261496,SERPINE1/CXCL12/TNF/VEGFC,4
GO:0052547,regulation of peptidase activity,6/137,304/18888,0.019736842105263157,2.721091048789858,2.5858337298121845,0.023596193936321584,0.09679371168558437,0.06820361211755842,SERPINE1/NGFR/SPINK5/SYK/MAP3K5/TNF,6
GO:0019934,cGMP-mediated signaling,2/137,33/18888,0.06060606060606061,8.355673523556735,3.6148951369044355,0.023811138704118145,0.09679371168558437,0.06820361211755842,APOE/NPR1,2
GO:0035305,negative regulation of dephosphorylation,2/137,33/18888,0.06060606060606061,8.355673523556735,3.6148951369044355,0.023811138704118145,0.09679371168558437,0.06820361211755842,PPP4R4/TNF,2
GO:0042573,retinoic acid metabolic process,2/137,33/18888,0.06060606060606061,8.355673523556735,3.6148951369044355,0.023811138704118145,0.09679371168558437,0.06820361211755842,AKR1C3/CRABP2,2
GO:1903715,regulation of aerobic respiration,2/137,33/18888,0.06060606060606061,8.355673523556735,3.6148951369044355,0.023811138704118145,0.09679371168558437,0.06820361211755842,CBFA2T3/TNF,2
GO:0002705,positive regulation of leukocyte mediated immunity,4/137,150/18888,0.02666666666666667,3.6764963503649635,2.8130679619372807,0.023817849762737178,0.09679371168558437,0.06820361211755842,C3/TNF/PTPRC/CD177,4
GO:0035107,appendage morphogenesis,4/137,150/18888,0.02666666666666667,3.6764963503649635,2.8130679619372807,0.023817849762737178,0.09679371168558437,0.06820361211755842,PRRX1/LEF1/GJA1/CRABP2,4
GO:0035108,limb morphogenesis,4/137,150/18888,0.02666666666666667,3.6764963503649635,2.8130679619372807,0.023817849762737178,0.09679371168558437,0.06820361211755842,PRRX1/LEF1/GJA1/CRABP2,4
GO:2001057,reactive nitrogen species metabolic process,3/137,85/18888,0.03529411764705882,4.865951051953628,3.053386616303429,0.023946114234333814,0.0971855593659399,0.06847971917797309,TNF/ASS1/CPS1,3
GO:0001906,cell killing,5/137,226/18888,0.022123893805309734,3.050190556165622,2.6503236534127446,0.02459156942226404,0.0996167158058731,0.07019278140008234,CHGA/C3/SYK/PTPRC/APOL1,5
GO:0051607,defense response to virus,6/137,307/18888,0.019543973941368076,2.694500582515038,2.55862079566009,0.024610420615212424,0.0996167158058731,0.07019278140008234,IFI44L/IL15/IL33/TNF/PTPRC/IFIT1,6
GO:0071230,cellular response to amino acid stimulus,3/137,86/18888,0.03488372093023256,4.809370225768121,3.026425177421912,0.02468321953124613,0.09964707144095661,0.07021417084702847,TNF/ASS1/PDGFC,3
GO:1901379,regulation of potassium ion transmembrane transport,3/137,86/18888,0.03488372093023256,4.809370225768121,3.026425177421912,0.02468321953124613,0.09964707144095661,0.07021417084702847,AKAP6/KCNIP3/DPP6,3
GO:0035296,regulation of tube diameter,4/137,152/18888,0.02631578947368421,3.628121398386477,2.7807268750675616,0.024853815308138138,0.09993918882798103,0.07042000509607686,APOE/TNF/NPR1/CPS1,4
GO:0097746,blood vessel diameter maintenance,4/137,152/18888,0.02631578947368421,3.628121398386477,2.7807268750675616,0.024853815308138138,0.09993918882798103,0.07042000509607686,APOE/TNF/NPR1/CPS1,4
GO:1902652,secondary alcohol metabolic process,4/137,152/18888,0.02631578947368421,3.628121398386477,2.7807268750675616,0.024853815308138138,0.09993918882798103,0.07042000509607686,APOE/VLDLR/APOL1/FGF1,4
GO:0070372,regulation of ERK1 and ERK2 cascade,6/137,308/18888,0.01948051948051948,2.685752204000379,2.549621991289396,0.0249548894635722,0.10019831033905868,0.07060258950910427,APOE/SYK/TNF/PTPRC/PDGFC/FGF1,6
GO:0009112,nucleobase metabolic process,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,GMPR/CPS1,2
GO:0032743,positive regulation of interleukin-2 production,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,PTPRC/CARD11,2
GO:0048841,regulation of axon extension involved in axon guidance,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,CXCL12/SEMA5B,2
GO:0050901,leukocyte tethering or rolling,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,CXCL12/TNF,2
GO:0060074,synapse maturation,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,SHANK1/RELN,2
GO:0070570,regulation of neuron projection regeneration,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,PRRX1/SPP1,2
GO:0110110,positive regulation of animal organ morphogenesis,2/137,34/18888,0.058823529411764705,8.109918419922714,3.546760650854263,0.025180899092417434,0.10019831033905868,0.07060258950910427,NGFR/FGF1,2
GO:1904062,regulation of monoatomic cation transmembrane transport,6/137,309/18888,0.019417475728155338,2.677060449294876,2.540658806496261,0.02530257382933046,0.10028421139747001,0.07066311784680666,AKAP6/DMD/GRIN1/KCNIP3/UTRN/DPP6,6
GO:0010950,positive regulation of endopeptidase activity,4/137,153/18888,0.026143790849673203,3.6044081866323174,2.7647602405891263,0.025381871818467763,0.10028421139747001,0.07066311784680666,NGFR/SYK/MAP3K5/TNF,4
GO:0016525,negative regulation of angiogenesis,4/137,153/18888,0.026143790849673203,3.6044081866323174,2.7647602405891263,0.025381871818467763,0.10028421139747001,0.07066311784680666,SERPINE1/SPINK5/TNF/NPR1,4
GO:0035150,regulation of tube size,4/137,153/18888,0.026143790849673203,3.6044081866323174,2.7647602405891263,0.025381871818467763,0.10028421139747001,0.07066311784680666,APOE/TNF/NPR1/CPS1,4
GO:0051651,maintenance of location in cell,5/137,228/18888,0.021929824561403508,3.0234344986553974,2.627424896885411,0.025420461995035445,0.10028421139747001,0.07066311784680666,APOE/AKAP6/DMD/PTPRC/RIT2,5
GO:0008306,associative learning,3/137,87/18888,0.034482758620689655,4.754090108230556,2.9998766738974547,0.025432496599489447,0.10028421139747001,0.07066311784680666,SHANK1/GRIN1/RELN,3
GO:0008543,fibroblast growth factor receptor signaling pathway,3/137,87/18888,0.034482758620689655,4.754090108230556,2.9998766738974547,0.025432496599489447,0.10028421139747001,0.07066311784680666,NGFR/FAM20C/FGF1,3
GO:2001233,regulation of apoptotic signaling pathway,7/137,396/18888,0.017676767676767676,2.4370714443707144,2.4703788878490283,0.025541600985848418,0.10058447252749596,0.07087469040962759,SERPINE1/NGFR/FAIM2/CXCL12/TNF/PTPRC/LTB,7
GO:0150063,visual system development,7/137,397/18888,0.017632241813602016,2.4309327253672617,2.462996683218204,0.02584808191190789,0.10166023968446247,0.07163270665494821,GJA1/ACHE/C3/CDKN1C/SIX3/PROM1/DIO3,7
GO:0034767,positive regulation of monoatomic ion transmembrane transport,4/137,154/18888,0.025974025974025976,3.5810029386671722,2.74892669218243,0.02591666580561771,0.10166794863591934,0.07163813860218776,AKAP6/DMD/GRIN1/RELN,4
GO:0042552,myelination,4/137,154/18888,0.025974025974025976,3.5810029386671722,2.74892669218243,0.02591666580561771,0.10166794863591934,0.07163813860218776,CXCR4/TNF/B4GALT6/TPPP,4
GO:0044403,biological process involved in symbiotic interaction,6/137,311/18888,0.01929260450160772,2.659844626469829,2.522838195908429,0.026007633558620027,0.10189383520013906,0.07179730472300618,LEF1/APOE/TNFRSF4/CXCR4/APOL1/IFIT1,6
GO:0033627,cell adhesion mediated by integrin,3/137,88/18888,0.03409090909090909,4.700066357000663,2.973729636174808,0.026193937754285416,0.10236094497577349,0.07212644360402332,SERPINE1/SYK/ITGA7,3
GO:0046889,positive regulation of lipid biosynthetic process,3/137,88/18888,0.03409090909090909,4.700066357000663,2.973729636174808,0.026193937754285416,0.10236094497577349,0.07212644360402332,APOE/TNF/FGF1,3
GO:0002685,regulation of leukocyte migration,5/137,230/18888,0.021739130434782608,2.997143763884481,2.604775264290256,0.026267115440610965,0.10251564747409804,0.07223545140014564,SERPINE1/CXCL12/IL33/TNF/VEGFC,5
GO:0008037,cell recognition,4/137,155/18888,0.025806451612903226,3.5578996939015775,2.7332241495547365,0.026458212695631894,0.10256441732818461,0.0722698160314138,CXCR4/DSCAML1/NDN/GAP43,4
GO:0016125,sterol metabolic process,4/137,155/18888,0.025806451612903226,3.5578996939015775,2.7332241495547365,0.026458212695631894,0.10256441732818461,0.0722698160314138,APOE/VLDLR/APOL1/FGF1,4
GO:2000181,negative regulation of blood vessel morphogenesis,4/137,155/18888,0.025806451612903226,3.5578996939015775,2.7332241495547365,0.026458212695631894,0.10256441732818461,0.0722698160314138,SERPINE1/SPINK5/TNF/NPR1,4
GO:0002446,neutrophil mediated immunity,2/137,35/18888,0.05714285714285714,7.8782064650677786,3.4813569393705404,0.026582062289185464,0.10256441732818461,0.0722698160314138,SYK/CD177,2
GO:0010613,positive regulation of cardiac muscle hypertrophy,2/137,35/18888,0.05714285714285714,7.8782064650677786,3.4813569393705404,0.026582062289185464,0.10256441732818461,0.0722698160314138,AKAP6/NR4A3,2
GO:0010614,negative regulation of cardiac muscle hypertrophy,2/137,35/18888,0.05714285714285714,7.8782064650677786,3.4813569393705404,0.026582062289185464,0.10256441732818461,0.0722698160314138,TRIM63/FOXO1,2
GO:0035640,exploration behavior,2/137,35/18888,0.05714285714285714,7.8782064650677786,3.4813569393705404,0.026582062289185464,0.10256441732818461,0.0722698160314138,APOE/GAD1,2
GO:0045577,regulation of B cell differentiation,2/137,35/18888,0.05714285714285714,7.8782064650677786,3.4813569393705404,0.026582062289185464,0.10256441732818461,0.0722698160314138,SYK/CARD11,2
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,2/137,35/18888,0.05714285714285714,7.8782064650677786,3.4813569393705404,0.026582062289185464,0.10256441732818461,0.0722698160314138,SYK/NR4A3,2
GO:0001666,response to hypoxia,6/137,313/18888,0.019169329073482427,2.6428488141601174,2.5051567946273448,0.02672568746701378,0.1029883815016743,0.07256855328961875,CBFA2T3/CXCL12/CXCR4/TNF/DIO3/VEGFC,6
GO:0016101,diterpenoid metabolic process,3/137,89/18888,0.033707865168539325,4.647256622652341,2.947973041991944,0.026967533333452323,0.10354763972270663,0.07296262259553345,AKR1C3/AKR1C1/CRABP2,3
GO:2000027,regulation of animal organ morphogenesis,3/137,89/18888,0.033707865168539325,4.647256622652341,2.947973041991944,0.026967533333452323,0.10354763972270663,0.07296262259553345,NGFR/TNF/FGF1,3
GO:0007272,ensheathment of neurons,4/137,156/18888,0.02564102564102564,3.5350926445816953,2.717650578478033,0.027006527267127944,0.10354763972270663,0.07296262259553345,CXCR4/TNF/B4GALT6/TPPP,4
GO:0008366,axon ensheathment,4/137,156/18888,0.02564102564102564,3.5350926445816953,2.717650578478033,0.027006527267127944,0.10354763972270663,0.07296262259553345,CXCR4/TNF/B4GALT6/TPPP,4
GO:0048754,branching morphogenesis of an epithelial tube,4/137,157/18888,0.025477707006369428,3.51257613092194,2.7022039894775167,0.027561623653717303,0.10541112204404161,0.07427568543008106,LEF1/ADAMTS16/TNF/FGF1,4
GO:1901343,negative regulation of vasculature development,4/137,157/18888,0.025477707006369428,3.51257613092194,2.7022039894775167,0.027561623653717303,0.10541112204404161,0.07427568543008106,SERPINE1/SPINK5/TNF/NPR1,4
GO:0048880,sensory system development,7/137,403/18888,0.017369727047146403,2.3947401785876004,2.4191659679251223,0.02774008372268305,0.10542437328443402,0.07428502263230279,GJA1/ACHE/C3/CDKN1C/SIX3/PROM1/DIO3,7
GO:0002088,lens development in camera-type eye,3/137,90/18888,0.03333333333333333,4.595620437956205,2.9225962940930392,0.027753271736129903,0.10542437328443402,0.07428502263230279,GJA1/CDKN1C/SIX3,3
GO:0031640,killing of cells of another organism,3/137,90/18888,0.03333333333333333,4.595620437956205,2.9225962940930392,0.027753271736129903,0.10542437328443402,0.07428502263230279,CHGA/SYK/APOL1,3
GO:0141061,disruption of cell in another organism,3/137,90/18888,0.03333333333333333,4.595620437956205,2.9225962940930392,0.027753271736129903,0.10542437328443402,0.07428502263230279,CHGA/SYK/APOL1,3
GO:2000628,regulation of miRNA metabolic process,3/137,90/18888,0.03333333333333333,4.595620437956205,2.9225962940930392,0.027753271736129903,0.10542437328443402,0.07428502263230279,NGFR/TNF/MYCN,3
GO:0002021,response to dietary excess,2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,VGF/APOE,2
GO:0014742,positive regulation of muscle hypertrophy,2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,AKAP6/NR4A3,2
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,AKAP6/DMD,2
GO:0021799,cerebral cortex radially oriented cell migration,2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,POU3F3/RELN,2
GO:0048265,response to pain,2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,TRPA1/RELN,2
GO:0048665,neuron fate specification,2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,ASCL1/LMO4,2
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",2/137,36/18888,0.05555555555555555,7.659367396593673,3.418495930230667,0.02801410781337826,0.10542437328443402,0.07428502263230279,GRIN1/RELN,2
GO:0046434,organophosphate catabolic process,5/137,234/18888,0.021367521367521368,2.945910537151413,2.560202805271303,0.028014143752842724,0.10542437328443402,0.07428502263230279,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0014910,regulation of smooth muscle cell migration,3/137,91/18888,0.03296703296703297,4.54511911446218,2.897589199286808,0.0285511394609856,0.10715080509258354,0.07550151576331247,SERPINE1/IGFBP3/NR4A3,3
GO:1903510,mucopolysaccharide metabolic process,3/137,91/18888,0.03296703296703297,4.54511911446218,2.897589199286808,0.0285511394609856,0.10715080509258354,0.07550151576331247,CHST1/CHST13/CHST15,3
GO:0043588,skin development,6/137,318/18888,0.018867924528301886,2.6012945875223794,2.4615485200796536,0.028578229143303737,0.10715080509258354,0.07550151576331247,NGFR/LDB2/SPINK5/AKR1C3/TNF/LTB,6
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/137,160/18888,0.025,3.4467153284671537,2.656606865200444,0.029267735418303954,0.10851910982571371,0.07646566233494277,NGFR/SYK/MAP3K5/TNF,4
GO:0060041,retina development in camera-type eye,4/137,160/18888,0.025,3.4467153284671537,2.656606865200444,0.029267735418303954,0.10851910982571371,0.07646566233494277,ACHE/SIX3/PROM1/DIO3,4
GO:0032411,positive regulation of transporter activity,3/137,92/18888,0.03260869565217391,4.495715645826722,2.872941948755129,0.02936112114390852,0.10851910982571371,0.07646566233494277,AKAP6/DMD/RELN,3
GO:0051262,protein tetramerization,3/137,92/18888,0.03260869565217391,4.495715645826722,2.872941948755129,0.02936112114390852,0.10851910982571371,0.07646566233494277,GRIN1/TRPA1/TRPM3,3
GO:0106027,neuron projection organization,3/137,92/18888,0.03260869565217391,4.495715645826722,2.872941948755129,0.02936112114390852,0.10851910982571371,0.07646566233494277,APOE/SHANK1/RELN,3
GO:0003161,cardiac conduction system development,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,GJA1/NKX2-5,2
GO:0008207,C21-steroid hormone metabolic process,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,AKR1C3/AKR1C1,2
GO:0014059,regulation of dopamine secretion,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,SYT4/CXCL12,2
GO:0014741,negative regulation of muscle hypertrophy,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,TRIM63/FOXO1,2
GO:0021955,central nervous system neuron axonogenesis,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,DRAXIN/B4GALT6,2
GO:0045773,positive regulation of axon extension,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,NTN1/CXCL12,2
GO:0070306,lens fiber cell differentiation,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,CDKN1C/SIX3,2
GO:0070873,regulation of glycogen metabolic process,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,PHLDA2/IGF2,2
GO:0097484,dendrite extension,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,SYT4/CXCR4,2
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,2/137,37/18888,0.05405405405405406,7.452357466956007,3.358007346044678,0.029476520984769546,0.10851910982571371,0.07646566233494277,AKAP6/DMD,2
GO:0051098,regulation of binding,5/137,238/18888,0.02100840336134454,2.896399435686684,2.516566636915342,0.02983349019026435,0.10962992458122535,0.07724837411859121,LEF1/APOE/MAP2/GREM2/IFIT1,5
GO:0010976,positive regulation of neuron projection development,4/137,161/18888,0.024844720496894408,3.4253071587251207,2.641649161414035,0.029850087590759588,0.10962992458122535,0.07724837411859121,APOE/VLDLR/RIT2/RELN,4
GO:0002690,positive regulation of leukocyte chemotaxis,3/137,93/18888,0.03225806451612903,4.447374617376972,2.8486450995246035,0.03018319959519672,0.11045458652822589,0.07782945446546372,SERPINE1/CXCL12/VEGFC,3
GO:0007589,body fluid secretion,3/137,93/18888,0.03225806451612903,4.447374617376972,2.8486450995246035,0.03018319959519672,0.11045458652822589,0.07782945446546372,GJA1/NPR1/VIP,3
GO:0141060,disruption of anatomical structure in another organism,3/137,93/18888,0.03225806451612903,4.447374617376972,2.8486450995246035,0.03018319959519672,0.11045458652822589,0.07782945446546372,CHGA/SYK/APOL1,3
GO:0120254,olefinic compound metabolic process,4/137,162/18888,0.024691358024691357,3.4041632873749657,2.6268091208076236,0.03043928266192434,0.11125831219663843,0.07839578251284138,GRIN1/PTGDS/AKR1C3/AKR1C1,4
GO:0060070,canonical Wnt signaling pathway,6/137,323/18888,0.018575851393188854,2.561026869449278,2.4187652453665387,0.030513798140398802,0.11139726306758031,0.078493691262698,LEF1/APOE/FOXO1/DRAXIN/NKX2-5/WWTR1,6
GO:0035633,maintenance of blood-brain barrier,2/137,38/18888,0.05263157894736842,7.256242796772954,3.2997365905727625,0.030968792868199126,0.1123861543801947,0.07919049230831818,GJA1/DMD,2
GO:0045823,positive regulation of heart contraction,2/137,38/18888,0.05263157894736842,7.256242796772954,3.2997365905727625,0.030968792868199126,0.1123861543801947,0.07919049230831818,CHGA/NKX2-5,2
GO:0048846,axon extension involved in axon guidance,2/137,38/18888,0.05263157894736842,7.256242796772954,3.2997365905727625,0.030968792868199126,0.1123861543801947,0.07919049230831818,CXCL12/SEMA5B,2
GO:0055094,response to lipoprotein particle,2/137,38/18888,0.05263157894736842,7.256242796772954,3.2997365905727625,0.030968792868199126,0.1123861543801947,0.07919049230831818,APOE/SYK,2
GO:1902284,neuron projection extension involved in neuron projection guidance,2/137,38/18888,0.05263157894736842,7.256242796772954,3.2997365905727625,0.030968792868199126,0.1123861543801947,0.07919049230831818,CXCL12/SEMA5B,2
GO:0071356,cellular response to tumor necrosis factor,5/137,241/18888,0.02074688796680498,2.8603446709270983,2.484431386978323,0.031245923702819683,0.11325719612946042,0.07980425318772423,SYK/TNFRSF4/MAP3K5/TNF/ASS1,5
GO:0007584,response to nutrient,4/137,164/18888,0.024390243902439025,3.3626491009435644,2.597475081582039,0.03163824215100589,0.11454319696900353,0.08071040608666422,ASCL1/AKR1C3/SPP1/ASS1,4
GO:0033555,multicellular organismal response to stress,3/137,95/18888,0.031578947368421054,4.353745678063772,2.801066558629894,0.031863569135726424,0.1148141830014605,0.08090135058011444,APOE/TRPA1/RELN,3
GO:0046330,positive regulation of JNK cascade,3/137,95/18888,0.031578947368421054,4.353745678063772,2.801066558629894,0.031863569135726424,0.1148141830014605,0.08090135058011444,MAP3K5/TNF/TNIK,3
GO:0071229,cellular response to acid chemical,3/137,95/18888,0.031578947368421054,4.353745678063772,2.801066558629894,0.031863569135726424,0.1148141830014605,0.08090135058011444,TNF/ASS1/PDGFC,3
GO:0071901,negative regulation of protein serine/threonine kinase activity,3/137,95/18888,0.031578947368421054,4.353745678063772,2.801066558629894,0.031863569135726424,0.1148141830014605,0.08090135058011444,APOE/CDKN1C/CDKN2A,3
GO:0036293,response to decreased oxygen levels,6/137,327/18888,0.01834862385321101,2.5296993236456173,2.3851122472153916,0.03212284447702723,0.11561193554703668,0.08146346979464576,CBFA2T3/CXCL12/CXCR4/TNF/DIO3/VEGFC,6
GO:0050807,regulation of synapse organization,5/137,243/18888,0.0205761316872428,2.8368027394791384,2.4632813471092208,0.032210535116774956,0.11565331764506884,0.08149262880212306,NTN1/APOE/TNF/SLC18A3/RELN,5
GO:0050905,neuromuscular process,4/137,165/18888,0.024242424242424242,3.342269409422694,2.582977700061791,0.03224802533288125,0.11565331764506884,0.08149262880212306,ASCL1/DMD/SHANK1/TNF,4
GO:0051147,regulation of muscle cell differentiation,4/137,165/18888,0.024242424242424242,3.342269409422694,2.582977700061791,0.03224802533288125,0.11565331764506884,0.08149262880212306,BHLHE41/AKAP6/IGF2/NKX2-5,4
GO:0014912,negative regulation of smooth muscle cell migration,2/137,39/18888,0.05128205128205128,7.0701852891633905,3.2435429343916775,0.032490420218315406,0.11570684073080352,0.08153034269608596,SERPINE1/IGFBP3,2
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,2/137,39/18888,0.05128205128205128,7.0701852891633905,3.2435429343916775,0.032490420218315406,0.11570684073080352,0.08153034269608596,NGFR/FAM20C,2
GO:0060306,regulation of membrane repolarization,2/137,39/18888,0.05128205128205128,7.0701852891633905,3.2435429343916775,0.032490420218315406,0.11570684073080352,0.08153034269608596,GJA1/AKAP6,2
GO:0060416,response to growth hormone,2/137,39/18888,0.05128205128205128,7.0701852891633905,3.2435429343916775,0.032490420218315406,0.11570684073080352,0.08153034269608596,ASS1/CPS1,2
GO:0097106,postsynaptic density organization,2/137,39/18888,0.05128205128205128,7.0701852891633905,3.2435429343916775,0.032490420218315406,0.11570684073080352,0.08153034269608596,SHANK1/RELN,2
GO:1903524,positive regulation of blood circulation,2/137,39/18888,0.05128205128205128,7.0701852891633905,3.2435429343916775,0.032490420218315406,0.11570684073080352,0.08153034269608596,CHGA/NKX2-5,2
GO:0016079,synaptic vesicle exocytosis,3/137,96/18888,0.03125,4.3083941605839415,2.7777676582032225,0.03272181704531222,0.11612440188638708,0.08182456820510754,SYT4/GRIK5/RIMS3,3
GO:0042982,amyloid precursor protein metabolic process,3/137,96/18888,0.03125,4.3083941605839415,2.7777676582032225,0.03272181704531222,0.11612440188638708,0.08182456820510754,APOE/ACHE/TNF,3
GO:0060996,dendritic spine development,3/137,96/18888,0.03125,4.3083941605839415,2.7777676582032225,0.03272181704531222,0.11612440188638708,0.08182456820510754,APOE/SHANK1/RELN,3
GO:0010952,positive regulation of peptidase activity,4/137,167/18888,0.023952095808383235,3.302242230866734,2.554314018360319,0.03348824082966721,0.11870628456695045,0.08364383643866999,NGFR/SYK/MAP3K5/TNF,4
GO:0051153,regulation of striated muscle cell differentiation,3/137,97/18888,0.030927835051546393,4.263977725938747,2.7547847114354447,0.03359207543486956,0.11879839423780059,0.08370873954191439,BHLHE41/AKAP6/NKX2-5,3
GO:0140747,regulation of ncRNA transcription,3/137,97/18888,0.030927835051546393,4.263977725938747,2.7547847114354447,0.03359207543486956,0.11879839423780059,0.08370873954191439,NGFR/TNF/MYCN,3
GO:0002703,regulation of leukocyte mediated immunity,5/137,246/18888,0.02032520325203252,2.8022075841196368,2.4319557665178433,0.03369214431111586,0.11901438013602501,0.08386092937086953,C3/SYK/TNF/PTPRC/CD177,5
GO:0001953,negative regulation of cell-matrix adhesion,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,SERPINE1/CDKN2A,2
GO:0009167,purine ribonucleoside monophosphate metabolic process,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,NT5C1A/CARD11,2
GO:0044060,regulation of endocrine process,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,GJA1/SPP1,2
GO:0045429,positive regulation of nitric oxide biosynthetic process,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,TNF/ASS1,2
GO:0046676,negative regulation of insulin secretion,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,CHGA/FOXO1,2
GO:0051385,response to mineralocorticoid,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,PTPRC/MAOB,2
GO:0052652,cyclic purine nucleotide metabolic process,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,NPR1/PDE1A,2
GO:0070884,regulation of calcineurin-NFAT signaling cascade,2/137,40/18888,0.05,6.893430656934307,3.189297951030475,0.03404090542480825,0.11914316898682886,0.08395167767127384,AKAP6/TNF,2
GO:0051924,regulation of calcium ion transport,5/137,247/18888,0.020242914979757085,2.790862614143444,2.4216183591307763,0.03419530456572702,0.11954647140274782,0.08423585606532862,AKAP6/DMD/GRIN1/CXCL12/CXCR4,5
GO:0006576,biogenic amine metabolic process,3/137,98/18888,0.030612244897959183,4.220467749143452,2.732109862064482,0.034474318527209606,0.12010915541671657,0.08463233928273159,MAOA/NPR1/MAOB,3
GO:0006942,regulation of striated muscle contraction,3/137,98/18888,0.030612244897959183,4.220467749143452,2.732109862064482,0.034474318527209606,0.12010915541671657,0.08463233928273159,CHGA/DMD/NKX2-5,3
GO:0014909,smooth muscle cell migration,3/137,98/18888,0.030612244897959183,4.220467749143452,2.732109862064482,0.034474318527209606,0.12010915541671657,0.08463233928273159,SERPINE1/IGFBP3/NR4A3,3
GO:0046394,carboxylic acid biosynthetic process,6/137,334/18888,0.017964071856287425,2.47668167315005,2.327399298378433,0.03507011546001467,0.12132979543549653,0.08549243708171325,GAD1/PTGDS/AKR1C3/SYK/ASS1/CPS1,6
GO:0070588,calcium ion transmembrane transport,6/137,334/18888,0.017964071856287425,2.47668167315005,2.327399298378433,0.03507011546001467,0.12132979543549653,0.08549243708171325,AKAP6/DMD/GRIN1/TRPA1/PTPRC/TRPM3,6
GO:1903706,regulation of hemopoiesis,7/137,424/18888,0.01650943396226415,2.2761327640820825,2.2716710763965517,0.035100312326381514,0.12132979543549653,0.08549243708171325,LEF1/SPINK5/SYK/IL15/TNF/PTPRC/CARD11,7
GO:0050803,regulation of synapse structure or activity,5/137,249/18888,0.020080321285140562,2.768446046961569,2.4010971971743844,0.035215616625548965,0.12132979543549653,0.08549243708171325,NTN1/APOE/TNF/SLC18A3/RELN,5
GO:0001657,ureteric bud development,3/137,99/18888,0.030303030303030304,4.177836761778368,2.7097355288356857,0.03536851893234984,0.12132979543549653,0.08549243708171325,BASP1/ADAMTS16/FGF1,3
GO:0006835,dicarboxylic acid transport,3/137,99/18888,0.030303030303030304,4.177836761778368,2.7097355288356857,0.03536851893234984,0.12132979543549653,0.08549243708171325,SYT4/GJA1/TNF,3
GO:0050773,regulation of dendrite development,3/137,99/18888,0.030303030303030304,4.177836761778368,2.7097355288356857,0.03536851893234984,0.12132979543549653,0.08549243708171325,VLDLR/RELN/TNIK,3
GO:0051588,regulation of neurotransmitter transport,3/137,99/18888,0.030303030303030304,4.177836761778368,2.7097355288356857,0.03536851893234984,0.12132979543549653,0.08549243708171325,SYT4/RIMS3/SLC18A3,3
GO:0060419,heart growth,3/137,99/18888,0.030303030303030304,4.177836761778368,2.7097355288356857,0.03536851893234984,0.12132979543549653,0.08549243708171325,AKAP6/BASP1/NKX2-5,3
GO:0001941,postsynaptic membrane organization,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,APOE/RELN,2
GO:0009187,cyclic nucleotide metabolic process,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,NPR1/PDE1A,2
GO:0030851,granulocyte differentiation,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,LEF1/CBFA2T3,2
GO:0043506,regulation of JUN kinase activity,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,MAP3K5/TNF,2
GO:0060421,positive regulation of heart growth,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,AKAP6/BASP1,2
GO:0071402,cellular response to lipoprotein particle stimulus,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,APOE/SYK,2
GO:0090181,regulation of cholesterol metabolic process,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,APOE/FGF1,2
GO:0106056,regulation of calcineurin-mediated signaling,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,AKAP6/TNF,2
GO:1901661,quinone metabolic process,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,AKR1C3/AKR1C1,2
GO:1904407,positive regulation of nitric oxide metabolic process,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,TNF/ASS1,2
GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,2/137,41/18888,0.04878048780487805,6.725298201887129,3.1368841636834053,0.03561975645812742,0.12132979543549653,0.08549243708171325,CXCL12/TNF,2
GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,4/137,171/18888,0.023391812865497075,3.2249967985657575,2.4982671779750043,0.03605146633520153,0.12266340608142148,0.08643213720919642,AKR1C3/TNF/IGF2/RELN,4
GO:0006721,terpenoid metabolic process,3/137,100/18888,0.03,4.1360583941605835,2.68765439318178,0.036274647681311424,0.1228748332112791,0.08658111479983556,AKR1C3/AKR1C1/CRABP2,3
GO:0072163,mesonephric epithelium development,3/137,100/18888,0.03,4.1360583941605835,2.68765439318178,0.036274647681311424,0.1228748332112791,0.08658111479983556,BASP1/ADAMTS16/FGF1,3
GO:0072164,mesonephric tubule development,3/137,100/18888,0.03,4.1360583941605835,2.68765439318178,0.036274647681311424,0.1228748332112791,0.08658111479983556,BASP1/ADAMTS16/FGF1,3
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,3/137,100/18888,0.03,4.1360583941605835,2.68765439318178,0.036274647681311424,0.1228748332112791,0.08658111479983556,SERPINE1/FAIM2/TNF,3
GO:0016053,organic acid biosynthetic process,6/137,337/18888,0.017804154302670624,2.4546340618163702,2.303109556454751,0.036385025529997846,0.12311208194850713,0.08674828703207563,GAD1/PTGDS/AKR1C3/SYK/ASS1/CPS1,6
GO:0005976,polysaccharide metabolic process,3/137,101/18888,0.0297029702970297,4.095107320951072,2.6658593875723637,0.0371926742594534,0.12498926046365835,0.08807100059572809,CHST1/PHLDA2/IGF2,3
GO:0032755,positive regulation of interleukin-6 production,3/137,101/18888,0.0297029702970297,4.095107320951072,2.6658593875723637,0.0371926742594534,0.12498926046365835,0.08807100059572809,SYK/IL33/TNF,3
GO:0009126,purine nucleoside monophosphate metabolic process,2/137,42/18888,0.047619047619047616,6.565172054223148,3.086193869766663,0.0372264868156833,0.12498926046365835,0.08807100059572809,NT5C1A/CARD11,2
GO:0014046,dopamine secretion,2/137,42/18888,0.047619047619047616,6.565172054223148,3.086193869766663,0.0372264868156833,0.12498926046365835,0.08807100059572809,SYT4/CXCL12,2
GO:0032735,positive regulation of interleukin-12 production,2/137,42/18888,0.047619047619047616,6.565172054223148,3.086193869766663,0.0372264868156833,0.12498926046365835,0.08807100059572809,SYK/LTB,2
GO:0043647,inositol phosphate metabolic process,2/137,42/18888,0.047619047619047616,6.565172054223148,3.086193869766663,0.0372264868156833,0.12498926046365835,0.08807100059572809,NUDT11/NUDT10,2
GO:0051154,negative regulation of striated muscle cell differentiation,2/137,42/18888,0.047619047619047616,6.565172054223148,3.086193869766663,0.0372264868156833,0.12498926046365835,0.08807100059572809,BHLHE41/NKX2-5,2
GO:0050680,negative regulation of epithelial cell proliferation,4/137,173/18888,0.023121387283236993,3.187713598582338,2.4708601150383775,0.03737456764495812,0.1253485499477057,0.08832416622168819,APOE/NGFR/TNF/CDKN1C,4
GO:0042060,wound healing,7/137,430/18888,0.01627906976744186,2.2443727720251228,2.2311150388712537,0.03742073052792237,0.12536560874996605,0.0883361863406845,SERPINE1/APOE/SYK/CXCR4/TNF/ODAM/FGF1,7
GO:0046883,regulation of hormone secretion,5/137,254/18888,0.01968503937007874,2.7139490775331914,2.350667940150117,0.037848413760143335,0.1266593846446902,0.08924781776543494,GJA1/CHGA/FOXO1/SPP1/TNF,5
GO:0008585,female gonad development,3/137,102/18888,0.029411764705882353,4.054959209961357,2.644343684490354,0.038122566639349924,0.12743710118652352,0.08979581903982463,VGF/PTPRN/NRIP1,3
GO:0030098,lymphocyte differentiation,7/137,432/18888,0.016203703703703703,2.2339821573398213,2.2177445444670325,0.03821620400067292,0.12761034421231263,0.08991789102081627,LEF1/RORC/SPINK5/SYK/IL15/PTPRC/CARD11,7
GO:0030111,regulation of Wnt signaling pathway,6/137,342/18888,0.017543859649122806,2.418747598924318,2.2631983700691154,0.03864637010381844,0.1284968563487953,0.09054255277663957,LEF1/APOE/FOXO1/DRAXIN/NKX2-5/WWTR1,6
GO:0006476,protein deacetylation,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,NDN/TPPP,2
GO:0032768,regulation of monooxygenase activity,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,APOE/TNF,2
GO:0042554,superoxide anion generation,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,SYK/CD177,2
GO:0045663,positive regulation of myoblast differentiation,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,IGFBP3/MAP3K5,2
GO:0051353,positive regulation of oxidoreductase activity,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,APOE/TNF,2
GO:0051955,regulation of amino acid transport,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,SYT4/TNF,2
GO:0070296,sarcoplasmic reticulum calcium ion transport,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,AKAP6/DMD,2
GO:1904646,cellular response to amyloid-beta,2/137,43/18888,0.046511627906976744,6.412493634357494,3.037128116322207,0.03886061546852492,0.1284968563487953,0.09054255277663957,GJA1/TNF,2
GO:0001823,mesonephros development,3/137,104/18888,0.028846153846153848,3.976979225154408,2.6021240138404136,0.0400178133248799,0.13203715272165778,0.09303714665459986,BASP1/ADAMTS16/FGF1,3
GO:0032642,regulation of chemokine production,3/137,104/18888,0.028846153846153848,3.976979225154408,2.6021240138404136,0.0400178133248799,0.13203715272165778,0.09303714665459986,SYK/IL33/TNF,3
GO:0043010,camera-type eye development,6/137,346/18888,0.017341040462427744,2.3907851989367535,2.2317697052079106,0.040518797578697745,0.13269541534283052,0.09350097728681891,GJA1/ACHE/CDKN1C/SIX3/PROM1/DIO3,6
GO:0010828,positive regulation of glucose transmembrane transport,2/137,44/18888,0.045454545454545456,6.266755142667552,2.9895958038946584,0.04052166680849215,0.13269541534283052,0.09350097728681891,C3/NR4A3,2
GO:0010907,positive regulation of glucose metabolic process,2/137,44/18888,0.045454545454545456,6.266755142667552,2.9895958038946584,0.04052166680849215,0.13269541534283052,0.09350097728681891,FOXO1/IGF2,2
GO:0021762,substantia nigra development,2/137,44/18888,0.045454545454545456,6.266755142667552,2.9895958038946584,0.04052166680849215,0.13269541534283052,0.09350097728681891,BASP1/MAOB,2
GO:0045840,positive regulation of mitotic nuclear division,2/137,44/18888,0.045454545454545456,6.266755142667552,2.9895958038946584,0.04052166680849215,0.13269541534283052,0.09350097728681891,TNF/IGF2,2
GO:0071548,response to dexamethasone,2/137,44/18888,0.045454545454545456,6.266755142667552,2.9895958038946584,0.04052166680849215,0.13269541534283052,0.09350097728681891,ASS1/CPS1,2
GO:2000300,regulation of synaptic vesicle exocytosis,2/137,44/18888,0.045454545454545456,6.266755142667552,2.9895958038946584,0.04052166680849215,0.13269541534283052,0.09350097728681891,SYT4/RIMS3,2
GO:0097305,response to alcohol,5/137,259/18888,0.019305019305019305,2.661556238198574,2.3014402955469033,0.040599147929706224,0.13280664467466602,0.09357935264894209,GRIN1/AKR1C3/TNF/PTPRC/MAOB,5
GO:0043434,response to peptide hormone,7/137,438/18888,0.01598173515981735,2.2033796620337966,2.1780662934284716,0.04066930235939937,0.13289369464763048,0.09364069054463306,VGF/FOXO1/CXCL12/ASS1/IGF2/CPS1/NR4A3,7
GO:0032602,chemokine production,3/137,105/18888,0.02857142857142857,3.9391032325338893,2.5814075000987398,0.04098309630133135,0.13377583947771474,0.09426227497170836,SYK/IL33/TNF,3
GO:0009636,response to toxic substance,5/137,260/18888,0.019230769230769232,2.651319483436272,2.291734070028562,0.04116352240830584,0.13422122904930495,0.094576109176978,APOE/TNF/ASS1/MAOB/CPS1,5
GO:0051223,regulation of protein transport,7/137,440/18888,0.015909090909090907,2.1933642999336427,2.1649820087673217,0.041509380042442846,0.13520451215532078,0.09526895852014912,SYT4/APOE/ACHE/CHGA/FOXO1/TNF/VEGFC,7
GO:0002532,production of molecular mediator involved in inflammatory response,3/137,106/18888,0.02830188679245283,3.9019418812835696,2.5609451782843107,0.04196010248380866,0.1357921678603714,0.09568303750387624,SERPINE1/SYK/TNF,3
GO:0035303,regulation of dephosphorylation,3/137,106/18888,0.02830188679245283,3.9019418812835696,2.5609451782843107,0.04196010248380866,0.1357921678603714,0.09568303750387624,PPP4R4/TNF/PTPRC,3
GO:0046545,development of primary female sexual characteristics,3/137,106/18888,0.02830188679245283,3.9019418812835696,2.5609451782843107,0.04196010248380866,0.1357921678603714,0.09568303750387624,VGF/PTPRN/NRIP1,3
GO:0031641,regulation of myelination,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,TNF/TPPP,2
GO:0032881,regulation of polysaccharide metabolic process,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,PHLDA2/IGF2,2
GO:0033173,calcineurin-NFAT signaling cascade,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,AKAP6/TNF,2
GO:0034331,cell junction maintenance,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,SHANK1/CD177,2
GO:0043300,regulation of leukocyte degranulation,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,SYK/CD177,2
GO:0090278,negative regulation of peptide hormone secretion,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,CHGA/FOXO1,2
GO:1900744,regulation of p38MAPK cascade,2/137,45/18888,0.044444444444444446,6.127493917274939,2.943512900252738,0.04220917059583757,0.1357921678603714,0.09568303750387624,GDF6/MAP3K5,2
GO:0031214,biomineral tissue development,4/137,180/18888,0.022222222222222223,3.0637469586374695,2.3779820661547357,0.04222371143495821,0.1357921678603714,0.09568303750387624,GJA1/FAM20C/SPP1/ODAM,4
GO:0035265,organ growth,4/137,180/18888,0.022222222222222223,3.0637469586374695,2.3779820661547357,0.04222371143495821,0.1357921678603714,0.09568303750387624,AKAP6/BASP1/IGF2/NKX2-5,4
GO:1903522,regulation of blood circulation,5/137,262/18888,0.019083969465648856,2.631080403410041,2.2724575178345403,0.04230654681542769,0.1359153482954582,0.09576983395448062,GJA1/CHGA/DMD/TNF/NKX2-5,5
GO:0034612,response to tumor necrosis factor,5/137,263/18888,0.019011406844106463,2.621076295412284,2.262886365055654,0.042885207506944203,0.13754429748043898,0.09691763804667751,SYK/TNFRSF4/MAP3K5/TNF/ASS1,5
GO:0030316,osteoclast differentiation,3/137,107/18888,0.028037383177570093,3.8654751347295178,2.540731274921357,0.04294879275847258,0.13754429748043898,0.09691763804667751,FAM20C/TNF/TF,3
GO:1901655,cellular response to ketone,3/137,107/18888,0.028037383177570093,3.8654751347295178,2.540731274921357,0.04294879275847258,0.13754429748043898,0.09691763804667751,AKR1C3/SPP1/ASS1,3
GO:0060538,skeletal muscle organ development,4/137,182/18888,0.02197802197802198,3.030079409641454,2.3522734792937214,0.04367159199768491,0.1392863288137519,0.09814512304838761,DMD/BASP1/ASS1/IGF2,4
GO:0002792,negative regulation of peptide secretion,2/137,46/18888,0.043478260869565216,5.994287527768962,2.8988017483768678,0.043922661907313906,0.1392863288137519,0.09814512304838761,CHGA/FOXO1,2
GO:0003009,skeletal muscle contraction,2/137,46/18888,0.043478260869565216,5.994287527768962,2.8988017483768678,0.043922661907313906,0.1392863288137519,0.09814512304838761,DMD/TNF,2
GO:0045687,positive regulation of glial cell differentiation,2/137,46/18888,0.043478260869565216,5.994287527768962,2.8988017483768678,0.043922661907313906,0.1392863288137519,0.09814512304838761,IL33/CXCR4,2
GO:0048713,regulation of oligodendrocyte differentiation,2/137,46/18888,0.043478260869565216,5.994287527768962,2.8988017483768678,0.043922661907313906,0.1392863288137519,0.09814512304838761,IL33/CXCR4,2
GO:0090207,regulation of triglyceride metabolic process,2/137,46/18888,0.043478260869565216,5.994287527768962,2.8988017483768678,0.043922661907313906,0.1392863288137519,0.09814512304838761,APOE/C3,2
GO:0006641,triglyceride metabolic process,3/137,108/18888,0.027777777777777776,3.8296836982968365,2.520760201544673,0.04394912668664582,0.1392863288137519,0.09814512304838761,APOE/C3/CPS1,3
GO:0010586,miRNA metabolic process,3/137,108/18888,0.027777777777777776,3.8296836982968365,2.520760201544673,0.04394912668664582,0.1392863288137519,0.09814512304838761,NGFR/TNF/MYCN,3
GO:0060291,long-term synaptic potentiation,3/137,108/18888,0.027777777777777776,3.8296836982968365,2.520760201544673,0.04394912668664582,0.1392863288137519,0.09814512304838761,APOE/SLC18A3/RELN,3
GO:1902414,protein localization to cell junction,3/137,108/18888,0.027777777777777776,3.8296836982968365,2.520760201544673,0.04394912668664582,0.1392863288137519,0.09814512304838761,SHANK1/LGI1/RELN,3
GO:0009150,purine ribonucleotide metabolic process,7/137,446/18888,0.01569506726457399,2.163857156885208,2.126143920134141,0.044097350382318774,0.1396111134510756,0.09837397557444558,NT5C1A/CBFA2T3/NUDT11/NPR1/NUDT10/CARD11/PDE1A,7
GO:0002526,acute inflammatory response,3/137,109/18888,0.027522935779816515,3.7945489854684253,2.5010265471021467,0.044961062534632334,0.14205089322536013,0.10009311404408179,C3/TNF/ASS1,3
GO:0032760,positive regulation of tumor necrosis factor production,3/137,109/18888,0.027522935779816515,3.7945489854684253,2.5010265471021467,0.044961062534632334,0.14205089322536013,0.10009311404408179,SYK/IL33/PTPRC,3
GO:0006509,membrane protein ectodomain proteolysis,2/137,47/18888,0.0425531914893617,5.866749495263239,2.85539045563061,0.045661681084724015,0.14366953677379143,0.10123365649060354,APOE/TNF,2
GO:0006953,acute-phase response,2/137,47/18888,0.0425531914893617,5.866749495263239,2.85539045563061,0.045661681084724015,0.14366953677379143,0.10123365649060354,TNF/ASS1,2
GO:0010830,regulation of myotube differentiation,2/137,47/18888,0.0425531914893617,5.866749495263239,2.85539045563061,0.045661681084724015,0.14366953677379143,0.10123365649060354,BHLHE41/NKX2-5,2
GO:0050919,negative chemotaxis,2/137,47/18888,0.0425531914893617,5.866749495263239,2.85539045563061,0.045661681084724015,0.14366953677379143,0.10123365649060354,NTN1/SEMA5B,2
GO:0060828,regulation of canonical Wnt signaling pathway,5/137,268/18888,0.018656716417910446,2.5721756182590694,2.215685789664518,0.04585018742938482,0.14395967478233612,0.10143809601307605,APOE/FOXO1/DRAXIN/NKX2-5/WWTR1,5
GO:0006694,steroid biosynthetic process,4/137,185/18888,0.021621621621621623,2.980942986782403,2.3143645074629604,0.045895400905377796,0.14395967478233612,0.10143809601307605,APOE/AKR1C3/TNF/FGF1,4
GO:0050954,sensory perception of mechanical stimulus,4/137,185/18888,0.021621621621621623,2.980942986782403,2.3143645074629604,0.045895400905377796,0.14395967478233612,0.10143809601307605,TRPA1/CXCL12/CXCR4/TNF,4
GO:0051100,negative regulation of binding,3/137,110/18888,0.02727272727272727,3.7600530856005308,2.48152507073617,0.04598455730311855,0.14409124115925853,0.10153080143766477,LEF1/MAP2/IFIT1,3
GO:0015711,organic anion transport,7/137,451/18888,0.015521064301552107,2.1398676096913594,2.094243194922398,0.046332201949551774,0.145031672153879,0.10219345595998303,SYT4/APOE/GJA1/SYK/TNF/AKR1C1/CRABP2,7
GO:0048736,appendage development,4/137,186/18888,0.021505376344086023,2.9649164115846482,2.3018980373527937,0.04665052398248165,0.14558016277559713,0.10257993810807235,PRRX1/LEF1/GJA1/CRABP2,4
GO:0051302,regulation of cell division,4/137,186/18888,0.021505376344086023,2.9649164115846482,2.3018980373527937,0.04665052398248165,0.14558016277559713,0.10257993810807235,IGF2/PDGFC/VEGFC/FGF1,4
GO:0060173,limb development,4/137,186/18888,0.021505376344086023,2.9649164115846482,2.3018980373527937,0.04665052398248165,0.14558016277559713,0.10257993810807235,PRRX1/LEF1/GJA1/CRABP2,4
GO:0007229,integrin-mediated signaling pathway,3/137,111/18888,0.02702702702702703,3.7261787334780037,2.4622506949217735,0.04701956675616363,0.14605798313153256,0.10291662396969063,SYK/ITGA7/CD177,3
GO:0014812,muscle cell migration,3/137,111/18888,0.02702702702702703,3.7261787334780037,2.4622506949217735,0.04701956675616363,0.14605798313153256,0.10291662396969063,SERPINE1/IGFBP3/NR4A3,3
GO:0030203,glycosaminoglycan metabolic process,3/137,111/18888,0.02702702702702703,3.7261787334780037,2.4622506949217735,0.04701956675616363,0.14605798313153256,0.10291662396969063,CHST1/CHST13/CHST15,3
GO:0045445,myoblast differentiation,3/137,111/18888,0.02702702702702703,3.7261787334780037,2.4622506949217735,0.04701956675616363,0.14605798313153256,0.10291662396969063,IGFBP3/MAP3K5/TNF,3
GO:0097553,calcium ion transmembrane import into cytosol,4/137,187/18888,0.0213903743315508,2.9490612436082593,2.289514670864857,0.0474125680050916,0.14605798313153256,0.10291662396969063,AKAP6/DMD/GRIN1/PTPRC,4
GO:0002673,regulation of acute inflammatory response,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,C3/TNF,2
GO:0021795,cerebral cortex cell migration,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,POU3F3/RELN,2
GO:0042088,T-helper 1 type immune response,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,LEF1/IL33,2
GO:0045776,negative regulation of blood pressure,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,TNF/VEGFC,2
GO:0097720,calcineurin-mediated signaling,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,AKAP6/TNF,2
GO:1902003,regulation of amyloid-beta formation,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,APOE/TNF,2
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,SERPINE1/FAIM2,2
GO:2001222,regulation of neuron migration,2/137,48/18888,0.041666666666666664,5.744525547445256,2.813212353085752,0.04742577368392817,0.14605798313153256,0.10291662396969063,UNC5D/RELN,2
GO:0010038,response to metal ion,6/137,360/18888,0.016666666666666666,2.2978102189781024,2.125091947596631,0.04752168021229514,0.1462058145241177,0.10302079018858125,SYT4/AKR1C3/ASS1/MAOB/TF/CPS1,6
GO:0045833,negative regulation of lipid metabolic process,3/137,112/18888,0.026785714285714284,3.6929092805005213,2.4431984989408155,0.04806604544978127,0.1475830691274974,0.10399124309425305,APOE/AKR1C3/TNF,3
GO:1905954,positive regulation of lipid localization,3/137,112/18888,0.026785714285714284,3.6929092805005213,2.4431984989408155,0.04806604544978127,0.1475830691274974,0.10399124309425305,APOE/C3/SPP1,3
GO:0017157,regulation of exocytosis,4/137,188/18888,0.02127659574468085,2.9333747476316194,2.2772133440885485,0.04818152870005867,0.14778897044480307,0.10413632703964015,SYT4/SYK/RIMS3/CD177,4
GO:0042176,regulation of protein catabolic process,6/137,362/18888,0.016574585635359115,2.2851151348953502,2.110255547232235,0.04857971723622313,0.14886073996481225,0.10489152643585274,APOE/CBFA2T3/FOXO1/IL33/TNF/VIP,6
GO:0006869,lipid transport,7/137,456/18888,0.015350877192982455,2.116404149058778,2.062752818233819,0.04863876704767595,0.148892193610338,0.10491368957229792,APOE/SYK/SPP1/VLDLR/APOL1/AKR1C1/CRABP2,7
GO:1901136,carbohydrate derivative catabolic process,5/137,273/18888,0.018315018315018316,2.525066174701211,2.169541933921287,0.048934989181440514,0.14901054045136983,0.10499708013456183,NT5C1A/CBFA2T3/NUDT11/NUDT10/PDE1A,5
GO:0061138,morphogenesis of a branching epithelium,4/137,189/18888,0.021164021164021163,2.9178542463213994,2.2649930124947875,0.0489574012614142,0.14901054045136983,0.10499708013456183,LEF1/ADAMTS16/TNF/FGF1,4
GO:0060840,artery development,3/137,113/18888,0.02654867256637168,3.660228667398747,2.4243637126729007,0.04912394676011889,0.14901054045136983,0.10499708013456183,PRRX1/APOE/NGFR,3
GO:0062014,negative regulation of small molecule metabolic process,3/137,113/18888,0.02654867256637168,3.660228667398747,2.4243637126729007,0.04912394676011889,0.14901054045136983,0.10499708013456183,APOE/CBFA2T3/AKR1C3,3
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,3/137,113/18888,0.02654867256637168,3.660228667398747,2.4243637126729007,0.04912394676011889,0.14901054045136983,0.10499708013456183,SYK/IL33/PTPRC,3
GO:0010171,body morphogenesis,2/137,49/18888,0.04081632653061224,5.6272903321912695,2.77220551566553,0.04921449042430563,0.14901054045136983,0.10499708013456183,LEF1/GREM2,2
GO:0014075,response to amine,2/137,49/18888,0.04081632653061224,5.6272903321912695,2.77220551566553,0.04921449042430563,0.14901054045136983,0.10499708013456183,ASS1/CPS1,2
GO:0030195,negative regulation of blood coagulation,2/137,49/18888,0.04081632653061224,5.6272903321912695,2.77220551566553,0.04921449042430563,0.14901054045136983,0.10499708013456183,SERPINE1/APOE,2
GO:0033628,regulation of cell adhesion mediated by integrin,2/137,49/18888,0.04081632653061224,5.6272903321912695,2.77220551566553,0.04921449042430563,0.14901054045136983,0.10499708013456183,SERPINE1/SYK,2
GO:0035272,exocrine system development,2/137,49/18888,0.04081632653061224,5.6272903321912695,2.77220551566553,0.04921449042430563,0.14901054045136983,0.10499708013456183,TNF/IGF2,2
GO:2000649,regulation of sodium ion transmembrane transporter activity,2/137,49/18888,0.04081632653061224,5.6272903321912695,2.77220551566553,0.04921449042430563,0.14901054045136983,0.10499708013456183,DMD/UTRN,2
GO:2000116,regulation of cysteine-type endopeptidase activity,4/137,190/18888,0.021052631578947368,2.9024971187091815,2.2528526504809663,0.049740180354629474,0.15045295385761065,0.10601344579261178,NGFR/SYK/MAP3K5/TNF,4
GO:0042752,regulation of circadian rhythm,3/137,114/18888,0.02631578947368421,3.628121398386477,2.405741710685012,0.05019322291123918,0.151672986460497,0.10687311558901681,RORC/PTGDS/BMAL2,3
GO:0021543,pallium development,4/137,191/18888,0.020942408376963352,2.88730079871594,2.2407912509289156,0.050529860120903936,0.152388471431817,0.10737726672249506,LEF1/ASCL1/POU3F3/RELN,4
GO:0031503,protein-containing complex localization,4/137,191/18888,0.020942408376963352,2.88730079871594,2.2407912509289156,0.050529860120903936,0.152388471431817,0.10737726672249506,KIF17/LGI1/DLG3/RELN,4
GO:0001754,eye photoreceptor cell differentiation,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,PROM1/DIO3,2
GO:0007215,glutamate receptor signaling pathway,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,GRIK5/GRIN1,2
GO:0022602,ovulation cycle process,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,PTPRN/NRIP1,2
GO:0043114,regulation of vascular permeability,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,APOE/NPR1,2
GO:0043457,regulation of cellular respiration,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,CBFA2T3/TNF,2
GO:0051403,stress-activated MAPK cascade,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,FOXO1/MAP3K5,2
GO:0061082,myeloid leukocyte cytokine production,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,SYK/NR4A3,2
GO:0140374,antiviral innate immune response,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,TNF/IFIT1,2
GO:1900047,negative regulation of hemostasis,2/137,50/18888,0.04,5.514744525547445,2.7323123351758936,0.051027387138666995,0.15253240504134347,0.10747868645218481,SERPINE1/APOE,2
GO:0015908,fatty acid transport,3/137,115/18888,0.02608695652173913,3.596572516661377,2.387328006602981,0.0512738250025074,0.15282003311294198,0.10768135740144184,APOE/SYK/CRABP2,3
GO:0033559,unsaturated fatty acid metabolic process,3/137,115/18888,0.02608695652173913,3.596572516661377,2.387328006602981,0.0512738250025074,0.15282003311294198,0.10768135740144184,PTGDS/AKR1C3/AKR1C1,3
GO:0046634,regulation of alpha-beta T cell activation,3/137,115/18888,0.02608695652173913,3.596572516661377,2.387328006602981,0.0512738250025074,0.15282003311294198,0.10768135740144184,SYK/PTPRC/CARD11,3
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4/137,192/18888,0.020833333333333332,2.872262773722628,2.228807824775487,0.05132643418148079,0.15282758743597988,0.1076866803930837,C3/IL33/TNF/PTPRC,4
GO:0042113,B cell activation,5/137,278/18888,0.017985611510791366,2.479651315443995,2.124409098641445,0.052139975156190774,0.1549476184777938,0.10918051477896557,LEF1/SYK/TNFRSF4/PTPRC/CARD11,5
GO:0090596,sensory organ morphogenesis,5/137,278/18888,0.017985611510791366,2.479651315443995,2.124409098641445,0.052139975156190774,0.1549476184777938,0.10918051477896557,PRRX1/NTN1/SIX3/PROM1/DIO3,5
GO:0006636,unsaturated fatty acid biosynthetic process,2/137,51/18888,0.0392156862745098,5.406612279948476,2.693479139464947,0.05286402472361247,0.1560093186746567,0.10992861904267215,PTGDS/AKR1C3,2
GO:0010043,response to zinc ion,2/137,51/18888,0.0392156862745098,5.406612279948476,2.693479139464947,0.05286402472361247,0.1560093186746567,0.10992861904267215,ASS1/CPS1,2
GO:0010665,regulation of cardiac muscle cell apoptotic process,2/137,51/18888,0.0392156862745098,5.406612279948476,2.693479139464947,0.05286402472361247,0.1560093186746567,0.10992861904267215,MAP3K5/NKX2-5,2
GO:0035987,endodermal cell differentiation,2/137,51/18888,0.0392156862745098,5.406612279948476,2.693479139464947,0.05286402472361247,0.1560093186746567,0.10992861904267215,LAMB3/ITGA7,2
GO:0002040,sprouting angiogenesis,4/137,194/18888,0.020618556701030927,2.8426518172924973,2.2050710241952376,0.05294023709680315,0.1560093186746567,0.10992861904267215,LEF1/NGFR/VEGFC/FGF1,4
GO:0002377,immunoglobulin production,4/137,194/18888,0.020618556701030927,2.8426518172924973,2.2050710241952376,0.05294023709680315,0.1560093186746567,0.10992861904267215,TNFRSF4/IL33/TNF/PTPRC,4
GO:0050777,negative regulation of immune response,4/137,194/18888,0.020618556701030927,2.8426518172924973,2.2050710241952376,0.05294023709680315,0.1560093186746567,0.10992861904267215,SPINK5/SYK/IL33/PTPRC,4
GO:0071466,cellular response to xenobiotic stimulus,4/137,194/18888,0.020618556701030927,2.8426518172924973,2.2050710241952376,0.05294023709680315,0.1560093186746567,0.10992861904267215,GRIN1/RORC/CXCR4/AKR1C1,4
GO:0050878,regulation of body fluid levels,6/137,370/18888,0.016216216216216217,2.235707240086802,2.051865882220084,0.05295729166020456,0.1560093186746567,0.10992861904267215,SERPINE1/APOE/GJA1/SYK/NPR1/VIP,6
GO:0052548,regulation of endopeptidase activity,5/137,280/18888,0.017857142857142856,2.4619395203336807,2.1066293485199914,0.05345567163466969,0.15676039937468342,0.1104578519426358,SERPINE1/NGFR/SYK/MAP3K5/TNF,5
GO:0033209,tumor necrosis factor-mediated signaling pathway,3/137,117/18888,0.02564102564102564,3.5350926445816953,2.3511082100306133,0.05346880594106948,0.15676039937468342,0.1104578519426358,SYK/TNFRSF4/TNF,3
GO:0051928,positive regulation of calcium ion transport,3/137,117/18888,0.02564102564102564,3.5350926445816953,2.3511082100306133,0.05346880594106948,0.15676039937468342,0.1104578519426358,AKAP6/GRIN1/CXCL12,3
GO:0009259,ribonucleotide metabolic process,7/137,466/18888,0.015021459227467811,2.0709877510103065,2.0009610273613707,0.053469061516725244,0.15676039937468342,0.1104578519426358,NT5C1A/CBFA2T3/NUDT11/NPR1/NUDT10/CARD11/PDE1A,7
GO:0016055,Wnt signaling pathway,7/137,466/18888,0.015021459227467811,2.0709877510103065,2.0009610273613707,0.053469061516725244,0.15676039937468342,0.1104578519426358,LEF1/APOE/FOXO1/DRAXIN/NKX2-5/TNIK/WWTR1,7
GO:0198738,cell-cell signaling by wnt,7/137,468/18888,0.014957264957264958,2.062137376005989,1.9887874104959706,0.05447010951653178,0.159367894717269,0.11229516758894274,LEF1/APOE/FOXO1/DRAXIN/NKX2-5/TNIK/WWTR1,7
GO:0009308,amine metabolic process,3/137,118/18888,0.025423728813559324,3.5051342323394783,2.333293793066798,0.054583081604677314,0.159367894717269,0.11229516758894274,MAOA/NPR1/MAOB,3
GO:1904659,glucose transmembrane transport,3/137,118/18888,0.025423728813559324,3.5051342323394783,2.333293793066798,0.054583081604677314,0.159367894717269,0.11229516758894274,C3/TNF/NR4A3,3
GO:0090287,regulation of cellular response to growth factor stimulus,6/137,373/18888,0.0160857908847185,2.2177256805150583,2.0303531306793055,0.054659106386179816,0.159367894717269,0.11229516758894274,NGFR/FAM20C/CDKN1C/GREM2/VEGFC/FGF1,6
GO:0010543,regulation of platelet activation,2/137,52/18888,0.038461538461538464,5.302638966872544,2.6556558519289952,0.05472396909033352,0.159367894717269,0.11229516758894274,APOE/SYK,2
GO:0035176,social behavior,2/137,52/18888,0.038461538461538464,5.302638966872544,2.6556558519289952,0.05472396909033352,0.159367894717269,0.11229516758894274,SHANK1/GAD1,2
GO:0035601,protein deacylation,2/137,52/18888,0.038461538461538464,5.302638966872544,2.6556558519289952,0.05472396909033352,0.159367894717269,0.11229516758894274,NDN/TPPP,2
GO:0045582,positive regulation of T cell differentiation,3/137,119/18888,0.025210084033613446,3.47567932282402,2.315671015539099,0.0557084768931538,0.16192597283610038,0.1140976624488353,LEF1/SYK/PTPRC,3
GO:0051702,biological process involved in interaction with symbiont,3/137,119/18888,0.025210084033613446,3.47567932282402,2.315671015539099,0.0557084768931538,0.16192597283610038,0.1140976624488353,LEF1/APOE/APOL1,3
GO:0010662,regulation of striated muscle cell apoptotic process,2/137,53/18888,0.03773584905660377,5.202589175044759,2.6187956864043564,0.05660679111585272,0.16375727628965167,0.11538805113463417,MAP3K5/NKX2-5,2
GO:0048009,insulin-like growth factor receptor signaling pathway,2/137,53/18888,0.03773584905660377,5.202589175044759,2.6187956864043564,0.05660679111585272,0.16375727628965167,0.11538805113463417,IGFBP3/IGF2,2
GO:0050819,negative regulation of coagulation,2/137,53/18888,0.03773584905660377,5.202589175044759,2.6187956864043564,0.05660679111585272,0.16375727628965167,0.11538805113463417,SERPINE1/APOE,2
GO:1902692,regulation of neuroblast proliferation,2/137,53/18888,0.03773584905660377,5.202589175044759,2.6187956864043564,0.05660679111585272,0.16375727628965167,0.11538805113463417,SIX3/VEGFC,2
GO:1902930,regulation of alcohol biosynthetic process,2/137,53/18888,0.03773584905660377,5.202589175044759,2.6187956864043564,0.05660679111585272,0.16375727628965167,0.11538805113463417,APOE/FGF1,2
GO:0002718,regulation of cytokine production involved in immune response,3/137,120/18888,0.025,3.4467153284671537,2.298236010754777,0.05684493767973464,0.16397991474343113,0.11554492854412285,SYK/TNF/NR4A3,3
GO:0007265,Ras protein signal transduction,3/137,120/18888,0.025,3.4467153284671537,2.298236010754777,0.05684493767973464,0.16397991474343113,0.11554492854412285,NTN1/RIT2/CDKN2A,3
GO:0035710,"CD4-positive, alpha-beta T cell activation",3/137,120/18888,0.025,3.4467153284671537,2.298236010754777,0.05684493767973464,0.16397991474343113,0.11554492854412285,LEF1/RORC/CARD11,3
GO:0043122,regulation of canonical NF-kappaB signal transduction,5/137,286/18888,0.017482517482517484,2.41029043948752,2.054193332070243,0.05751837956417414,0.16576590597720442,0.11680338894648154,GJA1/TNF/S100A13/CARD11/LTB,5
GO:0030705,cytoskeleton-dependent intracellular transport,4/137,200/18888,0.02,2.7573722627737225,2.1356344085832806,0.05794628768444702,0.16665991701414093,0.11743333464161204,SYT4/NEFH/KIF17/MAP2,4
GO:0008645,hexose transmembrane transport,3/137,121/18888,0.024793388429752067,3.4182300778186643,2.2809850224111052,0.05799240886927185,0.16665991701414093,0.11743333464161204,C3/TNF/NR4A3,3
GO:0046660,female sex differentiation,3/137,121/18888,0.024793388429752067,3.4182300778186643,2.2809850224111052,0.05799240886927185,0.16665991701414093,0.11743333464161204,VGF/PTPRN/NRIP1,3
GO:0010883,regulation of lipid storage,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,C3/TNF,2
GO:0021872,forebrain generation of neurons,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,LEF1/ASCL1,2
GO:0031103,axon regeneration,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,SPP1/GAP43,2
GO:0038093,Fc receptor signaling pathway,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,SYK/NR4A3,2
GO:0048146,positive regulation of fibroblast proliferation,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,NGFR/PDGFC,2
GO:0051703,biological process involved in intraspecies interaction between organisms,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,SHANK1/GAD1,2
GO:0086009,membrane repolarization,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,GJA1/AKAP6,2
GO:1904645,response to amyloid-beta,2/137,54/18888,0.037037037037037035,5.10624493106245,2.5828548731752843,0.05851206659469945,0.16689610023086235,0.11759975607768912,GJA1/TNF,2
GO:0050728,negative regulation of inflammatory response,4/137,201/18888,0.01990049751243781,2.743653992809674,2.1243110166838597,0.05880453972407757,0.1675737210437766,0.11807722704436628,APOE/SYK/IL33/PTPRC,4
GO:0002367,cytokine production involved in immune response,3/137,122/18888,0.02459016393442623,3.390211798492282,2.26391440054996,0.059150834422991565,0.16808970824857564,0.11844080635712219,SYK/TNF/NR4A3,3
GO:0006022,aminoglycan metabolic process,3/137,122/18888,0.02459016393442623,3.390211798492282,2.26391440054996,0.059150834422991565,0.16808970824857564,0.11844080635712219,CHST1/CHST13/CHST15,3
GO:0045471,response to ethanol,3/137,122/18888,0.02459016393442623,3.390211798492282,2.26391440054996,0.059150834422991565,0.16808970824857564,0.11844080635712219,GRIN1/TNF/MAOB,3
GO:0051090,regulation of DNA-binding transcription factor activity,6/137,381/18888,0.015748031496062992,2.171159262026553,1.9739674613151492,0.05935858864645151,0.16852317446415815,0.11874623902541044,SYK/TNFRSF4/TNF/CARD11/RELN/CDKN2A,6
GO:0007626,locomotory behavior,4/137,202/18888,0.019801980198019802,2.730071547300715,2.113056614310587,0.05966959463909819,0.16924870152279523,0.11925746610025202,APOE/GAD1/CXCL12/RELN,4
GO:0002688,regulation of leukocyte chemotaxis,3/137,123/18888,0.024390243902439025,3.3626491009435644,2.2470205976926727,0.06032015738289356,0.1700101162534418,0.11979398065316327,SERPINE1/CXCL12/VEGFC,3
GO:0015749,monosaccharide transmembrane transport,3/137,123/18888,0.024390243902439025,3.3626491009435644,2.2470205976926727,0.06032015738289356,0.1700101162534418,0.11979398065316327,C3/TNF/NR4A3,3
GO:0071675,regulation of mononuclear cell migration,3/137,123/18888,0.024390243902439025,3.3626491009435644,2.2470205976926727,0.06032015738289356,0.1700101162534418,0.11979398065316327,SERPINE1/CXCL12/TNF,3
GO:0002686,negative regulation of leukocyte migration,2/137,55/18888,0.03636363636363636,5.01340411413404,2.5477924124122477,0.060439376191017156,0.1700101162534418,0.11979398065316327,CXCL12/IL33,2
GO:0010559,regulation of glycoprotein biosynthetic process,2/137,55/18888,0.03636363636363636,5.01340411413404,2.5477924124122477,0.060439376191017156,0.1700101162534418,0.11979398065316327,IL15/IL33,2
GO:0010659,cardiac muscle cell apoptotic process,2/137,55/18888,0.03636363636363636,5.01340411413404,2.5477924124122477,0.060439376191017156,0.1700101162534418,0.11979398065316327,MAP3K5/NKX2-5,2
GO:0034381,plasma lipoprotein particle clearance,2/137,55/18888,0.03636363636363636,5.01340411413404,2.5477924124122477,0.060439376191017156,0.1700101162534418,0.11979398065316327,APOE/VLDLR,2
GO:0045071,negative regulation of viral genome replication,2/137,55/18888,0.03636363636363636,5.01340411413404,2.5477924124122477,0.060439376191017156,0.1700101162534418,0.11979398065316327,TNF/IFIT1,2
GO:1902991,regulation of amyloid precursor protein catabolic process,2/137,55/18888,0.03636363636363636,5.01340411413404,2.5477924124122477,0.060439376191017156,0.1700101162534418,0.11979398065316327,APOE/TNF,2
GO:0000302,response to reactive oxygen species,4/137,203/18888,0.019704433497536946,2.7166229189888895,2.101870385873427,0.06054144062256158,0.1701404021915819,0.11988578384403734,APOE/PTPRN/TRPA1/MAP3K5,4
GO:0019693,ribose phosphate metabolic process,7/137,480/18888,0.014583333333333334,2.0105839416058395,1.9169874320470182,0.06072329440378726,0.17049447517972283,0.12013527377808296,NT5C1A/CBFA2T3/NUDT11/NPR1/NUDT10/CARD11/PDE1A,7
GO:0031348,negative regulation of defense response,5/137,291/18888,0.01718213058419244,2.368876514410415,2.011494633387235,0.061036392966087025,0.17121605821001618,0.1206437217779758,APOE/SPINK5/SYK/IL33/PTPRC,5
GO:0051346,negative regulation of hydrolase activity,4/137,204/18888,0.0196078431372549,2.703306139974238,2.090751529527873,0.06142006540101974,0.17213410431947865,0.12129060327126125,SERPINE1/PPP4R4/SPINK5/TNF,4
GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/137,56/18888,0.03571428571428571,4.923879040667361,2.5135698518498786,0.06238830539109855,0.1740485448387868,0.12263957270664326,IL33/PTPRC,2
GO:0014888,striated muscle adaptation,2/137,56/18888,0.03571428571428571,4.923879040667361,2.5135698518498786,0.06238830539109855,0.1740485448387868,0.12263957270664326,TRIM63/FOXO1,2
GO:0015872,dopamine transport,2/137,56/18888,0.03571428571428571,4.923879040667361,2.5135698518498786,0.06238830539109855,0.1740485448387868,0.12263957270664326,SYT4/CXCL12,2
GO:0034205,amyloid-beta formation,2/137,56/18888,0.03571428571428571,4.923879040667361,2.5135698518498786,0.06238830539109855,0.1740485448387868,0.12263957270664326,APOE/TNF,2
GO:0098732,macromolecule deacylation,2/137,56/18888,0.03571428571428571,4.923879040667361,2.5135698518498786,0.06238830539109855,0.1740485448387868,0.12263957270664326,NDN/TPPP,2
GO:0001952,regulation of cell-matrix adhesion,3/137,125/18888,0.024,3.308846715328467,2.213749749468448,0.06269126323703426,0.1742565896169659,0.12278616699574442,SERPINE1/UTRN/CDKN2A,3
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/137,125/18888,0.024,3.308846715328467,2.213749749468448,0.06269126323703426,0.1742565896169659,0.12278616699574442,C3/TNF/PTPRC,3
GO:0022612,gland morphogenesis,3/137,125/18888,0.024,3.308846715328467,2.213749749468448,0.06269126323703426,0.1742565896169659,0.12278616699574442,NTN1/TNF/FGF1,3
GO:0046632,alpha-beta T cell differentiation,3/137,125/18888,0.024,3.308846715328467,2.213749749468448,0.06269126323703426,0.1742565896169659,0.12278616699574442,LEF1/RORC/SYK,3
GO:1903131,mononuclear cell differentiation,7/137,484/18888,0.014462809917355372,1.993967545394221,1.8935131676352999,0.06290219055111598,0.1746837903202966,0.1230871848052583,LEF1/RORC/SPINK5/SYK/IL15/PTPRC/CARD11,7
GO:0001763,morphogenesis of a branching structure,4/137,206/18888,0.019417475728155338,2.677060449294876,2.068712792676051,0.06319759994399488,0.17502638387393135,0.12332858600208381,LEF1/ADAMTS16/TNF/FGF1,4
GO:0016051,carbohydrate biosynthetic process,4/137,206/18888,0.019417475728155338,2.677060449294876,2.068712792676051,0.06319759994399488,0.17502638387393135,0.12332858600208381,FOXO1/CHST13/IGF2/CHST15,4
GO:0071674,mononuclear cell migration,4/137,206/18888,0.019417475728155338,2.677060449294876,2.068712792676051,0.06319759994399488,0.17502638387393135,0.12332858600208381,SERPINE1/CXCL12/CXCR4/TNF,4
GO:0006805,xenobiotic metabolic process,3/137,126/18888,0.023809523809523808,3.282586027111574,2.1973660890942543,0.06389292783380353,0.17679167338963586,0.1245724593829848,GRIN1/RORC/AKR1C1,3
GO:0002819,regulation of adaptive immune response,4/137,207/18888,0.01932367149758454,2.664127790119539,2.0577913745581617,0.0640964828702048,0.1771162961954598,0.12480119787794866,C3/IL33/TNF/PTPRC,4
GO:0010658,striated muscle cell apoptotic process,2/137,57/18888,0.03508771929824561,4.837495197848636,2.480151085934862,0.06435844445634499,0.1771162961954598,0.12480119787794866,MAP3K5/NKX2-5,2
GO:0019748,secondary metabolic process,2/137,57/18888,0.03508771929824561,4.837495197848636,2.480151085934862,0.06435844445634499,0.1771162961954598,0.12480119787794866,AKR1C3/AKR1C1,2
GO:0060632,regulation of microtubule-based movement,2/137,57/18888,0.03508771929824561,4.837495197848636,2.480151085934862,0.06435844445634499,0.1771162961954598,0.12480119787794866,NEFH/MAP2,2
GO:0060986,endocrine hormone secretion,2/137,57/18888,0.03508771929824561,4.837495197848636,2.480151085934862,0.06435844445634499,0.1771162961954598,0.12480119787794866,GJA1/SPP1,2
GO:0060997,dendritic spine morphogenesis,2/137,57/18888,0.03508771929824561,4.837495197848636,2.480151085934862,0.06435844445634499,0.1771162961954598,0.12480119787794866,SHANK1/RELN,2
GO:0021987,cerebral cortex development,3/137,127/18888,0.023622047244094488,3.25673889303983,2.181146011097787,0.0651052532881733,0.17901011985180623,0.1261356400832035,ASCL1/POU3F3/RELN,3
GO:0002708,positive regulation of lymphocyte mediated immunity,3/137,128/18888,0.0234375,3.2312956204379564,2.165086428100366,0.06632817839975383,0.18083894883540116,0.12742428518684024,C3/TNF/PTPRC,3
GO:0019369,arachidonic acid metabolic process,2/137,58/18888,0.034482758620689655,4.754090108230556,2.4475021740331226,0.06634938837664672,0.18083894883540116,0.12742428518684024,PTGDS/AKR1C3,2
GO:0048008,platelet-derived growth factor receptor signaling pathway,2/137,58/18888,0.034482758620689655,4.754090108230556,2.4475021740331226,0.06634938837664672,0.18083894883540116,0.12742428518684024,PDGFC/NR4A3,2
GO:0061756,leukocyte adhesion to vascular endothelial cell,2/137,58/18888,0.034482758620689655,4.754090108230556,2.4475021740331226,0.06634938837664672,0.18083894883540116,0.12742428518684024,CXCL12/TNF,2
GO:0001654,eye development,6/137,393/18888,0.015267175572519083,2.1048643227280324,1.8919411102375359,0.06684908582778698,0.18083894883540116,0.12742428518684024,GJA1/ACHE/CDKN1C/SIX3/PROM1/DIO3,6
GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,5/137,299/18888,0.016722408026755852,2.305495202988062,1.9449678085041189,0.06691503452680796,0.18083894883540116,0.12742428518684024,AKR1C3/TNF/IGF2/COL6A3/RELN,5
GO:0051209,release of sequestered calcium ion into cytosol,3/137,129/18888,0.023255813953488372,3.206246817178747,2.149184335306906,0.0675616411880328,0.18083894883540116,0.12742428518684024,AKAP6/DMD/PTPRC,3
GO:0007566,embryo implantation,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,GJA1/SPP1,2
GO:0009161,ribonucleoside monophosphate metabolic process,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,NT5C1A/CARD11,2
GO:0010718,positive regulation of epithelial to mesenchymal transition,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,LEF1/WWTR1,2
GO:0031098,stress-activated protein kinase signaling cascade,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,FOXO1/MAP3K5,2
GO:0038066,p38MAPK cascade,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,GDF6/MAP3K5,2
GO:1902305,regulation of sodium ion transmembrane transport,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,DMD/UTRN,2
GO:1903409,reactive oxygen species biosynthetic process,2/137,59/18888,0.03389830508474576,4.673512309785971,2.4155911755928563,0.0683607368241804,0.18083894883540116,0.12742428518684024,GRIN1/MAOB,2
GO:0042594,response to starvation,4/137,212/18888,0.018867924528301886,2.6012945875223794,2.004134159191268,0.0686914771103788,0.18083894883540116,0.12742428518684024,AKR1C3/FOXO1/MAP3K5/CPS1,4
GO:0051283,negative regulation of sequestering of calcium ion,3/137,130/18888,0.023076923076923078,3.1815833801235263,2.13343680766771,0.06880557891438138,0.18083894883540116,0.12742428518684024,AKAP6/DMD/PTPRC,3
GO:0002821,positive regulation of adaptive immune response,3/137,131/18888,0.022900763358778626,3.1572964840920488,2.1178409971589507,0.07005992810373443,0.18083894883540116,0.12742428518684024,C3/TNF/PTPRC,3
GO:0001794,type IIa hypersensitivity,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,C3,1
GO:0001915,negative regulation of T cell mediated cytotoxicity,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,PTPRC,1
GO:0002445,type II hypersensitivity,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,C3,1
GO:0002775,antimicrobial peptide production,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,SPINK5,1
GO:0002883,regulation of hypersensitivity,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,C3,1
GO:0008300,isoprenoid catabolic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,AKR1C3,1
GO:0009128,purine nucleoside monophosphate catabolic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NT5C1A,1
GO:0009155,purine deoxyribonucleotide catabolic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NT5C1A,1
GO:0009169,purine ribonucleoside monophosphate catabolic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NT5C1A,1
GO:0009170,purine deoxyribonucleoside monophosphate metabolic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NT5C1A,1
GO:0009750,response to fructose,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,TNF,1
GO:0014745,negative regulation of muscle adaptation,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,FOXO1,1
GO:0014889,muscle atrophy,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,TRIM63,1
GO:0016102,diterpenoid biosynthetic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,AKR1C3,1
GO:0017038,protein import,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:0021520,spinal cord motor neuron cell fate specification,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,LMO4,1
GO:0021892,cerebral cortex GABAergic interneuron differentiation,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,ASCL1,1
GO:0030953,astral microtubule organization,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,TPPP,1
GO:0032819,positive regulation of natural killer cell proliferation,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,IL15,1
GO:0033605,positive regulation of catecholamine secretion,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,CXCL12,1
GO:0035768,endothelial cell chemotaxis to fibroblast growth factor,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,FGF1,1
GO:0035907,dorsal aorta development,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NGFR,1
GO:0036093,germ cell proliferation,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,PTGDS,1
GO:0038063,collagen-activated tyrosine kinase receptor signaling pathway,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,SYK,1
GO:0042368,vitamin D biosynthetic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,TNF,1
GO:0045541,negative regulation of cholesterol biosynthetic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:0045542,positive regulation of cholesterol biosynthetic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,FGF1,1
GO:0046085,adenosine metabolic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NT5C1A,1
GO:0048263,determination of dorsal identity,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,GREM2,1
GO:0048304,positive regulation of isotype switching to IgG isotypes,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,PTPRC,1
GO:0048340,paraxial mesoderm morphogenesis,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,LEF1,1
GO:0048664,neuron fate determination,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,PRRX1,1
GO:0048672,positive regulation of collateral sprouting,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,CRABP2,1
GO:0055015,ventricular cardiac muscle cell development,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NKX2-5,1
GO:0060052,neurofilament cytoskeleton organization,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NEFH,1
GO:0060054,positive regulation of epithelial cell proliferation involved in wound healing,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,ODAM,1
GO:0060368,regulation of Fc receptor mediated stimulatory signaling pathway,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,PTPRC,1
GO:0060371,regulation of atrial cardiac muscle cell membrane depolarization,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,GJA1,1
GO:0071803,positive regulation of podosome assembly,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,TNF,1
GO:0097113,AMPA glutamate receptor clustering,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:0097688,glutamate receptor clustering,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:0098917,retrograde trans-synaptic signaling,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,SYT4,1
GO:0106119,negative regulation of sterol biosynthetic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:0106120,positive regulation of sterol biosynthetic process,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,FGF1,1
GO:1901856,negative regulation of cellular respiration,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,TNF,1
GO:1902460,regulation of mesenchymal stem cell proliferation,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,VEGFC,1
GO:1905770,regulation of mesodermal cell differentiation,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,GJA1,1
GO:1905918,regulation of CoA-transferase activity,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:1990504,dense core granule exocytosis,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,SYT4,1
GO:2000253,positive regulation of feeding behavior,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,NR4A3,1
GO:2000425,regulation of apoptotic cell clearance,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,C3,1
GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,FGF1,1
GO:2000563,"positive regulation of CD4-positive, alpha-beta T cell proliferation",1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,CARD11,1
GO:2000822,regulation of behavioral fear response,1/137,10/18888,0.1,13.786861313868615,3.457128487403695,0.07022677566064794,0.18083894883540116,0.12742428518684024,APOE,1
GO:0001658,branching involved in ureteric bud morphogenesis,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,ADAMTS16/FGF1,2
GO:0001706,endoderm formation,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,LAMB3/ITGA7,2
GO:0006695,cholesterol biosynthetic process,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,APOE/FGF1,2
GO:0043030,regulation of macrophage activation,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,IL33/PTPRC,2
GO:0097300,programmed necrotic cell death,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,MAP3K5/TNF,2
GO:0099518,vesicle cytoskeletal trafficking,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,SYT4/MAP2,2
GO:1902653,secondary alcohol biosynthetic process,2/137,60/18888,0.03333333333333333,4.595620437956205,2.3843880004235496,0.07039209410762011,0.18083894883540116,0.12742428518684024,APOE/FGF1,2
GO:0001667,ameboidal-type cell migration,7/137,498/18888,0.014056224899598393,1.9379122328730982,1.8130741411201061,0.07090245375394559,0.18199687876958953,0.12824019567023226,APOE/GDF6/GJA1/TNF/SEMA5B/VEGFC/FGF1,7
GO:0010466,negative regulation of peptidase activity,3/137,132/18888,0.022727272727272728,3.133377571333776,2.102394130176023,0.07132462456594821,0.1827730933461578,0.12878713861702434,SERPINE1/SPINK5/TNF,3
GO:0051282,regulation of sequestering of calcium ion,3/137,132/18888,0.022727272727272728,3.133377571333776,2.102394130176023,0.07132462456594821,0.1827730933461578,0.12878713861702434,AKAP6/DMD/PTPRC,3
GO:0060348,bone development,4/137,215/18888,0.018604651162790697,2.564997453742998,1.9726742402239963,0.07152837500304217,0.1831414433802724,0.1290466885651847,GJA1/FAM20C/PTPRC/PDGFC,4
GO:0001701,in utero embryonic development,6/137,401/18888,0.014962593516209476,2.0628720170376975,1.838863513893817,0.07213720611193745,0.18454547615560193,0.13003601013516408,LEF1/GJA1/PPP4R4/PHLDA2/IGF2/CDKN1C,6
GO:0002820,negative regulation of adaptive immune response,2/137,61/18888,0.03278688524590164,4.5202823979897095,2.3538642724778045,0.0724430691267589,0.18466695241072978,0.13012160577192555,IL33/PTPRC,2
GO:0051785,positive regulation of nuclear division,2/137,61/18888,0.03278688524590164,4.5202823979897095,2.3538642724778045,0.0724430691267589,0.18466695241072978,0.13012160577192555,TNF/IGF2,2
GO:1903018,regulation of glycoprotein metabolic process,2/137,61/18888,0.03278688524590164,4.5202823979897095,2.3538642724778045,0.0724430691267589,0.18466695241072978,0.13012160577192555,IL15/IL33,2
GO:0002064,epithelial cell development,4/137,216/18888,0.018518518518518517,2.553122465531225,1.9623059231787239,0.07248722443907414,0.18466695241072978,0.13012160577192555,GJA1/CXCR4/TNF/SIX3,4
GO:1903828,negative regulation of protein localization,4/137,216/18888,0.018518518518518517,2.553122465531225,1.9623059231787239,0.07248722443907414,0.18466695241072978,0.13012160577192555,SYT4/APOE/CHGA/FOXO1,4
GO:0048593,camera-type eye morphogenesis,3/137,133/18888,0.022556390977443608,3.109818341474123,2.087093505034245,0.07259960341684042,0.1847989905155938,0.1302146435894868,SIX3/PROM1/DIO3,3
GO:0002763,positive regulation of myeloid leukocyte differentiation,2/137,62/18888,0.03225806451612903,4.447374617376972,2.3239932057183923,0.07451327532753642,0.18630089529784719,0.13127292856918735,LEF1/TNF,2
GO:0033619,membrane protein proteolysis,2/137,62/18888,0.03225806451612903,4.447374617376972,2.3239932057183923,0.07451327532753642,0.18630089529784719,0.13127292856918735,APOE/TNF,2
GO:0006720,isoprenoid metabolic process,3/137,135/18888,0.022222222222222223,3.0637469586374695,2.0569205188495103,0.07518014540177699,0.18630089529784719,0.13127292856918735,AKR1C3/AKR1C1/CRABP2,3
GO:0030879,mammary gland development,3/137,135/18888,0.022222222222222223,3.0637469586374695,2.0569205188495103,0.07518014540177699,0.18630089529784719,0.13127292856918735,LEF1/NTN1/GJA1,3
GO:0007162,negative regulation of cell adhesion,5/137,310/18888,0.016129032258064516,2.223687308688486,1.8568694894223052,0.0754972320212351,0.18630089529784719,0.13127292856918735,SERPINE1/CXCL12/ASS1/PTPRC/CDKN2A,5
GO:0007249,canonical NF-kappaB signal transduction,5/137,311/18888,0.01607717041800643,2.2165371887248573,1.849044445193388,0.07630588559088579,0.18630089529784719,0.13127292856918735,GJA1/TNF/S100A13/CARD11/LTB,5
GO:0071375,cellular response to peptide hormone stimulus,5/137,311/18888,0.01607717041800643,2.2165371887248573,1.849044445193388,0.07630588559088579,0.18630089529784719,0.13127292856918735,FOXO1/ASS1/IGF2/CPS1/NR4A3,5
GO:0006639,acylglycerol metabolic process,3/137,136/18888,0.022058823529411766,3.0412194074710177,2.0420430929442737,0.07648557548223851,0.18630089529784719,0.13127292856918735,APOE/C3/CPS1,3
GO:0051208,sequestering of calcium ion,3/137,136/18888,0.022058823529411766,3.0412194074710177,2.0420430929442737,0.07648557548223851,0.18630089529784719,0.13127292856918735,AKAP6/DMD/PTPRC,3
GO:0032615,interleukin-12 production,2/137,63/18888,0.031746031746031744,4.376781369482099,2.2947494908220514,0.07660233065747024,0.18630089529784719,0.13127292856918735,SYK/LTB,2
GO:0032623,interleukin-2 production,2/137,63/18888,0.031746031746031744,4.376781369482099,2.2947494908220514,0.07660233065747024,0.18630089529784719,0.13127292856918735,PTPRC/CARD11,2
GO:0032655,regulation of interleukin-12 production,2/137,63/18888,0.031746031746031744,4.376781369482099,2.2947494908220514,0.07660233065747024,0.18630089529784719,0.13127292856918735,SYK/LTB,2
GO:0032663,regulation of interleukin-2 production,2/137,63/18888,0.031746031746031744,4.376781369482099,2.2947494908220514,0.07660233065747024,0.18630089529784719,0.13127292856918735,PTPRC/CARD11,2
GO:0045428,regulation of nitric oxide biosynthetic process,2/137,63/18888,0.031746031746031744,4.376781369482099,2.2947494908220514,0.07660233065747024,0.18630089529784719,0.13127292856918735,TNF/ASS1,2
GO:0001660,fever generation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,TNF,1
GO:0002759,regulation of antimicrobial humoral response,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SPINK5,1
GO:0003357,noradrenergic neuron differentiation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,ASCL1,1
GO:0006182,cGMP biosynthetic process,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,NPR1,1
GO:0007168,receptor guanylyl cyclase signaling pathway,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,NPR1,1
GO:0010172,embryonic body morphogenesis,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,GREM2,1
GO:0014049,positive regulation of glutamate secretion,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SYT4,1
GO:0021548,pons development,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,ASCL1,1
GO:0030223,neutrophil differentiation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,LEF1,1
GO:0031650,regulation of heat generation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,TNF,1
GO:0032610,interleukin-1 alpha production,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,S100A13,1
GO:0032650,regulation of interleukin-1 alpha production,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,S100A13,1
GO:0032754,positive regulation of interleukin-5 production,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,IL33,1
GO:0035581,sequestering of extracellular ligand from receptor,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,GREM2,1
GO:0035723,interleukin-15-mediated signaling pathway,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,IL15,1
GO:0035766,cell chemotaxis to fibroblast growth factor,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,FGF1,1
GO:0042048,olfactory behavior,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SHANK1,1
GO:0042939,tripeptide transport,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,GJA1,1
GO:0044062,regulation of excretion,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,NPR1,1
GO:0044848,biological phase,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SPINK5,1
GO:0046549,retinal cone cell development,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,DIO3,1
GO:0046710,GDP metabolic process,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,CARD11,1
GO:0048241,epinephrine transport,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,VIP,1
GO:0048262,determination of dorsal/ventral asymmetry,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,GREM2,1
GO:0048630,skeletal muscle tissue growth,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,IGF2,1
GO:0048671,negative regulation of collateral sprouting,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SPP1,1
GO:0051095,regulation of helicase activity,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,IFIT1,1
GO:0051593,response to folic acid,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,ASCL1,1
GO:0060579,ventral spinal cord interneuron fate commitment,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,ASCL1,1
GO:0060581,cell fate commitment involved in pattern specification,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,ASCL1,1
GO:0060920,cardiac pacemaker cell differentiation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,NKX2-5,1
GO:0061140,lung secretory cell differentiation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,ASCL1,1
GO:0061370,testosterone biosynthetic process,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,AKR1C3,1
GO:0071350,cellular response to interleukin-15,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,IL15,1
GO:0071838,cell proliferation in bone marrow,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,LEF1,1
GO:0071918,urea transmembrane transport,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,POU3F3,1
GO:0090206,negative regulation of cholesterol metabolic process,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,APOE,1
GO:0097168,mesenchymal stem cell proliferation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,VEGFC,1
GO:0097278,complement-dependent cytotoxicity,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,C3,1
GO:0099550,"trans-synaptic signaling, modulating synaptic transmission",1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SYT4,1
GO:1900222,negative regulation of amyloid-beta clearance,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,TNF,1
GO:1903365,regulation of fear response,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,APOE,1
GO:1904847,regulation of cell chemotaxis to fibroblast growth factor,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,FGF1,1
GO:2000109,regulation of macrophage apoptotic process,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,CDKN2A,1
GO:2000169,regulation of peptidyl-cysteine S-nitrosylation,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,DMD,1
GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,TNF,1
GO:2000644,regulation of receptor catabolic process,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,APOE,1
GO:2000833,positive regulation of steroid hormone secretion,1/137,11/18888,0.09090909090909091,12.533510285335105,3.270550947067778,0.07697425588813411,0.18630089529784719,0.13127292856918735,SPP1,1
GO:0006638,neutral lipid metabolic process,3/137,137/18888,0.021897810218978103,3.01902072566466,2.0273017748293456,0.07780102188412372,0.1880037361760456,0.13247279885757782,APOE/C3/CPS1,3
GO:0034219,carbohydrate transmembrane transport,3/137,137/18888,0.021897810218978103,3.01902072566466,2.0273017748293456,0.07780102188412372,0.1880037361760456,0.13247279885757782,C3/TNF/NR4A3,3
GO:0040014,regulation of multicellular organism growth,2/137,64/18888,0.03125,4.3083941605839415,2.2661091916181344,0.07870985752148704,0.1895994357976152,0.13359717435832513,IGF2/DIO3,2
GO:0048814,regulation of dendrite morphogenesis,2/137,64/18888,0.03125,4.3083941605839415,2.2661091916181344,0.07870985752148704,0.1895994357976152,0.13359717435832513,RELN/TNIK,2
GO:0071384,cellular response to corticosteroid stimulus,2/137,64/18888,0.03125,4.3083941605839415,2.2661091916181344,0.07870985752148704,0.1895994357976152,0.13359717435832513,AKR1C3/ASS1,2
GO:2000179,positive regulation of neural precursor cell proliferation,2/137,64/18888,0.03125,4.3083941605839415,2.2661091916181344,0.07870985752148704,0.1895994357976152,0.13359717435832513,ASCL1/VEGFC,2
GO:0046328,regulation of JNK cascade,3/137,138/18888,0.021739130434782608,2.997143763884481,2.0126941883397453,0.07912641655777243,0.19030246125636047,0.13409254616360092,MAP3K5/TNF/TNIK,3
GO:1904064,positive regulation of cation transmembrane transport,3/137,138/18888,0.021739130434782608,2.997143763884481,2.0126941883397453,0.07912641655777243,0.19030246125636047,0.13409254616360092,AKAP6/DMD/GRIN1,3
GO:0002931,response to ischemia,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,FAIM2/MAP3K5,2
GO:0010573,vascular endothelial growth factor production,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,C3/TNF,2
GO:0010812,negative regulation of cell-substrate adhesion,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,SERPINE1/CDKN2A,2
GO:0030166,proteoglycan biosynthetic process,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,CHST13/CHST15,2
GO:0030225,macrophage differentiation,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,IL15/IL33,2
GO:0050435,amyloid-beta metabolic process,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,APOE/TNF,2
GO:0080164,regulation of nitric oxide metabolic process,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,TNF/ASS1,2
GO:0090303,positive regulation of wound healing,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,SERPINE1/CXCR4,2
GO:1904036,negative regulation of epithelial cell apoptotic process,2/137,65/18888,0.03076923076923077,4.242111173498035,2.2380496502876026,0.08083548273814983,0.1930437349896974,0.13602412588257978,SERPINE1/NKX2-5,2
GO:0019058,viral life cycle,5/137,319/18888,0.01567398119122257,2.160950049195707,1.7874922788297212,0.0829442548077704,0.19360907764408922,0.1364224824539126,APOE/TNFRSF4/CXCR4/TNF/IFIT1,5
GO:0001947,heart looping,2/137,66/18888,0.030303030303030304,4.177836761778368,2.2105494004587816,0.08297883749627874,0.19360907764408922,0.1364224824539126,GJA1/NKX2-5,2
GO:0015909,long-chain fatty acid transport,2/137,66/18888,0.030303030303030304,4.177836761778368,2.2105494004587816,0.08297883749627874,0.19360907764408922,0.1364224824539126,APOE/SYK,2
GO:0017156,calcium-ion regulated exocytosis,2/137,66/18888,0.030303030303030304,4.177836761778368,2.2105494004587816,0.08297883749627874,0.19360907764408922,0.1364224824539126,SYT4/RIMS3,2
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,2/137,66/18888,0.030303030303030304,4.177836761778368,2.2105494004587816,0.08297883749627874,0.19360907764408922,0.1364224824539126,IL15/TNF,2
GO:0046530,photoreceptor cell differentiation,2/137,66/18888,0.030303030303030304,4.177836761778368,2.2105494004587816,0.08297883749627874,0.19360907764408922,0.1364224824539126,PROM1/DIO3,2
GO:0060042,retina morphogenesis in camera-type eye,2/137,66/18888,0.030303030303030304,4.177836761778368,2.2105494004587816,0.08297883749627874,0.19360907764408922,0.1364224824539126,PROM1/DIO3,2
GO:0001553,luteinization,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,PTPRN,1
GO:0002638,negative regulation of immunoglobulin production,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,IL33,1
GO:0003207,cardiac chamber formation,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,NKX2-5,1
GO:0010459,negative regulation of heart rate,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,TNF,1
GO:0010752,regulation of cGMP-mediated signaling,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,NPR1,1
GO:0010944,negative regulation of transcription by competitive promoter binding,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,BHLHE41,1
GO:0015840,urea transport,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,POU3F3,1
GO:0031630,regulation of synaptic vesicle fusion to presynaptic active zone membrane,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,GRIK5,1
GO:0032276,regulation of gonadotropin secretion,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,GJA1,1
GO:0032351,negative regulation of hormone metabolic process,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,AKR1C3,1
GO:0032782,bile acid secretion,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,TNF,1
GO:0032817,regulation of natural killer cell proliferation,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,IL15,1
GO:0033629,negative regulation of cell adhesion mediated by integrin,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,SERPINE1,1
GO:0034370,triglyceride-rich lipoprotein particle remodeling,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,APOE,1
GO:0034372,very-low-density lipoprotein particle remodeling,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,APOE,1
GO:0035812,renal sodium excretion,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,NPR1,1
GO:0036295,cellular response to increased oxygen levels,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,FOXO1,1
GO:0040034,"regulation of development, heterochronic",1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,ASCL1,1
GO:0042487,regulation of odontogenesis of dentin-containing tooth,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,NGFR,1
GO:0045060,negative thymic T cell selection,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,PTPRC,1
GO:0048505,regulation of timing of cell differentiation,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,ASCL1,1
GO:0051798,positive regulation of hair follicle development,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,TNF,1
GO:0060049,regulation of protein glycosylation,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,IL15,1
GO:0070672,response to interleukin-15,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,IL15,1
GO:0071394,cellular response to testosterone stimulus,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,SPP1,1
GO:0072017,distal tubule development,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,POU3F3,1
GO:0072070,loop of Henle development,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,POU3F3,1
GO:0097048,dendritic cell apoptotic process,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,CXCL12,1
GO:0098935,dendritic transport,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,KIF17,1
GO:0098976,excitatory chemical synaptic transmission,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,GRIN1,1
GO:0106014,regulation of inflammatory response to wounding,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,IL33,1
GO:1901632,regulation of synaptic vesicle membrane organization,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,GRIK5,1
GO:1903818,positive regulation of voltage-gated potassium channel activity,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,AKAP6,1
GO:2000668,regulation of dendritic cell apoptotic process,1/137,12/18888,0.08333333333333333,11.489051094890511,3.106714872564438,0.08367312366073187,0.19360907764408922,0.1364224824539126,CXCL12,1
GO:0043254,regulation of protein-containing complex assembly,6/137,418/18888,0.014354066985645933,1.978975308210806,1.7300393770716527,0.08415349255008815,0.19457307519914321,0.13710174264739242,APOE/LMO4/MAP2/SYK/TNF/TPPP,6
GO:0008652,amino acid biosynthetic process,2/137,67/18888,0.029850746268656716,4.115480989214511,2.183588087433141,0.08513955731196107,0.1959622390015876,0.13808058711465943,GAD1/ASS1,2
GO:0009620,response to fungus,2/137,67/18888,0.029850746268656716,4.115480989214511,2.183588087433141,0.08513955731196107,0.1959622390015876,0.13808058711465943,CHGA/SYK,2
GO:0016126,sterol biosynthetic process,2/137,67/18888,0.029850746268656716,4.115480989214511,2.183588087433141,0.08513955731196107,0.1959622390015876,0.13808058711465943,APOE/FGF1,2
GO:0055021,regulation of cardiac muscle tissue growth,2/137,67/18888,0.029850746268656716,4.115480989214511,2.183588087433141,0.08513955731196107,0.1959622390015876,0.13808058711465943,AKAP6/NKX2-5,2
GO:0060675,ureteric bud morphogenesis,2/137,67/18888,0.029850746268656716,4.115480989214511,2.183588087433141,0.08513955731196107,0.1959622390015876,0.13808058711465943,ADAMTS16/FGF1,2
GO:0070301,cellular response to hydrogen peroxide,2/137,67/18888,0.029850746268656716,4.115480989214511,2.183588087433141,0.08513955731196107,0.1959622390015876,0.13808058711465943,TRPA1/MAP3K5,2
GO:0071241,cellular response to inorganic substance,4/137,229/18888,0.017467248908296942,2.408185382335129,1.83258002072967,0.08554388715438155,0.19674449404308403,0.13863178634545792,SYT4/AKR1C3/FOXO1/TF,4
GO:0003158,endothelium development,3/137,143/18888,0.02097902097902098,2.892348527385024,1.9415830848121094,0.08590019311614451,0.1974152028542719,0.1391043869184236,CXCR4/TNF/FGF1,3
GO:0009101,glycoprotein biosynthetic process,5/137,324/18888,0.015432098765432098,2.127602054609354,1.749935899114703,0.08724472682092169,0.199470317830175,0.14055247959131115,IL15/IL33/CHST13/B4GALT6/CHST15,5
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,NGFR/TNF,2
GO:0034394,protein localization to cell surface,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,TNF/CD177,2
GO:0042987,amyloid precursor protein catabolic process,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,APOE/TNF,2
GO:0045668,negative regulation of osteoblast differentiation,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,TNF/VEGFC,2
GO:0050854,regulation of antigen receptor-mediated signaling pathway,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,PTPRC/CARD11,2
GO:0051055,negative regulation of lipid biosynthetic process,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,APOE/AKR1C3,2
GO:0072171,mesonephric tubule morphogenesis,2/137,68/18888,0.029411764705882353,4.054959209961357,2.157146394859053,0.08731728198594815,0.199470317830175,0.14055247959131115,ADAMTS16/FGF1,2
GO:0019731,antibacterial humoral response,2/137,69/18888,0.028985507246376812,3.9961916851793085,2.1312059772457235,0.08951165556143495,0.20092420826614155,0.1415769322921043,SPINK5/TF,2
GO:0030193,regulation of blood coagulation,2/137,69/18888,0.028985507246376812,3.9961916851793085,2.1312059772457235,0.08951165556143495,0.20092420826614155,0.1415769322921043,SERPINE1/APOE,2
GO:0043525,positive regulation of neuron apoptotic process,2/137,69/18888,0.028985507246376812,3.9961916851793085,2.1312059772457235,0.08951165556143495,0.20092420826614155,0.1415769322921043,ASCL1/TNF,2
GO:1901607,alpha-amino acid biosynthetic process,2/137,69/18888,0.028985507246376812,3.9961916851793085,2.1312059772457235,0.08951165556143495,0.20092420826614155,0.1415769322921043,ASS1/CPS1,2
GO:0098781,ncRNA transcription,3/137,146/18888,0.02054794520547945,2.832916708329167,1.900381299265921,0.0900793648661003,0.20092420826614155,0.1415769322921043,NGFR/TNF/MYCN,3
GO:0010524,positive regulation of calcium ion transport into cytosol,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,GRIN1,1
GO:0014874,response to stimulus involved in regulation of muscle adaptation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,TRIM63,1
GO:0021681,cerebellar granular layer development,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,FAIM2,1
GO:0021702,cerebellar Purkinje cell differentiation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,FAIM2,1
GO:0021781,glial cell fate commitment,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,ASCL1,1
GO:0021978,telencephalon regionalization,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,SIX3,1
GO:0031115,negative regulation of microtubule polymerization,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,MAP2,1
GO:0032823,regulation of natural killer cell differentiation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,IL15,1
GO:0034380,high-density lipoprotein particle assembly,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,APOE,1
GO:0035810,positive regulation of urine volume,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,NPR1,1
GO:0042362,fat-soluble vitamin biosynthetic process,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,TNF,1
GO:0042670,retinal cone cell differentiation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,DIO3,1
GO:0043383,negative T cell selection,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,PTPRC,1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,IGFBP3,1
GO:0045956,positive regulation of calcium ion-dependent exocytosis,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,SYT4,1
GO:0051132,NK T cell activation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,IL15,1
GO:0051610,serotonin uptake,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,SLC18A3,1
GO:0051918,negative regulation of fibrinolysis,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,SERPINE1,1
GO:0060100,"positive regulation of phagocytosis, engulfment",1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,C3,1
GO:0060911,cardiac cell fate commitment,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,NKX2-5,1
GO:0061517,macrophage proliferation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,IL33,1
GO:0070417,cellular response to cold,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,FOXO1,1
GO:0070486,leukocyte aggregation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,NR4A3,1
GO:0071801,regulation of podosome assembly,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,TNF,1
GO:1900115,extracellular regulation of signal transduction,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,GREM2,1
GO:1900116,extracellular negative regulation of signal transduction,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,GREM2,1
GO:1901862,negative regulation of muscle tissue development,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,LEF1,1
GO:1902950,regulation of dendritic spine maintenance,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,APOE,1
GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,CXCL12,1
GO:1905155,positive regulation of membrane invagination,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,C3,1
GO:1905907,negative regulation of amyloid fibril formation,1/137,13/18888,0.07692307692307693,10.605277933745088,2.961199645707561,0.0903237266517517,0.20092420826614155,0.1415769322921043,APOE,1
GO:0010594,regulation of endothelial cell migration,4/137,234/18888,0.017094017094017096,2.3567284297211306,1.7850255011456837,0.09085226179946261,0.20195273343915504,0.14230166048706414,APOE/TNF/VEGFC/FGF1,4
GO:0009799,specification of symmetry,3/137,147/18888,0.02040816326530612,2.8136451660956348,1.886879501992376,0.09149114310515562,0.20270567691045394,0.14283220594883678,GJA1/GREM2/NKX2-5,3
GO:0009855,determination of bilateral symmetry,3/137,147/18888,0.02040816326530612,2.8136451660956348,1.886879501992376,0.09149114310515562,0.20270567691045394,0.14283220594883678,GJA1/GREM2/NKX2-5,3
GO:0170039,proteinogenic amino acid metabolic process,3/137,147/18888,0.02040816326530612,2.8136451660956348,1.886879501992376,0.09149114310515562,0.20270567691045394,0.14283220594883678,GAD1/ASS1/CPS1,3
GO:0016032,viral process,6/137,428/18888,0.014018691588785047,1.9327375673647589,1.6683803339309906,0.09171244657369976,0.20270567691045394,0.14283220594883678,LEF1/APOE/TNFRSF4/CXCR4/TNF/IFIT1,6
GO:0002548,monocyte chemotaxis,2/137,70/18888,0.02857142857142857,3.9391032325338893,2.1057493977747206,0.09172232628222048,0.20270567691045394,0.14283220594883678,SERPINE1/CXCL12,2
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,2/137,70/18888,0.02857142857142857,3.9391032325338893,2.1057493977747206,0.09172232628222048,0.20270567691045394,0.14283220594883678,LEF1/PTPRC,2
GO:0016444,somatic cell DNA recombination,2/137,70/18888,0.02857142857142857,3.9391032325338893,2.1057493977747206,0.09172232628222048,0.20270567691045394,0.14283220594883678,LEF1/PTPRC,2
GO:0050918,positive chemotaxis,2/137,70/18888,0.02857142857142857,3.9391032325338893,2.1057493977747206,0.09172232628222048,0.20270567691045394,0.14283220594883678,CXCL12/VEGFC,2
GO:0019933,cAMP-mediated signaling,2/137,71/18888,0.028169014084507043,3.883622905315103,2.080760070923893,0.09394894655124321,0.2070268482847612,0.14587702664198357,AKAP6/PDE1A,2
GO:0032091,negative regulation of protein binding,2/137,71/18888,0.028169014084507043,3.883622905315103,2.080760070923893,0.09394894655124321,0.2070268482847612,0.14587702664198357,MAP2/IFIT1,2
GO:0061371,determination of heart left/right asymmetry,2/137,71/18888,0.028169014084507043,3.883622905315103,2.080760070923893,0.09394894655124321,0.2070268482847612,0.14587702664198357,GJA1/NKX2-5,2
GO:1900046,regulation of hemostasis,2/137,71/18888,0.028169014084507043,3.883622905315103,2.080760070923893,0.09394894655124321,0.2070268482847612,0.14587702664198357,SERPINE1/APOE,2
GO:0006909,phagocytosis,4/137,237/18888,0.016877637130801686,2.3268964242816224,1.757072544103288,0.0941117823435901,0.20723604596871356,0.1460244333014009,C3/SYK/IL15/PTPRC,4
GO:0002429,immune response-activating cell surface receptor signaling pathway,5/137,332/18888,0.015060240963855422,2.0763345352211764,1.6912339651391004,0.09436455973275754,0.2076428524184398,0.14631108073769486,C3/SYK/PTPRC/CARD11/NR4A3,5
GO:0003143,embryonic heart tube morphogenesis,2/137,72/18888,0.027777777777777776,3.8296836982968365,2.056222209469096,0.09619117288949179,0.20803052287074794,0.14658424440399323,GJA1/NKX2-5,2
GO:0032008,positive regulation of TOR signaling,2/137,72/18888,0.027777777777777776,3.8296836982968365,2.056222209469096,0.09619117288949179,0.20803052287074794,0.14658424440399323,SYK/RELN,2
GO:0042698,ovulation cycle,2/137,72/18888,0.027777777777777776,3.8296836982968365,2.056222209469096,0.09619117288949179,0.20803052287074794,0.14658424440399323,PTPRN/NRIP1,2
GO:0043112,receptor metabolic process,2/137,72/18888,0.027777777777777776,3.8296836982968365,2.056222209469096,0.09619117288949179,0.20803052287074794,0.14658424440399323,APOE/ACHE,2
GO:0051341,regulation of oxidoreductase activity,2/137,72/18888,0.027777777777777776,3.8296836982968365,2.056222209469096,0.09619117288949179,0.20803052287074794,0.14658424440399323,APOE/TNF,2
GO:0002069,columnar/cuboidal epithelial cell maturation,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,GJA1,1
GO:0003222,ventricular trabecula myocardium morphogenesis,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,NKX2-5,1
GO:0009158,ribonucleoside monophosphate catabolic process,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,NT5C1A,1
GO:0009159,deoxyribonucleoside monophosphate catabolic process,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,NT5C1A,1
GO:0009214,cyclic nucleotide catabolic process,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,PDE1A,1
GO:0021819,layer formation in cerebral cortex,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,RELN,1
GO:0032621,interleukin-18 production,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,TNF,1
GO:0032661,regulation of interleukin-18 production,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,TNF,1
GO:0032736,positive regulation of interleukin-13 production,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,IL33,1
GO:0032908,regulation of transforming growth factor beta1 production,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,LUM,1
GO:0033700,phospholipid efflux,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,APOE,1
GO:0034116,positive regulation of heterotypic cell-cell adhesion,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,TNF,1
GO:0034616,response to laminar fluid shear stress,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,ASS1,1
GO:0043306,positive regulation of mast cell degranulation,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,SYK,1
GO:0045348,positive regulation of MHC class II biosynthetic process,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,IL33,1
GO:0045989,positive regulation of striated muscle contraction,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,CHGA,1
GO:0048302,regulation of isotype switching to IgG isotypes,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,PTPRC,1
GO:0050667,homocysteine metabolic process,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,CPS1,1
GO:0055012,ventricular cardiac muscle cell differentiation,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,NKX2-5,1
GO:0070365,hepatocyte differentiation,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,CPS1,1
GO:0070593,dendrite self-avoidance,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,DSCAML1,1
GO:0071888,macrophage apoptotic process,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,CDKN2A,1
GO:0072075,metanephric mesenchyme development,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,BASP1,1
GO:0072672,neutrophil extravasation,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,CD177,1
GO:0098883,synapse pruning,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,C3,1
GO:1900272,negative regulation of long-term synaptic potentiation,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,APOE,1
GO:1901077,regulation of relaxation of muscle,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,CHGA,1
GO:1904936,interneuron migration,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,RELN,1
GO:2000651,positive regulation of sodium ion transmembrane transporter activity,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,DMD,1
GO:2001140,positive regulation of phospholipid transport,1/137,14/18888,0.07142857142857142,9.847758081334723,2.830706478110959,0.0969264100662528,0.20803052287074794,0.14658424440399323,APOE,1
GO:0071496,cellular response to external stimulus,5/137,335/18888,0.014925373134328358,2.0577404946072555,1.6696445311239223,0.09710945248005647,0.20827691424394404,0.14675785879850234,AKR1C3/FOXO1/MAP3K5/IL33/PTPRC,5
GO:0060485,mesenchyme development,5/137,336/18888,0.01488095238095238,2.051616266944734,1.6624979677346432,0.09803341330977894,0.21011093920045315,0.14805016513296745,LEF1/BASP1/NKX2-5/SEMA5B/WWTR1,5
GO:0006801,superoxide metabolic process,2/137,73/18888,0.0273972602739726,3.7772222777722226,2.0321207754738175,0.09844866589528485,0.21046481284689417,0.14829951460516136,SYK/CD177,2
GO:0032732,positive regulation of interleukin-1 production,2/137,73/18888,0.0273972602739726,3.7772222777722226,2.0321207754738175,0.09844866589528485,0.21046481284689417,0.14829951460516136,TNF/S100A13,2
GO:0045665,negative regulation of neuron differentiation,2/137,73/18888,0.0273972602739726,3.7772222777722226,2.0321207754738175,0.09844866589528485,0.21046481284689417,0.14829951460516136,ASCL1/SIX3,2
GO:0006813,potassium ion transport,4/137,241/18888,0.016597510373443983,2.288275736741679,1.720451444005063,0.09854332161147175,0.21046481284689417,0.14829951460516136,AKAP6/KCNIP3/VIP/DPP6,4
GO:0007160,cell-matrix adhesion,4/137,241/18888,0.016597510373443983,2.288275736741679,1.720451444005063,0.09854332161147175,0.21046481284689417,0.14829951460516136,SERPINE1/UTRN/CDKN2A/ITGA7,4
GO:0060537,muscle tissue development,6/137,438/18888,0.0136986301369863,1.8886111388861113,1.608348579119138,0.09962955274143774,0.2126359405362713,0.1498293531474106,LEF1/GJA1/AKAP6/DMD/IGF2/NKX2-5,6
GO:0015980,energy derivation by oxidation of organic compounds,5/137,338/18888,0.014792899408284023,2.0394765257202088,1.6482786610104208,0.09989475920199878,0.21305297350419306,0.1501232064803292,CBFA2T3/TNF/PHLDA2/IGF2/NR4A3,5
GO:0007612,learning,3/137,153/18888,0.0196078431372549,2.703306139974238,1.808177810806792,0.10015325502186016,0.21345512173653436,0.1504065716036903,SHANK1/GRIN1/RELN,3
GO:0003281,ventricular septum development,2/137,74/18888,0.02702702702702703,3.7261787334780037,2.0084414349163877,0.10072109020391842,0.2139184184428386,0.15073302368721778,LMO4/NKX2-5,2
GO:0014823,response to activity,2/137,74/18888,0.02702702702702703,3.7261787334780037,2.0084414349163877,0.10072109020391842,0.2139184184428386,0.15073302368721778,CXCR4/TNF,2
GO:0042093,T-helper cell differentiation,2/137,74/18888,0.02702702702702703,3.7261787334780037,2.0084414349163877,0.10072109020391842,0.2139184184428386,0.15073302368721778,LEF1/RORC,2
GO:0050818,regulation of coagulation,2/137,74/18888,0.02702702702702703,3.7261787334780037,2.0084414349163877,0.10072109020391842,0.2139184184428386,0.15073302368721778,SERPINE1/APOE,2
GO:0060260,regulation of transcription initiation by RNA polymerase II,2/137,74/18888,0.02702702702702703,3.7261787334780037,2.0084414349163877,0.10072109020391842,0.2139184184428386,0.15073302368721778,FOXO1/NKX2-5,2
GO:0043523,regulation of neuron apoptotic process,4/137,244/18888,0.01639344262295082,2.2601411989948548,1.6934568435836794,0.10193019493430396,0.21484733934799735,0.1513875678719592,ASCL1/FAIM2/TNF/DRAXIN,4
GO:2001234,negative regulation of apoptotic signaling pathway,4/137,244/18888,0.01639344262295082,2.2601411989948548,1.6934568435836794,0.10193019493430396,0.21484733934799735,0.1513875678719592,SERPINE1/FAIM2/CXCL12/TNF,4
GO:0005977,glycogen metabolic process,2/137,75/18888,0.02666666666666667,3.6764963503649635,1.9851705156394899,0.10300811444767706,0.21484733934799735,0.1513875678719592,PHLDA2/IGF2,2
GO:1901019,regulation of calcium ion transmembrane transporter activity,2/137,75/18888,0.02666666666666667,3.6764963503649635,1.9851705156394899,0.10300811444767706,0.21484733934799735,0.1513875678719592,AKAP6/DMD,2
GO:0030183,B cell differentiation,3/137,155/18888,0.01935483870967742,2.668424770426183,1.78278252470819,0.1031117714108169,0.21484733934799735,0.1513875678719592,SYK/PTPRC/CARD11,3
GO:0001787,natural killer cell proliferation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,IL15,1
GO:0002430,complement receptor mediated signaling pathway,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,C3,1
GO:0016322,neuron remodeling,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,C3,1
GO:0021694,cerebellar Purkinje cell layer formation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,FAIM2,1
GO:0021859,pyramidal neuron differentiation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,UNC5D,1
GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,SYK,1
GO:0034310,primary alcohol catabolic process,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,AKR1C3,1
GO:0035672,oligopeptide transmembrane transport,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,GJA1,1
GO:0038065,collagen-activated signaling pathway,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,SYK,1
GO:0045059,positive thymic T cell selection,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,PTPRC,1
GO:0045187,"regulation of circadian sleep/wake cycle, sleep",1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,PTGDS,1
GO:0045725,positive regulation of glycogen biosynthetic process,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,IGF2,1
GO:0046321,positive regulation of fatty acid oxidation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,NR4A3,1
GO:0048291,isotype switching to IgG isotypes,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,PTPRC,1
GO:0048681,negative regulation of axon regeneration,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,SPP1,1
GO:0048820,hair follicle maturation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,SPINK5,1
GO:0051290,protein heterotetramerization,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,GRIN1,1
GO:0055057,neuroblast division,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,LEF1,1
GO:0060033,anatomical structure regression,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,LEF1,1
GO:0060099,"regulation of phagocytosis, engulfment",1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,C3,1
GO:0060347,heart trabecula formation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,NKX2-5,1
GO:0060413,atrial septum morphogenesis,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,NKX2-5,1
GO:0070341,fat cell proliferation,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,DIO3,1
GO:0071639,positive regulation of monocyte chemotactic protein-1 production,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,SYK,1
GO:0071732,cellular response to nitric oxide,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,FOXO1,1
GO:1901160,primary amino compound metabolic process,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,MAOB,1
GO:1905153,regulation of membrane invagination,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,C3,1
GO:2001138,regulation of phospholipid transport,1/137,15/18888,0.06666666666666667,9.19124087591241,2.712716528967007,0.10348151665843908,0.21484733934799735,0.1513875678719592,APOE,1
GO:0022604,regulation of cell morphogenesis,4/137,246/18888,0.016260162601626018,2.24176606729571,1.6756783040069108,0.10421780947248237,0.21622892896670032,0.15236107535316573,SYT4/CXCR4/RELN/ITGA7,4
GO:0032368,regulation of lipid transport,3/137,156/18888,0.019230769230769232,2.651319483436272,1.7702348507871306,0.10460403109990887,0.2167355756394582,0.15271807306043078,APOE/SYK/SPP1,3
GO:0043535,regulation of blood vessel endothelial cell migration,3/137,156/18888,0.019230769230769232,2.651319483436272,1.7702348507871306,0.10460403109990887,0.2167355756394582,0.15271807306043078,APOE/TNF/VEGFC,3
GO:0001707,mesoderm formation,2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,LEF1/GJA1,2
GO:0002200,somatic diversification of immune receptors,2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,LEF1/PTPRC,2
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,LEF1/RORC,2
GO:0006081,cellular aldehyde metabolic process,2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,AKR1C3/AKR1C1,2
GO:0008088,axo-dendritic transport,2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,KIF17/MAP2,2
GO:0009123,nucleoside monophosphate metabolic process,2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,NT5C1A/CARD11,2
GO:0031343,positive regulation of cell killing,2/137,76/18888,0.02631578947368421,3.628121398386477,1.9622949683378488,0.10530941121620639,0.21716508312963642,0.15302071629780203,SYK/PTPRC,2
GO:0006865,amino acid transport,3/137,158/18888,0.0189873417721519,2.617758477316825,1.7454318473575012,0.1076141735132966,0.21854662002456246,0.1539941866283304,SYT4/GJA1/TNF,3
GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3/137,158/18888,0.0189873417721519,2.617758477316825,1.7454318473575012,0.1076141735132966,0.21854662002456246,0.1539941866283304,CHGA/RIT2/VIP,3
GO:0030902,hindbrain development,3/137,158/18888,0.0189873417721519,2.617758477316825,1.7454318473575012,0.1076141735132966,0.21854662002456246,0.1539941866283304,LEF1/ASCL1/FAIM2,3
GO:0002287,alpha-beta T cell activation involved in immune response,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,LEF1/RORC,2
GO:0002293,alpha-beta T cell differentiation involved in immune response,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,LEF1/RORC,2
GO:0006809,nitric oxide biosynthetic process,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,TNF/ASS1,2
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,CBFA2T3/IL33,2
GO:0044042,glucan metabolic process,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,PHLDA2/IGF2,2
GO:0045913,positive regulation of carbohydrate metabolic process,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,FOXO1/IGF2,2
GO:0072078,nephron tubule morphogenesis,2/137,77/18888,0.025974025974025976,3.5810029386671722,1.93980233032767,0.10762465701724301,0.21854662002456246,0.1539941866283304,ADAMTS16/FGF1,2
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,4/137,249/18888,0.01606425702811245,2.214756837569255,1.6493289365244306,0.10769322280926276,0.21854662002456246,0.1539941866283304,CHGA/VIPR2/RIT2/VIP,4
GO:1901617,organic hydroxy compound biosynthetic process,4/137,249/18888,0.01606425702811245,2.214756837569255,1.6493289365244306,0.10769322280926276,0.21854662002456246,0.1539941866283304,APOE/AKR1C3/TNF/FGF1,4
GO:0008643,carbohydrate transport,3/137,159/18888,0.018867924528301886,2.6012945875223794,1.7331735788795206,0.10913190348092296,0.21854662002456246,0.1539941866283304,C3/TNF/NR4A3,3
GO:0032496,response to lipopolysaccharide,5/137,348/18888,0.014367816091954023,1.9808708784293982,1.5786147436662064,0.10946672441960442,0.21854662002456246,0.1539941866283304,SERPINE1/TNF/ASS1/MAOB/CPS1,5
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,2/137,78/18888,0.02564102564102564,3.5350926445816953,1.9176806918660667,0.1099535322376994,0.21854662002456246,0.1539941866283304,CDKN1C/CDKN2A,2
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,2/137,78/18888,0.02564102564102564,3.5350926445816953,1.9176806918660667,0.1099535322376994,0.21854662002456246,0.1539941866283304,IL15/TNF,2
GO:0048332,mesoderm morphogenesis,2/137,78/18888,0.02564102564102564,3.5350926445816953,1.9176806918660667,0.1099535322376994,0.21854662002456246,0.1539941866283304,LEF1/GJA1,2
GO:0050853,B cell receptor signaling pathway,2/137,78/18888,0.02564102564102564,3.5350926445816953,1.9176806918660667,0.1099535322376994,0.21854662002456246,0.1539941866283304,SYK/PTPRC,2
GO:2000242,negative regulation of reproductive process,2/137,78/18888,0.02564102564102564,3.5350926445816953,1.9176806918660667,0.1099535322376994,0.21854662002456246,0.1539941866283304,GJA1/PTGDS,2
GO:0002864,regulation of acute inflammatory response to antigenic stimulus,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,C3,1
GO:0006206,pyrimidine nucleobase metabolic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,CPS1,1
GO:0007252,I-kappaB phosphorylation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0009084,glutamine family amino acid biosynthetic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,ASS1,1
GO:0009151,purine deoxyribonucleotide metabolic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,NT5C1A,1
GO:0010958,regulation of amino acid import across plasma membrane,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0016114,terpenoid biosynthetic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,AKR1C3,1
GO:0017014,protein nitrosylation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,DMD,1
GO:0018119,peptidyl-cysteine S-nitrosylation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,DMD,1
GO:0018146,keratan sulfate biosynthetic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,CHST1,1
GO:0021513,spinal cord dorsal/ventral patterning,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,ASCL1,1
GO:0030033,microvillus assembly,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNIK,1
GO:0030299,intestinal cholesterol absorption,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,AKR1C1,1
GO:0030728,ovulation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,NRIP1,1
GO:0030852,regulation of granulocyte differentiation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,LEF1,1
GO:0031645,negative regulation of nervous system process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0031649,heat generation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0032793,positive regulation of CREB transcription factor activity,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,RELN,1
GO:0034374,low-density lipoprotein particle remodeling,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,APOE,1
GO:0043584,nose development,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,ASCL1,1
GO:0045579,positive regulation of B cell differentiation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,SYK,1
GO:0046325,negative regulation of glucose import,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0048172,regulation of short-term neuronal synaptic plasticity,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,SYT4,1
GO:0048385,regulation of retinoic acid receptor signaling pathway,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,AKR1C3,1
GO:0050665,hydrogen peroxide biosynthetic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,MAOB,1
GO:0050802,"circadian sleep/wake cycle, sleep",1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,PTGDS,1
GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,IL33,1
GO:0051956,negative regulation of amino acid transport,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0060841,venous blood vessel development,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,NKX2-5,1
GO:0061101,neuroendocrine cell differentiation,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,ASCL1,1
GO:0070571,negative regulation of neuron projection regeneration,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,SPP1,1
GO:0072350,tricarboxylic acid metabolic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,ASS1,1
GO:0099150,regulation of postsynaptic specialization assembly,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,GAP43,1
GO:1900006,positive regulation of dendrite development,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,VLDLR,1
GO:1901142,insulin metabolic process,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,PCSK2,1
GO:1902065,response to L-glutamate,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:1903789,regulation of amino acid transmembrane transport,1/137,16/18888,0.0625,8.616788321167883,2.605268391780378,0.10998938674892789,0.21854662002456246,0.1539941866283304,TNF,1
GO:0042246,tissue regeneration,2/137,79/18888,0.02531645569620253,3.4903446364224338,1.8959186648107407,0.11229572110510035,0.22269430852031594,0.1569167663333812,GJA1/GAP43,2
GO:0045685,regulation of glial cell differentiation,2/137,79/18888,0.02531645569620253,3.4903446364224338,1.8959186648107407,0.11229572110510035,0.22269430852031594,0.1569167663333812,IL33/CXCR4,2
GO:0072088,nephron epithelium morphogenesis,2/137,79/18888,0.02531645569620253,3.4903446364224338,1.8959186648107407,0.11229572110510035,0.22269430852031594,0.1569167663333812,ADAMTS16/FGF1,2
GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,4/137,253/18888,0.015810276679841896,2.1797409191887134,1.614774051791471,0.11240802198816151,0.22277226175835646,0.15697169440998904,AKR1C3/TNF/IGF2/RELN,4
GO:0048592,eye morphogenesis,3/137,162/18888,0.018518518518518517,2.553122465531225,1.6969547283301245,0.11373480698478909,0.2250832763485008,0.15860010125542776,SIX3/PROM1/DIO3,3
GO:1903036,positive regulation of response to wounding,2/137,80/18888,0.025,3.4467153284671537,1.8745053534298488,0.11465091164936915,0.2250832763485008,0.15860010125542776,SERPINE1/CXCR4,2
GO:0170033,L-amino acid metabolic process,3/137,163/18888,0.018404907975460124,2.5374591375218305,1.6850625544898907,0.11528542216042457,0.2250832763485008,0.15860010125542776,GAD1/ASS1/CPS1,3
GO:0001574,ganglioside biosynthetic process,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,B4GALT6,1
GO:0001956,positive regulation of neurotransmitter secretion,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,SLC18A3,1
GO:0002076,osteoblast development,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,ACHE,1
GO:0002921,negative regulation of humoral immune response,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,SPINK5,1
GO:0006857,oligopeptide transport,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,GJA1,1
GO:0021535,cell migration in hindbrain,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,LEF1,1
GO:0031643,positive regulation of myelination,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,TPPP,1
GO:0032905,transforming growth factor beta1 production,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,LUM,1
GO:0033151,V(D)J recombination,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,LEF1,1
GO:0034375,high-density lipoprotein particle remodeling,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,APOE,1
GO:0035821,modulation of process of another organism,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,SYK,1
GO:0042693,muscle cell fate commitment,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,NKX2-5,1
GO:0043031,negative regulation of macrophage activation,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,PTPRC,1
GO:0043649,dicarboxylic acid catabolic process,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,GAD1,1
GO:0043923,positive regulation by host of viral transcription,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,LEF1,1
GO:0044320,cellular response to leptin stimulus,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,NR4A3,1
GO:0045217,cell-cell junction maintenance,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,CD177,1
GO:0046112,nucleobase biosynthetic process,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,CPS1,1
GO:0051000,positive regulation of nitric-oxide synthase activity,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,APOE,1
GO:0051412,response to corticosterone,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,MAOB,1
GO:0055089,fatty acid homeostasis,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,APOE,1
GO:0055119,relaxation of cardiac muscle,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,CHGA,1
GO:0061003,positive regulation of dendritic spine morphogenesis,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,RELN,1
GO:0061548,ganglion development,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,ASCL1,1
GO:0070875,positive regulation of glycogen metabolic process,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,IGF2,1
GO:0071360,cellular response to exogenous dsRNA,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,IFIT1,1
GO:0072074,kidney mesenchyme development,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,BASP1,1
GO:0090209,negative regulation of triglyceride metabolic process,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,APOE,1
GO:0098712,L-glutamate import across plasma membrane,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,TNF,1
GO:0150079,negative regulation of neuroinflammatory response,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,PTPRC,1
GO:1900120,regulation of receptor binding,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,GREM2,1
GO:1901163,regulation of trophoblast cell migration,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,GJA1,1
GO:1901550,regulation of endothelial cell development,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,TNF,1
GO:1903140,regulation of establishment of endothelial barrier,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,TNF,1
GO:1905906,regulation of amyloid fibril formation,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,APOE,1
GO:2000310,regulation of NMDA receptor activity,1/137,17/18888,0.058823529411764705,8.109918419922714,2.5068086107736356,0.11645035824190131,0.2250832763485008,0.15860010125542776,RELN,1
GO:0002720,positive regulation of cytokine production involved in immune response,2/137,81/18888,0.024691358024691357,3.4041632873749657,1.8534303271895956,0.11701879566495813,0.22546803306152285,0.15887121181785582,SYK/NR4A3,2
GO:0048844,artery morphogenesis,2/137,81/18888,0.024691358024691357,3.4041632873749657,1.8534303271895956,0.11701879566495813,0.22546803306152285,0.15887121181785582,PRRX1/APOE,2
GO:0061333,renal tubule morphogenesis,2/137,81/18888,0.024691358024691357,3.4041632873749657,1.8534303271895956,0.11701879566495813,0.22546803306152285,0.15887121181785582,ADAMTS16/FGF1,2
GO:0072028,nephron morphogenesis,2/137,81/18888,0.024691358024691357,3.4041632873749657,1.8534303271895956,0.11701879566495813,0.22546803306152285,0.15887121181785582,ADAMTS16/FGF1,2
GO:1904029,regulation of cyclin-dependent protein kinase activity,2/137,81/18888,0.024691358024691357,3.4041632873749657,1.8534303271895956,0.11701879566495813,0.22546803306152285,0.15887121181785582,CDKN1C/CDKN2A,2
GO:1990778,protein localization to cell periphery,5/137,356/18888,0.014044943820224719,1.936356926105142,1.5245260065678663,0.11743614470166842,0.22612940922996344,0.15933723634435237,KCNIP3/LGI1/TNF/DPP6/TNIK,5
GO:0031929,TOR signaling,3/137,165/18888,0.01818181818181818,2.50670205706702,1.6615414940677382,0.1184106585982886,0.22761021620198882,0.1603806552047538,SYK/CARD11/RELN,3
GO:0042593,glucose homeostasis,4/137,258/18888,0.015503875968992248,2.1374978781191647,1.5724743773105803,0.1184289067263297,0.22761021620198882,0.1603806552047538,VGF/PTPRN/NGFR/FOXO1,4
GO:0051259,protein complex oligomerization,4/137,258/18888,0.015503875968992248,2.1374978781191647,1.5724743773105803,0.1184289067263297,0.22761021620198882,0.1603806552047538,GRIN1/TRPA1/TRPM3/CARD11,4
GO:0007260,tyrosine phosphorylation of STAT protein,2/137,82/18888,0.024390243902439025,3.3626491009435644,1.832683595362878,0.11939906867332292,0.22823083858296048,0.1608179634493303,IL15/TNF,2
GO:0030500,regulation of bone mineralization,2/137,82/18888,0.024390243902439025,3.3626491009435644,1.832683595362878,0.11939906867332292,0.22823083858296048,0.1608179634493303,GJA1/FAM20C,2
GO:0043537,negative regulation of blood vessel endothelial cell migration,2/137,82/18888,0.024390243902439025,3.3626491009435644,1.832683595362878,0.11939906867332292,0.22823083858296048,0.1608179634493303,APOE/TNF,2
GO:0140029,exocytic process,2/137,82/18888,0.024390243902439025,3.3626491009435644,1.832683595362878,0.11939906867332292,0.22823083858296048,0.1608179634493303,GRIK5/SYK,2
GO:1904427,positive regulation of calcium ion transmembrane transport,2/137,82/18888,0.024390243902439025,3.3626491009435644,1.832683595362878,0.11939906867332292,0.22823083858296048,0.1608179634493303,AKAP6/GRIN1,2
GO:2000142,regulation of DNA-templated transcription initiation,2/137,82/18888,0.024390243902439025,3.3626491009435644,1.832683595362878,0.11939906867332292,0.22823083858296048,0.1608179634493303,FOXO1/NKX2-5,2
GO:0033500,carbohydrate homeostasis,4/137,259/18888,0.015444015444015444,2.1292449905588593,1.5641299795150512,0.1196497656878453,0.22823083858296048,0.1608179634493303,VGF/PTPRN/NGFR/FOXO1,4
GO:0001678,intracellular glucose homeostasis,3/137,166/18888,0.018072289156626505,2.491601442265412,1.6499100768798396,0.1199851242973818,0.22823083858296048,0.1608179634493303,PTPRN/NGFR/FOXO1,3
GO:0002768,immune response-regulating cell surface receptor signaling pathway,5/137,360/18888,0.013888888888888888,1.9148418491484183,1.4980025727340331,0.12152226989837979,0.22823083858296048,0.1608179634493303,C3/SYK/PTPRC/CARD11/NR4A3,5
GO:0006937,regulation of muscle contraction,3/137,167/18888,0.017964071856287425,2.47668167315005,1.6383630913428773,0.12156738436081556,0.22823083858296048,0.1608179634493303,CHGA/DMD/NKX2-5,3
GO:0050796,regulation of insulin secretion,3/137,167/18888,0.017964071856287425,2.47668167315005,1.6383630913428773,0.12156738436081556,0.22823083858296048,0.1608179634493303,CHGA/FOXO1/TNF,3
GO:0051279,regulation of release of sequestered calcium ion into cytosol,2/137,83/18888,0.024096385542168676,3.322135256353883,1.8122555833164675,0.12179142988573634,0.22823083858296048,0.1608179634493303,AKAP6/DMD,2
GO:0001946,lymphangiogenesis,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,VEGFC,1
GO:0002524,hypersensitivity,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,C3,1
GO:0002830,positive regulation of type 2 immune response,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,IL33,1
GO:0006044,N-acetylglucosamine metabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CHST1,1
GO:0006957,"complement activation, alternative pathway",1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,C3,1
GO:0007096,regulation of exit from mitosis,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CDKN1C,1
GO:0009125,nucleoside monophosphate catabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,NT5C1A,1
GO:0010002,cardioblast differentiation,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,NKX2-5,1
GO:0010522,regulation of calcium ion transport into cytosol,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,GRIN1,1
GO:0010544,negative regulation of platelet activation,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,APOE,1
GO:0010612,regulation of cardiac muscle adaptation,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,FOXO1,1
GO:0010755,regulation of plasminogen activation,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,SERPINE1,1
GO:0014819,regulation of skeletal muscle contraction,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,DMD,1
GO:0016264,gap junction assembly,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,GJA1,1
GO:0030730,sequestering of triglyceride,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,TNF,1
GO:0030812,negative regulation of nucleotide catabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CBFA2T3,1
GO:0032274,gonadotropin secretion,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,GJA1,1
GO:0032604,granulocyte macrophage colony-stimulating factor production,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,SYK,1
GO:0032645,regulation of granulocyte macrophage colony-stimulating factor production,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,SYK,1
GO:0032780,negative regulation of ATP-dependent activity,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,IFIT1,1
GO:0033122,negative regulation of purine nucleotide catabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CBFA2T3,1
GO:0034384,high-density lipoprotein particle clearance,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,APOE,1
GO:0036035,osteoclast development,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,FAM20C,1
GO:0042053,regulation of dopamine metabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,MAOB,1
GO:0042069,regulation of catecholamine metabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,MAOB,1
GO:0042339,keratan sulfate metabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CHST1,1
GO:0042481,regulation of odontogenesis,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,NGFR,1
GO:0043117,positive regulation of vascular permeability,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,APOE,1
GO:0043217,myelin maintenance,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CXCR4,1
GO:0045346,regulation of MHC class II biosynthetic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,IL33,1
GO:0045820,negative regulation of glycolytic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CBFA2T3,1
GO:0046040,IMP metabolic process,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,NT5C1A,1
GO:0048490,anterograde synaptic vesicle transport,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,MAP2,1
GO:0050862,positive regulation of T cell receptor signaling pathway,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CARD11,1
GO:0051917,regulation of fibrinolysis,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,SERPINE1,1
GO:0061450,trophoblast cell migration,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,GJA1,1
GO:0098751,bone cell development,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,FAM20C,1
GO:0099514,synaptic vesicle cytoskeletal transport,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,MAP2,1
GO:0099517,synaptic vesicle transport along microtubule,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,MAP2,1
GO:1902307,positive regulation of sodium ion transmembrane transport,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,DMD,1
GO:1903236,regulation of leukocyte tethering or rolling,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,CXCL12,1
GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,FOXO1,1
GO:1905209,positive regulation of cardiocyte differentiation,1/137,18/18888,0.05555555555555555,7.659367396593673,2.416088481207605,0.12286476664213763,0.22823083858296048,0.1608179634493303,NKX2-5,1
GO:0030509,BMP signaling pathway,3/137,168/18888,0.017857142857142856,2.4619395203336807,1.6268993361778754,0.12315736065463567,0.22835739047262943,0.1609071355230675,LEF1/GDF6/GREM2,3
GO:0050792,regulation of viral process,3/137,168/18888,0.017857142857142856,2.4619395203336807,1.6268993361778754,0.12315736065463567,0.22835739047262943,0.1609071355230675,CXCR4/TNF/IFIT1,3
GO:1903169,regulation of calcium ion transmembrane transport,3/137,168/18888,0.017857142857142856,2.4619395203336807,1.6268993361778754,0.12315736065463567,0.22835739047262943,0.1609071355230675,AKAP6/DMD/GRIN1,3
GO:0086001,cardiac muscle cell action potential,2/137,84/18888,0.023809523809523808,3.282586027111574,1.7921371103469357,0.12419558216644024,0.23014263313416855,0.16216506846006287,GJA1/DMD,2
GO:1902904,negative regulation of supramolecular fiber organization,3/137,169/18888,0.01775147928994083,2.447371830864251,1.615517634504489,0.12475497492540026,0.23103894628174854,0.16279663628806382,APOE/SHANK1/MAP2,3
GO:0043409,negative regulation of MAPK cascade,3/137,170/18888,0.01764705882352941,2.432975525976814,1.6042168332018414,0.126360148811789,0.23338399311213304,0.1644490232213864,APOE/FOXO1/PTPRC,3
GO:0002292,T cell differentiation involved in immune response,2/137,85/18888,0.023529411764705882,3.2439673679690855,1.7723193689469978,0.12661123199612948,0.23338399311213304,0.1644490232213864,LEF1/RORC,2
GO:0007492,endoderm development,2/137,85/18888,0.023529411764705882,3.2439673679690855,1.7723193689469978,0.12661123199612948,0.23338399311213304,0.1644490232213864,LAMB3/ITGA7,2
GO:0045069,regulation of viral genome replication,2/137,85/18888,0.023529411764705882,3.2439673679690855,1.7723193689469978,0.12661123199612948,0.23338399311213304,0.1644490232213864,TNF/IFIT1,2
GO:0014706,striated muscle tissue development,4/137,265/18888,0.01509433962264151,2.081035670017904,1.5148432511007204,0.1270890764637572,0.23338399311213304,0.1644490232213864,LEF1/GJA1/AKAP6/NKX2-5,4
GO:0071216,cellular response to biotic stimulus,4/137,265/18888,0.01509433962264151,2.081035670017904,1.5148432511007204,0.1270890764637572,0.23338399311213304,0.1644490232213864,SERPINE1/SYK/TNF/ASS1,4
GO:0007254,JNK cascade,3/137,171/18888,0.017543859649122806,2.418747598924318,1.5929958022897885,0.1279728038560139,0.23338399311213304,0.1644490232213864,MAP3K5/TNF/TNIK,3
GO:0035050,embryonic heart tube development,2/137,86/18888,0.023255813953488372,3.206246817178747,1.75279390539426,0.12903808943576955,0.23338399311213304,0.1644490232213864,GJA1/NKX2-5,2
GO:0048678,response to axon injury,2/137,86/18888,0.023255813953488372,3.206246817178747,1.75279390539426,0.12903808943576955,0.23338399311213304,0.1644490232213864,SPP1/GAP43,2
GO:0048864,stem cell development,2/137,86/18888,0.023255813953488372,3.206246817178747,1.75279390539426,0.12903808943576955,0.23338399311213304,0.1644490232213864,PTPRC/SEMA5B,2
GO:0051851,modulation by host of symbiont process,2/137,86/18888,0.023255813953488372,3.206246817178747,1.75279390539426,0.12903808943576955,0.23338399311213304,0.1644490232213864,LEF1/APOE,2
GO:0002523,leukocyte migration involved in inflammatory response,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,TNF,1
GO:0002544,chronic inflammatory response,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,TNF,1
GO:0006144,purine nucleobase metabolic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,GMPR,1
GO:0006525,arginine metabolic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,ASS1,1
GO:0007620,copulation,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,VIP,1
GO:0007635,chemosensory behavior,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,SHANK1,1
GO:0010663,positive regulation of striated muscle cell apoptotic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,MAP3K5,1
GO:0010666,positive regulation of cardiac muscle cell apoptotic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,MAP3K5,1
GO:0021692,cerebellar Purkinje cell layer morphogenesis,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,FAIM2,1
GO:0022410,circadian sleep/wake cycle process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,PTGDS,1
GO:0032516,positive regulation of phosphoprotein phosphatase activity,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,PTPRC,1
GO:0033003,regulation of mast cell activation,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,NR4A3,1
GO:0042749,regulation of circadian sleep/wake cycle,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,PTGDS,1
GO:0045342,MHC class II biosynthetic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,IL33,1
GO:0048339,paraxial mesoderm development,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,LEF1,1
GO:0055003,cardiac myofibril assembly,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,NKX2-5,1
GO:0060231,mesenchymal to epithelial transition,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,BASP1,1
GO:0060438,trachea development,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,LEF1,1
GO:0060602,branch elongation of an epithelium,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,FGF1,1
GO:0071625,vocalization behavior,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,SHANK1,1
GO:0086014,atrial cardiac muscle cell action potential,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,GJA1,1
GO:0086026,atrial cardiac muscle cell to AV node cell signaling,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,GJA1,1
GO:0086066,atrial cardiac muscle cell to AV node cell communication,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,GJA1,1
GO:0097154,GABAergic neuron differentiation,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,ASCL1,1
GO:1902259,regulation of delayed rectifier potassium channel activity,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,AKAP6,1
GO:1902931,negative regulation of alcohol biosynthetic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,APOE,1
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,GRIN1,1
GO:1903978,regulation of microglial cell activation,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,PTPRC,1
GO:1904044,response to aldosterone,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,PTPRC,1
GO:1905038,regulation of membrane lipid metabolic process,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,TNF,1
GO:2001224,positive regulation of neuron migration,1/137,19/18888,0.05263157894736842,7.256242796772954,2.332091090921014,0.12923294507192162,0.23338399311213304,0.1644490232213864,RELN,1
GO:0009267,cellular response to starvation,3/137,172/18888,0.01744186046511628,2.4046851128840605,1.5818534343298478,0.1295928615150315,0.23361926364080102,0.16461480155140942,AKR1C3/FOXO1/MAP3K5,3
GO:0010970,transport along microtubule,3/137,172/18888,0.01744186046511628,2.4046851128840605,1.5818534343298478,0.1295928615150315,0.23361926364080102,0.16461480155140942,NEFH/KIF17/MAP2,3
GO:0044272,sulfur compound biosynthetic process,3/137,172/18888,0.01744186046511628,2.4046851128840605,1.5818534343298478,0.1295928615150315,0.23361926364080102,0.16461480155140942,CHST1/CHST13/CHST15,3
GO:0002237,response to molecule of bacterial origin,5/137,369/18888,0.013550135501355014,1.8681383894130912,1.4395373429912346,0.13095686132794557,0.2359388080123317,0.16624921872428558,SERPINE1/TNF/ASS1/MAOB/CPS1,5
GO:0032370,positive regulation of lipid transport,2/137,87/18888,0.022988505747126436,3.1693934054870376,1.7335526015636715,0.13147586809074088,0.23631587126792766,0.16651490825701049,APOE/SPP1,2
GO:0033077,T cell differentiation in thymus,2/137,87/18888,0.022988505747126436,3.1693934054870376,1.7335526015636715,0.13147586809074088,0.23631587126792766,0.16651490825701049,PTPRC/CARD11,2
GO:0055013,cardiac muscle cell development,2/137,87/18888,0.022988505747126436,3.1693934054870376,1.7335526015636715,0.13147586809074088,0.23631587126792766,0.16651490825701049,AKAP6/NKX2-5,2
GO:0071277,cellular response to calcium ion,2/137,87/18888,0.022988505747126436,3.1693934054870376,1.7335526015636715,0.13147586809074088,0.23631587126792766,0.16651490825701049,SYT4/AKR1C3,2
GO:0031668,cellular response to extracellular stimulus,4/137,269/18888,0.01486988847583643,2.0500909016905,1.4827038542524498,0.13215499343553366,0.23739672746630297,0.16727651038616848,AKR1C3/FOXO1/MAP3K5/PTPRC,4
GO:0007259,receptor signaling pathway via JAK-STAT,3/137,174/18888,0.017241379310344827,2.377045054115278,1.5598003667580442,0.1328548701449158,0.23851356687193118,0.1680634673102557,IL15/TNF/PTPRC,3
GO:0048708,astrocyte differentiation,2/137,88/18888,0.022727272727272728,3.133377571333776,1.7145876578733872,0.13392428507530962,0.2392796671639594,0.1686032834434604,TNF/GAP43,2
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,2/137,88/18888,0.022727272727272728,3.133377571333776,1.7145876578733872,0.13392428507530962,0.2392796671639594,0.1686032834434604,LGI1/DLG3,2
GO:0002449,lymphocyte mediated immunity,5/137,372/18888,0.013440860215053764,1.853072757240405,1.4204093216372964,0.1341742392572324,0.2392796671639594,0.1686032834434604,C3/TNF/PTPRC/CFI/C1S,5
GO:0003215,cardiac right ventricle morphogenesis,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,NKX2-5,1
GO:0007351,tripartite regional subdivision,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,BASP1,1
GO:0007413,axonal fasciculation,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,NDN,1
GO:0008595,"anterior/posterior axis specification, embryo",1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,BASP1,1
GO:0010738,regulation of protein kinase A signaling,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,AKAP6,1
GO:0014048,regulation of glutamate secretion,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,SYT4,1
GO:0032303,regulation of icosanoid secretion,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,SYK,1
GO:0032332,positive regulation of chondrocyte differentiation,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,GDF6,1
GO:0043691,reverse cholesterol transport,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,APOE,1
GO:0044241,lipid digestion,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,AKR1C1,1
GO:0044794,positive regulation by host of viral process,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,APOE,1
GO:0045722,positive regulation of gluconeogenesis,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,FOXO1,1
GO:0048643,positive regulation of skeletal muscle tissue development,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,IGF2,1
GO:0051767,nitric-oxide synthase biosynthetic process,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,IL33,1
GO:0051769,regulation of nitric-oxide synthase biosynthetic process,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,IL33,1
GO:0055093,response to hyperoxia,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,FOXO1,1
GO:0071731,response to nitric oxide,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,FOXO1,1
GO:0072567,chemokine (C-X-C motif) ligand 2 production,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,TNF,1
GO:0090128,regulation of synapse maturation,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,RELN,1
GO:0097254,renal tubular secretion,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,NPR1,1
GO:0098856,intestinal lipid absorption,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,AKR1C1,1
GO:0099188,postsynaptic cytoskeleton organization,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,NEFH,1
GO:0106030,neuron projection fasciculation,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,NDN,1
GO:1900424,regulation of defense response to bacterium,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,SPINK5,1
GO:1902004,positive regulation of amyloid-beta formation,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,TNF,1
GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,1/137,20/18888,0.05,6.893430656934307,2.2539786539438453,0.1355552242878394,0.2392796671639594,0.1686032834434604,TNF,1
GO:0032635,interleukin-6 production,3/137,176/18888,0.017045454545454544,2.3500331785003317,1.5380492002165094,0.13614554506591056,0.23963218313361528,0.16885167625783817,SYK/IL33/TNF,3
GO:0032675,regulation of interleukin-6 production,3/137,176/18888,0.017045454545454544,2.3500331785003317,1.5380492002165094,0.13614554506591056,0.23963218313361528,0.16885167625783817,SYK/IL33/TNF,3
GO:0006029,proteoglycan metabolic process,2/137,89/18888,0.02247191011235955,3.0981710817682275,1.6958915772813723,0.13638306097742128,0.23963218313361528,0.16885167625783817,CHST13/CHST15,2
GO:0006112,energy reserve metabolic process,2/137,89/18888,0.02247191011235955,3.0981710817682275,1.6958915772813723,0.13638306097742128,0.23963218313361528,0.16885167625783817,PHLDA2/IGF2,2
GO:0035023,regulation of Rho protein signal transduction,2/137,89/18888,0.02247191011235955,3.0981710817682275,1.6958915772813723,0.13638306097742128,0.23963218313361528,0.16885167625783817,APOE/RIT2,2
GO:0050829,defense response to Gram-negative bacterium,2/137,89/18888,0.02247191011235955,3.0981710817682275,1.6958915772813723,0.13638306097742128,0.23963218313361528,0.16885167625783817,SERPINE1/CHGA,2
GO:0072384,organelle transport along microtubule,2/137,89/18888,0.02247191011235955,3.0981710817682275,1.6958915772813723,0.13638306097742128,0.23963218313361528,0.16885167625783817,NEFH/MAP2,2
GO:2000106,regulation of leukocyte apoptotic process,2/137,89/18888,0.02247191011235955,3.0981710817682275,1.6958915772813723,0.13638306097742128,0.23963218313361528,0.16885167625783817,CXCL12/CDKN2A,2
GO:0010631,epithelial cell migration,5/137,375/18888,0.013333333333333334,1.8382481751824817,1.4014558049546257,0.1374271039810343,0.2413276877733698,0.1700463772232167,APOE/GDF6/TNF/VEGFC/FGF1,5
GO:0001959,regulation of cytokine-mediated signaling pathway,3/137,177/18888,0.01694915254237288,2.3367561548929854,1.5272842847897448,0.13780143542991324,0.24184587747676553,0.17041150847935158,SYK/CXCR4/PTPRC,3
GO:0051345,positive regulation of hydrolase activity,6/137,482/18888,0.012448132780082987,1.716206802556259,1.3614817015115386,0.13855061881284605,0.24302097046942883,0.17123951254364456,NGFR/SYK/MAP3K5/TNF/PTPRC/ODAM,6
GO:0007422,peripheral nervous system development,2/137,90/18888,0.022222222222222223,3.0637469586374695,1.6774571502569466,0.13885191982381428,0.24326983886468495,0.17141487231860086,NEFH/ASCL1,2
GO:0048145,regulation of fibroblast proliferation,2/137,90/18888,0.022222222222222223,3.0637469586374695,1.6774571502569466,0.13885191982381428,0.24326983886468495,0.17141487231860086,NGFR/PDGFC,2
GO:1903829,positive regulation of protein localization,6/137,483/18888,0.012422360248447204,1.7126535793625604,1.3561685916869946,0.13950907914756977,0.2440084884964048,0.17193534593300508,NGFR/ACHE/TNF/WWTR1/ABLIM3/VEGFC,6
GO:0003018,vascular process in circulatory system,4/137,275/18888,0.014545454545454545,2.0053616456536165,1.4355225797536995,0.1399081918030936,0.2440084884964048,0.17193534593300508,APOE/TNF/NPR1/CPS1,4
GO:0090132,epithelium migration,5/137,378/18888,0.013227513227513227,1.8236589039508746,1.3826735179958058,0.14071497765180097,0.2440084884964048,0.17193534593300508,APOE/GDF6/TNF/VEGFC/FGF1,5
GO:0030901,midbrain development,2/137,91/18888,0.02197802197802198,3.030079409641454,1.6592774406577329,0.1413305890454509,0.2440084884964048,0.17193534593300508,BASP1/MAOB,2
GO:0033273,response to vitamin,2/137,91/18888,0.02197802197802198,3.030079409641454,1.6592774406577329,0.1413305890454509,0.2440084884964048,0.17193534593300508,ASCL1/SPP1,2
GO:0055017,cardiac muscle tissue growth,2/137,91/18888,0.02197802197802198,3.030079409641454,1.6592774406577329,0.1413305890454509,0.2440084884964048,0.17193534593300508,AKAP6/NKX2-5,2
GO:0060021,roof of mouth development,2/137,91/18888,0.02197802197802198,3.030079409641454,1.6592774406577329,0.1413305890454509,0.2440084884964048,0.17193534593300508,PRRX1/LEF1,2
GO:0097006,regulation of plasma lipoprotein particle levels,2/137,91/18888,0.02197802197802198,3.030079409641454,1.6592774406577329,0.1413305890454509,0.2440084884964048,0.17193534593300508,APOE/VLDLR,2
GO:0009190,cyclic nucleotide biosynthetic process,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,NPR1,1
GO:0010829,negative regulation of glucose transmembrane transport,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,TNF,1
GO:0019370,leukotriene biosynthetic process,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,SYK,1
GO:0035809,regulation of urine volume,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,NPR1,1
GO:0042359,vitamin D metabolic process,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,TNF,1
GO:0042474,middle ear morphogenesis,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,PRRX1,1
GO:0042745,circadian sleep/wake cycle,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,PTGDS,1
GO:0043586,tongue development,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,LEF1,1
GO:0044321,response to leptin,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,NR4A3,1
GO:0046128,purine ribonucleoside metabolic process,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,NT5C1A,1
GO:0055081,monoatomic anion homeostasis,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,CPS1,1
GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,AKAP6,1
GO:0070166,enamel mineralization,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,FAM20C,1
GO:0071379,cellular response to prostaglandin stimulus,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,AKR1C3,1
GO:0071498,cellular response to fluid shear stress,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,ASS1,1
GO:0071605,monocyte chemotactic protein-1 production,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,SYK,1
GO:0071637,regulation of monocyte chemotactic protein-1 production,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,SYK,1
GO:0071800,podosome assembly,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,TNF,1
GO:0090043,regulation of tubulin deacetylation,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,TPPP,1
GO:1901018,positive regulation of potassium ion transmembrane transporter activity,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,AKAP6,1
GO:1903975,regulation of glial cell migration,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,NTN1,1
GO:2000010,positive regulation of protein localization to cell surface,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,TNF,1
GO:2000738,positive regulation of stem cell differentiation,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,NKX2-5,1
GO:2001044,regulation of integrin-mediated signaling pathway,1/137,21/18888,0.047619047619047616,6.565172054223148,2.1810537832377475,0.14183193269745153,0.2440084884964048,0.17193534593300508,CD177,1
GO:0071772,response to BMP,3/137,180/18888,0.016666666666666666,2.2978102189781024,1.4954204598997123,0.14281037217129378,0.2454151215466152,0.1729264997308874,LEF1/GDF6/GREM2,3
GO:0071773,cellular response to BMP stimulus,3/137,180/18888,0.016666666666666666,2.2978102189781024,1.4954204598997123,0.14281037217129378,0.2454151215466152,0.1729264997308874,LEF1/GDF6/GREM2,3
GO:0019319,hexose biosynthetic process,2/137,92/18888,0.021739130434782608,2.997143763884481,1.6413457724481189,0.14381879944326295,0.24700899037751184,0.1740495852042687,FOXO1/CHST15,2
GO:0019827,stem cell population maintenance,3/137,182/18888,0.016483516483516484,2.27255955723109,1.474527588960247,0.14618326298197998,0.2500771918866134,0.17621152756582434,PRRX1/LDB2/FOXO1,3
GO:0090130,tissue migration,5/137,383/18888,0.013054830287206266,1.7998513464580432,1.3517415995751654,0.14627123562402303,0.2500771918866134,0.17621152756582434,APOE/GDF6/TNF/VEGFC/FGF1,5
GO:0048525,negative regulation of viral process,2/137,93/18888,0.021505376344086023,2.9649164115846482,1.6236557172005202,0.1463162851542095,0.2500771918866134,0.17621152756582434,TNF/IFIT1,2
GO:0050886,endocrine process,2/137,93/18888,0.021505376344086023,2.9649164115846482,1.6236557172005202,0.1463162851542095,0.2500771918866134,0.17621152756582434,GJA1/SPP1,2
GO:0070098,chemokine-mediated signaling pathway,2/137,93/18888,0.021505376344086023,2.9649164115846482,1.6236557172005202,0.1463162851542095,0.2500771918866134,0.17621152756582434,CXCL12/CXCR4,2
GO:0043534,blood vessel endothelial cell migration,3/137,183/18888,0.01639344262295082,2.2601411989948548,1.4641833232749557,0.1478795518318323,0.2500771918866134,0.17621152756582434,APOE/TNF/VEGFC,3
GO:0001759,organ induction,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,FGF1,1
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,SYK,1
GO:0003228,atrial cardiac muscle tissue development,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,NKX2-5,1
GO:0010566,regulation of ketone biosynthetic process,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,AKR1C3,1
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,DMD,1
GO:0010888,negative regulation of lipid storage,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,TNF,1
GO:0030431,sleep,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,PTGDS,1
GO:0030449,regulation of complement activation,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,C3,1
GO:0032148,activation of protein kinase B activity,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,FGF1,1
GO:0033630,positive regulation of cell adhesion mediated by integrin,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,SYK,1
GO:0035584,calcium-mediated signaling using intracellular calcium source,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,PTPRC,1
GO:0035739,"CD4-positive, alpha-beta T cell proliferation",1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,CARD11,1
GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,MAP3K5,1
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,SYK,1
GO:0048485,sympathetic nervous system development,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,ASCL1,1
GO:0050908,detection of light stimulus involved in visual perception,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,SEMA5B,1
GO:0050962,detection of light stimulus involved in sensory perception,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,SEMA5B,1
GO:0060445,branching involved in salivary gland morphogenesis,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,TNF,1
GO:0060713,labyrinthine layer morphogenesis,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,LEF1,1
GO:0061099,negative regulation of protein tyrosine kinase activity,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,PTPRC,1
GO:0097062,dendritic spine maintenance,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,APOE,1
GO:0098801,regulation of renal system process,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,NPR1,1
GO:2000561,"regulation of CD4-positive, alpha-beta T cell proliferation",1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,CARD11,1
GO:2000831,regulation of steroid hormone secretion,1/137,22/18888,0.045454545454545456,6.266755142667552,2.1127305399789154,0.1480633963758553,0.2500771918866134,0.17621152756582434,SPP1,1
GO:0021766,hippocampus development,2/137,94/18888,0.02127659574468085,2.9333747476316194,1.6062010823253863,0.1488227836176435,0.2505279291787358,0.17652912992762546,LEF1/RELN,2
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",2/137,94/18888,0.02127659574468085,2.9333747476316194,1.6062010823253863,0.1488227836176435,0.2505279291787358,0.17652912992762546,LEF1/RORC,2
GO:0043648,dicarboxylic acid metabolic process,2/137,94/18888,0.02127659574468085,2.9333747476316194,1.6062010823253863,0.1488227836176435,0.2505279291787358,0.17652912992762546,GAD1/ASS1,2
GO:0048704,embryonic skeletal system morphogenesis,2/137,94/18888,0.02127659574468085,2.9333747476316194,1.6062010823253863,0.1488227836176435,0.2505279291787358,0.17652912992762546,PRRX1/DSCAML1,2
GO:0055006,cardiac cell development,2/137,94/18888,0.02127659574468085,2.9333747476316194,1.6062010823253863,0.1488227836176435,0.2505279291787358,0.17652912992762546,AKAP6/NKX2-5,2
GO:1900182,positive regulation of protein localization to nucleus,2/137,94/18888,0.02127659574468085,2.9333747476316194,1.6062010823253863,0.1488227836176435,0.2505279291787358,0.17652912992762546,NGFR/WWTR1,2
GO:0009100,glycoprotein metabolic process,5/137,386/18888,0.012953367875647668,1.7858628644907528,1.3334005740807686,0.1496500560894188,0.25178168202034523,0.17741255996673977,IL15/IL33/CHST13/B4GALT6/CHST15,5
GO:0046785,microtubule polymerization,2/137,95/18888,0.021052631578947368,2.9024971187091815,1.5889758999801784,0.1513380355419859,0.2543412359439102,0.17921609472077277,MAP2/TPPP,2
GO:0060395,SMAD protein signal transduction,2/137,95/18888,0.021052631578947368,2.9024971187091815,1.5889758999801784,0.1513380355419859,0.2543412359439102,0.17921609472077277,GDF6/WWTR1,2
GO:0002706,regulation of lymphocyte mediated immunity,3/137,186/18888,0.016129032258064516,2.223687308688486,1.4335487238013744,0.153006847197792,0.2557147279080119,0.18018389636340915,C3/TNF/PTPRC,3
GO:0098727,maintenance of cell number,3/137,186/18888,0.016129032258064516,2.223687308688486,1.4335487238013744,0.153006847197792,0.2557147279080119,0.18018389636340915,PRRX1/LDB2/FOXO1,3
GO:0003073,regulation of systemic arterial blood pressure,2/137,96/18888,0.020833333333333332,2.872262773722628,1.5719744166114211,0.1538617848717022,0.2557147279080119,0.18018389636340915,ADAMTS16/TNF,2
GO:0046364,monosaccharide biosynthetic process,2/137,96/18888,0.020833333333333332,2.872262773722628,1.5719744166114211,0.1538617848717022,0.2557147279080119,0.18018389636340915,FOXO1/CHST15,2
GO:0002223,stimulatory C-type lectin receptor signaling pathway,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,SYK,1
GO:0003085,negative regulation of systemic arterial blood pressure,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,TNF,1
GO:0003283,atrial septum development,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,NKX2-5,1
GO:0006925,inflammatory cell apoptotic process,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,CDKN2A,1
GO:0009162,deoxyribonucleoside monophosphate metabolic process,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,NT5C1A,1
GO:0010866,regulation of triglyceride biosynthetic process,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,C3,1
GO:0021533,cell differentiation in hindbrain,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,FAIM2,1
GO:0021542,dentate gyrus development,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,LEF1,1
GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,GRIK5,1
GO:0032816,positive regulation of natural killer cell activation,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,IL15,1
GO:0034105,positive regulation of tissue remodeling,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,IL15,1
GO:0036303,lymph vessel morphogenesis,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,VEGFC,1
GO:0045063,T-helper 1 cell differentiation,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,LEF1,1
GO:0046033,AMP metabolic process,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,NT5C1A,1
GO:0051590,positive regulation of neurotransmitter transport,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,SLC18A3,1
GO:0071359,cellular response to dsRNA,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,IFIT1,1
GO:0071636,positive regulation of transforming growth factor beta production,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,LUM,1
GO:0090042,tubulin deacetylation,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,TPPP,1
GO:1903579,negative regulation of ATP metabolic process,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,CBFA2T3,1
GO:1990840,response to lectin,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,SYK,1
GO:1990858,cellular response to lectin,1/137,23/18888,0.043478260869565216,5.994287527768962,2.048512468666038,0.15424993908212647,0.2557147279080119,0.18018389636340915,SYK,1
GO:0043542,endothelial cell migration,4/137,286/18888,0.013986013986013986,1.9282323515900157,1.3520397315754231,0.15458119416091584,0.25612475818627317,0.18047281540130927,APOE/TNF/VEGFC/FGF1,4
GO:0002757,immune response-activating signaling pathway,6/137,500/18888,0.012,1.6544233576642335,1.2676696805461671,0.15627293870864245,0.25864696797113707,0.18225003640926848,C3/SYK/TNF/PTPRC/CARD11/NR4A3,6
GO:0007264,small GTPase-mediated signal transduction,6/137,500/18888,0.012,1.6544233576642335,1.2676696805461671,0.15627293870864245,0.25864696797113707,0.18225003640926848,NTN1/APOE/NGFR/RIT2/RELN/CDKN2A,6
GO:0032640,tumor necrosis factor production,3/137,189/18888,0.015873015873015872,2.1883906847410497,1.4034938276541435,0.15819013457508346,0.2612534040709712,0.1840866056828979,SYK/IL33/PTPRC,3
GO:0032680,regulation of tumor necrosis factor production,3/137,189/18888,0.015873015873015872,2.1883906847410497,1.4034938276541435,0.15819013457508346,0.2612534040709712,0.1840866056828979,SYK/IL33/PTPRC,3
GO:0060759,regulation of response to cytokine stimulus,3/137,189/18888,0.015873015873015872,2.1883906847410497,1.4034938276541435,0.15819013457508346,0.2612534040709712,0.1840866056828979,SYK/CXCR4/PTPRC,3
GO:0061136,regulation of proteasomal protein catabolic process,3/137,189/18888,0.015873015873015872,2.1883906847410497,1.4034938276541435,0.15819013457508346,0.2612534040709712,0.1840866056828979,APOE/CBFA2T3/IL33,3
GO:0030101,natural killer cell activation,2/137,98/18888,0.02040816326530612,2.8136451660956348,1.5386205453829993,0.15893376750931992,0.2619133358508686,0.18455161245199855,IL15/PTPRC,2
GO:0002082,regulation of oxidative phosphorylation,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNF,1
GO:0002407,dendritic cell chemotaxis,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,CXCR4,1
GO:0003148,outflow tract septum morphogenesis,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,NKX2-5,1
GO:0006706,steroid catabolic process,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,SPP1,1
GO:0009651,response to salt stress,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNF,1
GO:0016093,polyprenol metabolic process,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,AKR1C3,1
GO:0021871,forebrain regionalization,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,SIX3,1
GO:0032288,myelin assembly,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TPPP,1
GO:0032528,microvillus organization,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNIK,1
GO:0032891,negative regulation of organic acid transport,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNF,1
GO:0034114,regulation of heterotypic cell-cell adhesion,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNF,1
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,NGFR,1
GO:0045822,negative regulation of heart contraction,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNF,1
GO:0046628,positive regulation of insulin receptor signaling pathway,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,IGF2,1
GO:0051957,positive regulation of amino acid transport,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,SYT4,1
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,GJA1,1
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,CHGA,1
GO:0099500,vesicle fusion to plasma membrane,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,GRIK5,1
GO:2000810,regulation of bicellular tight junction assembly,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,TNF,1
GO:2001026,regulation of endothelial cell chemotaxis,1/137,24/18888,0.041666666666666664,5.744525547445256,1.987975708219175,0.1603918822756466,0.2619133358508686,0.18455161245199855,FGF1,1
GO:0009798,axis specification,2/137,99/18888,0.020202020202020204,2.7852245078522455,1.5222576357787165,0.16148150459338123,0.26327005983920915,0.1855075989002912,BASP1/SIX3,2
GO:0038202,TORC1 signaling,2/137,99/18888,0.020202020202020204,2.7852245078522455,1.5222576357787165,0.16148150459338123,0.26327005983920915,0.1855075989002912,SYK/CARD11,2
GO:0061337,cardiac conduction,2/137,99/18888,0.020202020202020204,2.7852245078522455,1.5222576357787165,0.16148150459338123,0.26327005983920915,0.1855075989002912,GJA1/NKX2-5,2
GO:0097696,receptor signaling pathway via STAT,3/137,191/18888,0.015706806282722512,2.1654755990369545,1.3837685689901618,0.16167571990154597,0.2634459675064166,0.18563154846368532,IL15/TNF/PTPRC,3
GO:0006979,response to oxidative stress,5/137,398/18888,0.01256281407035176,1.7320177529985696,1.2616074678203637,0.16349183696929093,0.26626311976001915,0.1876165943539074,APOE/PTPRN/TRPA1/FOXO1/MAP3K5,5
GO:0008593,regulation of Notch signaling pathway,2/137,100/18888,0.02,2.7573722627737225,1.506097364543444,0.16403674657117853,0.26662869449809695,0.18787418874926262,ASCL1/DLK1,2
GO:0072659,protein localization to plasma membrane,4/137,293/18888,0.013651877133105802,1.8821653670810392,1.300814230955581,0.16421014106788445,0.26662869449809695,0.18787418874926262,KCNIP3/TNF/DPP6/TNIK,4
GO:0030324,lung development,3/137,193/18888,0.015544041450777202,2.1430354373889036,1.3642852116672763,0.16518462323730457,0.26662869449809695,0.18787418874926262,ASCL1/TNF/FGF1,3
GO:0001919,regulation of receptor recycling,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,ACHE,1
GO:0007097,nuclear migration,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,NTN1,1
GO:0007350,blastoderm segmentation,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,BASP1,1
GO:0009110,vitamin biosynthetic process,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,TNF,1
GO:0010842,retina layer formation,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,PROM1,1
GO:0035994,response to muscle stretch,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,DMD,1
GO:0036315,cellular response to sterol,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,RORC,1
GO:0042659,regulation of cell fate specification,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,LMO4,1
GO:0043501,skeletal muscle adaptation,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,TRIM63,1
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,IGFBP3,1
GO:0045662,negative regulation of myoblast differentiation,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,TNF,1
GO:0046697,decidualization,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,SPP1,1
GO:0046716,muscle cell cellular homeostasis,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,DMD,1
GO:0048011,neurotrophin TRK receptor signaling pathway,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,NDN,1
GO:0048520,positive regulation of behavior,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,NR4A3,1
GO:0086064,cell communication by electrical coupling involved in cardiac conduction,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,GJA1,1
GO:0090280,positive regulation of calcium ion import,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,CXCL12,1
GO:0099633,protein localization to postsynaptic specialization membrane,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,LGI1,1
GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,LGI1,1
GO:1901071,glucosamine-containing compound metabolic process,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,CHST1,1
GO:1902993,positive regulation of amyloid precursor protein catabolic process,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,TNF,1
GO:1903306,negative regulation of regulated secretory pathway,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,SYT4,1
GO:1903523,negative regulation of blood circulation,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,TNF,1
GO:2000353,positive regulation of endothelial cell apoptotic process,1/137,25/18888,0.04,5.514744525547445,1.9307558476332152,0.16648954513231706,0.26662869449809695,0.18787418874926262,AKR1C3,1
GO:0010596,negative regulation of endothelial cell migration,2/137,101/18888,0.019801980198019802,2.730071547300715,1.4901349120670326,0.1665992530825265,0.26662869449809695,0.18787418874926262,APOE/TNF,2
GO:0042542,response to hydrogen peroxide,2/137,101/18888,0.019801980198019802,2.730071547300715,1.4901349120670326,0.1665992530825265,0.26662869449809695,0.18787418874926262,TRPA1/MAP3K5,2
GO:0042632,cholesterol homeostasis,2/137,101/18888,0.019801980198019802,2.730071547300715,1.4901349120670326,0.1665992530825265,0.26662869449809695,0.18787418874926262,APOE/AKR1C1,2
GO:0043255,regulation of carbohydrate biosynthetic process,2/137,101/18888,0.019801980198019802,2.730071547300715,1.4901349120670326,0.1665992530825265,0.26662869449809695,0.18787418874926262,FOXO1/IGF2,2
GO:1990868,response to chemokine,2/137,101/18888,0.019801980198019802,2.730071547300715,1.4901349120670326,0.1665992530825265,0.26662869449809695,0.18787418874926262,CXCL12/CXCR4,2
GO:1990869,cellular response to chemokine,2/137,101/18888,0.019801980198019802,2.730071547300715,1.4901349120670326,0.1665992530825265,0.26662869449809695,0.18787418874926262,CXCL12/CXCR4,2
GO:0071706,tumor necrosis factor superfamily cytokine production,3/137,194/18888,0.015463917525773196,2.1319888629693735,1.3546323933911446,0.16694762406673655,0.2669001850786504,0.18806548876170337,SYK/IL33/PTPRC,3
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,3/137,194/18888,0.015463917525773196,2.1319888629693735,1.3546323933911446,0.16694762406673655,0.2669001850786504,0.18806548876170337,SYK/IL33/PTPRC,3
GO:0006631,fatty acid metabolic process,5/137,401/18888,0.012468827930174564,1.7190600141980816,1.2440380433516716,0.1670312429555119,0.2669001850786504,0.18806548876170337,PTGDS/AKR1C3/C3/AKR1C1/NR4A3,5
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,2/137,102/18888,0.0196078431372549,2.703306139974238,1.474365621415774,0.16916878681138997,0.2689489184878146,0.18950908480051226,CHGA/VIP,2
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,2/137,102/18888,0.0196078431372549,2.703306139974238,1.474365621415774,0.16916878681138997,0.2689489184878146,0.18950908480051226,CXCL12/TNF,2
GO:0055092,sterol homeostasis,2/137,102/18888,0.0196078431372549,2.703306139974238,1.474365621415774,0.16916878681138997,0.2689489184878146,0.18950908480051226,APOE/AKR1C1,2
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,2/137,102/18888,0.0196078431372549,2.703306139974238,1.474365621415774,0.16916878681138997,0.2689489184878146,0.18950908480051226,CBFA2T3/IL33,2
GO:0048839,inner ear development,3/137,196/18888,0.015306122448979591,2.110233874571726,1.3355008856869197,0.1704903349207714,0.2689489184878146,0.18950908480051226,PRRX1/NTN1/CEBPD,3
GO:0010632,regulation of epithelial cell migration,4/137,298/18888,0.013422818791946308,1.850585411257532,1.265073981125578,0.17121860352073623,0.2689489184878146,0.18950908480051226,APOE/TNF/VEGFC/FGF1,4
GO:0035282,segmentation,2/137,103/18888,0.019417475728155338,2.677060449294876,1.45878499128359,0.17174511345491827,0.2689489184878146,0.18950908480051226,LEF1/BASP1,2
GO:0070167,regulation of biomineral tissue development,2/137,103/18888,0.019417475728155338,2.677060449294876,1.45878499128359,0.17174511345491827,0.2689489184878146,0.18950908480051226,GJA1/FAM20C,2
GO:0099175,regulation of postsynapse organization,2/137,103/18888,0.019417475728155338,2.677060449294876,1.45878499128359,0.17174511345491827,0.2689489184878146,0.18950908480051226,APOE/RELN,2
GO:0030323,respiratory tube development,3/137,197/18888,0.015228426395939087,2.0995220274926822,1.3260207969364075,0.17226988969076573,0.2689489184878146,0.18950908480051226,ASCL1/TNF/FGF1,3
GO:0031334,positive regulation of protein-containing complex assembly,3/137,197/18888,0.015228426395939087,2.0995220274926822,1.3260207969364075,0.17226988969076573,0.2689489184878146,0.18950908480051226,SYK/TNF/TPPP,3
GO:0090276,regulation of peptide hormone secretion,3/137,197/18888,0.015228426395939087,2.0995220274926822,1.3260207969364075,0.17226988969076573,0.2689489184878146,0.18950908480051226,CHGA/FOXO1/TNF,3
GO:0001835,blastocyst hatching,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,PPP4R4,1
GO:0001911,negative regulation of leukocyte mediated cytotoxicity,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,PTPRC,1
GO:0002026,regulation of the force of heart contraction,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,CHGA,1
GO:0002053,positive regulation of mesenchymal cell proliferation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,PRRX1,1
GO:0002092,positive regulation of receptor internalization,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,SYK,1
GO:0008045,motor neuron axon guidance,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,LMO4,1
GO:0009065,glutamine family amino acid catabolic process,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,GAD1,1
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,DMD,1
GO:0021697,cerebellar cortex formation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,FAIM2,1
GO:0021895,cerebral cortex neuron differentiation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,ASCL1,1
GO:0022010,central nervous system myelination,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,B4GALT6,1
GO:0032291,axon ensheathment in central nervous system,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,B4GALT6,1
GO:0033622,integrin activation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,CXCL12,1
GO:0034138,toll-like receptor 3 signaling pathway,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,TNF,1
GO:0035188,hatching,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,PPP4R4,1
GO:0035988,chondrocyte proliferation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,LEF1,1
GO:0042278,purine nucleoside metabolic process,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,NT5C1A,1
GO:0048143,astrocyte activation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,TNF,1
GO:0048596,embryonic camera-type eye morphogenesis,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,SIX3,1
GO:0048641,regulation of skeletal muscle tissue development,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,IGF2,1
GO:0060065,uterus development,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,CDKN1C,1
GO:0060259,regulation of feeding behavior,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,NR4A3,1
GO:0060343,trabecula formation,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,NKX2-5,1
GO:0062009,secondary palate development,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,LEF1,1
GO:0071467,cellular response to pH,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,GJA1,1
GO:0071684,organism emergence from protective structure,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,PPP4R4,1
GO:0097186,amelogenesis,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,FAM20C,1
GO:0099558,maintenance of synapse structure,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,SHANK1,1
GO:1900078,positive regulation of cellular response to insulin stimulus,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,IGF2,1
GO:1900543,negative regulation of purine nucleotide metabolic process,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,CBFA2T3,1
GO:1902932,positive regulation of alcohol biosynthetic process,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,FGF1,1
GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,NGFR,1
GO:1904754,positive regulation of vascular associated smooth muscle cell migration,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,NR4A3,1
GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,TNF,1
GO:2000108,positive regulation of leukocyte apoptotic process,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,CDKN2A,1
GO:2000272,negative regulation of signaling receptor activity,1/137,26/18888,0.038461538461538464,5.302638966872544,1.876537582268615,0.17254324456066217,0.2689489184878146,0.18950908480051226,TNF,1
GO:0002027,regulation of heart rate,2/137,104/18888,0.019230769230769232,2.651319483436272,1.4433886693143447,0.17432800169276214,0.2714536026358725,0.19127395674452904,DMD/TNF,2
GO:1990830,cellular response to leukemia inhibitory factor,2/137,104/18888,0.019230769230769232,2.651319483436272,1.4433886693143447,0.17432800169276214,0.2714536026358725,0.19127395674452904,NEFH/VEGFC,2
GO:0099504,synaptic vesicle cycle,3/137,199/18888,0.01507537688442211,2.078421303598283,1.3072285416010496,0.17584501085508636,0.27367617191724813,0.19284004250084083,SYT4/GRIK5/RIMS3,3
GO:0045639,positive regulation of myeloid cell differentiation,2/137,105/18888,0.01904761904761905,2.62606882168926,1.4281724457723601,0.17691722315667352,0.27397921418037546,0.19305357472942922,LEF1/TNF,2
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,2/137,105/18888,0.01904761904761905,2.62606882168926,1.4281724457723601,0.17691722315667352,0.27397921418037546,0.19305357472942922,GDF6/CDKN1C,2
GO:0002791,regulation of peptide secretion,3/137,200/18888,0.015,2.0680291970802918,1.2979150467847882,0.17764042288306578,0.27397921418037546,0.19305357472942922,CHGA/FOXO1/TNF,3
GO:0071248,cellular response to metal ion,3/137,200/18888,0.015,2.0680291970802918,1.2979150467847882,0.17764042288306578,0.27397921418037546,0.19305357472942922,SYT4/AKR1C3/TF,3
GO:0006541,glutamine metabolic process,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,CPS1,1
GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,GAP43,1
GO:0007274,neuromuscular synaptic transmission,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,CHAT,1
GO:0010875,positive regulation of cholesterol efflux,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,APOE,1
GO:0010884,positive regulation of lipid storage,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,C3,1
GO:0016540,protein autoprocessing,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,PCSK2,1
GO:0019755,one-carbon compound transport,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,POU3F3,1
GO:0021801,cerebral cortex radial glia-guided migration,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,RELN,1
GO:0022030,telencephalon glial cell migration,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,RELN,1
GO:0031579,membrane raft organization,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,PTPRC,1
GO:0031639,plasminogen activation,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,SERPINE1,1
GO:0032740,positive regulation of interleukin-17 production,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,IL15,1
GO:0034377,plasma lipoprotein particle assembly,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,APOE,1
GO:0035929,steroid hormone secretion,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,SPP1,1
GO:0036296,response to increased oxygen levels,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,FOXO1,1
GO:0042104,positive regulation of activated T cell proliferation,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,IGF2,1
GO:0042730,fibrinolysis,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,SERPINE1,1
GO:0045980,negative regulation of nucleotide metabolic process,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,CBFA2T3,1
GO:0046037,GMP metabolic process,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,CARD11,1
GO:0071549,cellular response to dexamethasone stimulus,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,ASS1,1
GO:0099170,postsynaptic modulation of chemical synaptic transmission,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,NEFH,1
GO:0150146,cell junction disassembly,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,C3,1
GO:1902894,negative regulation of miRNA transcription,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,TNF,1
GO:1905564,positive regulation of vascular endothelial cell proliferation,1/137,27/18888,0.037037037037037035,5.10624493106245,1.8250464912897035,0.1785532952178135,0.27397921418037546,0.19305357472942922,IGF2,1
GO:0032526,response to retinoic acid,2/137,106/18888,0.018867924528301886,2.6012945875223794,1.4131322475398262,0.17951255240038236,0.27476043627179886,0.19360404611412194,ASCL1/TNF,2
GO:0034308,primary alcohol metabolic process,2/137,106/18888,0.018867924528301886,2.6012945875223794,1.4131322475398262,0.17951255240038236,0.27476043627179886,0.19360404611412194,AKR1C3/AKR1C1,2
GO:0042472,inner ear morphogenesis,2/137,106/18888,0.018867924528301886,2.6012945875223794,1.4131322475398262,0.17951255240038236,0.27476043627179886,0.19360404611412194,PRRX1/NTN1,2
GO:0046425,regulation of receptor signaling pathway via JAK-STAT,2/137,106/18888,0.018867924528301886,2.6012945875223794,1.4131322475398262,0.17951255240038236,0.27476043627179886,0.19360404611412194,TNF/PTPRC,2
GO:1990823,response to leukemia inhibitory factor,2/137,106/18888,0.018867924528301886,2.6012945875223794,1.4131322475398262,0.17951255240038236,0.27476043627179886,0.19360404611412194,NEFH/VEGFC,2
GO:0051701,biological process involved in interaction with host,3/137,202/18888,0.01485148514851485,2.047553660475536,1.279450086654913,0.18124656513907464,0.2771365314651582,0.195278310610236,TNFRSF4/CXCR4/IFIT1,3
GO:0090087,regulation of peptide transport,3/137,202/18888,0.01485148514851485,2.047553660475536,1.279450086654913,0.18124656513907464,0.2771365314651582,0.195278310610236,CHGA/FOXO1/TNF,3
GO:0019751,polyol metabolic process,2/137,107/18888,0.018691588785046728,2.5769834231530115,1.398264132421307,0.18211376686975206,0.27823867048986345,0.19605490922631963,NUDT11/NUDT10,2
GO:0001573,ganglioside metabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,B4GALT6,1
GO:0003156,regulation of animal organ formation,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,FGF1,1
GO:0009264,deoxyribonucleotide catabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,NT5C1A,1
GO:0010039,response to iron ion,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,TF,1
GO:0010922,positive regulation of phosphatase activity,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,PTPRC,1
GO:0019433,triglyceride catabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,CPS1,1
GO:0021544,subpallium development,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,ASCL1,1
GO:0021680,cerebellar Purkinje cell layer development,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,FAIM2,1
GO:0030194,positive regulation of blood coagulation,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,SERPINE1,1
GO:0032703,negative regulation of interleukin-2 production,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,PTPRC,1
GO:0032801,receptor catabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,APOE,1
GO:0043304,regulation of mast cell degranulation,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,SYK,1
GO:0045830,positive regulation of isotype switching,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,PTPRC,1
GO:0045948,positive regulation of translational initiation,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,TNF,1
GO:0046386,deoxyribose phosphate catabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,NT5C1A,1
GO:0048499,synaptic vesicle membrane organization,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,GRIK5,1
GO:0048843,negative regulation of axon extension involved in axon guidance,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,SEMA5B,1
GO:0050995,negative regulation of lipid catabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,TNF,1
GO:0050999,regulation of nitric-oxide synthase activity,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,APOE,1
GO:0051873,killing by host of symbiont cells,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,APOL1,1
GO:0060402,calcium ion transport into cytosol,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,GRIN1,1
GO:0090330,regulation of platelet aggregation,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,SYK,1
GO:0120255,olefinic compound biosynthetic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,AKR1C3,1
GO:1900048,positive regulation of hemostasis,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,SERPINE1,1
GO:1903672,positive regulation of sprouting angiogenesis,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,FGF1,1
GO:1903779,regulation of cardiac conduction,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,NKX2-5,1
GO:2000629,negative regulation of miRNA metabolic process,1/137,28/18888,0.03571428571428571,4.923879040667361,1.7760424402311388,0.18452000952538783,0.27823867048986345,0.19605490922631963,TNF,1
GO:0003279,cardiac septum development,2/137,108/18888,0.018518518518518517,2.553122465531225,1.3835642837369013,0.18472064687320694,0.27840366136149514,0.19617116650394373,LMO4/NKX2-5,2
GO:0055001,muscle cell development,3/137,204/18888,0.014705882352941176,2.0274796049806785,1.2611969776052938,0.1848726207621329,0.27849518191807976,0.1962356545004611,AKAP6/DMD/NKX2-5,3
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,5/137,417/18888,0.011990407673860911,1.6531008769626634,1.1527434072192528,0.18640932261287368,0.2806715602439519,0.19776919279105806,LEF1/GDF6/CDKN1C/GREM2/WWTR1,5
GO:0001676,long-chain fatty acid metabolic process,2/137,109/18888,0.01834862385321101,2.5296993236456173,1.3690290051868954,0.18733297555243253,0.2817842490813327,0.19855322510628498,PTGDS/AKR1C3,2
GO:1901800,positive regulation of proteasomal protein catabolic process,2/137,109/18888,0.01834862385321101,2.5296993236456173,1.3690290051868954,0.18733297555243253,0.2817842490813327,0.19855322510628498,CBFA2T3/IL33,2
GO:0034504,protein localization to nucleus,4/137,311/18888,0.012861736334405145,1.773229750979886,1.1752506944783472,0.1899145724630103,0.2827014422837483,0.19919950561691996,NGFR/SYK/IL33/WWTR1,4
GO:0001708,cell fate specification,2/137,110/18888,0.01818181818181818,2.50670205706702,1.3546547159719062,0.18995053885334579,0.2827014422837483,0.19919950561691996,ASCL1/LMO4,2
GO:0009135,purine nucleoside diphosphate metabolic process,2/137,110/18888,0.01818181818181818,2.50670205706702,1.3546547159719062,0.18995053885334579,0.2827014422837483,0.19919950561691996,CBFA2T3/CARD11,2
GO:0009179,purine ribonucleoside diphosphate metabolic process,2/137,110/18888,0.01818181818181818,2.50670205706702,1.3546547159719062,0.18995053885334579,0.2827014422837483,0.19919950561691996,CBFA2T3/CARD11,2
GO:0031341,regulation of cell killing,2/137,110/18888,0.01818181818181818,2.50670205706702,1.3546547159719062,0.18995053885334579,0.2827014422837483,0.19919950561691996,SYK/PTPRC,2
GO:0048144,fibroblast proliferation,2/137,110/18888,0.01818181818181818,2.50670205706702,1.3546547159719062,0.18995053885334579,0.2827014422837483,0.19919950561691996,NGFR/PDGFC,2
GO:0002710,negative regulation of T cell mediated immunity,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,PTPRC,1
GO:0003209,cardiac atrium morphogenesis,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,NKX2-5,1
GO:0003401,axis elongation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,FGF1,1
GO:0006656,phosphatidylcholine biosynthetic process,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,CHAT,1
GO:0007263,nitric oxide mediated signal transduction,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,APOE,1
GO:0008299,isoprenoid biosynthetic process,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,AKR1C3,1
GO:0015813,L-glutamate transmembrane transport,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,TNF,1
GO:0021522,spinal cord motor neuron differentiation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,LMO4,1
GO:0021952,central nervous system projection neuron axonogenesis,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,DRAXIN,1
GO:0031342,negative regulation of cell killing,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,PTPRC,1
GO:0033137,negative regulation of peptidyl-serine phosphorylation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,DMD,1
GO:0042403,thyroid hormone metabolic process,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,DIO3,1
GO:0045672,positive regulation of osteoclast differentiation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,TNF,1
GO:0051291,protein heterooligomerization,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,GRIN1,1
GO:0060479,lung cell differentiation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,ASCL1,1
GO:0060487,lung epithelial cell differentiation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,ASCL1,1
GO:0098698,postsynaptic specialization assembly,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,GAP43,1
GO:0099623,regulation of cardiac muscle cell membrane repolarization,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,GJA1,1
GO:0099625,ventricular cardiac muscle cell membrane repolarization,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,GJA1,1
GO:1902430,negative regulation of amyloid-beta formation,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,APOE,1
GO:2000273,positive regulation of signaling receptor activity,1/137,29/18888,0.034482758620689655,4.754090108230556,1.7293142419313412,0.19044369768525116,0.2827014422837483,0.19919950561691996,RELN,1
GO:0007416,synapse assembly,3/137,208/18888,0.014423076923076924,1.988489612577204,1.2253069540855772,0.19218203323232805,0.2848662289582638,0.20072487609910086,NTN1/ACHE/GAP43,3
GO:0009746,response to hexose,3/137,208/18888,0.014423076923076924,1.988489612577204,1.2253069540855772,0.19218203323232805,0.2848662289582638,0.20072487609910086,PTPRN/TNF/COL6A3,3
GO:0050851,antigen receptor-mediated signaling pathway,3/137,208/18888,0.014423076923076924,1.988489612577204,1.2253069540855772,0.19218203323232805,0.2848662289582638,0.20072487609910086,SYK/PTPRC/CARD11,3
GO:0090398,cellular senescence,2/137,111/18888,0.018018018018018018,2.484119155652002,1.3404379461535931,0.1925731254973306,0.28530736845526844,0.20103571558050404,MAP3K5/CDKN2A,2
GO:0051146,striated muscle cell differentiation,4/137,313/18888,0.012779552715654952,1.7618992094400783,1.1618092699088673,0.1928479530615814,0.28557591108391384,0.20122493838188452,BHLHE41/AKAP6/IGF2/NKX2-5,4
GO:0006470,protein dephosphorylation,3/137,210/18888,0.014285714285714285,1.9695516162669446,1.2076607548620508,0.1958641786176717,0.28696498362340483,0.20220371854266955,PPP4R4/TNF/PTPRC,3
GO:0002438,acute inflammatory response to antigenic stimulus,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,C3,1
GO:0005979,regulation of glycogen biosynthetic process,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,IGF2,1
GO:0007588,excretion,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,NPR1,1
GO:0008209,androgen metabolic process,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SPP1,1
GO:0009649,entrainment of circadian clock,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,BMAL2,1
GO:0010894,negative regulation of steroid biosynthetic process,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,APOE,1
GO:0010955,negative regulation of protein processing,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SERPINE1,1
GO:0010962,regulation of glucan biosynthetic process,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,IGF2,1
GO:0015721,bile acid and bile salt transport,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,AKR1C1,1
GO:0038094,Fc-gamma receptor signaling pathway,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SYK,1
GO:0043032,positive regulation of macrophage activation,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,IL33,1
GO:0043392,negative regulation of DNA binding,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,LEF1,1
GO:0050482,arachidonic acid secretion,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SYK,1
GO:0050820,positive regulation of coagulation,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SERPINE1,1
GO:0060037,pharyngeal system development,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,NKX2-5,1
GO:0060441,epithelial tube branching involved in lung morphogenesis,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,TNF,1
GO:0060603,mammary gland duct morphogenesis,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,NTN1,1
GO:0065005,protein-lipid complex assembly,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,APOE,1
GO:0097421,liver regeneration,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,TNF,1
GO:0099505,regulation of presynaptic membrane potential,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,GRIK5,1
GO:1900017,positive regulation of cytokine production involved in inflammatory response,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,TNF,1
GO:1901021,positive regulation of calcium ion transmembrane transporter activity,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,AKAP6,1
GO:1901385,regulation of voltage-gated calcium channel activity,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,DMD,1
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,CXCL12,1
GO:1903318,negative regulation of protein maturation,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SERPINE1,1
GO:1903963,arachidonate transport,1/137,30/18888,0.03333333333333333,4.595620437956205,1.684675301423894,0.19632466769517343,0.28696498362340483,0.20220371854266955,SYK,1
GO:0006766,vitamin metabolic process,2/137,113/18888,0.017699115044247787,2.440152444932498,1.3124636129966811,0.19783253740666193,0.28903059079230836,0.2036592043142326,AKR1C3/TNF,2
GO:0002285,lymphocyte activation involved in immune response,3/137,212/18888,0.014150943396226415,1.9509709406417848,1.1902078239628195,0.19956381479983548,0.29142046065507077,0.20534317483558998,LEF1/RORC/PTPRC,3
GO:0042692,muscle cell differentiation,5/137,428/18888,0.011682242990654205,1.6106146394706322,1.0922015921170407,0.20018986560762805,0.292194868404821,0.20588884464063234,BHLHE41/AKAP6/DMD/IGF2/NKX2-5,5
GO:0045216,cell-cell junction organization,3/137,213/18888,0.014084507042253521,1.9418114526575514,1.1815524922127143,0.20142000523938947,0.2925567395979444,0.20614382941249929,GJA1/TNF/CD177,3
GO:0071383,cellular response to steroid hormone stimulus,3/137,213/18888,0.014084507042253521,1.9418114526575514,1.1815524922127143,0.20142000523938947,0.2925567395979444,0.20614382941249929,AKR1C3/ASS1/NR4A3,3
GO:0099111,microtubule-based transport,3/137,213/18888,0.014084507042253521,1.9418114526575514,1.1815524922127143,0.20142000523938947,0.2925567395979444,0.20614382941249929,NEFH/KIF17/MAP2,3
GO:0002825,regulation of T-helper 1 type immune response,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,IL33,1
GO:0003298,physiological muscle hypertrophy,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,AKAP6,1
GO:0003301,physiological cardiac muscle hypertrophy,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,AKAP6,1
GO:0003338,metanephros morphogenesis,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,BASP1,1
GO:0010458,exit from mitosis,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,CDKN1C,1
GO:0010575,positive regulation of vascular endothelial growth factor production,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,C3,1
GO:0030878,thyroid gland development,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,NKX2-5,1
GO:0031646,positive regulation of nervous system process,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,TPPP,1
GO:0033238,regulation of amine metabolic process,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,MAOB,1
GO:0035767,endothelial cell chemotaxis,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,FGF1,1
GO:0036336,dendritic cell migration,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,CXCR4,1
GO:0045070,positive regulation of viral genome replication,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,IFIT1,1
GO:0060325,face morphogenesis,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,LEF1,1
GO:0061049,cell growth involved in cardiac muscle cell development,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,AKAP6,1
GO:2000191,regulation of fatty acid transport,1/137,31/18888,0.03225806451612903,4.447374617376972,1.6419600372213734,0.20216322536437248,0.2925567395979444,0.20614382941249929,SYK,1
GO:0022037,metencephalon development,2/137,115/18888,0.017391304347826087,2.397715011107585,1.2850803009949947,0.2031095754844494,0.29364776142990984,0.20691259453725105,ASCL1/FAIM2,2
GO:0032355,response to estradiol,2/137,115/18888,0.017391304347826087,2.397715011107585,1.2850803009949947,0.2031095754844494,0.29364776142990984,0.20691259453725105,ASS1/NRIP1,2
GO:2000241,regulation of reproductive process,3/137,214/18888,0.014018691588785047,1.9327375673647589,1.1729438843699231,0.2032803448063579,0.29375549827130887,0.2069885089909236,GJA1/PTGDS/VIP,3
GO:0034284,response to monosaccharide,3/137,215/18888,0.013953488372093023,1.9237480903072481,1.1643814869135674,0.20514475947338606,0.29630942068754107,0.20878807562414514,PTPRN/TNF/COL6A3,3
GO:0071887,leukocyte apoptotic process,2/137,116/18888,0.017241379310344827,2.377045054115278,1.271602661967519,0.2057542048256574,0.29690866814558226,0.20921032248790247,CXCL12/CDKN2A,2
GO:2001257,regulation of cation channel activity,2/137,116/18888,0.017241379310344827,2.377045054115278,1.271602661967519,0.2057542048256574,0.29690866814558226,0.20921032248790247,AKAP6/DMD,2
GO:1901605,alpha-amino acid metabolic process,3/137,216/18888,0.013888888888888888,1.9148418491484183,1.155864794436345,0.2070131754597847,0.29783806947534597,0.20986520519353377,GAD1/ASS1/CPS1,3
GO:0003299,muscle hypertrophy in response to stress,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,FOXO1,1
GO:0010644,cell communication by electrical coupling,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,GJA1,1
GO:0010667,negative regulation of cardiac muscle cell apoptotic process,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,NKX2-5,1
GO:0014887,cardiac muscle adaptation,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,FOXO1,1
GO:0014898,cardiac muscle hypertrophy in response to stress,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,FOXO1,1
GO:0033032,regulation of myeloid cell apoptotic process,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,CDKN2A,1
GO:0034505,tooth mineralization,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,FAM20C,1
GO:0034694,response to prostaglandin,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,AKR1C3,1
GO:0042219,cellular modified amino acid catabolic process,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,DIO3,1
GO:0048384,retinoic acid receptor signaling pathway,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,AKR1C3,1
GO:0048679,regulation of axon regeneration,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,SPP1,1
GO:0061036,positive regulation of cartilage development,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,GDF6,1
GO:0061384,heart trabecula morphogenesis,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,NKX2-5,1
GO:1901889,negative regulation of cell junction assembly,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,TNF,1
GO:1902992,negative regulation of amyloid precursor protein catabolic process,1/137,32/18888,0.03125,4.3083941605839415,1.6010209203896963,0.20795967432895224,0.29783806947534597,0.20986520519353377,APOE,1
GO:0071805,potassium ion transmembrane transport,3/137,217/18888,0.013824884792626729,1.9060176931615596,1.147393309478593,0.20888551923607884,0.29902373579198527,0.21070065952370348,AKAP6/KCNIP3/DPP6,3
GO:0007088,regulation of mitotic nuclear division,2/137,118/18888,0.01694915254237288,2.3367561548929854,1.2450609627184923,0.21105470800988432,0.30170443505675265,0.2125895567431005,TNF/IGF2,2
GO:0010633,negative regulation of epithelial cell migration,2/137,118/18888,0.01694915254237288,2.3367561548929854,1.2450609627184923,0.21105470800988432,0.30170443505675265,0.2125895567431005,APOE/TNF,2
GO:0050830,defense response to Gram-positive bacterium,2/137,118/18888,0.01694915254237288,2.3367561548929854,1.2450609627184923,0.21105470800988432,0.30170443505675265,0.2125895567431005,CHGA/TNF,2
GO:0006790,sulfur compound metabolic process,4/137,326/18888,0.012269938650306749,1.6916394250145539,1.0767272732544726,0.21225209107045026,0.3023903999245161,0.2130729071689958,CHST1/CHST13/CHST15/CPS1,4
GO:1904951,positive regulation of establishment of protein localization,4/137,326/18888,0.012269938650306749,1.6916394250145539,1.0767272732544726,0.21225209107045026,0.3023903999245161,0.2130729071689958,ACHE/TNF/ABLIM3/VEGFC,4
GO:0007601,visual perception,3/137,219/18888,0.0136986301369863,1.8886111388861113,1.1305840110543675,0.21264169732305624,0.3023903999245161,0.2130729071689958,LUM/SIX3/SEMA5B,3
GO:0009952,anterior/posterior pattern specification,3/137,219/18888,0.0136986301369863,1.8886111388861113,1.1305840110543675,0.21264169732305624,0.3023903999245161,0.2130729071689958,LEF1/BHLHE41/BASP1,3
GO:0006906,vesicle fusion,2/137,119/18888,0.01680672268907563,2.3171195485493468,1.2319913707953487,0.21371019914008482,0.3023903999245161,0.2130729071689958,SYT4/GRIK5,2
GO:0032609,type II interferon production,2/137,119/18888,0.01680672268907563,2.3171195485493468,1.2319913707953487,0.21371019914008482,0.3023903999245161,0.2130729071689958,IL33/TNF,2
GO:0032649,regulation of type II interferon production,2/137,119/18888,0.01680672268907563,2.3171195485493468,1.2319913707953487,0.21371019914008482,0.3023903999245161,0.2130729071689958,IL33/TNF,2
GO:0002862,negative regulation of inflammatory response to antigenic stimulus,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,SYK,1
GO:0006536,glutamate metabolic process,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,GAD1,1
GO:0010464,regulation of mesenchymal cell proliferation,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,PRRX1,1
GO:0017145,stem cell division,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,WWTR1,1
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,CDKN1C,1
GO:0031069,hair follicle morphogenesis,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,NGFR,1
GO:0031128,developmental induction,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,FGF1,1
GO:0034368,protein-lipid complex remodeling,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,APOE,1
GO:0034369,plasma lipoprotein particle remodeling,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,APOE,1
GO:0035115,embryonic forelimb morphogenesis,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,CRABP2,1
GO:0048566,embryonic digestive tract development,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,TNF,1
GO:0051647,nucleus localization,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,NTN1,1
GO:0072539,T-helper 17 cell differentiation,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,RORC,1
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,CDKN1C,1
GO:1905207,regulation of cardiocyte differentiation,1/137,33/18888,0.030303030303030304,4.177836761778368,1.5617260090785152,0.21371431606722846,0.3023903999245161,0.2130729071689958,NKX2-5,1
GO:0040029,epigenetic regulation of gene expression,3/137,220/18888,0.013636363636363636,1.8800265428002654,1.1222452409707282,0.21452538587029601,0.30339734832073373,0.21378243175114128,IGF2/CDKN1C/NDN,3
GO:0009185,ribonucleoside diphosphate metabolic process,2/137,120/18888,0.016666666666666666,2.2978102189781024,1.2190523947261316,0.2163689323851755,0.3053590351468019,0.21516469228285728,CBFA2T3/CARD11,2
GO:0010717,regulation of epithelial to mesenchymal transition,2/137,120/18888,0.016666666666666666,2.2978102189781024,1.2190523947261316,0.2163689323851755,0.3053590351468019,0.21516469228285728,LEF1/WWTR1,2
GO:0071346,cellular response to type II interferon,2/137,120/18888,0.016666666666666666,2.2978102189781024,1.2190523947261316,0.2163689323851755,0.3053590351468019,0.21516469228285728,TNF/ASS1,2
GO:0010810,regulation of cell-substrate adhesion,3/137,221/18888,0.013574660633484163,1.8715196353667802,1.1139497648683288,0.2164127106889032,0.3053590351468019,0.21516469228285728,SERPINE1/UTRN/CDKN2A,3
GO:0099003,vesicle-mediated transport in synapse,3/137,221/18888,0.013574660633484163,1.8715196353667802,1.1139497648683288,0.2164127106889032,0.3053590351468019,0.21516469228285728,SYT4/GRIK5/RIMS3,3
GO:0090174,organelle membrane fusion,2/137,121/18888,0.01652892561983471,2.27882005187911,1.2062414620723183,0.2190307226963672,0.3069168547847972,0.21626237646593796,SYT4/GRIK5,2
GO:0000096,sulfur amino acid metabolic process,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,CPS1,1
GO:0002828,regulation of type 2 immune response,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,IL33,1
GO:0006691,leukotriene metabolic process,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,SYK,1
GO:0007435,salivary gland morphogenesis,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,TNF,1
GO:0009954,proximal/distal pattern formation,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,SIX3,1
GO:0010664,negative regulation of striated muscle cell apoptotic process,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,NKX2-5,1
GO:0019068,virion assembly,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,APOE,1
GO:0034405,response to fluid shear stress,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,ASS1,1
GO:0045939,negative regulation of steroid metabolic process,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,APOE,1
GO:0046320,regulation of fatty acid oxidation,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,NR4A3,1
GO:0050775,positive regulation of dendrite morphogenesis,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,RELN,1
GO:0071353,cellular response to interleukin-4,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,LEF1,1
GO:0071875,adrenergic receptor signaling pathway,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,CHGA,1
GO:0086019,cell-cell signaling involved in cardiac conduction,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,GJA1,1
GO:0090075,relaxation of muscle,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,CHGA,1
GO:0090183,regulation of kidney development,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,BASP1,1
GO:1903749,positive regulation of establishment of protein localization to mitochondrion,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,ABLIM3,1
GO:1903955,positive regulation of protein targeting to mitochondrion,1/137,34/18888,0.029411764705882353,4.054959209961357,1.5239568833159054,0.21942744991495,0.3069168547847972,0.21626237646593796,ABLIM3,1
GO:0043583,ear development,3/137,223/18888,0.013452914798206279,1.8547347059016073,1.0974868613646127,0.22019798058097875,0.3075717330586486,0.2167238223904322,PRRX1/NTN1/CEBPD,3
GO:0050953,sensory perception of light stimulus,3/137,223/18888,0.013452914798206279,1.8547347059016073,1.0974868613646127,0.22019798058097875,0.3075717330586486,0.2167238223904322,LUM/SIX3/SEMA5B,3
GO:1902115,regulation of organelle assembly,3/137,223/18888,0.013452914798206279,1.8547347059016073,1.0974868613646127,0.22019798058097875,0.3075717330586486,0.2167238223904322,ADAMTS16/TNF/GAP43,3
GO:0030278,regulation of ossification,2/137,122/18888,0.01639344262295082,2.2601411989948548,1.193556072700457,0.2216953875009234,0.30938012009731053,0.21799806351617768,GJA1/FAM20C,2
GO:1904892,regulation of receptor signaling pathway via STAT,2/137,122/18888,0.01639344262295082,2.2601411989948548,1.193556072700457,0.2216953875009234,0.30938012009731053,0.21799806351617768,TNF/PTPRC,2
GO:0071222,cellular response to lipopolysaccharide,3/137,225/18888,0.013333333333333334,1.8382481751824817,1.0811917035759204,0.22399693266672616,0.31142488061714535,0.21943886014376357,SERPINE1/TNF/ASS1,3
GO:0045446,endothelial cell differentiation,2/137,123/18888,0.016260162601626018,2.24176606729571,1.180993796165051,0.22436274667642822,0.31142488061714535,0.21943886014376357,CXCR4/TNF,2
GO:0000132,establishment of mitotic spindle orientation,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,GJA1,1
GO:0001893,maternal placenta development,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,SPP1,1
GO:0002719,negative regulation of cytokine production involved in immune response,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,TNF,1
GO:0009119,ribonucleoside metabolic process,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,NT5C1A,1
GO:0010669,epithelial structure maintenance,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,LDB2,1
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,VEGFC,1
GO:0032872,regulation of stress-activated MAPK cascade,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,FOXO1,1
GO:0034110,regulation of homotypic cell-cell adhesion,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,SYK,1
GO:0036314,response to sterol,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,RORC,1
GO:0046164,alcohol catabolic process,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,AKR1C3,1
GO:0048048,embryonic eye morphogenesis,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,SIX3,1
GO:0048333,mesodermal cell differentiation,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,GJA1,1
GO:0070293,renal absorption,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,AKR1C3,1
GO:0098810,neurotransmitter reuptake,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,SLC18A3,1
GO:0099171,presynaptic modulation of chemical synaptic transmission,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,NGFR,1
GO:1901099,negative regulation of signal transduction in absence of ligand,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,TNF,1
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/137,35/18888,0.02857142857142857,3.9391032325338893,1.487606905386405,0.22509937308041372,0.31142488061714535,0.21943886014376357,TNF,1
GO:0007596,blood coagulation,3/137,226/18888,0.01327433628318584,1.8301143336993735,1.073105934969822,0.2259013612918262,0.31239282041805777,0.22012089815620198,SERPINE1/APOE/SYK,3
GO:0002286,T cell activation involved in immune response,2/137,124/18888,0.016129032258064516,2.223687308688486,1.168552269206812,0.22703262252529094,0.3136729578755944,0.22102291954881678,LEF1/RORC,2
GO:0010951,negative regulation of endopeptidase activity,2/137,124/18888,0.016129032258064516,2.223687308688486,1.168552269206812,0.22703262252529094,0.3136729578755944,0.22102291954881678,SERPINE1/TNF,2
GO:0042180,cellular ketone metabolic process,3/137,227/18888,0.013215859030837005,1.8220521560178784,1.065060802717954,0.227808997154686,0.3146031942606795,0.22167839065826317,AKR1C3/AKR1C1/NR4A3,3
GO:0021761,limbic system development,2/137,125/18888,0.016,2.2058978102189783,1.1562291933603006,0.2297048397494901,0.3163473143633011,0.22290734746644966,LEF1/RELN,2
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,2/137,125/18888,0.016,2.2058978102189783,1.1562291933603006,0.2297048397494901,0.3163473143633011,0.22290734746644966,CBFA2T3/IL33,2
GO:1903050,regulation of proteolysis involved in protein catabolic process,3/137,228/18888,0.013157894736842105,1.8140606991932384,1.0570558869375708,0.22971976975977063,0.3163473143633011,0.22290734746644966,APOE/CBFA2T3/IL33,3
GO:0001569,branching involved in blood vessel morphogenesis,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,LEF1,1
GO:0007617,mating behavior,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,VIP,1
GO:0010770,positive regulation of cell morphogenesis,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,RELN,1
GO:0016486,peptide hormone processing,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,PCSK2,1
GO:0032094,response to food,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,CPS1,1
GO:0032232,negative regulation of actin filament bundle assembly,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,SHANK1,1
GO:0034367,protein-containing complex remodeling,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,APOE,1
GO:0035883,enteroendocrine cell differentiation,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,ASCL1,1
GO:0042462,eye photoreceptor cell development,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,DIO3,1
GO:0045920,negative regulation of exocytosis,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,SYT4,1
GO:1905332,positive regulation of morphogenesis of an epithelium,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,GJA1,1
GO:2000352,negative regulation of endothelial cell apoptotic process,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,SERPINE1,1
GO:2000406,positive regulation of T cell migration,1/137,36/18888,0.027777777777777776,3.8296836982968365,1.4525797467512842,0.23073038065947193,0.3163473143633011,0.22290734746644966,CXCL12,1
GO:0008286,insulin receptor signaling pathway,2/137,126/18888,0.015873015873015872,2.1883906847410497,1.1440223326653352,0.23237922542554976,0.31832199102279074,0.2242987610055741,FOXO1/IGF2,2
GO:0033135,regulation of peptidyl-serine phosphorylation,2/137,126/18888,0.015873015873015872,2.1883906847410497,1.1440223326653352,0.23237922542554976,0.31832199102279074,0.2242987610055741,DMD/TNF,2
GO:0034329,cell junction assembly,5/137,453/18888,0.011037527593818985,1.521728621839803,0.9607308786078519,0.232725557464534,0.31865338778903446,0.22453227262640452,NTN1/GJA1/ACHE/TNF/GAP43,5
GO:0051091,positive regulation of DNA-binding transcription factor activity,3/137,230/18888,0.013043478260869565,1.7982862583306884,1.0411650563794232,0.23355044470701658,0.31927887417668366,0.22497300818892346,TNF/CARD11/RELN,3
GO:0016042,lipid catabolic process,4/137,340/18888,0.011764705882352941,1.6219836839845427,0.9892349781055352,0.2337342568387703,0.31927887417668366,0.22497300818892346,AKR1C3/SPP1/TNF/CPS1,4
GO:0003014,renal system process,2/137,127/18888,0.015748031496062992,2.171159262026553,1.131929511476878,0.2350556089797477,0.31927887417668366,0.22497300818892346,AKR1C3/NPR1,2
GO:0003231,cardiac ventricle development,2/137,127/18888,0.015748031496062992,2.171159262026553,1.131929511476878,0.2350556089797477,0.31927887417668366,0.22497300818892346,LMO4/NKX2-5,2
GO:0009132,nucleoside diphosphate metabolic process,2/137,127/18888,0.015748031496062992,2.171159262026553,1.131929511476878,0.2350556089797477,0.31927887417668366,0.22497300818892346,CBFA2T3/CARD11,2
GO:0030282,bone mineralization,2/137,127/18888,0.015748031496062992,2.171159262026553,1.131929511476878,0.2350556089797477,0.31927887417668366,0.22497300818892346,GJA1/FAM20C,2
GO:0031623,receptor internalization,2/137,127/18888,0.015748031496062992,2.171159262026553,1.131929511476878,0.2350556089797477,0.31927887417668366,0.22497300818892346,ACHE/SYK,2
GO:0042471,ear morphogenesis,2/137,127/18888,0.015748031496062992,2.171159262026553,1.131929511476878,0.2350556089797477,0.31927887417668366,0.22497300818892346,PRRX1/NTN1,2
GO:0045861,negative regulation of proteolysis,3/137,231/18888,0.012987012987012988,1.7905014693335861,1.0332783325968171,0.23547020756036727,0.31927887417668366,0.22497300818892346,SERPINE1/SPINK5/TNF,3
GO:0050817,coagulation,3/137,231/18888,0.012987012987012988,1.7905014693335861,1.0332783325968171,0.23547020756036727,0.31927887417668366,0.22497300818892346,SERPINE1/APOE/SYK,3
GO:0001736,establishment of planar polarity,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,DLG3,1
GO:0002052,positive regulation of neuroblast proliferation,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,VEGFC,1
GO:0003230,cardiac atrium development,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,NKX2-5,1
GO:0007164,establishment of tissue polarity,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,DLG3,1
GO:0007431,salivary gland development,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,TNF,1
GO:0010092,specification of animal organ identity,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,FGF1,1
GO:0021696,cerebellar cortex morphogenesis,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,FAIM2,1
GO:0031076,embryonic camera-type eye development,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,SIX3,1
GO:0033280,response to vitamin D,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,SPP1,1
GO:0043243,positive regulation of protein-containing complex disassembly,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,TNF,1
GO:0043267,negative regulation of potassium ion transport,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,VIP,1
GO:0045191,regulation of isotype switching,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,PTPRC,1
GO:0045880,positive regulation of smoothened signaling pathway,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,PRRX1,1
GO:0048730,epidermis morphogenesis,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,NGFR,1
GO:0055023,positive regulation of cardiac muscle tissue growth,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,AKAP6,1
GO:0060323,head morphogenesis,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,LEF1,1
GO:0060391,positive regulation of SMAD protein signal transduction,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,GDF6,1
GO:0070670,response to interleukin-4,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,LEF1,1
GO:0071404,cellular response to low-density lipoprotein particle stimulus,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,SYK,1
GO:1901381,positive regulation of potassium ion transmembrane transport,1/137,37/18888,0.02702702702702703,3.7261787334780037,1.4187881344969397,0.23632076565043525,0.31927887417668366,0.22497300818892346,AKAP6,1
GO:0002761,regulation of myeloid leukocyte differentiation,2/137,128/18888,0.015625,2.1541970802919708,1.1199486123684166,0.23773382216355704,0.32090385901953833,0.22611801889250074,LEF1/TNF,2
GO:0048706,embryonic skeletal system development,2/137,128/18888,0.015625,2.1541970802919708,1.1199486123684166,0.23773382216355704,0.32090385901953833,0.22611801889250074,PRRX1/DSCAML1,2
GO:0007599,hemostasis,3/137,233/18888,0.012875536480686695,1.7751323580088343,1.0176202899000708,0.2393182376052341,0.32289976179097013,0.22752438895597432,SERPINE1/APOE/SYK,3
GO:0019079,viral genome replication,2/137,129/18888,0.015503875968992248,2.1374978781191647,1.10807757412415,0.24041369902931337,0.32366237734338965,0.22806174964218287,TNF/IFIT1,2
GO:0032612,interleukin-1 production,2/137,129/18888,0.015503875968992248,2.1374978781191647,1.10807757412415,0.24041369902931337,0.32366237734338965,0.22806174964218287,TNF/S100A13,2
GO:0032652,regulation of interleukin-1 production,2/137,129/18888,0.015503875968992248,2.1374978781191647,1.10807757412415,0.24041369902931337,0.32366237734338965,0.22806174964218287,TNF/S100A13,2
GO:0097237,cellular response to toxic substance,2/137,129/18888,0.015503875968992248,2.1374978781191647,1.10807757412415,0.24041369902931337,0.32366237734338965,0.22806174964218287,APOE/TNF,2
GO:1990266,neutrophil migration,2/137,129/18888,0.015503875968992248,2.1374978781191647,1.10807757412415,0.24041369902931337,0.32366237734338965,0.22806174964218287,SYK/CD177,2
GO:0003180,aortic valve morphogenesis,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,NKX2-5,1
GO:0006688,glycosphingolipid biosynthetic process,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,B4GALT6,1
GO:0032885,regulation of polysaccharide biosynthetic process,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,IGF2,1
GO:0046461,neutral lipid catabolic process,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,CPS1,1
GO:0046464,acylglycerol catabolic process,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,CPS1,1
GO:0048536,spleen development,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,NKX2-5,1
GO:0070302,regulation of stress-activated protein kinase signaling cascade,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,FOXO1,1
GO:0071392,cellular response to estradiol stimulus,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,NRIP1,1
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/137,38/18888,0.02631578947368421,3.628121398386477,1.3861527796197892,0.24187081896887452,0.3243364409020233,0.22853671406595627,CXCL12,1
GO:0055007,cardiac muscle cell differentiation,2/137,130/18888,0.015384615384615385,2.1210555867490175,1.096314389815553,0.24309507590610935,0.325834945834627,0.22959260341454887,AKAP6/NKX2-5,2
GO:0010595,positive regulation of endothelial cell migration,2/137,131/18888,0.015267175572519083,2.1048643227280324,1.0846571049581537,0.2457777913759136,0.32914164953018354,0.23192260122444816,VEGFC/FGF1,2
GO:1903052,positive regulation of proteolysis involved in protein catabolic process,2/137,131/18888,0.015267175572519083,2.1048643227280324,1.0846571049581537,0.2457777913759136,0.32914164953018354,0.23192260122444816,CBFA2T3/IL33,2
GO:0010737,protein kinase A signaling,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,AKAP6,1
GO:0017158,regulation of calcium ion-dependent exocytosis,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,SYT4,1
GO:0031111,negative regulation of microtubule polymerization or depolymerization,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,MAP2,1
GO:0032350,regulation of hormone metabolic process,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,AKR1C3,1
GO:0032373,positive regulation of sterol transport,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,APOE,1
GO:0032376,positive regulation of cholesterol transport,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,APOE,1
GO:0032438,melanosome organization,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,APOE,1
GO:0033028,myeloid cell apoptotic process,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,CDKN2A,1
GO:0038179,neurotrophin signaling pathway,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,NDN,1
GO:0045746,negative regulation of Notch signaling pathway,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,DLK1,1
GO:0050892,intestinal absorption,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,AKR1C1,1
GO:0051938,L-glutamate import,1/137,39/18888,0.02564102564102564,3.5350926445816953,1.3546014567365112,0.24738082946231021,0.32955316085507236,0.23221256385007685,TNF,1
GO:0019730,antimicrobial humoral response,2/137,132/18888,0.015151515151515152,2.088918380889184,1.073103815744589,0.24846168624991283,0.3307043464608521,0.23302372208716315,SPINK5/TF,2
GO:0030301,cholesterol transport,2/137,132/18888,0.015151515151515152,2.088918380889184,1.073103815744589,0.24846168624991283,0.3307043464608521,0.23302372208716315,APOE/AKR1C1,2
GO:0071219,cellular response to molecule of bacterial origin,3/137,238/18888,0.012605042016806723,1.73783966141201,0.9791305778521412,0.24898472463760501,0.33125605038969946,0.23341246842317584,SERPINE1/TNF/ASS1,3
GO:0009743,response to carbohydrate,3/137,239/18888,0.012552301255230125,1.7305683657575666,0.9715420353079238,0.25092543611302337,0.33340558243565327,0.23492709005864654,PTPRN/TNF/COL6A3,3
GO:0031669,cellular response to nutrient levels,3/137,239/18888,0.012552301255230125,1.7305683657575666,0.9715420353079238,0.25092543611302337,0.33340558243565327,0.23492709005864654,AKR1C3/FOXO1/MAP3K5,3
GO:0002244,hematopoietic progenitor cell differentiation,2/137,133/18888,0.015037593984962405,2.073212227649415,1.061652667350224,0.25114660354507434,0.33340558243565327,0.23492709005864654,PTPRC/CEBPD,2
GO:0014902,myotube differentiation,2/137,133/18888,0.015037593984962405,2.073212227649415,1.061652667350224,0.25114660354507434,0.33340558243565327,0.23492709005864654,BHLHE41/NKX2-5,2
GO:0043271,negative regulation of monoatomic ion transport,2/137,133/18888,0.015037593984962405,2.073212227649415,1.061652667350224,0.25114660354507434,0.33340558243565327,0.23492709005864654,VIP/MAOB,2
GO:0001916,positive regulation of T cell mediated cytotoxicity,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,PTPRC,1
GO:0040001,establishment of mitotic spindle localization,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,GJA1,1
GO:0043403,skeletal muscle tissue regeneration,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,GJA1,1
GO:0045923,positive regulation of fatty acid metabolic process,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,NR4A3,1
GO:0048753,pigment granule organization,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,APOE,1
GO:0099622,cardiac muscle cell membrane repolarization,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,GJA1,1
GO:0140448,signaling receptor ligand precursor processing,1/137,40/18888,0.025,3.4467153284671537,1.3240682105343267,0.25285108392481037,0.33464939641739866,0.23580351689340742,PCSK2,1
GO:0010927,cellular component assembly involved in morphogenesis,2/137,135/18888,0.014814814814814815,2.04249797242498,1.0390496089480314,0.2565188883565516,0.33920955254081264,0.2390167330623164,NKX2-5/TPPP,2
GO:0031109,microtubule polymerization or depolymerization,2/137,135/18888,0.014814814814814815,2.04249797242498,1.0390496089480314,0.2565188883565516,0.33920955254081264,0.2390167330623164,MAP2/TPPP,2
GO:0009268,response to pH,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,GJA1,1
GO:0009394,2'-deoxyribonucleotide metabolic process,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,NT5C1A,1
GO:0032814,regulation of natural killer cell activation,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,IL15,1
GO:0035136,forelimb morphogenesis,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,CRABP2,1
GO:0048489,synaptic vesicle transport,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,MAP2,1
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,AKAP6,1
GO:0071634,regulation of transforming growth factor beta production,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,LUM,1
GO:0099068,postsynapse assembly,1/137,41/18888,0.024390243902439025,3.3626491009435644,1.2944926688094305,0.25828186711147705,0.34036107876693783,0.23982813131022074,GAP43,1
GO:0030168,platelet activation,2/137,136/18888,0.014705882352941176,2.0274796049806785,1.0278942199023238,0.2592059527278099,0.3414314060100456,0.24058231443696051,APOE/SYK,2
GO:0006814,sodium ion transport,3/137,244/18888,0.012295081967213115,1.695105899246141,0.93412693992760365,0.26066239416909115,0.3432017372752658,0.2418297403784811,DMD/UTRN/NKX2-5,3
GO:0007368,determination of left/right symmetry,2/137,137/18888,0.014598540145985401,2.01268048377644,1.0168340106658231,0.2618934331847535,0.34361883852572417,0.24212364182522403,GJA1/NKX2-5,2
GO:0090288,negative regulation of cellular response to growth factor stimulus,2/137,137/18888,0.014598540145985401,2.01268048377644,1.0168340106658231,0.2618934331847535,0.34361883852572417,0.24212364182522403,NGFR/GREM2,2
GO:0045333,cellular respiration,3/137,245/18888,0.012244897959183673,1.6881870996573811,0.9267470805009178,0.2626160058651207,0.34361883852572417,0.24212364182522403,CBFA2T3/TNF/NR4A3,3
GO:0000578,embryonic axis specification,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,BASP1,1
GO:0001662,behavioral fear response,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,APOE,1
GO:0002691,regulation of cellular extravasation,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,CXCL12,1
GO:0003016,respiratory system process,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,NDN,1
GO:0006040,amino sugar metabolic process,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,CHST1,1
GO:0009262,deoxyribonucleotide metabolic process,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,NT5C1A,1
GO:0019692,deoxyribose phosphate metabolic process,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,NT5C1A,1
GO:0021983,pituitary gland development,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,SIX3,1
GO:0030866,cortical actin cytoskeleton organization,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,TNF,1
GO:0032733,positive regulation of interleukin-10 production,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,SYK,1
GO:0042092,type 2 immune response,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,IL33,1
GO:0048512,circadian behavior,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,PTGDS,1
GO:0050691,regulation of defense response to virus by host,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,IL15,1
GO:0051294,establishment of spindle orientation,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,GJA1,1
GO:0070328,triglyceride homeostasis,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,APOE,1
GO:0072337,modified amino acid transport,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,GJA1,1
GO:0072528,pyrimidine-containing compound biosynthetic process,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,CPS1,1
GO:0095500,acetylcholine receptor signaling pathway,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,ACHE,1
GO:1990000,amyloid fibril formation,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,APOE,1
GO:2000008,regulation of protein localization to cell surface,1/137,42/18888,0.023809523809523808,3.282586027111574,1.2658194455535368,0.26367346175283835,0.34361883852572417,0.24212364182522403,TNF,1
GO:0031589,cell-substrate adhesion,4/137,359/18888,0.011142061281337047,1.536140536364191,0.8766564549791886,0.2636812974532261,0.34361883852572417,0.24212364182522403,SERPINE1/UTRN/CDKN2A/ITGA7,4
GO:0016482,cytosolic transport,2/137,138/18888,0.014492753623188406,1.9980958425896542,1.005867348216828,0.2645811834292683,0.3446443755126448,0.24284626445896854,SYT4/MAP2,2
GO:0042157,lipoprotein metabolic process,2/137,139/18888,0.014388489208633094,1.9837210523551962,0.9949926396906226,0.26726905923291766,0.3479970856565122,0.24520867972554825,APOE/APOL1,2
GO:0034599,cellular response to oxidative stress,3/137,248/18888,0.012096774193548387,1.6677654815163645,0.9048079519500889,0.2684881134207604,0.34820517618023256,0.24535530624826346,TRPA1/FOXO1/MAP3K5,3
GO:0048738,cardiac muscle tissue development,3/137,248/18888,0.012096774193548387,1.6677654815163645,0.9048079519500889,0.2684881134207604,0.34820517618023256,0.24535530624826346,GJA1/AKAP6/NKX2-5,3
GO:0048863,stem cell differentiation,3/137,248/18888,0.012096774193548387,1.6677654815163645,0.9048079519500889,0.2684881134207604,0.34820517618023256,0.24535530624826346,PTPRC/NKX2-5/SEMA5B,3
GO:0002209,behavioral defense response,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,APOE,1
GO:0003176,aortic valve development,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,NKX2-5,1
GO:0007595,lactation,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,GJA1,1
GO:0010453,regulation of cell fate commitment,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,LMO4,1
GO:0019098,reproductive behavior,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,VIP,1
GO:0043368,positive T cell selection,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,PTPRC,1
GO:0045494,photoreceptor cell maintenance,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,PROM1,1
GO:0055090,acylglycerol homeostasis,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,APOE,1
GO:0060412,ventricular septum morphogenesis,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,NKX2-5,1
GO:0061001,regulation of dendritic spine morphogenesis,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,RELN,1
GO:2000403,positive regulation of lymphocyte migration,1/137,43/18888,0.023255813953488372,3.206246817178747,1.23799762044346,0.2690261485691312,0.34820517618023256,0.24535530624826346,CXCL12,1
GO:0007498,mesoderm development,2/137,140/18888,0.014285714285714285,1.9695516162669446,0.9842083311049881,0.2699569184149999,0.34926176981881296,0.24609981228524344,LEF1/GJA1,2
GO:0051092,positive regulation of NF-kappaB transcription factor activity,2/137,141/18888,0.014184397163120567,1.9555831650877467,0.9735129061350548,0.2726446208208023,0.35214251819431475,0.2481296698182331,TNF/CARD11,2
GO:0007622,rhythmic behavior,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,PTGDS,1
GO:0014002,astrocyte development,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,TNF,1
GO:0021879,forebrain neuron differentiation,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,ASCL1,1
GO:0030501,positive regulation of bone mineralization,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,FAM20C,1
GO:0032689,negative regulation of type II interferon production,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,IL33,1
GO:0035307,positive regulation of protein dephosphorylation,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,PTPRC,1
GO:0035329,hippo signaling,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,WWTR1,1
GO:0043268,positive regulation of potassium ion transport,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,AKAP6,1
GO:0046006,regulation of activated T cell proliferation,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,IGF2,1
GO:0046717,acid secretion,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,TNF,1
GO:0051602,response to electrical stimulus,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,TRIM63,1
GO:0060443,mammary gland morphogenesis,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,NTN1,1
GO:0071526,semaphorin-plexin signaling pathway,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,SEMA5B,1
GO:0071604,transforming growth factor beta production,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,LUM,1
GO:1903539,protein localization to postsynaptic membrane,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,LGI1,1
GO:1904037,positive regulation of epithelial cell apoptotic process,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,AKR1C3,1
GO:1905145,cellular response to acetylcholine,1/137,44/18888,0.022727272727272728,3.133377571333776,1.2109802834221148,0.27434020628449485,0.35214251819431475,0.2481296698182331,ACHE,1
GO:0051222,positive regulation of protein transport,3/137,251/18888,0.01195219123505976,1.6478320295460493,0.8831629290735711,0.274375789078008,0.35214251819431475,0.2481296698182331,ACHE/TNF/VEGFC,3
GO:0034341,response to type II interferon,2/137,142/18888,0.014084507042253521,1.9418114526575514,0.9629048849352455,0.27533202830006664,0.3530728362906737,0.2487851985037754,TNF/ASS1,2
GO:0046165,alcohol biosynthetic process,2/137,142/18888,0.014084507042253521,1.9418114526575514,0.9629048849352455,0.27533202830006664,0.3530728362906737,0.2487851985037754,APOE/FGF1,2
GO:0060972,left/right pattern formation,2/137,143/18888,0.013986013986013986,1.9282323515900157,0.9523828230061826,0.2780190046856541,0.35587479663407046,0.25075953974043114,GJA1/NKX2-5,2
GO:1903900,regulation of viral life cycle,2/137,143/18888,0.013986013986013986,1.9282323515900157,0.9523828230061826,0.2780190046856541,0.35587479663407046,0.25075953974043114,TNF/IFIT1,2
GO:0001504,neurotransmitter uptake,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,SLC18A3,1
GO:0007020,microtubule nucleation,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,TPPP,1
GO:0009066,aspartate family amino acid metabolic process,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,ASS1,1
GO:0010463,mesenchymal cell proliferation,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,PRRX1,1
GO:0018198,peptidyl-cysteine modification,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,DMD,1
GO:0019432,triglyceride biosynthetic process,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,C3,1
GO:0021587,cerebellum morphogenesis,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,FAIM2,1
GO:0030574,collagen catabolic process,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,MMP19,1
GO:0032309,icosanoid secretion,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,SYK,1
GO:0032941,secretion by tissue,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,GJA1,1
GO:0033574,response to testosterone,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,SPP1,1
GO:0048701,embryonic cranial skeleton morphogenesis,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,PRRX1,1
GO:0060428,lung epithelium development,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,ASCL1,1
GO:0062237,protein localization to postsynapse,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,LGI1,1
GO:1903214,regulation of protein targeting to mitochondrion,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,ABLIM3,1
GO:1903426,regulation of reactive oxygen species biosynthetic process,1/137,45/18888,0.022222222222222223,3.0637469586374695,1.1847241349503523,0.27961591164105537,0.35587479663407046,0.25075953974043114,GRIN1,1
GO:0030522,intracellular receptor signaling pathway,4/137,369/18888,0.01084010840108401,1.494510711530473,0.8199921169694414,0.27973366951384454,0.35587626484212315,0.2507605742817334,RORC/AKR1C3/TNF/NR4A3,4
GO:0010565,regulation of cellular ketone metabolic process,2/137,144/18888,0.013888888888888888,1.9148418491484183,0.9419453101045344,0.2807054157724105,0.3566664983086581,0.25131739533854885,AKR1C3/NR4A3,2
GO:0030534,adult behavior,2/137,144/18888,0.013888888888888888,1.9148418491484183,0.9419453101045344,0.2807054157724105,0.3566664983086581,0.25131739533854885,SHANK1/CXCL12,2
GO:1900180,regulation of protein localization to nucleus,2/137,144/18888,0.013888888888888888,1.9148418491484183,0.9419453101045344,0.2807054157724105,0.3566664983086581,0.25131739533854885,NGFR/WWTR1,2
GO:0016050,vesicle organization,4/137,371/18888,0.01078167115902965,1.4864540500127885,0.8088593719191582,0.2829637736011985,0.3593863658056004,0.253233891612348,SYT4/APOE/PTPRN/GRIK5,4
GO:0015918,sterol transport,2/137,145/18888,0.013793103448275862,1.9016360432922226,0.9315909691938914,0.28339112929622956,0.3593935520000914,0.25323895521010786,APOE/AKR1C1,2
GO:0032006,regulation of TOR signaling,2/137,145/18888,0.013793103448275862,1.9016360432922226,0.9315909691938914,0.28339112929622956,0.3593935520000914,0.25323895521010786,SYK/RELN,2
GO:0005978,glycogen biosynthetic process,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,IGF2,1
GO:0009250,glucan biosynthetic process,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,IGF2,1
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,WWTR1,1
GO:0032892,positive regulation of organic acid transport,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,SYT4,1
GO:0045601,regulation of endothelial cell differentiation,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,TNF,1
GO:0047496,vesicle transport along microtubule,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,MAP2,1
GO:0048483,autonomic nervous system development,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,ASCL1,1
GO:0050856,regulation of T cell receptor signaling pathway,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,CARD11,1
GO:0061383,trabecula morphogenesis,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,NKX2-5,1
GO:0070849,response to epidermal growth factor,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,ASCL1,1
GO:0140467,integrated stress response signaling,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,CEBPD,1
GO:1905144,response to acetylcholine,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,ACHE,1
GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,CARD11,1
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/137,46/18888,0.021739130434782608,2.997143763884481,1.159189134049414,0.28485353941291647,0.3593935520000914,0.25323895521010786,TNF,1
GO:0050852,T cell receptor signaling pathway,2/137,146/18888,0.0136986301369863,1.8886111388861113,0.9213184554348502,0.2860760149133149,0.3606377519683755,0.2541156540220015,PTPRC/CARD11,2
GO:0051592,response to calcium ion,2/137,146/18888,0.0136986301369863,1.8886111388861113,0.9213184554348502,0.2860760149133149,0.3606377519683755,0.2541156540220015,SYT4/AKR1C3,2
GO:0032886,regulation of microtubule-based process,3/137,258/18888,0.011627906976744186,1.6031234085893735,0.8337563740612584,0.2881647459280965,0.3631020763355191,0.2558520873123631,NEFH/MAP2/TPPP,3
GO:0031333,negative regulation of protein-containing complex assembly,2/137,147/18888,0.013605442176870748,1.875763444063757,0.9111264552125814,0.28875994417963446,0.3631020763355191,0.2558520873123631,LMO4/MAP2,2
GO:0050714,positive regulation of protein secretion,2/137,147/18888,0.013605442176870748,1.875763444063757,0.9111264552125814,0.28875994417963446,0.3631020763355191,0.2558520873123631,ACHE/VEGFC,2
GO:0051783,regulation of nuclear division,2/137,147/18888,0.013605442176870748,1.875763444063757,0.9111264552125814,0.28875994417963446,0.3631020763355191,0.2558520873123631,TNF/IGF2,2
GO:0001881,receptor recycling,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,ACHE,1
GO:0006775,fat-soluble vitamin metabolic process,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,TNF,1
GO:0045933,positive regulation of muscle contraction,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,CHGA,1
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,PTPRC,1
GO:0050798,activated T cell proliferation,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,IGF2,1
GO:0055010,ventricular cardiac muscle tissue morphogenesis,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,NKX2-5,1
GO:0055078,sodium ion homeostasis,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,NPR1,1
GO:0060711,labyrinthine layer development,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,LEF1,1
GO:0072538,T-helper 17 type immune response,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,RORC,1
GO:0140353,lipid export from cell,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,SPP1,1
GO:0140894,endolysosomal toll-like receptor signaling pathway,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,TNF,1
GO:1903747,regulation of establishment of protein localization to mitochondrion,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,ABLIM3,1
GO:1905314,semi-lunar valve development,1/137,47/18888,0.02127659574468085,2.9333747476316194,1.1343381875146141,0.290053362420051,0.3631020763355191,0.2558520873123631,NKX2-5,1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,2/137,148/18888,0.013513513513513514,1.8630893667390018,0.9010136852002444,0.29144279053057076,0.3646918395651094,0.2569722798618744,CXCL12/ASS1,2
GO:0006367,transcription initiation at RNA polymerase II promoter,2/137,149/18888,0.013422818791946308,1.850585411257532,0.8909788914566922,0.29412442926076265,0.3671549178918,0.258707835156566,FOXO1/NKX2-5,2
GO:0008277,regulation of G protein-coupled receptor signaling pathway,2/137,149/18888,0.013422818791946308,1.850585411257532,0.8909788914566922,0.29412442926076265,0.3671549178918,0.258707835156566,CHGA/C3,2
GO:0008584,male gonad development,2/137,149/18888,0.013422818791946308,1.850585411257532,0.8909788914566922,0.29412442926076265,0.3671549178918,0.258707835156566,GJA1/AKR1C3,2
GO:0003254,regulation of membrane depolarization,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,GJA1,1
GO:0021575,hindbrain morphogenesis,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,FAIM2,1
GO:0031295,T cell costimulation,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,CARD11,1
GO:0032620,interleukin-17 production,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,IL15,1
GO:0032660,regulation of interleukin-17 production,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,IL15,1
GO:0042596,fear response,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,APOE,1
GO:0043277,apoptotic cell clearance,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,C3,1
GO:0043407,negative regulation of MAP kinase activity,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,APOE,1
GO:0060043,regulation of cardiac muscle cell proliferation,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,NKX2-5,1
GO:0090279,regulation of calcium ion import,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,CXCL12,1
GO:0120163,negative regulation of cold-induced thermogenesis,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,IL15,1
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/137,48/18888,0.020833333333333332,2.872262773722628,1.1101368747176852,0.29521565154209606,0.3671549178918,0.258707835156566,NGFR,1
GO:0016331,morphogenesis of embryonic epithelium,2/137,150/18888,0.013333333333333334,1.8382481751824817,0.8810208485569906,0.2968047375041345,0.3688306428593724,0.2598885988003372,LMO4/VEGFC,2
GO:0046546,development of primary male sexual characteristics,2/137,150/18888,0.013333333333333334,1.8382481751824817,0.8810208485569906,0.2968047375041345,0.3688306428593724,0.2598885988003372,GJA1/AKR1C3,2
GO:0001818,negative regulation of cytokine production,4/137,381/18888,0.010498687664041995,1.447439508017702,0.7541510863394237,0.2991970874323769,0.3711092074227595,0.26149414043067454,LEF1/IL33/TNF/PTPRC,4
GO:0034614,cellular response to reactive oxygen species,2/137,151/18888,0.013245033112582781,1.8260743462077633,0.87113835875434,0.2994835942141171,0.3711092074227595,0.26149414043067454,TRPA1/MAP3K5,2
GO:0006911,"phagocytosis, engulfment",1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,C3,1
GO:0008542,visual learning,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,GRIN1,1
GO:0031294,lymphocyte costimulation,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,CARD11,1
GO:0042181,ketone biosynthetic process,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,AKR1C3,1
GO:0044788,modulation by host of viral process,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,APOE,1
GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,TNF,1
GO:0048538,thymus development,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,LMO4,1
GO:0051489,regulation of filopodium assembly,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,GAP43,1
GO:0061028,establishment of endothelial barrier,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,TNF,1
GO:0070266,necroptotic process,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,TNF,1
GO:0098926,postsynaptic signal transduction,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,ACHE,1
GO:2001259,positive regulation of cation channel activity,1/137,49/18888,0.02040816326530612,2.8136451660956348,1.086553203271668,0.3003406757320498,0.3711092074227595,0.26149414043067454,AKAP6,1
GO:0001914,regulation of T cell mediated cytotoxicity,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,PTPRC,1
GO:0014911,positive regulation of smooth muscle cell migration,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,NR4A3,1
GO:0032924,activin receptor signaling pathway,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,GDF6,1
GO:0035094,response to nicotine,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,TNF,1
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,TNF,1
GO:0043330,response to exogenous dsRNA,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,IFIT1,1
GO:0045747,positive regulation of Notch signaling pathway,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,ASCL1,1
GO:0071827,plasma lipoprotein particle organization,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,APOE,1
GO:2000404,regulation of T cell migration,1/137,50/18888,0.02,2.7573722627737225,1.063557391542631,0.3054287020298744,0.37602597765033346,0.26495863707650935,CXCL12,1
GO:0097530,granulocyte migration,2/137,154/18888,0.012987012987012988,1.7905014693335861,0.8419326288650709,0.3075102715604551,0.37843602774294716,0.26665682716384115,SYK/CD177,2
GO:0032868,response to insulin,3/137,269/18888,0.011152416356877323,1.537568176267875,0.7590337232640451,0.30993559879798793,0.38009825370956735,0.26782807902622824,VGF/FOXO1/IGF2,3
GO:0048762,mesenchymal cell differentiation,3/137,269/18888,0.011152416356877323,1.537568176267875,0.7590337232640451,0.30993559879798793,0.38009825370956735,0.26782807902622824,LEF1/SEMA5B/WWTR1,3
GO:0006110,regulation of glycolytic process,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,CBFA2T3,1
GO:0008089,anterograde axonal transport,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,MAP2,1
GO:0008206,bile acid metabolic process,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,AKR1C1,1
GO:0019083,viral transcription,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,LEF1,1
GO:0030811,regulation of nucleotide catabolic process,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,CBFA2T3,1
GO:0030865,cortical cytoskeleton organization,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,TNF,1
GO:0033121,regulation of purine nucleotide catabolic process,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,CBFA2T3,1
GO:0034198,cellular response to amino acid starvation,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,MAP3K5,1
GO:0042461,photoreceptor cell development,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,DIO3,1
GO:0050885,neuromuscular process controlling balance,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,SHANK1,1
GO:0089718,amino acid import across plasma membrane,1/137,51/18888,0.0196078431372549,2.703306139974238,1.0411216745841805,0.3104799955759998,0.38009825370956735,0.26782807902622824,TNF,1
GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,4/137,388/18888,0.010309278350515464,1.4213259086462486,0.716766536775545,0.31062962774631625,0.3801289590544335,0.26784971488866927,LEF1/GDF6/CDKN1C/GREM2,4
GO:0007043,cell-cell junction assembly,2/137,156/18888,0.01282051282051282,1.7675463222908476,0.8228191230962284,0.31285199304537226,0.38238857940507653,0.2694419078859665,GJA1/TNF,2
GO:0043433,negative regulation of DNA-binding transcription factor activity,2/137,156/18888,0.01282051282051282,1.7675463222908476,0.8228191230962284,0.31285199304537226,0.38238857940507653,0.2694419078859665,TNFRSF4/CDKN2A,2
GO:0046718,symbiont entry into host cell,2/137,156/18888,0.01282051282051282,1.7675463222908476,0.8228191230962284,0.31285199304537226,0.38238857940507653,0.2694419078859665,TNFRSF4/CXCR4,2
GO:0006111,regulation of gluconeogenesis,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,FOXO1,1
GO:0006968,cellular defense response,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,IL33,1
GO:0010332,response to gamma radiation,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,PTPRC,1
GO:0021695,cerebellar cortex development,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,FAIM2,1
GO:0042572,retinol metabolic process,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,AKR1C3,1
GO:0051155,positive regulation of striated muscle cell differentiation,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,AKAP6,1
GO:0060324,face development,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,LEF1,1
GO:0101023,vascular endothelial cell proliferation,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,IGF2,1
GO:1904263,positive regulation of TORC1 signaling,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,SYK,1
GO:1904752,regulation of vascular associated smooth muscle cell migration,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,NR4A3,1
GO:1905562,regulation of vascular endothelial cell proliferation,1/137,52/18888,0.019230769230769232,2.651319483436272,1.0192201305654671,0.315494819624738,0.38392750777300655,0.27052628074093,IGF2,1
GO:1902903,regulation of supramolecular fiber organization,4/137,392/18888,0.01020408163265306,1.4068225830478174,0.6957268029527888,0.31718293152869015,0.38582794221823924,0.2718653810967313,APOE/SHANK1/MAP2/CXCL12,4
GO:0002066,columnar/cuboidal epithelial cell development,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,GJA1,1
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,PTPRC,1
GO:0002208,somatic diversification of immunoglobulins involved in immune response,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,PTPRC,1
GO:0009584,detection of visible light,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,SEMA5B,1
GO:0032330,regulation of chondrocyte differentiation,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,GDF6,1
GO:0038084,vascular endothelial growth factor signaling pathway,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,VEGFC,1
GO:0045190,isotype switching,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,PTPRC,1
GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,DLG3,1
GO:0045778,positive regulation of ossification,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,FAM20C,1
GO:0060688,regulation of morphogenesis of a branching structure,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,TNF,1
GO:0071825,protein-lipid complex organization,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,APOE,1
GO:1904894,positive regulation of receptor signaling pathway via STAT,1/137,53/18888,0.018867924528301886,2.6012945875223794,0.99782852517855,0.32047343555760144,0.38797498029424815,0.27337824540979133,TNF,1
GO:0048284,organelle fusion,2/137,159/18888,0.012578616352201259,1.7341963916815866,0.7946631417396339,0.3208482521921463,0.3882747286639296,0.27358945666703743,SYT4/GRIK5,2
GO:0070507,regulation of microtubule cytoskeleton organization,2/137,160/18888,0.0125,1.7233576642335768,0.7854109198728043,0.32350888867069794,0.39133932945817285,0.27574886186212566,MAP2/TPPP,2
GO:0010656,negative regulation of muscle cell apoptotic process,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,NKX2-5,1
GO:0010874,regulation of cholesterol efflux,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,APOE,1
GO:0032092,positive regulation of protein binding,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,APOE,1
GO:0035306,positive regulation of dephosphorylation,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,PTPRC,1
GO:0035315,hair cell differentiation,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,SPINK5,1
GO:0046638,positive regulation of alpha-beta T cell differentiation,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,SYK,1
GO:0050805,negative regulation of synaptic transmission,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,ACHE,1
GO:0050873,brown fat cell differentiation,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,LAMB3,1
GO:0070169,positive regulation of biomineral tissue development,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,FAM20C,1
GO:0071385,cellular response to glucocorticoid stimulus,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,ASS1,1
GO:0120009,intermembrane lipid transfer,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,APOE,1
GO:1904738,vascular associated smooth muscle cell migration,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,NR4A3,1
GO:1990928,response to amino acid starvation,1/137,54/18888,0.018518518518518517,2.553122465531225,0.97692417186068925,0.3254161028965238,0.3916285276183717,0.2759526391406268,MAP3K5,1
GO:0140014,mitotic nuclear division,3/137,277/18888,0.010830324909747292,1.4931618751482252,0.706763449976484,0.32580954903613457,0.3919474748357441,0.2761773784539646,TNF/IGF2/CDKN1C,3
GO:0006606,protein import into nucleus,2/137,161/18888,0.012422360248447204,1.7126535793625604,0.7762236315219595,0.32616695900271775,0.39222283643668027,0.27637140609786087,SYK/IL33,2
GO:0043524,negative regulation of neuron apoptotic process,2/137,162/18888,0.012345679012345678,1.7020816436874828,0.7671003358526255,0.3288223609029419,0.3952602778557616,0.2785116740219773,FAIM2/DRAXIN,2
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,3/137,279/18888,0.010752688172043012,1.4824582057923241,0.6939526490225509,0.3297795136133663,0.3956629843208469,0.27879543249206395,DSCAML1/UNC5D/CD177,3
GO:0001895,retina homeostasis,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,PROM1,1
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,NGFR,1
GO:0042743,hydrogen peroxide metabolic process,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,MAOB,1
GO:0046460,neutral lipid biosynthetic process,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,C3,1
GO:0046463,acylglycerol biosynthetic process,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,C3,1
GO:0060425,lung morphogenesis,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,TNF,1
GO:0097479,synaptic vesicle localization,1/137,55/18888,0.01818181818181818,2.50670205706702,0.9564858059626418,0.3303230793169962,0.3956629843208469,0.27879543249206395,MAP2,1
GO:0046486,glycerolipid metabolic process,4/137,400/18888,0.01,1.3786861313868612,0.654325712146631,0.3303241428733676,0.3956629843208469,0.27879543249206395,APOE/CHAT/C3/CPS1,4
GO:0044409,symbiont entry into host,2/137,163/18888,0.012269938650306749,1.6916394250145539,0.7580401116737938,0.33147499368235234,0.3968857123258295,0.2796570015457231,TNFRSF4/CXCR4,2
GO:0001954,positive regulation of cell-matrix adhesion,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,UTRN,1
GO:0007528,neuromuscular junction development,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,SLC18A3,1
GO:0009116,nucleoside metabolic process,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,NT5C1A,1
GO:0045912,negative regulation of carbohydrate metabolic process,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,CBFA2T3,1
GO:0050832,defense response to fungus,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,CHGA,1
GO:0170038,proteinogenic amino acid biosynthetic process,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,ASS1,1
GO:1901016,regulation of potassium ion transmembrane transporter activity,1/137,56/18888,0.017857142857142856,2.4619395203336807,0.9364934712446267,0.3351946206611035,0.40024021215089506,0.2820206778727594,AKAP6,1
GO:0035051,cardiocyte differentiation,2/137,165/18888,0.012121212121212121,1.671134704711347,0.7401052880736855,0.3367715569991956,0.40180875369880564,0.283125917019611,AKAP6/NKX2-5,2
GO:0051494,negative regulation of cytoskeleton organization,2/137,165/18888,0.012121212121212121,1.671134704711347,0.7401052880736855,0.3367715569991956,0.40180875369880564,0.283125917019611,SHANK1/MAP2,2
GO:0006633,fatty acid biosynthetic process,2/137,166/18888,0.012048192771084338,1.6610676281769414,0.731228939797521,0.33941529398336423,0.40364626754603156,0.2844206817260614,PTGDS/AKR1C3,2
GO:0051170,import into nucleus,2/137,166/18888,0.012048192771084338,1.6610676281769414,0.731228939797521,0.33941529398336423,0.40364626754603156,0.2844206817260614,SYK/IL33,2
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,2/137,166/18888,0.012048192771084338,1.6610676281769414,0.731228939797521,0.33941529398336423,0.40364626754603156,0.2844206817260614,CBFA2T3/IL33,2
GO:0001541,ovarian follicle development,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,VGF,1
GO:0001755,neural crest cell migration,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,SEMA5B,1
GO:0002707,negative regulation of lymphocyte mediated immunity,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,PTPRC,1
GO:0007632,visual behavior,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,GRIN1,1
GO:0035088,establishment or maintenance of apical/basal cell polarity,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,DLG3,1
GO:0051293,establishment of spindle localization,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,GJA1,1
GO:0061245,establishment or maintenance of bipolar cell polarity,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,DLG3,1
GO:0170034,L-amino acid biosynthetic process,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,ASS1,1
GO:0170040,proteinogenic amino acid catabolic process,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,GAD1,1
GO:2000107,negative regulation of leukocyte apoptotic process,1/137,57/18888,0.017543859649122806,2.418747598924318,0.9169284172947688,0.3400309809504741,0.40364626754603156,0.2844206817260614,CXCL12,1
GO:0003205,cardiac chamber development,2/137,168/18888,0.011904761904761904,1.641293013555787,0.7136541310623348,0.34469320620065713,0.40760206144158373,0.28720804701840225,LMO4/NKX2-5,2
GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,PTPRC,1
GO:0006826,iron ion transport,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,TF,1
GO:0031638,zymogen activation,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,SERPINE1,1
GO:0042733,embryonic digit morphogenesis,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,GJA1,1
GO:0043331,response to dsRNA,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,IFIT1,1
GO:0071868,cellular response to monoamine stimulus,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,NR4A3,1
GO:0071870,cellular response to catecholamine stimulus,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,NR4A3,1
GO:0072132,mesenchyme morphogenesis,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,LEF1,1
GO:0086065,cell communication involved in cardiac conduction,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,GJA1,1
GO:0099024,plasma membrane invagination,1/137,58/18888,0.017241379310344827,2.377045054115278,0.8977730066466789,0.344832412399138,0.40760206144158373,0.28720804701840225,C3,1
GO:0007204,positive regulation of cytosolic calcium ion concentration,2/137,169/18888,0.011834319526627219,1.6315812205761673,0.7049540261215465,0.34732719699437287,0.4103920268009392,0.28917393624691967,GRIN1/CXCR4,2
GO:0061448,connective tissue development,3/137,288/18888,0.010416666666666666,1.436131386861314,0.6375095149226647,0.3476352317202682,0.4105970306541249,0.28931838781347075,PRRX1/GDF6/RORC,3
GO:0003229,ventricular cardiac muscle tissue development,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,NKX2-5,1
GO:0009948,anterior/posterior axis specification,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,BASP1,1
GO:0031122,cytoplasmic microtubule organization,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,TPPP,1
GO:0060135,maternal process involved in female pregnancy,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,SPP1,1
GO:0060612,adipose tissue development,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,RORC,1
GO:0090497,mesenchymal cell migration,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,SEMA5B,1
GO:0098900,regulation of action potential,1/137,59/18888,0.01694915254237288,2.3367561548929854,0.8790106305284346,0.3495991654262923,0.41180110107334783,0.29016681019964463,TNF,1
GO:0007009,plasma membrane organization,2/137,170/18888,0.011764705882352941,1.6219836839845427,0.696311051889551,0.34995775709178456,0.41190554363444914,0.29024040340938795,CXCR4/PTPRC,2
GO:0007519,skeletal muscle tissue development,2/137,170/18888,0.011764705882352941,1.6219836839845427,0.696311051889551,0.34995775709178456,0.41190554363444914,0.29024040340938795,DMD/IGF2,2
GO:0001913,T cell mediated cytotoxicity,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,PTPRC,1
GO:0001961,positive regulation of cytokine-mediated signaling pathway,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,CXCR4,1
GO:0006473,protein acetylation,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,FOXO1,1
GO:0046324,regulation of glucose import,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,TNF,1
GO:0051289,protein homotetramerization,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,TRPA1,1
GO:0060038,cardiac muscle cell proliferation,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,NKX2-5,1
GO:0071168,protein localization to chromatin,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,LEF1,1
GO:0071867,response to monoamine,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,NR4A3,1
GO:0071869,response to catecholamine,1/137,60/18888,0.016666666666666666,2.2978102189781024,0.8606256323087842,0.35433148866898156,0.4156109544264918,0.2928513416201016,NR4A3,1
GO:0046661,male sex differentiation,2/137,173/18888,0.011560693641618497,1.593856799291169,0.6707171726517359,0.3578279750701755,0.41918838090733757,0.29537209843198275,GJA1/AKR1C3,2
GO:0001738,morphogenesis of a polarized epithelium,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,DLG3,1
GO:0003179,heart valve morphogenesis,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,NKX2-5,1
GO:0010574,regulation of vascular endothelial growth factor production,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,C3,1
GO:0016447,somatic recombination of immunoglobulin gene segments,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,PTPRC,1
GO:0031113,regulation of microtubule polymerization,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,MAP2,1
GO:0042908,xenobiotic transport,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,GJA1,1
GO:0043470,regulation of carbohydrate catabolic process,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,CBFA2T3,1
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,VEGFC,1
GO:0055008,cardiac muscle tissue morphogenesis,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,NKX2-5,1
GO:0086002,cardiac muscle cell action potential involved in contraction,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,GJA1,1
GO:0170035,L-amino acid catabolic process,1/137,61/18888,0.01639344262295082,2.2601411989948548,0.8426032378212638,0.3590296289946856,0.41918838090733757,0.29537209843198275,GAD1,1
GO:0006520,amino acid metabolic process,3/137,295/18888,0.010169491525423728,1.402053692935791,0.5949081049193368,0.36149589653098413,0.4219064918594889,0.29728735699418357,GAD1/ASS1/CPS1,3
GO:0002090,regulation of receptor internalization,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,SYK,1
GO:0032731,positive regulation of interleukin-1 beta production,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,TNF,1
GO:0051653,spindle localization,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,GJA1,1
GO:0060261,positive regulation of transcription initiation by RNA polymerase II,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,NKX2-5,1
GO:0071715,icosanoid transport,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,SYK,1
GO:0072348,sulfur compound transport,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,GJA1,1
GO:1903078,positive regulation of protein localization to plasma membrane,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,TNF,1
GO:1903670,regulation of sprouting angiogenesis,1/137,62/18888,0.016129032258064516,2.223687308688486,0.8249294918460819,0.36369383151381895,0.42317711543277753,0.29818267463239445,FGF1,1
GO:0055088,lipid homeostasis,2/137,176/18888,0.011363636363636364,1.566688785666888,0.6456102319906115,0.3656642153712344,0.4253076163540424,0.29968388639418797,APOE/AKR1C1,2
GO:0010634,positive regulation of epithelial cell migration,2/137,177/18888,0.011299435028248588,1.5578374365953234,0.6373461212509912,0.36826836142770725,0.42742429065978443,0.30117535552801944,VEGFC/FGF1,2
GO:0015695,organic cation transport,1/137,63/18888,0.015873015873015872,2.1883906847410497,0.8075912001153469,0.36832433959214717,0.42742429065978443,0.30117535552801944,SLC18A3,1
GO:0033059,cellular pigmentation,1/137,63/18888,0.015873015873015872,2.1883906847410497,0.8075912001153469,0.36832433959214717,0.42742429065978443,0.30117535552801944,APOE,1
GO:0050688,regulation of defense response to virus,1/137,63/18888,0.015873015873015872,2.1883906847410497,0.8075912001153469,0.36832433959214717,0.42742429065978443,0.30117535552801944,IL15,1
GO:0050909,sensory perception of taste,1/137,63/18888,0.015873015873015872,2.1883906847410497,0.8075912001153469,0.36832433959214717,0.42742429065978443,0.30117535552801944,LEF1,1
GO:2000117,negative regulation of cysteine-type endopeptidase activity,1/137,63/18888,0.015873015873015872,2.1883906847410497,0.8075912001153469,0.36832433959214717,0.42742429065978443,0.30117535552801944,TNF,1
GO:0001885,endothelial cell development,1/137,64/18888,0.015625,2.1541970802919708,0.7905758762815609,0.37292139486311005,0.4319377977693403,0.30435570147022223,TNF,1
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,1/137,64/18888,0.015625,2.1541970802919708,0.7905758762815609,0.37292139486311005,0.4319377977693403,0.30435570147022223,MAP3K5,1
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1/137,64/18888,0.015625,2.1541970802919708,0.7905758762815609,0.37292139486311005,0.4319377977693403,0.30435570147022223,SYK,1
GO:0022617,extracellular matrix disassembly,1/137,64/18888,0.015625,2.1541970802919708,0.7905758762815609,0.37292139486311005,0.4319377977693403,0.30435570147022223,MMP19,1
GO:0048524,positive regulation of viral process,1/137,64/18888,0.015625,2.1541970802919708,0.7905758762815609,0.37292139486311005,0.4319377977693403,0.30435570147022223,IFIT1,1
GO:0010324,membrane invagination,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,C3,1
GO:0032613,interleukin-10 production,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,SYK,1
GO:0032653,regulation of interleukin-10 production,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,SYK,1
GO:0033363,secretory granule organization,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,PTPRN,1
GO:0035904,aorta development,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,NGFR,1
GO:0043462,regulation of ATP-dependent activity,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,IFIT1,1
GO:0046503,glycerolipid catabolic process,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,CPS1,1
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,MAP3K5,1
GO:0098930,axonal transport,1/137,65/18888,0.015384615384615385,2.1210555867490175,0.7738716933539239,0.37748523724006233,0.4357356066780144,0.30703174603131117,MAP2,1
GO:0051056,regulation of small GTPase mediated signal transduction,3/137,304/18888,0.009868421052631578,1.360545524394929,0.5416975346939141,0.37925340760415216,0.4376111153148856,0.30835328295106273,APOE/RIT2/RELN,3
GO:0035725,sodium ion transmembrane transport,2/137,182/18888,0.01098901098901099,1.515039704820727,0.5967816986267724,0.38122607205856385,0.43864302191179944,0.3090803937938215,DMD/UTRN,2
GO:0009314,response to radiation,4/137,431/18888,0.009280742459396751,1.2795230917743492,0.5017707338254042,0.38141186060541943,0.43864302191179944,0.3090803937938215,GRIN1/PTPRC/COL6A3/SEMA5B,4
GO:0000271,polysaccharide biosynthetic process,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,IGF2,1
GO:0001756,somitogenesis,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,LEF1,1
GO:0016445,somatic diversification of immunoglobulins,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,PTPRC,1
GO:0030199,collagen fibril organization,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,LUM,1
GO:0032507,maintenance of protein location in cell,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,RIT2,1
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,PTPRN,1
GO:0042446,hormone biosynthetic process,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,DIO3,1
GO:0048255,mRNA stabilization,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,VIP,1
GO:0050994,regulation of lipid catabolic process,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,TNF,1
GO:0070613,regulation of protein processing,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,SERPINE1,1
GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,1/137,66/18888,0.015151515151515152,2.088918380889184,0.7574674391632616,0.3820161049284282,0.43864302191179944,0.3090803937938215,TNF,1
GO:0007219,Notch signaling pathway,2/137,183/18888,0.01092896174863388,1.506760799329903,0.5888155326245786,0.3838044866467043,0.44019965924304455,0.31017724488981857,ASCL1/DLK1,2
GO:0007565,female pregnancy,2/137,183/18888,0.01092896174863388,1.506760799329903,0.5888155326245786,0.3838044866467043,0.44019965924304455,0.31017724488981857,GJA1/SPP1,2
GO:0061025,membrane fusion,2/137,183/18888,0.01092896174863388,1.506760799329903,0.5888155326245786,0.3838044866467043,0.44019965924304455,0.31017724488981857,SYT4/GRIK5,2
GO:0034605,cellular response to heat,1/137,67/18888,0.014925373134328358,2.0577404946072555,0.741352475465551,0.38651423443776867,0.44247616035411474,0.31178133255275453,FGF1,1
GO:0060760,positive regulation of response to cytokine stimulus,1/137,67/18888,0.014925373134328358,2.0577404946072555,0.741352475465551,0.38651423443776867,0.44247616035411474,0.31178133255275453,CXCR4,1
GO:0061180,mammary gland epithelium development,1/137,67/18888,0.014925373134328358,2.0577404946072555,0.741352475465551,0.38651423443776867,0.44247616035411474,0.31178133255275453,NTN1,1
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,1/137,67/18888,0.014925373134328358,2.0577404946072555,0.741352475465551,0.38651423443776867,0.44247616035411474,0.31178133255275453,TNF,1
GO:1905953,negative regulation of lipid localization,1/137,67/18888,0.014925373134328358,2.0577404946072555,0.741352475465551,0.38651423443776867,0.44247616035411474,0.31178133255275453,TNF,1
GO:0016311,dephosphorylation,3/137,309/18888,0.009708737864077669,1.338530224647438,0.5128555723064712,0.3890769513744077,0.44524291548357414,0.3137308671907781,PPP4R4/TNF/PTPRC,3
GO:0002704,negative regulation of leukocyte mediated immunity,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,PTPRC,1
GO:0006687,glycosphingolipid metabolic process,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,B4GALT6,1
GO:0032715,negative regulation of interleukin-6 production,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,TNF,1
GO:0035019,somatic stem cell population maintenance,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,LDB2,1
GO:0046513,ceramide biosynthetic process,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,B4GALT6,1
GO:0046847,filopodium assembly,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,GAP43,1
GO:0071300,cellular response to retinoic acid,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,TNF,1
GO:2000144,positive regulation of DNA-templated transcription initiation,1/137,68/18888,0.014705882352941176,2.0274796049806785,0.7255167003369942,0.3909798605937662,0.44608244281576614,0.3143224221123716,NKX2-5,1
GO:0062197,cellular response to chemical stress,3/137,311/18888,0.00964630225080386,1.3299223132349145,0.5014569437633064,0.39299643141527485,0.44821566094148685,0.31582554849398414,TRPA1/FOXO1/MAP3K5,3
GO:0001837,epithelial to mesenchymal transition,2/137,187/18888,0.0106951871657754,1.4745306218041296,0.5574195392566853,0.39407201021776184,0.4492744770954834,0.3165716205787655,LEF1/WWTR1,2
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,1/137,69/18888,0.014492753623188406,1.9980958425896542,0.7099505135512976,0.39541321655012407,0.44979542933692834,0.3169386983980632,PTPRC,1
GO:0002711,positive regulation of T cell mediated immunity,1/137,69/18888,0.014492753623188406,1.9980958425896542,0.7099505135512976,0.39541321655012407,0.44979542933692834,0.3169386983980632,PTPRC,1
GO:0009583,detection of light stimulus,1/137,69/18888,0.014492753623188406,1.9980958425896542,0.7099505135512976,0.39541321655012407,0.44979542933692834,0.3169386983980632,SEMA5B,1
GO:0038034,signal transduction in absence of ligand,1/137,69/18888,0.014492753623188406,1.9980958425896542,0.7099505135512976,0.39541321655012407,0.44979542933692834,0.3169386983980632,TNF,1
GO:0045911,positive regulation of DNA recombination,1/137,69/18888,0.014492753623188406,1.9980958425896542,0.7099505135512976,0.39541321655012407,0.44979542933692834,0.3169386983980632,PTPRC,1
GO:0048645,animal organ formation,1/137,69/18888,0.014492753623188406,1.9980958425896542,0.7099505135512976,0.39541321655012407,0.44979542933692834,0.3169386983980632,FGF1,1
GO:0006352,DNA-templated transcription initiation,2/137,189/18888,0.010582010582010581,1.4589271231606997,0.5419946428134993,0.39917714514766467,0.4537872655852622,0.31975146016096123,FOXO1/NKX2-5,2
GO:0046626,regulation of insulin receptor signaling pathway,1/137,70/18888,0.014285714285714285,1.9695516162669446,0.6946447846629302,0.39981453380038345,0.4537872655852622,0.31975146016096123,IGF2,1
GO:0050922,negative regulation of chemotaxis,1/137,70/18888,0.014285714285714285,1.9695516162669446,0.6946447846629302,0.39981453380038345,0.4537872655852622,0.31975146016096123,SEMA5B,1
GO:1903317,regulation of protein maturation,1/137,70/18888,0.014285714285714285,1.9695516162669446,0.6946447846629302,0.39981453380038345,0.4537872655852622,0.31975146016096123,SERPINE1,1
GO:2000401,regulation of lymphocyte migration,1/137,70/18888,0.014285714285714285,1.9695516162669446,0.6946447846629302,0.39981453380038345,0.4537872655852622,0.31975146016096123,CXCL12,1
GO:2000573,positive regulation of DNA biosynthetic process,1/137,70/18888,0.014285714285714285,1.9695516162669446,0.6946447846629302,0.39981453380038345,0.4537872655852622,0.31975146016096123,TNF,1
GO:0003208,cardiac ventricle morphogenesis,1/137,71/18888,0.014084507042253521,1.9418114526575514,0.679590823549281,0.40418404218965676,0.4581541629775194,0.32282850071155134,NKX2-5,1
GO:0045670,regulation of osteoclast differentiation,1/137,71/18888,0.014084507042253521,1.9418114526575514,0.679590823549281,0.40418404218965676,0.4581541629775194,0.32282850071155134,TNF,1
GO:0070830,bicellular tight junction assembly,1/137,71/18888,0.014084507042253521,1.9418114526575514,0.679590823549281,0.40418404218965676,0.4581541629775194,0.32282850071155134,TNF,1
GO:0006575,cellular modified amino acid metabolic process,2/137,191/18888,0.010471204188481676,1.44365039935797,0.526745887051408,0.40426250357092386,0.4581541629775194,0.32282850071155134,ASS1/DIO3,2
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3/137,317/18888,0.00946372239747634,1.3047502820695849,0.4677196965036321,0.4047165802093924,0.45849851625800503,0.32307114186214536,GDF6/CDKN1C/GREM2,3
GO:0002067,glandular epithelial cell differentiation,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,ASCL1,1
GO:0030032,lamellipodium assembly,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,ABLIM3,1
GO:0030514,negative regulation of BMP signaling pathway,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,GREM2,1
GO:0060411,cardiac septum morphogenesis,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,NKX2-5,1
GO:0061035,regulation of cartilage development,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,GDF6,1
GO:1900076,regulation of cellular response to insulin stimulus,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,IGF2,1
GO:1903578,regulation of ATP metabolic process,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,CBFA2T3,1
GO:1904888,cranial skeletal system development,1/137,72/18888,0.013888888888888888,1.9148418491484183,0.6647803531903526,0.4085219699262791,0.4613674261748739,0.3250926576792672,PRRX1,1
GO:0097193,intrinsic apoptotic signaling pathway,3/137,319/18888,0.009404388714733543,1.2965700295174245,0.45662312367526686,0.4086094865500276,0.4613674261748739,0.3250926576792672,CXCL12/MAP3K5/TNF,3
GO:0009416,response to light stimulus,3/137,321/18888,0.009345794392523364,1.2884917115765058,0.44559934586855593,0.4124949790898945,0.4650988243067493,0.3277219073114054,GRIN1/COL6A3/SEMA5B,3
GO:0003170,heart valve development,1/137,73/18888,0.0136986301369863,1.8886111388861113,0.6502054844873382,0.41282854359337606,0.4650988243067493,0.3277219073114054,NKX2-5,1
GO:0006879,intracellular iron ion homeostasis,1/137,73/18888,0.0136986301369863,1.8886111388861113,0.6502054844873382,0.41282854359337606,0.4650988243067493,0.3277219073114054,TF,1
GO:0032481,positive regulation of type I interferon production,1/137,73/18888,0.0136986301369863,1.8886111388861113,0.6502054844873382,0.41282854359337606,0.4650988243067493,0.3277219073114054,SYK,1
GO:0045109,intermediate filament organization,1/137,73/18888,0.0136986301369863,1.8886111388861113,0.6502054844873382,0.41282854359337606,0.4650988243067493,0.3277219073114054,NEFH,1
GO:0071260,cellular response to mechanical stimulus,1/137,73/18888,0.0136986301369863,1.8886111388861113,0.6502054844873382,0.41282854359337606,0.4650988243067493,0.3277219073114054,IL33,1
GO:0051260,protein homooligomerization,2/137,195/18888,0.010256410256410256,1.4140370578326782,0.4967599484340898,0.414371926968504,0.46666535834238904,0.3288257319078088,TRPA1/CARD11,2
GO:0051650,establishment of vesicle localization,2/137,196/18888,0.01020408163265306,1.4068225830478174,0.48936708960297565,0.416886170185491,0.46784320906483035,0.32965567914721955,SYT4/MAP2,2
GO:0009880,embryonic pattern specification,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,BASP1,1
GO:0033344,cholesterol efflux,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,APOE,1
GO:0046637,regulation of alpha-beta T cell differentiation,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,SYK,1
GO:0060415,muscle tissue morphogenesis,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,NKX2-5,1
GO:0070373,negative regulation of ERK1 and ERK2 cascade,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,PTPRC,1
GO:0070527,platelet aggregation,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,SYK,1
GO:0072678,T cell migration,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,CXCL12,1
GO:1902017,regulation of cilium assembly,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,ADAMTS16,1
GO:1902475,L-alpha-amino acid transmembrane transport,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,TNF,1
GO:1904377,positive regulation of protein localization to cell periphery,1/137,74/18888,0.013513513513513514,1.8630893667390018,0.6358586929415442,0.417103988160355,0.46784320906483035,0.32965567914721955,TNF,1
GO:0043489,RNA stabilization,1/137,75/18888,0.013333333333333334,1.8382481751824817,0.6217327970329415,0.42134852699431025,0.47225696084709323,0.3327657346384119,VIP,1
GO:0060390,regulation of SMAD protein signal transduction,1/137,75/18888,0.013333333333333334,1.8382481751824817,0.6217327970329415,0.42134852699431025,0.47225696084709323,0.3327657346384119,GDF6,1
GO:0009060,aerobic respiration,2/137,199/18888,0.010050251256281407,1.3856142023988556,0.46742946355062187,0.42439653226919616,0.47549861104463537,0.33504989389673384,CBFA2T3/TNF,2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1/137,76/18888,0.013157894736842105,1.8140606991932384,0.6078209381534719,0.42556238187135154,0.4761057146156029,0.33547767640190274,VEGFC,1
GO:0046470,phosphatidylcholine metabolic process,1/137,76/18888,0.013157894736842105,1.8140606991932384,0.6078209381534719,0.42556238187135154,0.4761057146156029,0.33547767640190274,CHAT,1
GO:0051057,positive regulation of small GTPase mediated signal transduction,1/137,76/18888,0.013157894736842105,1.8140606991932384,0.6078209381534719,0.42556238187135154,0.4761057146156029,0.33547767640190274,RELN,1
GO:1902373,negative regulation of mRNA catabolic process,1/137,76/18888,0.013157894736842105,1.8140606991932384,0.6078209381534719,0.42556238187135154,0.4761057146156029,0.33547767640190274,VIP,1
GO:0007585,respiratory gaseous exchange by respiratory system,1/137,77/18888,0.012987012987012988,1.7905014693335861,0.5941165619643163,0.42974577298785277,0.479730833635306,0.33803203873799065,NDN,1
GO:0030239,myofibril assembly,1/137,77/18888,0.012987012987012988,1.7905014693335861,0.5941165619643163,0.42974577298785277,0.479730833635306,0.33803203873799065,NKX2-5,1
GO:0031016,pancreas development,1/137,77/18888,0.012987012987012988,1.7905014693335861,0.5941165619643163,0.42974577298785277,0.479730833635306,0.33803203873799065,IGF2,1
GO:0032729,positive regulation of type II interferon production,1/137,77/18888,0.012987012987012988,1.7905014693335861,0.5941165619643163,0.42974577298785277,0.479730833635306,0.33803203873799065,TNF,1
GO:0043536,positive regulation of blood vessel endothelial cell migration,1/137,77/18888,0.012987012987012988,1.7905014693335861,0.5941165619643163,0.42974577298785277,0.479730833635306,0.33803203873799065,VEGFC,1
GO:0120192,tight junction assembly,1/137,77/18888,0.012987012987012988,1.7905014693335861,0.5941165619643163,0.42974577298785277,0.479730833635306,0.33803203873799065,TNF,1
GO:0045787,positive regulation of cell cycle,3/137,332/18888,0.009036144578313253,1.245800721132706,0.38622427751971444,0.4337196822155521,0.4834828407087946,0.3406758100186477,ASCL1/TNF/IGF2,3
GO:0009247,glycolipid biosynthetic process,1/137,78/18888,0.01282051282051282,1.7675463222908476,0.5806134010588956,0.43389891897162136,0.4834828407087946,0.3406758100186477,B4GALT6,1
GO:0046323,glucose import,1/137,78/18888,0.01282051282051282,1.7675463222908476,0.5806134010588956,0.43389891897162136,0.4834828407087946,0.3406758100186477,TNF,1
GO:0051101,regulation of DNA binding,1/137,78/18888,0.01282051282051282,1.7675463222908476,0.5806134010588956,0.43389891897162136,0.4834828407087946,0.3406758100186477,LEF1,1
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",1/137,78/18888,0.01282051282051282,1.7675463222908476,0.5806134010588956,0.43389891897162136,0.4834828407087946,0.3406758100186477,CARD11,1
GO:0009749,response to glucose,2/137,203/18888,0.009852216748768473,1.3583114594944448,0.43872433328226673,0.434332849732574,0.48361322779416854,0.3407676844807499,PTPRN/COL6A3,2
GO:0022408,negative regulation of cell-cell adhesion,2/137,203/18888,0.009852216748768473,1.3583114594944448,0.43872433328226673,0.434332849732574,0.48361322779416854,0.3407676844807499,CXCL12/ASS1,2
GO:0032271,regulation of protein polymerization,2/137,204/18888,0.00980392156862745,1.351653069987119,0.43164242568271444,0.43680275298970717,0.4858316334273274,0.34233083641168166,MAP2/TPPP,2
GO:0044703,multi-organism reproductive process,2/137,204/18888,0.00980392156862745,1.351653069987119,0.43164242568271444,0.43680275298970717,0.4858316334273274,0.34233083641168166,GJA1/SPP1,2
GO:0120032,regulation of plasma membrane bounded cell projection assembly,2/137,204/18888,0.00980392156862745,1.351653069987119,0.43164242568271444,0.43680275298970717,0.4858316334273274,0.34233083641168166,ADAMTS16/GAP43,2
GO:0071214,cellular response to abiotic stimulus,3/137,334/18888,0.008982035928143712,1.238340836575025,0.37564920450074274,0.4375499983958918,0.48630165754725185,0.34266202882287217,GJA1/ASCL1/IL33,3
GO:0104004,cellular response to environmental stimulus,3/137,334/18888,0.008982035928143712,1.238340836575025,0.37564920450074274,0.4375499983958918,0.48630165754725185,0.34266202882287217,GJA1/ASCL1/IL33,3
GO:0043297,apical junction assembly,1/137,79/18888,0.012658227848101266,1.7451723182112169,0.5673054588245695,0.4380220368929867,0.48630165754725185,0.34266202882287217,TNF,1
GO:0055002,striated muscle cell development,1/137,79/18888,0.012658227848101266,1.7451723182112169,0.5673054588245695,0.4380220368929867,0.48630165754725185,0.34266202882287217,NKX2-5,1
GO:1903533,regulation of protein targeting,1/137,79/18888,0.012658227848101266,1.7451723182112169,0.5673054588245695,0.4380220368929867,0.48630165754725185,0.34266202882287217,ABLIM3,1
GO:0032869,cellular response to insulin stimulus,2/137,206/18888,0.009708737864077669,1.338530224647438,0.41758888698979496,0.44172521187100233,0.48959942838381504,0.3449857322853467,FOXO1/IGF2,2
GO:0060491,regulation of cell projection assembly,2/137,206/18888,0.009708737864077669,1.338530224647438,0.41758888698979496,0.44172521187100233,0.48959942838381504,0.3449857322853467,ADAMTS16/GAP43,2
GO:0002534,cytokine production involved in inflammatory response,1/137,80/18888,0.0125,1.7233576642335768,0.5541869944060204,0.4421153422758173,0.48959942838381504,0.3449857322853467,TNF,1
GO:0014032,neural crest cell development,1/137,80/18888,0.0125,1.7233576642335768,0.5541869944060204,0.4421153422758173,0.48959942838381504,0.3449857322853467,SEMA5B,1
GO:0021536,diencephalon development,1/137,80/18888,0.0125,1.7233576642335768,0.5541869944060204,0.4421153422758173,0.48959942838381504,0.3449857322853467,SIX3,1
GO:0032272,negative regulation of protein polymerization,1/137,80/18888,0.0125,1.7233576642335768,0.5541869944060204,0.4421153422758173,0.48959942838381504,0.3449857322853467,MAP2,1
GO:1900015,regulation of cytokine production involved in inflammatory response,1/137,80/18888,0.0125,1.7233576642335768,0.5541869944060204,0.4421153422758173,0.48959942838381504,0.3449857322853467,TNF,1
GO:0003151,outflow tract morphogenesis,1/137,81/18888,0.012345679012345678,1.7020816436874828,0.5412525086822647,0.4461790491084531,0.4930262338446773,0.3474003572272456,NKX2-5,1
GO:0006970,response to osmotic stress,1/137,81/18888,0.012345679012345678,1.7020816436874828,0.5412525086822647,0.4461790491084531,0.4930262338446773,0.3474003572272456,TNF,1
GO:0008344,adult locomotory behavior,1/137,81/18888,0.012345679012345678,1.7020816436874828,0.5412525086822647,0.4461790491084531,0.4930262338446773,0.3474003572272456,CXCL12,1
GO:0032088,negative regulation of NF-kappaB transcription factor activity,1/137,81/18888,0.012345679012345678,1.7020816436874828,0.5412525086822647,0.4461790491084531,0.4930262338446773,0.3474003572272456,CDKN2A,1
GO:0043242,negative regulation of protein-containing complex disassembly,1/137,81/18888,0.012345679012345678,1.7020816436874828,0.5412525086822647,0.4461790491084531,0.4930262338446773,0.3474003572272456,TNF,1
GO:0048644,muscle organ morphogenesis,1/137,81/18888,0.012345679012345678,1.7020816436874828,0.5412525086822647,0.4461790491084531,0.4930262338446773,0.3474003572272456,NKX2-5,1
GO:0051216,cartilage development,2/137,209/18888,0.009569377990430622,1.319316872140537,0.39677815654411985,0.4490648470685775,0.4960354372976108,0.34952072787439425,PRRX1/GDF6,2
GO:0032147,activation of protein kinase activity,1/137,82/18888,0.012195121951219513,1.6813245504717822,0.5284967311772838,0.45021336985456584,0.4969443778647866,0.3501611933426774,FGF1,1
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,1/137,82/18888,0.012195121951219513,1.6813245504717822,0.5284967311772838,0.45021336985456584,0.4969443778647866,0.3501611933426774,SPINK5,1
GO:0001570,vasculogenesis,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,NKX2-5,1
GO:0032371,regulation of sterol transport,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,APOE,1
GO:0032374,regulation of cholesterol transport,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,APOE,1
GO:0070509,calcium ion import,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,CXCL12,1
GO:0086003,cardiac muscle cell contraction,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,GJA1,1
GO:0120193,tight junction organization,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,TNF,1
GO:0140115,export across plasma membrane,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,GJA1,1
GO:2000736,regulation of stem cell differentiation,1/137,83/18888,0.012048192771084338,1.6610676281769414,0.515914607831467,0.45421851546394176,0.49991882769417606,0.35225707559467534,NKX2-5,1
GO:0044706,multi-multicellular organism process,2/137,212/18888,0.009433962264150943,1.3006472937611897,0.37628148873437145,0.45635057516363475,0.5020843386443451,0.3537829564221553,GJA1/SPP1,2
GO:0032956,regulation of actin cytoskeleton organization,3/137,344/18888,0.00872093023255814,1.2023425564420303,0.3237384637226657,0.4565539684108656,0.5021271032756619,0.35381308960204777,SHANK1/CXCL12/ODAM,3
GO:0006446,regulation of translational initiation,1/137,84/18888,0.011904761904761904,1.641293013555787,0.5035012895675494,0.4581946953831886,0.5030252555070114,0.3544459533009672,TNF,1
GO:0014855,striated muscle cell proliferation,1/137,84/18888,0.011904761904761904,1.641293013555787,0.5035012895675494,0.4581946953831886,0.5030252555070114,0.3544459533009672,NKX2-5,1
GO:0071357,cellular response to type I interferon,1/137,84/18888,0.011904761904761904,1.641293013555787,0.5035012895675494,0.4581946953831886,0.5030252555070114,0.3544459533009672,IFIT1,1
GO:0072527,pyrimidine-containing compound metabolic process,1/137,84/18888,0.011904761904761904,1.641293013555787,0.5035012895675494,0.4581946953831886,0.5030252555070114,0.3544459533009672,CPS1,1
GO:1902117,positive regulation of organelle assembly,1/137,84/18888,0.011904761904761904,1.641293013555787,0.5035012895675494,0.4581946953831886,0.5030252555070114,0.3544459533009672,TNF,1
GO:0008589,regulation of smoothened signaling pathway,1/137,85/18888,0.011764705882352941,1.6219836839845427,0.491252121590567,0.46214211756636825,0.5068119808884498,0.3571141880923994,PRRX1,1
GO:0051149,positive regulation of muscle cell differentiation,1/137,85/18888,0.011764705882352941,1.6219836839845427,0.491252121590567,0.46214211756636825,0.5068119808884498,0.3571141880923994,AKAP6,1
GO:0061053,somite development,1/137,85/18888,0.011764705882352941,1.6219836839845427,0.491252121590567,0.46214211756636825,0.5068119808884498,0.3571141880923994,LEF1,1
GO:0050866,negative regulation of cell activation,2/137,215/18888,0.009302325581395349,1.282498726871499,0.3560887336031385,0.46358129068837883,0.5078428209551085,0.3578405474274976,APOE/PTPRC,2
GO:0051648,vesicle localization,2/137,215/18888,0.009302325581395349,1.282498726871499,0.3560887336031385,0.46358129068837883,0.5078428209551085,0.3578405474274976,SYT4/MAP2,2
GO:1901888,regulation of cell junction assembly,2/137,215/18888,0.009302325581395349,1.282498726871499,0.3560887336031385,0.46358129068837883,0.5078428209551085,0.3578405474274976,NTN1/TNF,2
GO:0022412,cellular process involved in reproduction in multicellular organism,4/137,482/18888,0.008298755186721992,1.1441378683708394,0.2740005674078492,0.46427844198096613,0.5084240419540397,0.3582500923336218,PTGDS/IGF2/CDKN1C/NDN,4
GO:0006643,membrane lipid metabolic process,2/137,217/18888,0.009216589861751152,1.2706784621077063,0.3427909397205955,0.468370691953121,0.5127214317937322,0.3612781558786627,TNF/B4GALT6,2
GO:0002312,B cell activation involved in immune response,1/137,87/18888,0.011494252873563218,1.5846967027435188,0.4672285292298885,0.4699515131413051,0.5137149061988765,0.3619781863020986,PTPRC,1
GO:0009791,post-embryonic development,1/137,87/18888,0.011494252873563218,1.5846967027435188,0.4672285292298885,0.4699515131413051,0.5137149061988765,0.3619781863020986,NDN,1
GO:0010232,vascular transport,1/137,87/18888,0.011494252873563218,1.5846967027435188,0.4672285292298885,0.4699515131413051,0.5137149061988765,0.3619781863020986,APOE,1
GO:0150104,transport across blood-brain barrier,1/137,87/18888,0.011494252873563218,1.5846967027435188,0.4672285292298885,0.4699515131413051,0.5137149061988765,0.3619781863020986,APOE,1
GO:0045637,regulation of myeloid cell differentiation,2/137,218/18888,0.009174311926605505,1.2648496618228087,0.33619021382636916,0.4707559602348308,0.5144100217102412,0.36246798453266976,LEF1/TNF,2
GO:0009895,negative regulation of catabolic process,3/137,353/18888,0.0084985835694051,1.1716879303571062,0.2783302307916034,0.47342919530906435,0.5168263072777326,0.3641705683135848,CBFA2T3/TNF/VIP,3
GO:0045185,maintenance of protein location,1/137,88/18888,0.011363636363636364,1.566688785666888,0.45544567957196663,0.47381389507309823,0.5168263072777326,0.3641705683135848,RIT2,1
GO:0061515,myeloid cell development,1/137,88/18888,0.011363636363636364,1.566688785666888,0.45544567957196663,0.47381389507309823,0.5168263072777326,0.3641705683135848,FAM20C,1
GO:1901264,carbohydrate derivative transport,1/137,88/18888,0.011363636363636364,1.566688785666888,0.45544567957196663,0.47381389507309823,0.5168263072777326,0.3641705683135848,VLDLR,1
GO:1902369,negative regulation of RNA catabolic process,1/137,88/18888,0.011363636363636364,1.566688785666888,0.45544567957196663,0.47381389507309823,0.5168263072777326,0.3641705683135848,VIP,1
GO:0001843,neural tube closure,1/137,89/18888,0.011235955056179775,1.5490855408841138,0.4438101125708005,0.47764833636964,0.5204508113531385,0.36672449734236817,LMO4,1
GO:0006094,gluconeogenesis,1/137,89/18888,0.011235955056179775,1.5490855408841138,0.4438101125708005,0.47764833636964,0.5204508113531385,0.36672449734236817,FOXO1,1
GO:2000243,positive regulation of reproductive process,1/137,89/18888,0.011235955056179775,1.5490855408841138,0.4438101125708005,0.47764833636964,0.5204508113531385,0.36672449734236817,VIP,1
GO:0006096,glycolytic process,1/137,90/18888,0.011111111111111112,1.5318734793187347,0.43231800642085416,0.48145503767914355,0.5238505436708543,0.36912004577483454,CBFA2T3,1
GO:0034340,response to type I interferon,1/137,90/18888,0.011111111111111112,1.5318734793187347,0.43231800642085416,0.48145503767914355,0.5238505436708543,0.36912004577483454,IFIT1,1
GO:0060606,tube closure,1/137,90/18888,0.011111111111111112,1.5318734793187347,0.43231800642085416,0.48145503767914355,0.5238505436708543,0.36912004577483454,LMO4,1
GO:1901606,alpha-amino acid catabolic process,1/137,90/18888,0.011111111111111112,1.5318734793187347,0.43231800642085416,0.48145503767914355,0.5238505436708543,0.36912004577483454,GAD1,1
GO:0031330,negative regulation of cellular catabolic process,2/137,224/18888,0.008928571428571428,1.2309697601668403,0.29723936613002505,0.48493337279657245,0.5272106703332036,0.37148768693203243,CBFA2T3/VIP,2
GO:0032273,positive regulation of protein polymerization,1/137,91/18888,0.01098901098901099,1.515039704820727,0.42096568202865786,0.48523419821951796,0.5272106703332036,0.37148768693203243,TPPP,1
GO:0097581,lamellipodium organization,1/137,91/18888,0.01098901098901099,1.515039704820727,0.42096568202865786,0.48523419821951796,0.5272106703332036,0.37148768693203243,ABLIM3,1
GO:1900542,regulation of purine nucleotide metabolic process,1/137,91/18888,0.01098901098901099,1.515039704820727,0.42096568202865786,0.48523419821951796,0.5272106703332036,0.37148768693203243,CBFA2T3,1
GO:0006486,protein glycosylation,2/137,225/18888,0.008888888888888889,1.225498783454988,0.2908534978736105,0.487273609927782,0.5288616847438089,0.3726510388120306,IL15/B4GALT6,2
GO:0043413,macromolecule glycosylation,2/137,225/18888,0.008888888888888889,1.225498783454988,0.2908534978736105,0.487273609927782,0.5288616847438089,0.3726510388120306,IL15/B4GALT6,2
GO:0072330,monocarboxylic acid biosynthetic process,2/137,225/18888,0.008888888888888889,1.225498783454988,0.2908534978736105,0.487273609927782,0.5288616847438089,0.3726510388120306,PTGDS/AKR1C3,2
GO:0006140,regulation of nucleotide metabolic process,1/137,92/18888,0.010869565217391304,1.4985718819422404,0.40974959614110834,0.488986015788488,0.5301546430502541,0.37356209414074265,CBFA2T3,1
GO:0045995,regulation of embryonic development,1/137,92/18888,0.010869565217391304,1.4985718819422404,0.40974959614110834,0.488986015788488,0.5301546430502541,0.37356209414074265,PHLDA2,1
GO:0046032,ADP catabolic process,1/137,92/18888,0.010869565217391304,1.4985718819422404,0.40974959614110834,0.488986015788488,0.5301546430502541,0.37356209414074265,CBFA2T3,1
GO:0007163,establishment or maintenance of cell polarity,2/137,226/18888,0.008849557522123894,1.220076222466249,0.28449707574836064,0.4896072907191743,0.5306397199129688,0.3739038931441661,GJA1/DLG3,2
GO:0014033,neural crest cell differentiation,1/137,93/18888,0.010752688172043012,1.4824582057923241,0.39866633487643693,0.49271068677364305,0.5330567231595741,0.37560698262227005,SEMA5B,1
GO:0015807,L-amino acid transport,1/137,93/18888,0.010752688172043012,1.4824582057923241,0.39866633487643693,0.49271068677364305,0.5330567231595741,0.37560698262227005,TNF,1
GO:0033138,positive regulation of peptidyl-serine phosphorylation,1/137,93/18888,0.010752688172043012,1.4824582057923241,0.39866633487643693,0.49271068677364305,0.5330567231595741,0.37560698262227005,TNF,1
GO:0051899,membrane depolarization,1/137,93/18888,0.010752688172043012,1.4824582057923241,0.39866633487643693,0.49271068677364305,0.5330567231595741,0.37560698262227005,GJA1,1
GO:1903432,regulation of TORC1 signaling,1/137,93/18888,0.010752688172043012,1.4824582057923241,0.39866633487643693,0.49271068677364305,0.5330567231595741,0.37560698262227005,SYK,1
GO:0019364,pyridine nucleotide catabolic process,1/137,94/18888,0.010638297872340425,1.4666873738158097,0.3877126076301538,0.49640840616241744,0.5366599554656615,0.3781459229552136,CBFA2T3,1
GO:0045104,intermediate filament cytoskeleton organization,1/137,94/18888,0.010638297872340425,1.4666873738158097,0.3877126076301538,0.49640840616241744,0.5366599554656615,0.3781459229552136,NEFH,1
GO:0048705,skeletal system morphogenesis,2/137,229/18888,0.008733624454148471,1.2040926911675645,0.2656015272580203,0.4965687137074142,0.5366599554656615,0.3781459229552136,PRRX1/DSCAML1,2
GO:0044242,cellular lipid catabolic process,2/137,230/18888,0.008695652173913044,1.1988575055537924,0.2593599524240068,0.498875891505663,0.5389625560620472,0.3797684010604823,AKR1C3/CPS1,2
GO:0009137,purine nucleoside diphosphate catabolic process,1/137,95/18888,0.010526315789473684,1.4512485593545907,0.3768852413304627,0.5000793675519964,0.5394988440327654,0.3801462848723665,CBFA2T3,1
GO:0009181,purine ribonucleoside diphosphate catabolic process,1/137,95/18888,0.010526315789473684,1.4512485593545907,0.3768852413304627,0.5000793675519964,0.5394988440327654,0.3801462848723665,CBFA2T3,1
GO:0014020,primary neural tube formation,1/137,95/18888,0.010526315789473684,1.4512485593545907,0.3768852413304627,0.5000793675519964,0.5394988440327654,0.3801462848723665,LMO4,1
GO:0045103,intermediate filament-based process,1/137,95/18888,0.010526315789473684,1.4512485593545907,0.3768852413304627,0.5000793675519964,0.5394988440327654,0.3801462848723665,NEFH,1
GO:0001910,regulation of leukocyte mediated cytotoxicity,1/137,96/18888,0.010416666666666666,1.436131386861314,0.36618117501961955,0.5037237631591573,0.5428548464554196,0.3825110199725537,PTPRC,1
GO:0001960,negative regulation of cytokine-mediated signaling pathway,1/137,96/18888,0.010416666666666666,1.436131386861314,0.36618117501961955,0.5037237631591573,0.5428548464554196,0.3825110199725537,PTPRC,1
GO:0031110,regulation of microtubule polymerization or depolymerization,1/137,96/18888,0.010416666666666666,1.436131386861314,0.36618117501961955,0.5037237631591573,0.5428548464554196,0.3825110199725537,MAP2,1
GO:0007281,germ cell development,3/137,371/18888,0.008086253369272238,1.1148405375095916,0.190952968812624,0.5064498060028219,0.5456000027958391,0.38444533548730747,IGF2/CDKN1C/NDN,3
GO:0021675,nerve development,1/137,97/18888,0.010309278350515464,1.4213259086462486,0.35559745473952864,0.5073417838300385,0.5461753524688809,0.3848507432896198,NGFR,1
GO:0072526,pyridine-containing compound catabolic process,1/137,97/18888,0.010309278350515464,1.4213259086462486,0.35559745473952864,0.5073417838300385,0.5461753524688809,0.3848507432896198,CBFA2T3,1
GO:0009191,ribonucleoside diphosphate catabolic process,1/137,98/18888,0.01020408163265306,1.4068225830478174,0.3451312287015171,0.5109336190498395,0.5492671381965868,0.38702930376478817,CBFA2T3,1
GO:0034109,homotypic cell-cell adhesion,1/137,98/18888,0.01020408163265306,1.4068225830478174,0.3451312287015171,0.5109336190498395,0.5492671381965868,0.38702930376478817,SYK,1
GO:0046031,ADP metabolic process,1/137,98/18888,0.01020408163265306,1.4068225830478174,0.3451312287015171,0.5109336190498395,0.5492671381965868,0.38702930376478817,CBFA2T3,1
GO:0070664,negative regulation of leukocyte proliferation,1/137,98/18888,0.01020408163265306,1.4068225830478174,0.3451312287015171,0.5109336190498395,0.5492671381965868,0.38702930376478817,IL33,1
GO:0002709,regulation of T cell mediated immunity,1/137,99/18888,0.010101010101010102,1.3926122539261228,0.3347797427217472,0.5144994569524566,0.5525166582051012,0.38931900831655575,PTPRC,1
GO:0019217,regulation of fatty acid metabolic process,1/137,99/18888,0.010101010101010102,1.3926122539261228,0.3347797427217472,0.5144994569524566,0.5525166582051012,0.38931900831655575,NR4A3,1
GO:0098869,cellular oxidant detoxification,1/137,99/18888,0.010101010101010102,1.3926122539261228,0.3347797427217472,0.5144994569524566,0.5525166582051012,0.38931900831655575,APOE,1
GO:0000041,transition metal ion transport,1/137,100/18888,0.01,1.3786861313868612,0.32454033590510833,0.5180394843300451,0.555536369000456,0.39144678273709443,TF,1
GO:0002220,innate immune response activating cell surface receptor signaling pathway,1/137,100/18888,0.01,1.3786861313868612,0.32454033590510833,0.5180394843300451,0.555536369000456,0.39144678273709443,SYK,1
GO:0006493,protein O-linked glycosylation,1/137,100/18888,0.01,1.3786861313868612,0.32454033590510833,0.5180394843300451,0.555536369000456,0.39144678273709443,IL15,1
GO:1903312,negative regulation of mRNA metabolic process,1/137,100/18888,0.01,1.3786861313868612,0.32454033590510833,0.5180394843300451,0.555536369000456,0.39144678273709443,VIP,1
GO:0043543,protein acylation,1/137,101/18888,0.009900990099009901,1.3650357736503576,0.31441043656170187,0.5215538866425203,0.558912381331802,0.39382561739010535,FOXO1,1
GO:0060761,negative regulation of response to cytokine stimulus,1/137,101/18888,0.009900990099009901,1.3650357736503576,0.31441043656170187,0.5215538866425203,0.558912381331802,0.39382561739010535,PTPRC,1
GO:0070085,glycosylation,2/137,241/18888,0.008298755186721992,1.1441378683708394,0.19249155805854218,0.523808084843479,0.5611310196357662,0.39538893326752783,IL15/B4GALT6,2
GO:0001841,neural tube formation,1/137,102/18888,0.00980392156862745,1.351653069987119,0.3043875583411946,0.525042848026987,0.561665184780359,0.39576532127553066,LMO4,1
GO:0009134,nucleoside diphosphate catabolic process,1/137,102/18888,0.00980392156862745,1.351653069987119,0.3043875583411946,0.525042848026987,0.561665184780359,0.39576532127553066,CBFA2T3,1
GO:0019080,viral gene expression,1/137,102/18888,0.00980392156862745,1.351653069987119,0.3043875583411946,0.525042848026987,0.561665184780359,0.39576532127553066,LEF1,1
GO:0042158,lipoprotein biosynthetic process,1/137,102/18888,0.00980392156862745,1.351653069987119,0.3043875583411946,0.525042848026987,0.561665184780359,0.39576532127553066,APOE,1
GO:0015914,phospholipid transport,1/137,103/18888,0.009708737864077669,1.338530224647438,0.2944692965713801,0.5285065513071052,0.5651723877327558,0.39823659658481764,APOE,1
GO:0032970,regulation of actin filament-based process,3/137,385/18888,0.007792207792207792,1.0743008816001516,0.12590205360006632,0.5313889279896663,0.5678547335653358,0.4001266540228948,SHANK1/CXCL12/ODAM,3
GO:0060271,cilium assembly,3/137,385/18888,0.007792207792207792,1.0743008816001516,0.12590205360006632,0.5313889279896663,0.5678547335653358,0.4001266540228948,ADAMTS16/WWTR1/ABLIM3,3
GO:0003333,amino acid transmembrane transport,1/137,104/18888,0.009615384615384616,1.325659741718136,0.28465332478827615,0.5319451780023903,0.5678547335653358,0.4001266540228948,TNF,1
GO:0009408,response to heat,1/137,104/18888,0.009615384615384616,1.325659741718136,0.28465332478827615,0.5319451780023903,0.5678547335653358,0.4001266540228948,FGF1,1
GO:0022600,digestive system process,1/137,104/18888,0.009615384615384616,1.325659741718136,0.28465332478827615,0.5319451780023903,0.5678547335653358,0.4001266540228948,AKR1C1,1
GO:0016485,protein processing,2/137,245/18888,0.00816326530612245,1.1254580664382543,0.1689480910857338,0.5326679103322405,0.5684274343825167,0.400530195365759,SERPINE1/PCSK2,2
GO:0009913,epidermal cell differentiation,2/137,246/18888,0.008130081300813009,1.120883033647855,0.16312337898504556,0.5348654215714075,0.5705011830467466,0.4019914178673185,SPINK5/AKR1C3,2
GO:0021549,cerebellum development,1/137,105/18888,0.009523809523809525,1.31303441084463,0.2749373914459808,0.535358908337445,0.5705011830467466,0.4019914178673185,FAIM2,1
GO:1901222,regulation of non-canonical NF-kappaB signal transduction,1/137,105/18888,0.009523809523809525,1.31303441084463,0.2749373914459808,0.535358908337445,0.5705011830467466,0.4019914178673185,TNF,1
GO:1905477,positive regulation of protein localization to membrane,1/137,105/18888,0.009523809523809525,1.31303441084463,0.2749373914459808,0.535358908337445,0.5705011830467466,0.4019914178673185,TNF,1
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,3/137,389/18888,0.007712082262210797,1.0632540859024637,0.10775038121224643,0.5383862864217677,0.5731121142065017,0.40383115448847445,CBFA2T3/IL33/WWTR1,3
GO:0006626,protein targeting to mitochondrion,1/137,106/18888,0.009433962264150943,1.3006472937611897,0.26531931679534193,0.5387479212511315,0.5731121142065017,0.40383115448847445,ABLIM3,1
GO:0019395,fatty acid oxidation,1/137,106/18888,0.009433962264150943,1.3006472937611897,0.26531931679534193,0.5387479212511315,0.5731121142065017,0.40383115448847445,NR4A3,1
GO:0030148,sphingolipid biosynthetic process,1/137,106/18888,0.009433962264150943,1.3006472937611897,0.26531931679534193,0.5387479212511315,0.5731121142065017,0.40383115448847445,B4GALT6,1
GO:0097306,cellular response to alcohol,1/137,106/18888,0.009433962264150943,1.3006472937611897,0.26531931679534193,0.5387479212511315,0.5731121142065017,0.40383115448847445,AKR1C3,1
GO:0045930,negative regulation of mitotic cell cycle,2/137,248/18888,0.008064516129032258,1.111843654344243,0.15154576064044148,0.5392394016771576,0.5734350710518066,0.40405871910010377,TNF/CDKN1C,2
GO:0007631,feeding behavior,1/137,107/18888,0.009345794392523364,1.2884917115765058,0.25579698992125743,0.5421123944056728,0.5756879010877222,0.4056461274478224,NR4A3,1
GO:0030593,neutrophil chemotaxis,1/137,107/18888,0.009345794392523364,1.2884917115765058,0.25579698992125743,0.5421123944056728,0.5756879010877222,0.4056461274478224,SYK,1
GO:0032231,regulation of actin filament bundle assembly,1/137,107/18888,0.009345794392523364,1.2884917115765058,0.25579698992125743,0.5421123944056728,0.5756879010877222,0.4056461274478224,SHANK1,1
GO:0032963,collagen metabolic process,1/137,107/18888,0.009345794392523364,1.2884917115765058,0.25579698992125743,0.5421123944056728,0.5756879010877222,0.4056461274478224,MMP19,1
GO:1903076,regulation of protein localization to plasma membrane,1/137,108/18888,0.009259259259259259,1.2765612327656124,0.24636836592912972,0.5454525041956957,0.579033406193135,0.4080034658386476,TNF,1
GO:1902476,chloride transmembrane transport,1/137,109/18888,0.009174311926605505,1.2648496618228087,0.2370314632716443,0.5487684257572076,0.5823509163459658,0.41034107818680005,APOL1,1
GO:0032611,interleukin-1 beta production,1/137,110/18888,0.00909090909090909,1.25335102853351,0.2277843612076428,0.5520603329765089,0.5853734142528303,0.41247081648566325,TNF,1
GO:0032651,regulation of interleukin-1 beta production,1/137,110/18888,0.00909090909090909,1.25335102853351,0.2277843612076428,0.5520603329765089,0.5853734142528303,0.41247081648566325,TNF,1
GO:0045017,glycerolipid biosynthetic process,2/137,254/18888,0.007874015748031496,1.0855796310132766,0.11737180385914374,0.5521920247817491,0.5853734142528303,0.41247081648566325,CHAT/C3,2
GO:0006672,ceramide metabolic process,1/137,111/18888,0.009009009009009009,1.242059577826001,0.21862519738541256,0.5553283984990469,0.5882895773061754,0.41452562821153216,B4GALT6,1
GO:0009063,amino acid catabolic process,1/137,111/18888,0.009009009009009009,1.242059577826001,0.21862519738541256,0.5553283984990469,0.5882895773061754,0.41452562821153216,GAD1,1
GO:0006664,glycolipid metabolic process,1/137,113/18888,0.008849557522123894,1.220076222466249,0.20056351332046163,0.5617936888840203,0.5945195348384292,0.41891543411564836,B4GALT6,1
GO:0034440,lipid oxidation,1/137,113/18888,0.008849557522123894,1.220076222466249,0.20056351332046163,0.5617936888840203,0.5945195348384292,0.41891543411564836,NR4A3,1
GO:0070252,actin-mediated cell contraction,1/137,113/18888,0.008849557522123894,1.220076222466249,0.20056351332046163,0.5617936888840203,0.5945195348384292,0.41891543411564836,GJA1,1
GO:0043473,pigmentation,1/137,114/18888,0.008771929824561403,1.209373799462159,0.19165754017297643,0.5649912529118707,0.5972820588455245,0.42086198738408176,APOE,1
GO:1903509,liposaccharide metabolic process,1/137,114/18888,0.008771929824561403,1.209373799462159,0.19165754017297643,0.5649912529118707,0.5972820588455245,0.42086198738408176,B4GALT6,1
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1/137,114/18888,0.008771929824561403,1.209373799462159,0.19165754017297643,0.5649912529118707,0.5972820588455245,0.42086198738408176,CXCL12,1
GO:0045786,negative regulation of cell cycle,3/137,405/18888,0.007407407407407408,1.02124898621249,0.036949541305905005,0.5657765523428054,0.5979051377251531,0.4213010265477298,TNF/CDKN1C/CDKN2A,3
GO:0051099,positive regulation of binding,1/137,115/18888,0.008695652173913044,1.1988575055537924,0.18283259538700872,0.5681656535910585,0.5998068401106574,0.42264102033043843,APOE,1
GO:0051963,regulation of synapse assembly,1/137,115/18888,0.008695652173913044,1.1988575055537924,0.18283259538700872,0.5681656535910585,0.5998068401106574,0.42264102033043843,NTN1,1
GO:2000278,regulation of DNA biosynthetic process,1/137,115/18888,0.008695652173913044,1.1988575055537924,0.18283259538700872,0.5681656535910585,0.5998068401106574,0.42264102033043843,TNF,1
GO:0090068,positive regulation of cell cycle process,2/137,263/18888,0.0076045627376425855,1.0484305181649136,0.0676049360033918,0.5711404942948102,0.6027167851606476,0.4246914506736577,TNF/IGF2,2
GO:0002062,chondrocyte differentiation,1/137,116/18888,0.008620689655172414,1.188522527057639,0.17408707618601205,0.5713170574933661,0.6027167851606476,0.4246914506736577,GDF6,1
GO:0001824,blastocyst development,1/137,117/18888,0.008547008547008548,1.1783642148605653,0.1654194259253728,0.5744456300015385,0.6058079000569093,0.4268695384618423,PPP4R4,1
GO:0044782,cilium organization,3/137,412/18888,0.007281553398058253,1.0038976684855785,0.006837212621917112,0.5774482728365817,0.6086627368058151,0.42888113792311516,ADAMTS16/WWTR1/ABLIM3,3
GO:0006090,pyruvate metabolic process,1/137,118/18888,0.00847457627118644,1.1683780774464927,0.15682813237018678,0.5775515353177065,0.6086627368058151,0.42888113792311516,CBFA2T3,1
GO:0032386,regulation of intracellular transport,2/137,267/18888,0.00749063670411985,1.0327236939227427,0.04603053359431221,0.5793755778401354,0.610374271166066,0.43008713388710523,NEFH/MAP2,2
GO:0002832,negative regulation of response to biotic stimulus,1/137,119/18888,0.008403361344537815,1.1585597742746734,0.14831172605159865,0.5806349364717542,0.6112790017632955,0.4307246328903956,SPINK5,1
GO:1990748,cellular detoxification,1/137,119/18888,0.008403361344537815,1.1585597742746734,0.14831172605159865,0.5806349364717542,0.6112790017632955,0.4307246328903956,APOE,1
GO:0003007,heart morphogenesis,2/137,269/18888,0.007434944237918215,1.02504545084525,0.03536359227564053,0.5834499134151303,0.6140307364630958,0.4326635837049405,GJA1/NKX2-5,2
GO:0072655,establishment of protein localization to mitochondrion,1/137,120/18888,0.008333333333333333,1.1489051094890512,0.13986877869748637,0.5836959953296245,0.6140779654415767,0.43269686259127443,ABLIM3,1
GO:0030510,regulation of BMP signaling pathway,1/137,121/18888,0.008264462809917356,1.139410025939555,0.13149790173353115,0.5867348726015682,0.6170623126050951,0.43479971878740753,GREM2,1
GO:0110053,regulation of actin filament organization,2/137,273/18888,0.007326007326007326,1.0100264698804844,0.014263542930634851,0.5915120213413484,0.6218720940867363,0.43818882810898885,SHANK1/CXCL12,2
GO:0001838,embryonic epithelial tube formation,1/137,123/18888,0.008130081300813009,1.120883033647855,0.11496699463742936,0.5927467194993004,0.6229555743498156,0.4389522792290382,LMO4,1
GO:0006413,translational initiation,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,TNF,1
GO:0006821,chloride transport,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,APOL1,1
GO:0010811,positive regulation of cell-substrate adhesion,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,UTRN,1
GO:0032479,regulation of type I interferon production,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,SYK,1
GO:0032606,type I interferon production,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,SYK,1
GO:0034502,protein localization to chromosome,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,LEF1,1
GO:0043244,regulation of protein-containing complex disassembly,1/137,124/18888,0.008064516129032258,1.111843654344243,0.10680437326789213,0.5957200048405527,0.6245748728180579,0.4400932831507527,TNF,1
GO:0072676,lymphocyte migration,1/137,125/18888,0.008,1.1029489051094892,0.09870863725215288,0.5986717400428998,0.6274540352372701,0.4421220231736713,CXCL12,1
GO:0007018,microtubule-based movement,3/137,426/18888,0.007042253521126761,0.9709057263287757,-0.051916152887507366,0.6002019685736338,0.628841883998191,0.44309994102514466,NEFH/KIF17/MAP2,3
GO:0002758,innate immune response-activating signaling pathway,2/137,278/18888,0.007194244604316547,0.9918605261775981,-0.011686248013962513,0.6014271695032528,0.629876346019838,0.44382885249311205,SYK/TNF,2
GO:0001578,microtubule bundle formation,1/137,126/18888,0.007936507936507936,1.0941953423705248,0.09067857623641586,0.6016020801598387,0.629876346019838,0.44382885249311205,TPPP,1
GO:0003206,cardiac chamber morphogenesis,1/137,127/18888,0.007874015748031496,1.0855796310132766,0.08271301185596858,0.6045111791374583,0.6324882134821813,0.44566924885979736,NKX2-5,1
GO:0070585,protein localization to mitochondrion,1/137,127/18888,0.007874015748031496,1.0855796310132766,0.08271301185596858,0.6045111791374583,0.6324882134821813,0.44566924885979736,ABLIM3,1
GO:0071621,granulocyte chemotaxis,1/137,128/18888,0.0078125,1.0770985401459854,0.07481079663646731,0.6073991898222924,0.6352920929875382,0.4476449423927503,SYK,1
GO:0018105,peptidyl-serine phosphorylation,2/137,282/18888,0.0070921985815602835,0.9777915825438733,-0.032117757525319424,0.6092292446498504,0.6369878912885726,0.4488398502802489,DMD/TNF,2
GO:0031331,positive regulation of cellular catabolic process,3/137,432/18888,0.006944444444444444,0.9574209245742091,-0.07652421201742955,0.609707881862288,0.6372700189875695,0.44903864550996914,APOE/FOXO1/TNF,3
GO:0002456,T cell mediated immunity,1/137,129/18888,0.007751937984496124,1.0687489390595823,0.06697081294139391,0.6102662639691123,0.6376352747804624,0.44929601516744316,PTPRC,1
GO:0098661,inorganic anion transmembrane transport,1/137,130/18888,0.007692307692307693,1.0605277933745088,0.059191971963396095,0.6131125522486706,0.6403899758600077,0.4512370561778285,APOL1,1
GO:0000018,regulation of DNA recombination,1/137,132/18888,0.007575757575757576,1.044459190444592,0.043813501313155034,0.6187433685149679,0.6459086109058204,0.45512564395412536,PTPRC,1
GO:0051258,protein polymerization,2/137,287/18888,0.006968641114982578,0.9607568859838755,-0.057261908806858414,0.618819390002824,0.6459086109058204,0.45512564395412536,MAP2/TPPP,2
GO:0045088,regulation of innate immune response,3/137,440/18888,0.006818181818181818,0.9400132714001327,-0.10882694261152465,0.6221492646607256,0.6491622412801827,0.4574182447869951,APOE/SYK/TNF,3
GO:0045727,positive regulation of translation,1/137,134/18888,0.007462686567164179,1.0288702473036277,0.028667215043936146,0.6242928225975095,0.6511762455801773,0.458837369704181,TNF,1
GO:0038061,non-canonical NF-kappaB signal transduction,1/137,135/18888,0.007407407407407408,1.02124898621249,0.021178699046552427,0.6270374041963223,0.6535922669423414,0.4605397673184809,TNF,1
GO:0072175,epithelial tube formation,1/137,135/18888,0.007407407407407408,1.02124898621249,0.021178699046552427,0.6270374041963223,0.6535922669423414,0.4605397673184809,LMO4,1
GO:0007586,digestion,1/137,136/18888,0.007352941176470588,1.0137398024903392,0.013745346860373708,0.6297620816146079,0.6562082188759929,0.4623830417202365,AKR1C1,1
GO:0000280,nuclear division,3/137,446/18888,0.006726457399103139,0.9273673529508036,-0.1326859228500058,0.6313038011540789,0.6575901710314842,0.4633568046552123,TNF/IGF2/CDKN1C,3
GO:0018209,peptidyl-serine modification,2/137,294/18888,0.006802721088435374,0.9378817220318785,-0.09175636842116228,0.6319429943673072,0.6580313950218428,0.4636677036730444,DMD/TNF,2
GO:1904375,regulation of protein localization to cell periphery,1/137,137/18888,0.0072992700729927005,1.00634024188822,0.006366246502300884,0.6324669981471802,0.658352414169575,0.4638939029276546,TNF,1
GO:0010212,response to ionizing radiation,1/137,138/18888,0.007246376811594203,0.9990479212948271,-9.594919060891575e-4,0.6351522960648291,0.6604718254139211,0.46538730058654926,PTPRC,1
GO:0030048,actin filament-based movement,1/137,138/18888,0.007246376811594203,0.9990479212948271,-9.594919060891575e-4,0.6351522960648291,0.6604718254139211,0.46538730058654926,GJA1,1
GO:0070555,response to interleukin-1,1/137,138/18888,0.007246376811594203,0.9990479212948271,-9.594919060891575e-4,0.6351522960648291,0.6604718254139211,0.46538730058654926,TRIM63,1
GO:0043401,steroid hormone mediated signaling pathway,1/137,139/18888,0.007194244604316547,0.9918605261775981,-0.008232736836173888,0.6378181166215822,0.6630180149622169,0.467181418420297,NR4A3,1
GO:0002218,activation of innate immune response,2/137,298/18888,0.006711409395973154,0.925292705628766,-0.11111200951543562,0.6392842181354492,0.6643157758765377,0.46809585780360297,SYK/TNF,2
GO:0008360,regulation of cell shape,1/137,140/18888,0.007142857142857143,0.9847758081334723,-0.01545433602294337,0.6404646000619172,0.6650894724018276,0.4686410264595895,ITGA7,1
GO:0032388,positive regulation of intracellular transport,1/137,140/18888,0.007142857142857143,0.9847758081334723,-0.01545433602294337,0.6404646000619172,0.6650894724018276,0.4686410264595895,MAP2,1
GO:0072594,establishment of protein localization to organelle,3/137,454/18888,0.006607929515418502,0.9110260780089392,-0.16402514353499253,0.6432726442814249,0.6677782688254793,0.4705356291682604,SYK/IL33/ABLIM3,3
GO:0051054,positive regulation of DNA metabolic process,2/137,301/18888,0.006644518272425249,0.9160705191939278,-0.1254650291083457,0.644715027305884,0.6688564933397323,0.4712953769376675,TNF/PTPRC,2
GO:1901987,regulation of cell cycle phase transition,3/137,455/18888,0.006593406593406593,0.909023822892436,-0.16790550183198702,0.6447496079310263,0.6688564933397323,0.4712953769376675,CDKN1C/SIX3/CDKN2A,3
GO:0001909,leukocyte mediated cytotoxicity,1/137,144/18888,0.006944444444444444,0.9574209245742091,-0.043840539699014254,0.6508599326140707,0.6745074751572645,0.4752772200270026,PTPRC,1
GO:0034763,negative regulation of transmembrane transport,1/137,144/18888,0.006944444444444444,0.9574209245742091,-0.043840539699014254,0.6508599326140707,0.6745074751572645,0.4752772200270026,TNF,1
GO:0046887,positive regulation of hormone secretion,1/137,144/18888,0.006944444444444444,0.9574209245742091,-0.043840539699014254,0.6508599326140707,0.6745074751572645,0.4752772200270026,SPP1,1
GO:0071333,cellular response to glucose stimulus,1/137,145/18888,0.006896551724137931,0.9508180216461113,-0.05081594421877236,0.6534117993037778,0.6769222034878242,0.476978706534326,PTPRN,1
GO:0007224,smoothened signaling pathway,1/137,146/18888,0.00684931506849315,0.9443055694430557,-0.05774438839622047,0.6559451495409536,0.678625286914912,0.4781787477295872,PRRX1,1
GO:0030177,positive regulation of Wnt signaling pathway,1/137,146/18888,0.00684931506849315,0.9443055694430557,-0.05774438839622047,0.6559451495409536,0.678625286914912,0.4781787477295872,LEF1,1
GO:0046467,membrane lipid biosynthetic process,1/137,146/18888,0.00684931506849315,0.9443055694430557,-0.05774438839622047,0.6559451495409536,0.678625286914912,0.4781787477295872,B4GALT6,1
GO:0098656,monoatomic anion transmembrane transport,1/137,146/18888,0.00684931506849315,0.9443055694430557,-0.05774438839622047,0.6559451495409536,0.678625286914912,0.4781787477295872,APOL1,1
GO:0006119,oxidative phosphorylation,1/137,148/18888,0.006756756756756757,0.9315446833695009,-0.07146325686045357,0.6609568332055231,0.6833469698317264,0.4815057802877206,TNF,1
GO:0071331,cellular response to hexose stimulus,1/137,148/18888,0.006756756756756757,0.9315446833695009,-0.07146325686045357,0.6609568332055231,0.6833469698317264,0.4815057802877206,PTPRN,1
GO:0007015,actin filament organization,3/137,467/18888,0.006423982869379015,0.8856656090279623,-0.2138495194008694,0.6621400160199922,0.6843384114097584,0.4822043783231483,SHANK1/CXCL12/TF,3
GO:0035148,tube formation,1/137,149/18888,0.006711409395973154,0.925292705628766,-0.07825507167375784,0.6634354305294742,0.6854451367555705,0.4829842085919951,LMO4,1
GO:0071326,cellular response to monosaccharide stimulus,1/137,150/18888,0.006666666666666667,0.9191240875912409,-0.08500270813315451,0.6658960392074966,0.6877545555537325,0.484611490996853,PTPRN,1
GO:0010508,positive regulation of autophagy,1/137,152/18888,0.006578947368421052,0.9070303495966192,-0.09836806077566874,0.6707638081036782,0.692547747744393,0.48798891103048736,FOXO1,1
GO:0008064,regulation of actin polymerization or depolymerization,1/137,154/18888,0.006493506493506494,0.8952507346667931,-0.1115644027936087,0.6755611656207513,0.6965583369846395,0.4908148866867691,CXCL12,1
GO:0009411,response to UV,1/137,154/18888,0.006493506493506494,0.8952507346667931,-0.1115644027936087,0.6755611656207513,0.6965583369846395,0.4908148866867691,COL6A3,1
GO:0015748,organophosphate ester transport,1/137,154/18888,0.006493506493506494,0.8952507346667931,-0.1115644027936087,0.6755611656207513,0.6965583369846395,0.4908148866867691,APOE,1
GO:0030010,establishment of cell polarity,1/137,154/18888,0.006493506493506494,0.8952507346667931,-0.1115644027936087,0.6755611656207513,0.6965583369846395,0.4908148866867691,GJA1,1
GO:0030832,regulation of actin filament length,1/137,157/18888,0.006369426751592357,0.878144032730485,-0.13105261840424431,0.6826273884089402,0.7036064807241086,0.4957812099466627,CXCL12,1
GO:0016052,carbohydrate catabolic process,1/137,158/18888,0.006329113924050633,0.8725861591056084,-0.13746933105865528,0.6849486765295942,0.7050466646773429,0.4967960046684871,CBFA2T3,1
GO:0021915,neural tube development,1/137,158/18888,0.006329113924050633,0.8725861591056084,-0.13746933105865528,0.6849486765295942,0.7050466646773429,0.4967960046684871,LMO4,1
GO:0098754,detoxification,1/137,158/18888,0.006329113924050633,0.8725861591056084,-0.13746933105865528,0.6849486765295942,0.7050466646773429,0.4967960046684871,APOE,1
GO:1905039,carboxylic acid transmembrane transport,1/137,158/18888,0.006329113924050633,0.8725861591056084,-0.13746933105865528,0.6849486765295942,0.7050466646773429,0.4967960046684871,TNF,1
GO:1903825,organic acid transmembrane transport,1/137,159/18888,0.006289308176100629,0.8670981958407933,-0.14384729540025265,0.6872531095950212,0.7071802058273785,0.4982993586622522,TNF,1
GO:0006605,protein targeting,2/137,327/18888,0.0061162079510703364,0.8432331078818724,-0.24443145693346885,0.6891208368439987,0.7088630920282724,0.49948516831543094,AKAP6/ABLIM3,2
GO:0071322,cellular response to carbohydrate stimulus,1/137,161/18888,0.006211180124223602,0.8563267896812802,-0.15648913342407844,0.6918118956607835,0.7111518711878447,0.5010979074418042,PTPRN,1
GO:1902600,proton transmembrane transport,1/137,161/18888,0.006211180124223602,0.8563267896812802,-0.15648913342407844,0.6918118956607835,0.7111518711878447,0.5010979074418042,SLC18A3,1
GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,1/137,163/18888,0.006134969325153374,0.8458197125072769,-0.16898233114230304,0.6963047081515458,0.7148072550550009,0.5036735952532824,TNF,1
GO:0007292,female gamete generation,1/137,163/18888,0.006134969325153374,0.8458197125072769,-0.16898233114230304,0.6963047081515458,0.7148072550550009,0.5036735952532824,NRIP1,1
GO:0034250,positive regulation of amide metabolic process,1/137,163/18888,0.006134969325153374,0.8458197125072769,-0.16898233114230304,0.6963047081515458,0.7148072550550009,0.5036735952532824,TNF,1
GO:0051017,actin filament bundle assembly,1/137,163/18888,0.006134969325153374,0.8458197125072769,-0.16898233114230304,0.6963047081515458,0.7148072550550009,0.5036735952532824,SHANK1,1
GO:0048285,organelle fission,3/137,493/18888,0.006085192697768763,0.8389570779230393,-0.30970253663457786,0.6977042139518133,0.7158243936068713,0.5043903001099669,TNF/IGF2/CDKN1C,3
GO:0019362,pyridine nucleotide metabolic process,1/137,164/18888,0.006097560975609756,0.8406622752358911,-0.17517445543033125,0.6985266710344955,0.7158243936068713,0.5043903001099669,CBFA2T3,1
GO:0046496,nicotinamide nucleotide metabolic process,1/137,164/18888,0.006097560975609756,0.8406622752358911,-0.17517445543033125,0.6985266710344955,0.7158243936068713,0.5043903001099669,CBFA2T3,1
GO:1902850,microtubule cytoskeleton organization involved in mitosis,1/137,164/18888,0.006097560975609756,0.8406622752358911,-0.17517445543033125,0.6985266710344955,0.7158243936068713,0.5043903001099669,GJA1,1
GO:0006913,nucleocytoplasmic transport,2/137,333/18888,0.006006006006006006,0.8280397185506675,-0.2706134272220755,0.6987027747558551,0.7158243936068713,0.5043903001099669,SYK/IL33,2
GO:0051169,nuclear transport,2/137,333/18888,0.006006006006006006,0.8280397185506675,-0.2706134272220755,0.6987027747558551,0.7158243936068713,0.5043903001099669,SYK/IL33,2
GO:0006665,sphingolipid metabolic process,1/137,167/18888,0.005988023952095809,0.8255605577166835,-0.19353876269200604,0.7050961902231372,0.7218898264210045,0.5086641772015288,B4GALT6,1
GO:0061572,actin filament bundle organization,1/137,167/18888,0.005988023952095809,0.8255605577166835,-0.19353876269200604,0.7050961902231372,0.7218898264210045,0.5086641772015288,SHANK1,1
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,1/137,168/18888,0.005952380952380952,0.8206465067778935,-0.19959107405320584,0.7072542919238707,0.7238565053493136,0.5100499553109774,DSCAML1,1
GO:0006310,DNA recombination,2/137,339/18888,0.0058997050147492625,0.8133841483108326,-0.29635870373707546,0.7080409705526849,0.7244187201229615,0.5104461078882564,LEF1/PTPRC,2
GO:0015698,inorganic anion transport,1/137,169/18888,0.005917159763313609,0.8157906102880836,-0.20560958226139608,0.7093967151079748,0.7255625919938132,0.5112521126589503,APOL1,1
GO:0072524,pyridine-containing compound metabolic process,1/137,170/18888,0.0058823529411764705,0.8109918419922714,-0.21159472942273935,0.7115235728477154,0.7274941187039288,0.5126131215120806,CBFA2T3,1
GO:0006820,monoatomic anion transport,1/137,171/18888,0.005847953216374269,0.8062491996414394,-0.21754694908064345,0.7136349774058873,0.7294085569466738,0.5139620893433312,APOL1,1
GO:0022900,electron transport chain,1/137,175/18888,0.005714285714285714,0.7878206465067779,-0.24103493581755242,0.7219282810682608,0.7373912696855194,0.5195869365963703,MAOB,1
GO:1902905,positive regulation of supramolecular fiber organization,1/137,175/18888,0.005714285714285714,0.7878206465067779,-0.24103493581755242,0.7219282810682608,0.7373912696855194,0.5195869365963703,APOE,1
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,1/137,177/18888,0.005649717514124294,0.7789187182976617,-0.25259204228776244,0.7259850741061007,0.7407911889574788,0.5219826167621333,CDKN1C,1
GO:0030216,keratinocyte differentiation,1/137,177/18888,0.005649717514124294,0.7789187182976617,-0.25259204228776244,0.7259850741061007,0.7407911889574788,0.5219826167621333,AKR1C3,1
GO:0071453,cellular response to oxygen levels,1/137,177/18888,0.005649717514124294,0.7789187182976617,-0.25259204228776244,0.7259850741061007,0.7407911889574788,0.5219826167621333,FOXO1,1
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,1/137,180/18888,0.005555555555555556,0.7659367396593674,-0.2697027526103344,0.7319603552653173,0.7463892429902267,0.5259271654235473,CDKN1C,1
GO:1905475,regulation of protein localization to membrane,1/137,180/18888,0.005555555555555556,0.7659367396593674,-0.2697027526103344,0.7319603552653173,0.7463892429902267,0.5259271654235473,TNF,1
GO:1901990,regulation of mitotic cell cycle phase transition,2/137,356/18888,0.0056179775280898875,0.7745427704420569,-0.36707734011168114,0.7332038745533832,0.7474075568259604,0.526644698418789,CDKN1C/CDKN2A,2
GO:2000045,regulation of G1/S transition of mitotic cell cycle,1/137,185/18888,0.005405405405405406,0.7452357466956008,-0.29764478309176673,0.7416330463176295,0.7557475984512204,0.5325213298047331,CDKN2A,1
GO:0010639,negative regulation of organelle organization,2/137,365/18888,0.005479452054794521,0.7554444555544446,-0.4032717864087155,0.7457703785629092,0.7594565216463125,0.5351347429548929,SHANK1/MAP2,2
GO:0045089,positive regulation of innate immune response,2/137,365/18888,0.005479452054794521,0.7554444555544446,-0.4032717864087155,0.7457703785629092,0.7594565216463125,0.5351347429548929,SYK/TNF,2
GO:2001242,regulation of intrinsic apoptotic signaling pathway,1/137,190/18888,0.005263157894736842,0.7256242796772954,-0.324903550537843,0.7509591372690292,0.7644854192611998,0.5386782477583746,CXCL12,1
GO:0002695,negative regulation of leukocyte activation,1/137,192/18888,0.005208333333333333,0.718065693430657,-0.3356245701050805,0.754595302704611,0.7676749546181576,0.5409256854124632,PTPRC,1
GO:0071897,DNA biosynthetic process,1/137,192/18888,0.005208333333333333,0.718065693430657,-0.3356245701050805,0.754595302704611,0.7676749546181576,0.5409256854124632,TNF,1
GO:0044282,small molecule catabolic process,2/137,373/18888,0.005361930294906166,0.7392418935050195,-0.43477036441258193,0.7565150097197769,0.7693714793951214,0.5421211051956379,GAD1/AKR1C3,2
GO:0030258,lipid modification,1/137,194/18888,0.005154639175257732,0.7106629543231243,-0.3462448682170411,0.7581787595588712,0.7708066536221435,0.5431323699213766,NR4A3,1
GO:0008154,actin polymerization or depolymerization,1/137,196/18888,0.00510204081632653,0.7034112915239087,-0.3567667064809684,0.7617102663398954,0.7738814024198937,0.5452989256893988,CXCL12,1
GO:0009755,hormone-mediated signaling pathway,1/137,196/18888,0.00510204081632653,0.7034112915239087,-0.3567667064809684,0.7617102663398954,0.7738814024198937,0.5452989256893988,NR4A3,1
GO:0007051,spindle organization,1/137,197/18888,0.005076142131979695,0.699840675830894,-0.3619913892495986,0.7634567725196212,0.7753976937537052,0.5463673478439744,TPPP,1
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/137,198/18888,0.005050505050505051,0.6963061269630614,-0.3671922712332497,0.7651905707200819,0.7769000737983001,0.5474259677070866,GREM2,1
GO:0098739,import across plasma membrane,1/137,203/18888,0.0049261083743842365,0.6791557297472224,-0.3928486930133133,0.7736721317879534,0.7852501982762998,0.5533097037588744,TNF,1
GO:0002833,positive regulation of response to biotic stimulus,2/137,390/18888,0.005128205128205128,0.7070185289163391,-0.49973483987714923,0.7780610330549559,0.7894422449746428,0.556263539519623,SYK/TNF,2
GO:0046474,glycerophospholipid biosynthetic process,1/137,210/18888,0.004761904761904762,0.656517205422315,-0.427837656110518,0.785037689211705,0.796256240436731,0.5610648752197839,CHAT,1
GO:0009152,purine ribonucleotide biosynthetic process,1/137,211/18888,0.004739336492890996,0.6534057494724462,-0.4327514973475567,0.786614401738635,0.7973255244458033,0.5618183232540443,NPR1,1
GO:1902806,regulation of cell cycle G1/S phase transition,1/137,211/18888,0.004739336492890996,0.6534057494724462,-0.4327514973475567,0.786614401738635,0.7973255244458033,0.5618183232540443,CDKN2A,1
GO:0031032,actomyosin structure organization,1/137,215/18888,0.004651162790697674,0.6412493634357495,-0.4522040197072904,0.7928072675756475,0.8033359165474356,0.5660534170885049,NKX2-5,1
GO:0046034,ATP metabolic process,1/137,220/18888,0.004545454545454545,0.626675514266755,-0.4760783988615079,0.8002979990219268,0.8106569840739861,0.5712120502390681,CBFA2T3,1
GO:0140694,non-membrane-bounded organelle assembly,2/137,413/18888,0.004842615012106538,0.6676446156837101,-0.5837341185931392,0.804565591339388,0.8147094176402828,0.5740675106018824,TNF/NKX2-5,2
GO:0009260,ribonucleotide biosynthetic process,1/137,226/18888,0.004424778761061947,0.6100381112331245,-0.5041117834731006,0.8089327648695326,0.8188599662957922,0.5769921056571371,NPR1,1
GO:0043547,positive regulation of GTPase activity,1/137,230/18888,0.004347826086956522,0.5994287527768962,-0.5224451515314097,0.8144823165667552,0.8242042540324062,0.5807578433428314,ODAM,1
GO:0046390,ribose phosphate biosynthetic process,1/137,233/18888,0.004291845493562232,0.5917107860029448,-0.5360160545717022,0.8185391984013117,0.8280350127679162,0.5834571052924236,NPR1,1
GO:0000082,G1/S transition of mitotic cell cycle,1/137,234/18888,0.004273504273504274,0.5891821074302827,-0.5405064112311735,0.8198718239611628,0.8288336557566971,0.5840198519386537,CDKN2A,1
GO:0034249,negative regulation of amide metabolic process,1/137,234/18888,0.004273504273504274,0.5891821074302827,-0.5405064112311735,0.8198718239611628,0.8288336557566971,0.5840198519386537,APOE,1
GO:0009205,purine ribonucleoside triphosphate metabolic process,1/137,244/18888,0.004098360655737705,0.5650352997487137,-0.5845328673845479,0.8326751521015957,0.8414982000708842,0.592943651357114,CBFA2T3,1
GO:0007179,transforming growth factor beta receptor signaling pathway,1/137,245/18888,0.004081632653061225,0.5627290332191272,-0.5888508983294501,0.8339046899776997,0.8424618053002118,0.5936226351066884,CDKN1C,1
GO:0009144,purine nucleoside triphosphate metabolic process,1/137,250/18888,0.004,0.5514744525547446,-0.6102209201095876,0.839919129951106,0.8476961589321348,0.5973109100842765,CBFA2T3,1
GO:0016054,organic acid catabolic process,1/137,250/18888,0.004,0.5514744525547446,-0.6102209201095876,0.839919129951106,0.8476961589321348,0.5973109100842765,GAD1,1
GO:0046395,carboxylic acid catabolic process,1/137,250/18888,0.004,0.5514744525547446,-0.6102209201095876,0.839919129951106,0.8476961589321348,0.5973109100842765,GAD1,1
GO:0009199,ribonucleoside triphosphate metabolic process,1/137,251/18888,0.00398406374501992,0.5492773431820165,-0.6144517770665385,0.8410958162477418,0.8486031177481348,0.5979499791541144,CBFA2T3,1
GO:0032984,protein-containing complex disassembly,1/137,252/18888,0.003968253968253968,0.5470976711852624,-0.6186685370670381,0.8422639158975813,0.8492265229703172,0.5983892482680411,TNF,1
GO:0044772,mitotic cell cycle phase transition,2/137,451/18888,0.004434589800443459,0.6113907456261026,-0.7139796582839697,0.8422702113470348,0.8492265229703172,0.5983892482680411,CDKN1C/CDKN2A,2
GO:0008654,phospholipid biosynthetic process,1/137,253/18888,0.003952569169960474,0.5449352297971783,-0.6228713193344959,0.8434234911026699,0.8501084857481337,0.5990107044158919,CHAT,1
GO:0006164,purine nucleotide biosynthetic process,1/137,256/18888,0.00390625,0.5385492700729927,-0.6353969693089893,0.8468516853798069,0.8532820547306605,0.6012468917068149,NPR1,1
GO:0002221,pattern recognition receptor signaling pathway,1/137,259/18888,0.003861003861003861,0.5323112476397148,-0.6478009685805055,0.8502053563509728,0.8563784645489007,0.603428710448163,TNF,1
GO:0044843,cell cycle G1/S phase transition,1/137,262/18888,0.003816793893129771,0.5262160806820081,-0.6600863004866974,0.8534861123759195,0.8593994110759836,0.6055573556005499,CDKN2A,1
GO:0072522,purine-containing compound biosynthetic process,1/137,264/18888,0.003787878787878788,0.522229595222296,-0.6682120189264654,0.855633553386107,0.861277574186807,0.6068807629384171,NPR1,1
GO:0009141,nucleoside triphosphate metabolic process,1/137,266/18888,0.0037593984962406013,0.5183030569123538,-0.6762871012000142,0.8577497459417951,0.8631230546041406,0.608181141117562,CBFA2T3,1
GO:0034976,response to endoplasmic reticulum stress,1/137,269/18888,0.0037174721189591076,0.512522725422625,-0.688306538712764,0.8608664296236058,0.8659737452904566,0.6101898191447894,MAP3K5,1
GO:0043488,regulation of mRNA stability,1/137,273/18888,0.003663003663003663,0.5050132349402422,-0.7041625873995825,0.864916797465404,0.8697614714545018,0.6128587591162126,VIP,1
GO:0043487,regulation of RNA stability,1/137,285/18888,0.0035087719298245615,0.4837495197848636,-0.7506214355694437,0.8763787889732804,0.8809973860166178,0.6207759052327896,VIP,1
GO:0061013,regulation of mRNA catabolic process,1/137,290/18888,0.0034482758620689655,0.47540901082305564,-0.7695135306416347,0.880864693286393,0.8852153585479328,0.6237480090754731,VIP,1
GO:0009165,nucleotide biosynthetic process,1/137,293/18888,0.0034129692832764505,0.4705413417702598,-0.7807236409731146,0.8834782753381244,0.8875496037959039,0.6253927849055085,NPR1,1
GO:1901293,nucleoside phosphate biosynthetic process,1/137,295/18888,0.003389830508474576,0.46735123097859704,-0.7881461489690786,0.8851889606137758,0.888975553732558,0.6263975499329572,NPR1,1
GO:0043087,regulation of GTPase activity,1/137,298/18888,0.003355704697986577,0.462646352814383,-0.7992050048359424,0.8877083495524896,0.8912124614586179,0.6279737389666676,ODAM,1
GO:0071560,cellular response to transforming growth factor beta stimulus,1/137,302/18888,0.0033112582781456954,0.45651858655194083,-0.8138132530502047,0.8909823560002958,0.8942052451538648,0.6300825397838676,CDKN1C,1
GO:0006650,glycerophospholipid metabolic process,1/137,307/18888,0.003257328990228013,0.4490834304191731,-0.8318596087533141,0.8949418988581558,0.8978838511883931,0.6326745905973259,CHAT,1
GO:0071559,response to transforming growth factor beta,1/137,309/18888,0.003236245954692557,0.4461767415491461,-0.839013250486722,0.8964854415945394,0.8991368937714538,0.6335575201679935,CDKN1C,1
GO:0048872,homeostasis of number of cells,1/137,322/18888,0.003105590062111801,0.4281633948406401,-0.8846475358967756,0.905984001810841,0.9083650372952321,0.6400599335014691,CARD11,1
GO:0031647,regulation of protein stability,1/137,326/18888,0.003067484662576687,0.42290985625363847,-0.8983997650003486,0.9087286627467149,0.910817694155328,0.6417881455333294,TF,1
GO:0006402,mRNA catabolic process,1/137,348/18888,0.0028735632183908046,0.3961741756858797,-0.971797990776297,0.9224620676471545,0.9242791301572933,0.6512734575813445,VIP,1
GO:0010506,regulation of autophagy,1/137,357/18888,0.0028011204481792717,0.38618659142489115,-1.0008076309241067,0.9274699456540878,0.9289918851776422,0.6545941992887918,FOXO1,1
GO:0006644,phospholipid metabolic process,1/137,383/18888,0.0026109660574412533,0.3599702692916087,-1.08164450281238,0.9402040597984578,0.9414379233939938,0.663364033073715,CHAT,1
GO:0006401,RNA catabolic process,1/137,404/18888,0.0024752475247524753,0.3412589434125894,-1.144028889314448,0.9488479175618945,0.9494701129176728,0.669023743081605,VIP,1
GO:1903311,regulation of mRNA metabolic process,1/137,404/18888,0.0024752475247524753,0.3412589434125894,-1.144028889314448,0.9488479175618945,0.9494701129176728,0.669023743081605,VIP,1
GO:0006417,regulation of translation,1/137,451/18888,0.0022172949002217295,0.3056953728130513,-1.275624228925243,0.9639569865380841,0.9642729344196109,0.6794542336411896,TNF,1
GO:0050907,detection of chemical stimulus involved in sensory perception,1/137,476/18888,0.0021008403361344537,0.28963994356866835,-1.341717496398238,0.9700918882602245,0.9700918882602245,0.6835544346125538,TRPA1,1
